id	sid	tid	token	lemma	pos
fnp-5643	1	1	fast	fast	ADJ
fnp-5643	1	2	-	-	PUNCT
fnp-5643	1	3	track	track	NOUN
fnp-5643	1	4	neuropathological	neuropathological	ADJ
fnp-5643	1	5	screening	screening	NOUN
fnp-5643	1	6	for	for	ADP
fnp-5643	1	7	neurodegenerative	neurodegenerative	ADJ
fnp-5643	1	8	diseases	disease	NOUN
fnp-5643	1	9	feel	feel	VERB
fnp-5643	1	10	free	free	ADJ
fnp-5643	1	11	to	to	PART
fnp-5643	1	12	add	add	VERB
fnp-5643	1	13	comments	comment	NOUN
fnp-5643	1	14	by	by	ADP
fnp-5643	1	15	clicking	click	VERB
fnp-5643	1	16	these	these	DET
fnp-5643	1	17	icons	icon	NOUN
fnp-5643	1	18	on	on	ADP
fnp-5643	1	19	the	the	DET
fnp-5643	1	20	sidebar	sidebar	NOUN
fnp-5643	1	21	free	free	ADJ
fnp-5643	1	22	neuropathology	neuropathology	NOUN
fnp-5643	1	23	5:16	5:16	NUM
fnp-5643	1	24	(	(	PUNCT
fnp-5643	1	25	2024	2024	NUM
fnp-5643	1	26	)	)	PUNCT
fnp-5643	1	27	original	original	ADJ
fnp-5643	1	28	paper	paper	NOUN
fnp-5643	1	29	fast	fast	ADJ
fnp-5643	1	30	-	-	PUNCT
fnp-5643	1	31	track	track	NOUN
fnp-5643	1	32	neuropathological	neuropathological	ADJ
fnp-5643	1	33	screening	screening	NOUN
fnp-5643	1	34	for	for	ADP
fnp-5643	1	35	neurodegenerative	neurodegenerative	ADJ
fnp-5643	1	36	diseases	disease	NOUN
fnp-5643	1	37	benjamin	benjamin	PROPN
fnp-5643	1	38	englert1,2	englert1,2	PROPN
fnp-5643	1	39	,	,	PUNCT
fnp-5643	1	40	*	*	ADJ
fnp-5643	1	41	,	,	PUNCT
fnp-5643	1	42	sigrun	sigrun	PROPN
fnp-5643	1	43	roeber1	roeber1	PROPN
fnp-5643	1	44	,	,	PUNCT
fnp-5643	1	45	thomas	thomas	PROPN
fnp-5643	1	46	arzberger1,3	arzberger1,3	PROPN
fnp-5643	1	47	,	,	PUNCT
fnp-5643	1	48	viktoria	viktoria	PROPN
fnp-5643	1	49	ruf1	ruf1	PROPN
fnp-5643	1	50	,	,	PUNCT
fnp-5643	1	51	otto	otto	PROPN
fnp-5643	1	52	windl1	windl1	PROPN
fnp-5643	1	53	,	,	PUNCT
fnp-5643	1	54	jochen	jochen	PROPN
fnp-5643	1	55	herms1,2,4	herms1,2,4	PROPN
fnp-5643	1	56	center	center	PROPN
fnp-5643	1	57	for	for	ADP
fnp-5643	1	58	neuropathology	neuropathology	NOUN
fnp-5643	1	59	and	and	CCONJ
fnp-5643	1	60	prion	prion	NOUN
fnp-5643	1	61	research	research	NOUN
fnp-5643	1	62	,	,	PUNCT
fnp-5643	1	63	faculty	faculty	NOUN
fnp-5643	1	64	of	of	ADP
fnp-5643	1	65	medicine	medicine	NOUN
fnp-5643	1	66	,	,	PUNCT
fnp-5643	1	67	lmu	lmu	PROPN
fnp-5643	1	68	munich	munich	PROPN
fnp-5643	1	69	,	,	PUNCT
fnp-5643	1	70	munich	munich	PROPN
fnp-5643	1	71	,	,	PUNCT
fnp-5643	1	72	germany	germany	PROPN
fnp-5643	1	73	german	german	ADJ
fnp-5643	1	74	center	center	NOUN
fnp-5643	1	75	for	for	ADP
fnp-5643	1	76	neurodegenerative	neurodegenerative	ADJ
fnp-5643	1	77	diseases	disease	NOUN
fnp-5643	1	78	(	(	PUNCT
fnp-5643	1	79	dzne	dzne	NOUN
fnp-5643	1	80	)	)	PUNCT
fnp-5643	1	81	,	,	PUNCT
fnp-5643	1	82	munich	munich	PROPN
fnp-5643	1	83	,	,	PUNCT
fnp-5643	1	84	germany	germany	PROPN
fnp-5643	1	85	department	department	PROPN
fnp-5643	1	86	of	of	ADP
fnp-5643	1	87	psychiatry	psychiatry	NOUN
fnp-5643	1	88	and	and	CCONJ
fnp-5643	1	89	psychotherapy	psychotherapy	NOUN
fnp-5643	1	90	,	,	PUNCT
fnp-5643	1	91	lmu	lmu	NOUN
fnp-5643	1	92	university	university	NOUN
fnp-5643	1	93	hospital	hospital	NOUN
fnp-5643	1	94	,	,	PUNCT
fnp-5643	1	95	lmu	lmu	PROPN
fnp-5643	1	96	munich	munich	PROPN
fnp-5643	1	97	,	,	PUNCT
fnp-5643	1	98	munich	munich	PROPN
fnp-5643	1	99	,	,	PUNCT
fnp-5643	1	100	germany	germany	PROPN
fnp-5643	1	101	munich	munich	PROPN
fnp-5643	1	102	cluster	cluster	PROPN
fnp-5643	1	103	of	of	ADP
fnp-5643	1	104	systems	system	NOUN
fnp-5643	1	105	neurology	neurology	NOUN
fnp-5643	1	106	(	(	PUNCT
fnp-5643	1	107	synergy	synergy	NOUN
fnp-5643	1	108	)	)	PUNCT
fnp-5643	1	109	,	,	PUNCT
fnp-5643	1	110	munich	munich	PROPN
fnp-5643	1	111	,	,	PUNCT
fnp-5643	1	112	germany	germany	PROPN
fnp-5643	1	113	*	*	PUNCT
fnp-5643	1	114	present	present	ADJ
fnp-5643	1	115	address	address	NOUN
fnp-5643	1	116	:	:	PUNCT
fnp-5643	1	117	department	department	NOUN
fnp-5643	1	118	of	of	ADP
fnp-5643	1	119	pathology	pathology	PROPN
fnp-5643	1	120	,	,	PUNCT
fnp-5643	1	121	university	university	PROPN
fnp-5643	1	122	of	of	ADP
fnp-5643	1	123	helsinki	helsinki	PROPN
fnp-5643	1	124	and	and	CCONJ
fnp-5643	1	125	hus	hus	CCONJ
fnp-5643	1	126	diagnostic	diagnostic	ADJ
fnp-5643	1	127	center	center	NOUN
fnp-5643	1	128	,	,	PUNCT
fnp-5643	1	129	helsinki	helsinki	PROPN
fnp-5643	1	130	university	university	PROPN
fnp-5643	1	131	hospital	hospital	NOUN
fnp-5643	1	132	,	,	PUNCT
fnp-5643	1	133	helsinki	helsinki	PROPN
fnp-5643	1	134	,	,	PUNCT
fnp-5643	1	135	finland	finland	PROPN
fnp-5643	1	136	corresponding	corresponding	ADJ
fnp-5643	1	137	author	author	NOUN
fnp-5643	1	138	:	:	PUNCT
fnp-5643	1	139	jochen	jochen	PROPN
fnp-5643	1	140	herms	herms	PROPN
fnp-5643	1	141	·	·	PUNCT
fnp-5643	1	142	center	center	VERB
fnp-5643	1	143	for	for	ADP
fnp-5643	1	144	neuropathology	neuropathology	NOUN
fnp-5643	1	145	and	and	CCONJ
fnp-5643	1	146	prion	prion	NOUN
fnp-5643	1	147	research	research	NOUN
fnp-5643	1	148	·	·	PUNCT
fnp-5643	1	149	faculty	faculty	NOUN
fnp-5643	1	150	of	of	ADP
fnp-5643	1	151	medicine	medicine	NOUN
fnp-5643	1	152	·	·	PUNCT
fnp-5643	1	153	lmu	lmu	PROPN
fnp-5643	1	154	munich	munich	PROPN
fnp-5643	1	155	·	·	PUNCT
fnp-5643	1	156	feodor	feodor	PROPN
fnp-5643	1	157	-	-	PUNCT
fnp-5643	1	158	lynen	lynen	NOUN
fnp-5643	1	159	-	-	PUNCT
fnp-5643	1	160	strasse	strasse	NOUN
fnp-5643	1	161	23	23	NUM
fnp-5643	1	162	·	·	SYM
fnp-5643	1	163	81377	81377	NUM
fnp-5643	1	164	munich	munich	PROPN
fnp-5643	1	165	·	·	PUNCT
fnp-5643	1	166	germany	germany	PROPN
fnp-5643	1	167	jochen.herms@med.uni-muenchen.de	jochen.herms@med.uni-muenchen.de	PROPN
fnp-5643	1	168	submitted	submit	VERB
fnp-5643	1	169	:	:	PUNCT
fnp-5643	1	170	07	07	NUM
fnp-5643	1	171	june	june	PROPN
fnp-5643	1	172	2024	2024	NUM
fnp-5643	1	173	accepted	accept	VERB
fnp-5643	1	174	:	:	PUNCT
fnp-5643	1	175	21	21	NUM
fnp-5643	1	176	july	july	PROPN
fnp-5643	1	177	2024	2024	NUM
fnp-5643	1	178	copyedited	copyedit	VERB
fnp-5643	1	179	by	by	ADP
fnp-5643	1	180	:	:	PUNCT
fnp-5643	1	181	georg	georg	NOUN
fnp-5643	1	182	haase	haase	NOUN
fnp-5643	1	183	published	publish	VERB
fnp-5643	1	184	:	:	PUNCT
fnp-5643	1	185	06	06	NUM
fnp-5643	1	186	august	august	PROPN
fnp-5643	1	187	2024	2024	NUM
fnp-5643	1	188	https://doi.org/10.17879/freeneuropathology-2024-5643	https://doi.org/10.17879/freeneuropathology-2024-5643	PROPN
fnp-5643	1	189	keywords	keyword	NOUN
fnp-5643	1	190	:	:	PUNCT
fnp-5643	1	191	neuropathology	neuropathology	NOUN
fnp-5643	1	192	,	,	PUNCT
fnp-5643	1	193	dementia	dementia	NOUN
fnp-5643	1	194	,	,	PUNCT
fnp-5643	1	195	movement	movement	NOUN
fnp-5643	1	196	disorders	disorder	NOUN
fnp-5643	1	197	,	,	PUNCT
fnp-5643	1	198	prion	prion	NOUN
fnp-5643	1	199	disease	disease	NOUN
fnp-5643	1	200	,	,	PUNCT
fnp-5643	1	201	alzheimer	alzheimer	PROPN
fnp-5643	1	202	disease	disease	PROPN
fnp-5643	1	203	,	,	PUNCT
fnp-5643	1	204	lewy	lewy	PROPN
fnp-5643	1	205	body	body	NOUN
fnp-5643	1	206	disease	disease	NOUN
fnp-5643	1	207	abstract	abstract	ADJ
fnp-5643	1	208	background	background	NOUN
fnp-5643	1	209	:	:	PUNCT
fnp-5643	1	210	the	the	DET
fnp-5643	1	211	postmortem	postmortem	NOUN
fnp-5643	1	212	diagnostic	diagnostic	NOUN
fnp-5643	1	213	of	of	ADP
fnp-5643	1	214	individuals	individual	NOUN
fnp-5643	1	215	having	having	AUX
fnp-5643	1	216	suffered	suffer	VERB
fnp-5643	1	217	presumptive	presumptive	ADJ
fnp-5643	1	218	neurodegenerative	neurodegenerative	ADJ
fnp-5643	1	219	disease	disease	NOUN
fnp-5643	1	220	comprises	comprise	VERB
fnp-5643	1	221	exclusion	exclusion	NOUN
fnp-5643	1	222	of	of	ADP
fnp-5643	1	223	a	a	DET
fnp-5643	1	224	prion	prion	NOUN
fnp-5643	1	225	disease	disease	NOUN
fnp-5643	1	226	,	,	PUNCT
fnp-5643	1	227	extensive	extensive	ADJ
fnp-5643	1	228	brain	brain	NOUN
fnp-5643	1	229	sampling	sampling	NOUN
fnp-5643	1	230	and	and	CCONJ
fnp-5643	1	231	histopathological	histopathological	ADJ
fnp-5643	1	232	evaluation	evaluation	NOUN
fnp-5643	1	233	,	,	PUNCT
fnp-5643	1	234	which	which	PRON
fnp-5643	1	235	are	be	AUX
fnp-5643	1	236	resource	resource	NOUN
fnp-5643	1	237	-	-	PUNCT
fnp-5643	1	238	intensive	intensive	ADJ
fnp-5643	1	239	and	and	CCONJ
fnp-5643	1	240	time	time	NOUN
fnp-5643	1	241	consuming	consume	VERB
fnp-5643	1	242	.	.	PUNCT
fnp-5643	2	1	to	to	PART
fnp-5643	2	2	exclude	exclude	VERB
fnp-5643	2	3	prion	prion	NOUN
fnp-5643	2	4	disease	disease	NOUN
fnp-5643	2	5	and	and	CCONJ
fnp-5643	2	6	to	to	PART
fnp-5643	2	7	achieve	achieve	VERB
fnp-5643	2	8	prompt	prompt	ADJ
fnp-5643	2	9	accurate	accurate	ADJ
fnp-5643	2	10	preliminary	preliminary	ADJ
fnp-5643	2	11	diagnosis	diagnosis	NOUN
fnp-5643	2	12	,	,	PUNCT
fnp-5643	2	13	we	we	PRON
fnp-5643	2	14	developed	develop	VERB
fnp-5643	2	15	a	a	DET
fnp-5643	2	16	fast	fast	ADJ
fnp-5643	2	17	-	-	PUNCT
fnp-5643	2	18	track	track	NOUN
fnp-5643	2	19	procedure	procedure	NOUN
fnp-5643	2	20	for	for	ADP
fnp-5643	2	21	the	the	DET
fnp-5643	2	22	histopathological	histopathological	ADJ
fnp-5643	2	23	assessment	assessment	NOUN
fnp-5643	2	24	of	of	ADP
fnp-5643	2	25	brains	brain	NOUN
fnp-5643	2	26	from	from	ADP
fnp-5643	2	27	patients	patient	NOUN
fnp-5643	2	28	with	with	ADP
fnp-5643	2	29	suspected	suspect	VERB
fnp-5643	2	30	neurodegenerative	neurodegenerative	ADJ
fnp-5643	2	31	disease	disease	NOUN
fnp-5643	2	32	.	.	PUNCT
fnp-5643	3	1	methods	method	NOUN
fnp-5643	3	2	:	:	PUNCT
fnp-5643	3	3	based	base	VERB
fnp-5643	3	4	on	on	ADP
fnp-5643	3	5	the	the	DET
fnp-5643	3	6	screening	screening	NOUN
fnp-5643	3	7	of	of	ADP
fnp-5643	3	8	two	two	NUM
fnp-5643	3	9	brain	brain	NOUN
fnp-5643	3	10	regions	region	NOUN
fnp-5643	3	11	(	(	PUNCT
fnp-5643	3	12	frontal	frontal	ADJ
fnp-5643	3	13	cortex	cortex	NOUN
fnp-5643	3	14	and	and	CCONJ
fnp-5643	3	15	cerebellum	cerebellum	NOUN
fnp-5643	3	16	)	)	PUNCT
fnp-5643	3	17	with	with	ADP
fnp-5643	3	18	h&e	h&e	PROPN
fnp-5643	3	19	and	and	CCONJ
fnp-5643	3	20	six	six	NUM
fnp-5643	3	21	immunohistochemical	immunohistochemical	ADJ
fnp-5643	3	22	stainings	staining	NOUN
fnp-5643	3	23	in	in	ADP
fnp-5643	3	24	133	133	NUM
fnp-5643	3	25	brain	brain	NOUN
fnp-5643	3	26	donors	donor	NOUN
fnp-5643	3	27	,	,	PUNCT
fnp-5643	3	28	a	a	DET
fnp-5643	3	29	main	main	ADJ
fnp-5643	3	30	histopathological	histopathological	ADJ
fnp-5643	3	31	diagnosis	diagnosis	NOUN
fnp-5643	3	32	was	be	AUX
fnp-5643	3	33	established	establish	VERB
fnp-5643	3	34	and	and	CCONJ
fnp-5643	3	35	compared	compare	VERB
fnp-5643	3	36	to	to	ADP
fnp-5643	3	37	the	the	DET
fnp-5643	3	38	final	final	ADJ
fnp-5643	3	39	diagnosis	diagnosis	NOUN
fnp-5643	3	40	made	make	VERB
fnp-5643	3	41	after	after	ADP
fnp-5643	3	42	a	a	DET
fnp-5643	3	43	full	full	ADJ
fnp-5643	3	44	histopathological	histopathological	ADJ
fnp-5643	3	45	work	work	NOUN
fnp-5643	3	46	-	-	PUNCT
fnp-5643	3	47	up	up	NOUN
fnp-5643	3	48	according	accord	VERB
fnp-5643	3	49	to	to	ADP
fnp-5643	3	50	our	our	PRON
fnp-5643	3	51	brain	brain	NOUN
fnp-5643	3	52	bank	bank	NOUN
fnp-5643	3	53	standard	standard	ADJ
fnp-5643	3	54	procedure	procedure	NOUN
fnp-5643	3	55	.	.	PUNCT
fnp-5643	4	1	results	result	NOUN
fnp-5643	4	2	:	:	PUNCT
fnp-5643	4	3	in	in	ADP
fnp-5643	4	4	over	over	ADP
fnp-5643	4	5	96	96	NUM
fnp-5643	4	6	 	 	SPACE
fnp-5643	4	7	%	%	NOUN
fnp-5643	4	8	of	of	ADP
fnp-5643	4	9	cases	case	NOUN
fnp-5643	4	10	there	there	PRON
fnp-5643	4	11	was	be	VERB
fnp-5643	4	12	a	a	DET
fnp-5643	4	13	concordance	concordance	NOUN
fnp-5643	4	14	between	between	ADP
fnp-5643	4	15	the	the	DET
fnp-5643	4	16	fast	fast	ADJ
fnp-5643	4	17	-	-	PUNCT
fnp-5643	4	18	track	track	NOUN
fnp-5643	4	19	and	and	CCONJ
fnp-5643	4	20	the	the	DET
fnp-5643	4	21	final	final	ADJ
fnp-5643	4	22	main	main	ADJ
fnp-5643	4	23	neuropathological	neuropathological	ADJ
fnp-5643	4	24	diagnosis	diagnosis	NOUN
fnp-5643	4	25	.	.	PUNCT
fnp-5643	5	1	a	a	DET
fnp-5643	5	2	prion	prion	NOUN
fnp-5643	5	3	disease	disease	NOUN
fnp-5643	5	4	was	be	AUX
fnp-5643	5	5	identified	identify	VERB
fnp-5643	5	6	in	in	ADP
fnp-5643	5	7	four	four	NUM
fnp-5643	5	8	cases	case	NOUN
fnp-5643	5	9	without	without	ADP
fnp-5643	5	10	prior	prior	ADJ
fnp-5643	5	11	clinical	clinical	ADJ
fnp-5643	5	12	suspicion	suspicion	NOUN
fnp-5643	5	13	of	of	ADP
fnp-5643	5	14	a	a	DET
fnp-5643	5	15	prion	prion	NOUN
fnp-5643	5	16	infection	infection	NOUN
fnp-5643	5	17	.	.	PUNCT
fnp-5643	6	1	conclusion	conclusion	NOUN
fnp-5643	6	2	:	:	PUNCT
fnp-5643	6	3	the	the	DET
fnp-5643	6	4	fast	fast	ADJ
fnp-5643	6	5	-	-	PUNCT
fnp-5643	6	6	track	track	NOUN
fnp-5643	6	7	screening	screening	NOUN
fnp-5643	6	8	approach	approach	NOUN
fnp-5643	6	9	relying	rely	VERB
fnp-5643	6	10	on	on	ADP
fnp-5643	6	11	two	two	NUM
fnp-5643	6	12	defined	define	VERB
fnp-5643	6	13	,	,	PUNCT
fnp-5643	6	14	easily	easily	ADV
fnp-5643	6	15	accessible	accessible	ADJ
fnp-5643	6	16	brain	brain	NOUN
fnp-5643	6	17	regions	region	NOUN
fnp-5643	6	18	is	be	AUX
fnp-5643	6	19	sufficient	sufficient	ADJ
fnp-5643	6	20	to	to	PART
fnp-5643	6	21	obtain	obtain	VERB
fnp-5643	6	22	a	a	DET
fnp-5643	6	23	reliable	reliable	ADJ
fnp-5643	6	24	tentative	tentative	ADJ
fnp-5643	6	25	main	main	ADJ
fnp-5643	6	26	diagnosis	diagnosis	NOUN
fnp-5643	6	27	in	in	ADP
fnp-5643	6	28	individuals	individual	NOUN
fnp-5643	6	29	with	with	ADP
fnp-5643	6	30	neurodegenerative	neurodegenerative	ADJ
fnp-5643	6	31	disease	disease	NOUN
fnp-5643	6	32	and	and	CCONJ
fnp-5643	6	33	thus	thus	ADV
fnp-5643	6	34	allows	allow	VERB
fnp-5643	6	35	for	for	ADP
fnp-5643	6	36	a	a	DET
fnp-5643	6	37	prompt	prompt	ADJ
fnp-5643	6	38	feedback	feedback	NOUN
fnp-5643	6	39	to	to	ADP
fnp-5643	6	40	the	the	DET
fnp-5643	6	41	physicians	physician	NOUN
fnp-5643	6	42	.	.	PUNCT
fnp-5643	7	1	however	however	ADV
fnp-5643	7	2	,	,	PUNCT
fnp-5643	7	3	a	a	DET
fnp-5643	7	4	more	more	ADV
fnp-5643	7	5	thorough	thorough	ADJ
fnp-5643	7	6	histological	histological	ADJ
fnp-5643	7	7	work	work	NOUN
fnp-5643	7	8	-	-	PUNCT
fnp-5643	7	9	up	up	ADP
fnp-5643	7	10	taking	take	VERB
fnp-5643	7	11	into	into	ADP
fnp-5643	7	12	account	account	NOUN
fnp-5643	7	13	the	the	DET
fnp-5643	7	14	clinical	clinical	ADJ
fnp-5643	7	15	history	history	NOUN
fnp-5643	7	16	and	and	CCONJ
fnp-5643	7	17	the	the	DET
fnp-5643	7	18	working	work	VERB
fnp-5643	7	19	diagnosis	diagnosis	NOUN
fnp-5643	7	20	from	from	ADP
fnp-5643	7	21	fast	fast	ADJ
fnp-5643	7	22	-	-	PUNCT
fnp-5643	7	23	track	track	NOUN
fnp-5643	7	24	screening	screening	NOUN
fnp-5643	7	25	is	be	AUX
fnp-5643	7	26	necessary	necessary	ADJ
fnp-5643	7	27	for	for	ADP
fnp-5643	7	28	accurate	accurate	ADJ
fnp-5643	7	29	staging	staging	NOUN
fnp-5643	7	30	and	and	CCONJ
fnp-5643	7	31	for	for	ADP
fnp-5643	7	32	assessment	assessment	NOUN
fnp-5643	7	33	of	of	ADP
fnp-5643	7	34	co	co	NOUN
fnp-5643	7	35	-	-	NOUN
fnp-5643	7	36	pathologies	pathology	NOUN
fnp-5643	7	37	.	.	PUNCT
fnp-5643	8	1	introduction	introduction	NOUN
fnp-5643	8	2	dementia	dementia	NOUN
fnp-5643	8	3	or	or	CCONJ
fnp-5643	8	4	cognitive	cognitive	ADJ
fnp-5643	8	5	impairment	impairment	NOUN
fnp-5643	8	6	are	be	AUX
fnp-5643	8	7	common	common	ADJ
fnp-5643	8	8	clinical	clinical	ADJ
fnp-5643	8	9	diagnoses	diagnosis	NOUN
fnp-5643	8	10	;	;	PUNCT
fnp-5643	8	11	however	however	ADV
fnp-5643	8	12	,	,	PUNCT
fnp-5643	8	13	they	they	PRON
fnp-5643	8	14	often	often	ADV
fnp-5643	8	15	lack	lack	VERB
fnp-5643	8	16	neuropathological	neuropathological	ADJ
fnp-5643	8	17	verification	verification	NOUN
fnp-5643	8	18	by	by	ADP
fnp-5643	8	19	autopsy	autopsy	ADJ
fnp-5643	8	20	.	.	PUNCT
fnp-5643	9	1	compared	compare	VERB
fnp-5643	9	2	to	to	ADP
fnp-5643	9	3	other	other	ADJ
fnp-5643	9	4	underlying	underlying	ADJ
fnp-5643	9	5	causes	cause	NOUN
fnp-5643	9	6	of	of	ADP
fnp-5643	9	7	death	death	NOUN
fnp-5643	9	8	,	,	PUNCT
fnp-5643	9	9	dementia	dementia	NOUN
fnp-5643	9	10	lowers	lower	VERB
fnp-5643	9	11	the	the	DET
fnp-5643	9	12	chances	chance	NOUN
fnp-5643	9	13	of	of	ADP
fnp-5643	9	14	an	an	DET
fnp-5643	9	15	autopsy	autopsy	NOUN
fnp-5643	9	16	to	to	PART
fnp-5643	9	17	be	be	AUX
fnp-5643	9	18	performed	perform	VERB
fnp-5643	9	19	[	[	PUNCT
fnp-5643	9	20	1	1	NUM
fnp-5643	9	21	]	]	PUNCT
fnp-5643	9	22	.	.	PUNCT
fnp-5643	10	1	the	the	DET
fnp-5643	10	2	low	low	ADJ
fnp-5643	10	3	autopsy	autopsy	ADJ
fnp-5643	10	4	rates	rate	NOUN
fnp-5643	10	5	,	,	PUNCT
fnp-5643	10	6	in	in	ADP
fnp-5643	10	7	turn	turn	NOUN
fnp-5643	10	8	,	,	PUNCT
fnp-5643	10	9	lead	lead	VERB
fnp-5643	10	10	to	to	ADP
fnp-5643	10	11	a	a	DET
fnp-5643	10	12	loss	loss	NOUN
fnp-5643	10	13	of	of	ADP
fnp-5643	10	14	expertise	expertise	NOUN
fnp-5643	10	15	for	for	ADP
fnp-5643	10	16	diagnosing	diagnose	VERB
fnp-5643	10	17	neurodegenerative	neurodegenerative	ADJ
fnp-5643	10	18	diseases	disease	NOUN
fnp-5643	10	19	with	with	ADP
fnp-5643	10	20	high	high	ADJ
fnp-5643	10	21	precision	precision	NOUN
fnp-5643	10	22	and	and	CCONJ
fnp-5643	10	23	according	accord	VERB
fnp-5643	10	24	to	to	ADP
fnp-5643	10	25	well	well	ADV
fnp-5643	10	26	-	-	PUNCT
fnp-5643	10	27	established	establish	VERB
fnp-5643	10	28	standards	standard	NOUN
fnp-5643	10	29	.	.	PUNCT
fnp-5643	11	1	a	a	DET
fnp-5643	11	2	study	study	NOUN
fnp-5643	11	3	by	by	ADP
fnp-5643	11	4	selvackadunko	selvackadunko	PROPN
fnp-5643	11	5	et	et	PROPN
fnp-5643	11	6	al	al	PROPN
fnp-5643	11	7	.	.	PROPN
fnp-5643	11	8	,	,	PUNCT
fnp-5643	11	9	comparing	compare	VERB
fnp-5643	11	10	the	the	DET
fnp-5643	11	11	antemortem	antemortem	NOUN
fnp-5643	11	12	clinical	clinical	ADJ
fnp-5643	11	13	diagnosis	diagnosis	NOUN
fnp-5643	11	14	and	and	CCONJ
fnp-5643	11	15	postmortem	postmortem	NOUN
fnp-5643	11	16	neuropathological	neuropathological	ADJ
fnp-5643	11	17	diagnosis	diagnosis	NOUN
fnp-5643	11	18	revealed	reveal	VERB
fnp-5643	11	19	that	that	SCONJ
fnp-5643	11	20	in	in	ADP
fnp-5643	11	21	one	one	NUM
fnp-5643	11	22	third	third	NOUN
fnp-5643	11	23	of	of	ADP
fnp-5643	11	24	cases	case	NOUN
fnp-5643	11	25	the	the	DET
fnp-5643	11	26	in	in	ADP
fnp-5643	11	27	-	-	PUNCT
fnp-5643	11	28	life	life	NOUN
fnp-5643	11	29	and	and	CCONJ
fnp-5643	11	30	the	the	DET
fnp-5643	11	31	neuropathological	neuropathological	ADJ
fnp-5643	11	32	diagnosis	diagnosis	NOUN
fnp-5643	11	33	differed	differ	VERB
fnp-5643	11	34	[	[	X
fnp-5643	11	35	2	2	NUM
fnp-5643	11	36	]	]	PUNCT
fnp-5643	11	37	.	.	PUNCT
fnp-5643	12	1	a	a	DET
fnp-5643	12	2	swedish	swedish	ADJ
fnp-5643	12	3	study	study	NOUN
fnp-5643	12	4	found	find	VERB
fnp-5643	12	5	a	a	DET
fnp-5643	12	6	full	full	ADJ
fnp-5643	12	7	accordance	accordance	NOUN
fnp-5643	12	8	of	of	ADP
fnp-5643	12	9	clinical	clinical	ADJ
fnp-5643	12	10	and	and	CCONJ
fnp-5643	12	11	neuropathological	neuropathological	ADJ
fnp-5643	12	12	dementia	dementia	NOUN
fnp-5643	12	13	diagnosis	diagnosis	NOUN
fnp-5643	12	14	in	in	ADP
fnp-5643	12	15	49	49	NUM
fnp-5643	12	16	 	 	SPACE
fnp-5643	12	17	%	%	NOUN
fnp-5643	12	18	of	of	ADP
fnp-5643	12	19	cases	case	NOUN
fnp-5643	12	20	,	,	PUNCT
fnp-5643	12	21	in	in	ADP
fnp-5643	12	22	a	a	DET
fnp-5643	12	23	further	further	ADJ
fnp-5643	12	24	14	14	NUM
fnp-5643	12	25	 	 	SPACE
fnp-5643	12	26	%	%	NOUN
fnp-5643	12	27	the	the	DET
fnp-5643	12	28	clinical	clinical	ADJ
fnp-5643	12	29	diagnosis	diagnosis	NOUN
fnp-5643	12	30	corresponded	correspond	VERB
fnp-5643	12	31	with	with	ADP
fnp-5643	12	32	some	some	DET
fnp-5643	12	33	but	but	CCONJ
fnp-5643	12	34	not	not	PART
fnp-5643	12	35	all	all	DET
fnp-5643	12	36	the	the	DET
fnp-5643	12	37	diagnoses	diagnosis	NOUN
fnp-5643	12	38	after	after	ADP
fnp-5643	12	39	postmortem	postmortem	NOUN
fnp-5643	12	40	evaluation	evaluation	NOUN
fnp-5643	12	41	[	[	X
fnp-5643	12	42	3	3	NUM
fnp-5643	12	43	]	]	PUNCT
fnp-5643	12	44	.	.	PUNCT
fnp-5643	13	1	in	in	ADP
fnp-5643	13	2	alzheimer	alzheimer	PROPN
fnp-5643	13	3	’s	’s	PART
fnp-5643	13	4	disease	disease	NOUN
fnp-5643	13	5	(	(	PUNCT
fnp-5643	13	6	ad	ad	NOUN
fnp-5643	13	7	)	)	PUNCT
fnp-5643	13	8	,	,	PUNCT
fnp-5643	13	9	the	the	DET
fnp-5643	13	10	commonest	commonest	NOUN
fnp-5643	13	11	neurodegenerative	neurodegenerative	ADJ
fnp-5643	13	12	disease	disease	NOUN
fnp-5643	13	13	(	(	PUNCT
fnp-5643	13	14	ndd	ndd	PROPN
fnp-5643	13	15	)	)	PUNCT
fnp-5643	13	16	,	,	PUNCT
fnp-5643	13	17	a	a	DET
fnp-5643	13	18	study	study	NOUN
fnp-5643	13	19	showed	show	VERB
fnp-5643	13	20	that	that	SCONJ
fnp-5643	13	21	119	119	NUM
fnp-5643	13	22	out	out	ADP
fnp-5643	13	23	of	of	ADP
fnp-5643	13	24	533	533	NUM
fnp-5643	13	25	clinically	clinically	ADV
fnp-5643	13	26	diagnosed	diagnose	VERB
fnp-5643	13	27	ad	ad	NOUN
fnp-5643	13	28	cases	case	NOUN
fnp-5643	13	29	did	do	AUX
fnp-5643	13	30	not	not	PART
fnp-5643	13	31	fulfil	fulfil	VERB
fnp-5643	13	32	the	the	DET
fnp-5643	13	33	neuropathological	neuropathological	ADJ
fnp-5643	13	34	criteria	criterion	NOUN
fnp-5643	13	35	for	for	ADP
fnp-5643	13	36	definite	definite	ADJ
fnp-5643	13	37	ad	ad	NOUN
fnp-5643	13	38	at	at	ADP
fnp-5643	13	39	autopsy	autopsy	ADJ
fnp-5643	13	40	,	,	PUNCT
fnp-5643	13	41	with	with	ADP
fnp-5643	13	42	dementia	dementia	NOUN
fnp-5643	13	43	with	with	ADP
fnp-5643	13	44	lewy	lewy	ADJ
fnp-5643	13	45	bodies	body	NOUN
fnp-5643	13	46	(	(	PUNCT
fnp-5643	13	47	dlb	dlb	PROPN
fnp-5643	13	48	)	)	PUNCT
fnp-5643	13	49	,	,	PUNCT
fnp-5643	13	50	vascular	vascular	ADJ
fnp-5643	13	51	dementia	dementia	NOUN
fnp-5643	13	52	,	,	PUNCT
fnp-5643	13	53	frontotemporal	frontotemporal	ADJ
fnp-5643	13	54	lobar	lobar	ADJ
fnp-5643	13	55	degeneration	degeneration	NOUN
fnp-5643	13	56	(	(	PUNCT
fnp-5643	13	57	ftld	ftld	ADJ
fnp-5643	13	58	)	)	PUNCT
fnp-5643	13	59	and	and	CCONJ
fnp-5643	13	60	hippocampal	hippocampal	ADJ
fnp-5643	13	61	sclerosis	sclerosis	NOUN
fnp-5643	13	62	being	be	AUX
fnp-5643	13	63	the	the	DET
fnp-5643	13	64	most	most	ADV
fnp-5643	13	65	frequently	frequently	ADV
fnp-5643	13	66	encountered	encounter	VERB
fnp-5643	13	67	ad	ad	NOUN
fnp-5643	13	68	mimics	mimic	VERB
fnp-5643	13	69	[	[	X
fnp-5643	13	70	4	4	NUM
fnp-5643	13	71	]	]	PUNCT
fnp-5643	13	72	.	.	PUNCT
fnp-5643	14	1	in	in	ADP
fnp-5643	14	2	progressive	progressive	ADJ
fnp-5643	14	3	supranuclear	supranuclear	ADJ
fnp-5643	14	4	palsy	palsy	ADJ
fnp-5643	14	5	(	(	PUNCT
fnp-5643	14	6	psp	psp	NOUN
fnp-5643	14	7	)	)	PUNCT
fnp-5643	14	8	,	,	PUNCT
fnp-5643	14	9	only	only	ADV
fnp-5643	14	10	78	78	NUM
fnp-5643	14	11	 	 	SPACE
fnp-5643	14	12	%	%	NOUN
fnp-5643	14	13	of	of	ADP
fnp-5643	14	14	clinically	clinically	ADV
fnp-5643	14	15	diagnosed	diagnose	VERB
fnp-5643	14	16	cases	case	NOUN
fnp-5643	14	17	were	be	AUX
fnp-5643	14	18	histologically	histologically	ADV
fnp-5643	14	19	confirmed	confirm	VERB
fnp-5643	14	20	as	as	ADP
fnp-5643	14	21	indeed	indeed	ADV
fnp-5643	14	22	being	be	AUX
fnp-5643	14	23	a	a	DET
fnp-5643	14	24	psp	psp	NOUN
fnp-5643	14	25	,	,	PUNCT
fnp-5643	14	26	clinically	clinically	ADV
fnp-5643	14	27	incorrect	incorrect	ADJ
fnp-5643	14	28	classified	classified	ADJ
fnp-5643	14	29	cases	case	NOUN
fnp-5643	14	30	histologically	histologically	ADV
fnp-5643	14	31	were	be	AUX
fnp-5643	14	32	classified	classify	VERB
fnp-5643	14	33	as	as	ADP
fnp-5643	14	34	parkinson	parkinson	NOUN
fnp-5643	14	35	’s	’s	PART
fnp-5643	14	36	disease	disease	NOUN
fnp-5643	14	37	(	(	PUNCT
fnp-5643	14	38	pd	pd	NOUN
fnp-5643	14	39	)	)	PUNCT
fnp-5643	14	40	,	,	PUNCT
fnp-5643	14	41	ad	ad	NOUN
fnp-5643	14	42	,	,	PUNCT
fnp-5643	14	43	multiple	multiple	ADJ
fnp-5643	14	44	system	system	NOUN
fnp-5643	14	45	atrophy	atrophy	NOUN
fnp-5643	14	46	(	(	PUNCT
fnp-5643	14	47	msa	msa	PROPN
fnp-5643	14	48	)	)	PUNCT
fnp-5643	14	49	,	,	PUNCT
fnp-5643	14	50	pick	pick	VERB
fnp-5643	14	51	’s	’s	PART
fnp-5643	14	52	disease	disease	NOUN
fnp-5643	14	53	(	(	PUNCT
fnp-5643	14	54	pid	pid	NOUN
fnp-5643	14	55	)	)	PUNCT
fnp-5643	14	56	,	,	PUNCT
fnp-5643	14	57	motor	motor	NOUN
fnp-5643	14	58	neuron	neuron	PROPN
fnp-5643	14	59	disease	disease	PROPN
fnp-5643	14	60	(	(	PUNCT
fnp-5643	14	61	mnd	mnd	PROPN
fnp-5643	14	62	)	)	PUNCT
fnp-5643	14	63	and	and	CCONJ
fnp-5643	14	64	corticobasal	corticobasal	NOUN
fnp-5643	14	65	degeneration	degeneration	NOUN
fnp-5643	14	66	(	(	PUNCT
fnp-5643	14	67	cbd	cbd	NOUN
fnp-5643	14	68	)	)	PUNCT
fnp-5643	15	1	[	[	X
fnp-5643	15	2	5	5	NUM
fnp-5643	15	3	]	]	PUNCT
fnp-5643	15	4	.	.	PUNCT
fnp-5643	16	1	furthermore	furthermore	ADV
fnp-5643	16	2	,	,	PUNCT
fnp-5643	16	3	prion	prion	NOUN
fnp-5643	16	4	disease	disease	NOUN
fnp-5643	16	5	can	can	AUX
fnp-5643	16	6	be	be	AUX
fnp-5643	16	7	mistaken	mistaken	ADJ
fnp-5643	16	8	for	for	ADP
fnp-5643	16	9	various	various	ADJ
fnp-5643	16	10	other	other	ADJ
fnp-5643	16	11	clinical	clinical	ADJ
fnp-5643	16	12	entities	entity	NOUN
fnp-5643	16	13	,	,	PUNCT
fnp-5643	16	14	especially	especially	ADV
fnp-5643	16	15	in	in	ADP
fnp-5643	16	16	the	the	DET
fnp-5643	16	17	elderly	elderly	ADJ
fnp-5643	16	18	due	due	ADP
fnp-5643	16	19	to	to	ADP
fnp-5643	16	20	a	a	DET
fnp-5643	16	21	less	less	ADV
fnp-5643	16	22	consistent	consistent	ADJ
fnp-5643	16	23	clinical	clinical	ADJ
fnp-5643	16	24	phenotype	phenotype	NOUN
fnp-5643	16	25	and	and	CCONJ
fnp-5643	16	26	a	a	DET
fnp-5643	16	27	high	high	ADJ
fnp-5643	16	28	incidence	incidence	NOUN
fnp-5643	16	29	of	of	ADP
fnp-5643	16	30	dementia	dementia	NOUN
fnp-5643	16	31	[	[	X
fnp-5643	16	32	6	6	NUM
fnp-5643	16	33	]	]	PUNCT
fnp-5643	16	34	.	.	PUNCT
fnp-5643	17	1	even	even	ADV
fnp-5643	17	2	though	though	SCONJ
fnp-5643	17	3	new	new	ADJ
fnp-5643	17	4	developments	development	NOUN
fnp-5643	17	5	in	in	ADP
fnp-5643	17	6	tau	tau	PROPN
fnp-5643	17	7	positron	positron	NOUN
fnp-5643	17	8	emission	emission	NOUN
fnp-5643	17	9	tomography	tomography	NOUN
fnp-5643	17	10	imaging	imaging	NOUN
fnp-5643	17	11	and	and	CCONJ
fnp-5643	17	12	cerebrospinal	cerebrospinal	ADJ
fnp-5643	17	13	fluid	fluid	NOUN
fnp-5643	17	14	analysis	analysis	NOUN
fnp-5643	17	15	have	have	AUX
fnp-5643	17	16	very	very	ADV
fnp-5643	17	17	much	much	ADV
fnp-5643	17	18	improved	improve	VERB
fnp-5643	17	19	the	the	DET
fnp-5643	17	20	clinical	clinical	ADJ
fnp-5643	17	21	diagnosis	diagnosis	NOUN
fnp-5643	17	22	of	of	ADP
fnp-5643	17	23	ndds	ndd	NOUN
fnp-5643	17	24	in	in	ADP
fnp-5643	17	25	the	the	DET
fnp-5643	17	26	last	last	ADJ
fnp-5643	17	27	three	three	NUM
fnp-5643	17	28	years	year	NOUN
fnp-5643	17	29	,	,	PUNCT
fnp-5643	17	30	these	these	DET
fnp-5643	17	31	expensive	expensive	ADJ
fnp-5643	17	32	methods	method	NOUN
fnp-5643	17	33	are	be	AUX
fnp-5643	17	34	often	often	ADV
fnp-5643	17	35	not	not	PART
fnp-5643	17	36	available	available	ADJ
fnp-5643	17	37	to	to	ADP
fnp-5643	17	38	clinicians	clinician	NOUN
fnp-5643	17	39	[	[	X
fnp-5643	17	40	7	7	NUM
fnp-5643	17	41	]	]	PUNCT
fnp-5643	17	42	.	.	PUNCT
fnp-5643	18	1	the	the	DET
fnp-5643	18	2	conventional	conventional	ADJ
fnp-5643	18	3	neuropathological	neuropathological	ADJ
fnp-5643	18	4	workup	workup	NOUN
fnp-5643	18	5	for	for	ADP
fnp-5643	18	6	brains	brain	NOUN
fnp-5643	18	7	of	of	ADP
fnp-5643	18	8	patients	patient	NOUN
fnp-5643	18	9	with	with	ADP
fnp-5643	18	10	suspected	suspect	VERB
fnp-5643	18	11	neurodegenerative	neurodegenerative	ADJ
fnp-5643	18	12	diseases	disease	NOUN
fnp-5643	18	13	is	be	AUX
fnp-5643	18	14	extensive	extensive	ADJ
fnp-5643	18	15	,	,	PUNCT
fnp-5643	18	16	since	since	SCONJ
fnp-5643	18	17	it	it	PRON
fnp-5643	18	18	typically	typically	ADV
fnp-5643	18	19	includes	include	VERB
fnp-5643	18	20	a	a	DET
fnp-5643	18	21	comprehensive	comprehensive	ADJ
fnp-5643	18	22	and	and	CCONJ
fnp-5643	18	23	detailed	detailed	ADJ
fnp-5643	18	24	characterization	characterization	NOUN
fnp-5643	18	25	of	of	ADP
fnp-5643	18	26	all	all	DET
fnp-5643	18	27	pathologies	pathology	NOUN
fnp-5643	18	28	and	and	CCONJ
fnp-5643	18	29	co	co	NOUN
fnp-5643	18	30	-	-	NOUN
fnp-5643	18	31	pathologies	pathology	NOUN
fnp-5643	18	32	present	present	ADJ
fnp-5643	18	33	,	,	PUNCT
fnp-5643	18	34	particularly	particularly	ADV
fnp-5643	18	35	in	in	ADP
fnp-5643	18	36	a	a	DET
fnp-5643	18	37	brain	brain	NOUN
fnp-5643	18	38	bank	bank	NOUN
fnp-5643	18	39	setting	setting	NOUN
fnp-5643	18	40	.	.	PUNCT
fnp-5643	19	1	for	for	ADP
fnp-5643	19	2	this	this	PRON
fnp-5643	19	3	,	,	PUNCT
fnp-5643	19	4	the	the	DET
fnp-5643	19	5	analysis	analysis	NOUN
fnp-5643	19	6	of	of	ADP
fnp-5643	19	7	at	at	ADV
fnp-5643	19	8	least	least	ADV
fnp-5643	19	9	seven	seven	NUM
fnp-5643	19	10	or	or	CCONJ
fnp-5643	19	11	eight	eight	NUM
fnp-5643	19	12	tissue	tissue	NOUN
fnp-5643	19	13	blocks	block	NOUN
fnp-5643	19	14	from	from	ADP
fnp-5643	19	15	different	different	ADJ
fnp-5643	19	16	brain	brain	NOUN
fnp-5643	19	17	regions	region	NOUN
fnp-5643	19	18	is	be	AUX
fnp-5643	19	19	required	require	VERB
fnp-5643	19	20	.	.	PUNCT
fnp-5643	20	1	a	a	DET
fnp-5643	20	2	report	report	NOUN
fnp-5643	20	3	by	by	ADP
fnp-5643	20	4	kovacs	kovacs	PROPN
fnp-5643	20	5	and	and	CCONJ
fnp-5643	20	6	budka	budka	ADV
fnp-5643	20	7	from	from	ADP
fnp-5643	20	8	the	the	DET
fnp-5643	20	9	vienna	vienna	PROPN
fnp-5643	20	10	brain	brain	NOUN
fnp-5643	20	11	bank	bank	PROPN
fnp-5643	20	12	describes	describe	VERB
fnp-5643	20	13	five	five	NUM
fnp-5643	20	14	immunostainings	immunostaining	NOUN
fnp-5643	20	15	on	on	ADP
fnp-5643	20	16	seven	seven	NUM
fnp-5643	20	17	brain	brain	NOUN
fnp-5643	20	18	regions	region	NOUN
fnp-5643	20	19	as	as	ADP
fnp-5643	20	20	minimal	minimal	ADJ
fnp-5643	20	21	number	number	NOUN
fnp-5643	20	22	to	to	PART
fnp-5643	20	23	assess	assess	VERB
fnp-5643	20	24	protein	protein	NOUN
fnp-5643	20	25	deposition	deposition	NOUN
fnp-5643	20	26	in	in	ADP
fnp-5643	20	27	ndd	ndd	PROPN
fnp-5643	20	28	[	[	X
fnp-5643	20	29	8	8	NUM
fnp-5643	20	30	]	]	PUNCT
fnp-5643	20	31	.	.	PUNCT
fnp-5643	21	1	the	the	DET
fnp-5643	21	2	national	national	PROPN
fnp-5643	21	3	institute	institute	PROPN
fnp-5643	21	4	of	of	ADP
fnp-5643	21	5	ageing	age	VERB
fnp-5643	21	6	guidelines	guideline	NOUN
fnp-5643	21	7	recommend	recommend	VERB
fnp-5643	21	8	the	the	DET
fnp-5643	21	9	sampling	sampling	NOUN
fnp-5643	21	10	of	of	ADP
fnp-5643	21	11	at	at	ADV
fnp-5643	21	12	least	least	ADV
fnp-5643	21	13	eight	eight	NUM
fnp-5643	21	14	brain	brain	NOUN
fnp-5643	21	15	regions	region	NOUN
fnp-5643	21	16	for	for	ADP
fnp-5643	21	17	ad	ad	NOUN
fnp-5643	21	18	,	,	PUNCT
fnp-5643	21	19	six	six	NUM
fnp-5643	21	20	for	for	ADP
fnp-5643	21	21	lewy	lewy	ADJ
fnp-5643	21	22	body	body	NOUN
fnp-5643	21	23	disease	disease	NOUN
fnp-5643	21	24	(	(	PUNCT
fnp-5643	21	25	lbd	lbd	PROPN
fnp-5643	21	26	)	)	PUNCT
fnp-5643	22	1	[	[	X
fnp-5643	22	2	9	9	NUM
fnp-5643	22	3	]	]	PUNCT
fnp-5643	22	4	.	.	PUNCT
fnp-5643	23	1	since	since	SCONJ
fnp-5643	23	2	up	up	ADP
fnp-5643	23	3	to	to	PART
fnp-5643	23	4	five	five	NUM
fnp-5643	23	5	immunohistological	immunohistological	ADJ
fnp-5643	23	6	stainings	staining	NOUN
fnp-5643	23	7	per	per	ADP
fnp-5643	23	8	region	region	NOUN
fnp-5643	23	9	are	be	AUX
fnp-5643	23	10	necessary	necessary	ADJ
fnp-5643	23	11	,	,	PUNCT
fnp-5643	23	12	these	these	DET
fnp-5643	23	13	approaches	approach	NOUN
fnp-5643	23	14	lead	lead	VERB
fnp-5643	23	15	to	to	ADP
fnp-5643	23	16	about	about	ADV
fnp-5643	23	17	50	50	NUM
fnp-5643	23	18	stained	stain	VERB
fnp-5643	23	19	sections	section	NOUN
fnp-5643	23	20	to	to	PART
fnp-5643	23	21	be	be	AUX
fnp-5643	23	22	analysed	analyse	VERB
fnp-5643	23	23	under	under	ADP
fnp-5643	23	24	the	the	DET
fnp-5643	23	25	microscope	microscope	NOUN
fnp-5643	23	26	,	,	PUNCT
fnp-5643	23	27	which	which	PRON
fnp-5643	23	28	is	be	AUX
fnp-5643	23	29	costly	costly	ADJ
fnp-5643	23	30	and	and	CCONJ
fnp-5643	23	31	time	time	NOUN
fnp-5643	23	32	-	-	PUNCT
fnp-5643	23	33	consuming	consume	VERB
fnp-5643	23	34	,	,	PUNCT
fnp-5643	23	35	taking	take	VERB
fnp-5643	23	36	a	a	DET
fnp-5643	23	37	considerable	considerable	ADJ
fnp-5643	23	38	time	time	NOUN
fnp-5643	23	39	until	until	SCONJ
fnp-5643	23	40	a	a	DET
fnp-5643	23	41	final	final	ADJ
fnp-5643	23	42	report	report	NOUN
fnp-5643	23	43	can	can	AUX
fnp-5643	23	44	be	be	AUX
fnp-5643	23	45	provided	provide	VERB
fnp-5643	23	46	.	.	PUNCT
fnp-5643	24	1	in	in	ADP
fnp-5643	24	2	contrast	contrast	NOUN
fnp-5643	24	3	,	,	PUNCT
fnp-5643	24	4	the	the	DET
fnp-5643	24	5	priority	priority	NOUN
fnp-5643	24	6	for	for	ADP
fnp-5643	24	7	clinicians	clinician	NOUN
fnp-5643	24	8	and	and	CCONJ
fnp-5643	24	9	relatives	relative	NOUN
fnp-5643	24	10	is	be	AUX
fnp-5643	24	11	to	to	PART
fnp-5643	24	12	receive	receive	VERB
fnp-5643	24	13	information	information	NOUN
fnp-5643	24	14	about	about	ADP
fnp-5643	24	15	the	the	DET
fnp-5643	24	16	definite	definite	ADJ
fnp-5643	24	17	(	(	PUNCT
fnp-5643	24	18	main	main	ADJ
fnp-5643	24	19	)	)	PUNCT
fnp-5643	24	20	diagnosis	diagnosis	NOUN
fnp-5643	24	21	in	in	ADP
fnp-5643	24	22	a	a	DET
fnp-5643	24	23	timely	timely	ADJ
fnp-5643	24	24	manner	manner	NOUN
fnp-5643	24	25	.	.	PUNCT
fnp-5643	25	1	to	to	PART
fnp-5643	25	2	reduce	reduce	VERB
fnp-5643	25	3	costs	cost	NOUN
fnp-5643	25	4	and	and	CCONJ
fnp-5643	25	5	effort	effort	NOUN
fnp-5643	25	6	,	,	PUNCT
fnp-5643	25	7	condensed	condense	VERB
fnp-5643	25	8	protocols	protocol	NOUN
fnp-5643	25	9	for	for	ADP
fnp-5643	25	10	common	common	ADJ
fnp-5643	25	11	neurodegenerative	neurodegenerative	ADJ
fnp-5643	25	12	alterations	alteration	NOUN
fnp-5643	25	13	have	have	AUX
fnp-5643	25	14	been	be	AUX
fnp-5643	25	15	deployed	deploy	VERB
fnp-5643	25	16	,	,	PUNCT
fnp-5643	25	17	essentially	essentially	ADV
fnp-5643	25	18	based	base	VERB
fnp-5643	25	19	on	on	ADP
fnp-5643	25	20	the	the	DET
fnp-5643	25	21	protocol	protocol	NOUN
fnp-5643	25	22	by	by	ADP
fnp-5643	25	23	flanagan	flanagan	NOUN
fnp-5643	25	24	et	et	PROPN
fnp-5643	25	25	al	al	PROPN
fnp-5643	25	26	.	.	PUNCT
fnp-5643	26	1	[	[	X
fnp-5643	26	2	10	10	NUM
fnp-5643	26	3	]	]	PUNCT
fnp-5643	26	4	.	.	PUNCT
fnp-5643	27	1	this	this	DET
fnp-5643	27	2	protocol	protocol	NOUN
fnp-5643	27	3	requires	require	VERB
fnp-5643	27	4	sampling	sample	VERB
fnp-5643	27	5	of	of	ADP
fnp-5643	27	6	20	20	NUM
fnp-5643	27	7	brain	brain	NOUN
fnp-5643	27	8	regions	region	NOUN
fnp-5643	27	9	(	(	PUNCT
fnp-5643	27	10	sometimes	sometimes	ADV
fnp-5643	27	11	bilateral	bilateral	ADJ
fnp-5643	27	12	sampling	sampling	NOUN
fnp-5643	27	13	of	of	ADP
fnp-5643	27	14	the	the	DET
fnp-5643	27	15	same	same	ADJ
fnp-5643	27	16	region	region	NOUN
fnp-5643	27	17	is	be	AUX
fnp-5643	27	18	needed	need	VERB
fnp-5643	27	19	)	)	PUNCT
fnp-5643	27	20	,	,	PUNCT
fnp-5643	27	21	with	with	ADP
fnp-5643	27	22	four	four	NUM
fnp-5643	27	23	regions	region	NOUN
fnp-5643	27	24	embedded	embed	VERB
fnp-5643	27	25	in	in	ADP
fnp-5643	27	26	the	the	DET
fnp-5643	27	27	same	same	ADJ
fnp-5643	27	28	tissue	tissue	NOUN
fnp-5643	27	29	cassette	cassette	NOUN
fnp-5643	27	30	,	,	PUNCT
fnp-5643	27	31	giving	give	VERB
fnp-5643	27	32	a	a	DET
fnp-5643	27	33	total	total	NOUN
fnp-5643	27	34	of	of	ADP
fnp-5643	27	35	five	five	NUM
fnp-5643	27	36	paraffin	paraffin	NOUN
fnp-5643	27	37	blocks	block	NOUN
fnp-5643	27	38	[	[	X
fnp-5643	27	39	10	10	NUM
fnp-5643	27	40	]	]	PUNCT
fnp-5643	27	41	.	.	PUNCT
fnp-5643	28	1	following	follow	VERB
fnp-5643	28	2	a	a	DET
fnp-5643	28	3	nontiered	nontiered	ADJ
fnp-5643	28	4	approach	approach	NOUN
fnp-5643	28	5	,	,	PUNCT
fnp-5643	28	6	all	all	DET
fnp-5643	28	7	blocks	block	NOUN
fnp-5643	28	8	are	be	AUX
fnp-5643	28	9	stained	stain	VERB
fnp-5643	28	10	with	with	ADP
fnp-5643	28	11	he	he	PRON
fnp-5643	28	12	and	and	CCONJ
fnp-5643	28	13	luxol	luxol	PROPN
fnp-5643	28	14	fast	fast	PROPN
fnp-5643	28	15	blue	blue	ADJ
fnp-5643	28	16	,	,	PUNCT
fnp-5643	28	17	and	and	CCONJ
fnp-5643	28	18	each	each	DET
fnp-5643	28	19	block	block	NOUN
fnp-5643	28	20	with	with	ADP
fnp-5643	28	21	an	an	DET
fnp-5643	28	22	additional	additional	ADJ
fnp-5643	28	23	specific	specific	ADJ
fnp-5643	28	24	stain	stain	NOUN
fnp-5643	28	25	(	(	PUNCT
fnp-5643	28	26	bielschowsky	bielschowsky	NOUN
fnp-5643	28	27	silver	silver	NOUN
fnp-5643	28	28	impregnation	impregnation	NOUN
fnp-5643	28	29	or	or	CCONJ
fnp-5643	28	30	immunohistochemical	immunohistochemical	ADJ
fnp-5643	28	31	stains	stain	NOUN
fnp-5643	28	32	for	for	ADP
fnp-5643	28	33	α	α	NOUN
fnp-5643	28	34	-	-	PUNCT
fnp-5643	28	35	synuclein	synuclein	NOUN
fnp-5643	28	36	,	,	PUNCT
fnp-5643	28	37	β	β	NOUN
fnp-5643	28	38	-	-	NOUN
fnp-5643	28	39	amyloid	amyloid	NOUN
fnp-5643	28	40	or	or	CCONJ
fnp-5643	28	41	phospho	phospho	NOUN
fnp-5643	28	42	-	-	PUNCT
fnp-5643	28	43	tau	tau	NOUN
fnp-5643	28	44	)	)	PUNCT
fnp-5643	29	1	[	[	X
fnp-5643	29	2	10	10	NUM
fnp-5643	29	3	]	]	PUNCT
fnp-5643	29	4	.	.	PUNCT
fnp-5643	30	1	clement	clement	PROPN
fnp-5643	30	2	et	et	PROPN
fnp-5643	30	3	al	al	PROPN
fnp-5643	30	4	.	.	PROPN
fnp-5643	30	5	further	further	PROPN
fnp-5643	30	6	simplified	simplify	VERB
fnp-5643	30	7	the	the	DET
fnp-5643	30	8	protocol	protocol	NOUN
fnp-5643	30	9	by	by	ADP
fnp-5643	30	10	unilateral	unilateral	ADJ
fnp-5643	30	11	sampling	sampling	NOUN
fnp-5643	30	12	of	of	ADP
fnp-5643	30	13	12	12	NUM
fnp-5643	30	14	brain	brain	NOUN
fnp-5643	30	15	regions	region	NOUN
fnp-5643	30	16	embedded	embed	VERB
fnp-5643	30	17	in	in	ADP
fnp-5643	30	18	six	six	NUM
fnp-5643	30	19	tissue	tissue	NOUN
fnp-5643	30	20	cassettes	cassette	NOUN
fnp-5643	30	21	,	,	PUNCT
fnp-5643	30	22	with	with	ADP
fnp-5643	30	23	better	well	ADJ
fnp-5643	30	24	preservation	preservation	NOUN
fnp-5643	30	25	of	of	ADP
fnp-5643	30	26	neuroanatomical	neuroanatomical	ADJ
fnp-5643	30	27	relationships	relationship	NOUN
fnp-5643	30	28	[	[	X
fnp-5643	30	29	1	1	NUM
fnp-5643	30	30	]	]	PUNCT
fnp-5643	30	31	.	.	PUNCT
fnp-5643	31	1	amended	amend	VERB
fnp-5643	31	2	protocols	protocol	NOUN
fnp-5643	31	3	have	have	AUX
fnp-5643	31	4	been	be	AUX
fnp-5643	31	5	published	publish	VERB
fnp-5643	31	6	for	for	ADP
fnp-5643	31	7	the	the	DET
fnp-5643	31	8	diagnosis	diagnosis	NOUN
fnp-5643	31	9	of	of	ADP
fnp-5643	31	10	frontotemporal	frontotemporal	ADJ
fnp-5643	31	11	lobar	lobar	ADJ
fnp-5643	31	12	degeneration	degeneration	NOUN
fnp-5643	31	13	(	(	PUNCT
fnp-5643	31	14	ftld	ftld	ADJ
fnp-5643	31	15	)	)	PUNCT
fnp-5643	31	16	and	and	CCONJ
fnp-5643	31	17	limbic	limbic	ADJ
fnp-5643	31	18	-	-	PUNCT
fnp-5643	31	19	predominant	predominant	ADJ
fnp-5643	31	20	age	age	NOUN
fnp-5643	31	21	-	-	PUNCT
fnp-5643	31	22	related	relate	VERB
fnp-5643	31	23	tdp-43	tdp-43	NOUN
fnp-5643	31	24	encephalopathy	encephalopathy	ADJ
fnp-5643	31	25	neuropathological	neuropathological	ADJ
fnp-5643	31	26	changes	change	NOUN
fnp-5643	31	27	(	(	PUNCT
fnp-5643	31	28	late	late	PROPN
fnp-5643	31	29	-	-	PUNCT
fnp-5643	31	30	nc	nc	NOUN
fnp-5643	31	31	)	)	PUNCT
fnp-5643	32	1	[	[	X
fnp-5643	32	2	12,13	12,13	NUM
fnp-5643	32	3	]	]	PUNCT
fnp-5643	32	4	.	.	PUNCT
fnp-5643	33	1	condensed	condense	VERB
fnp-5643	33	2	protocols	protocol	NOUN
fnp-5643	33	3	have	have	AUX
fnp-5643	33	4	been	be	AUX
fnp-5643	33	5	reliably	reliably	ADV
fnp-5643	33	6	applied	apply	VERB
fnp-5643	33	7	in	in	ADP
fnp-5643	33	8	clinical	clinical	ADJ
fnp-5643	33	9	and	and	CCONJ
fnp-5643	33	10	medicolegal	medicolegal	ADJ
fnp-5643	33	11	autopsy	autopsy	ADJ
fnp-5643	33	12	settings	setting	NOUN
fnp-5643	33	13	[	[	X
fnp-5643	33	14	14,15,16	14,15,16	NUM
fnp-5643	33	15	]	]	PUNCT
fnp-5643	33	16	.	.	PUNCT
fnp-5643	34	1	previous	previous	ADJ
fnp-5643	34	2	studies	study	NOUN
fnp-5643	34	3	have	have	AUX
fnp-5643	34	4	already	already	ADV
fnp-5643	34	5	addressed	address	VERB
fnp-5643	34	6	the	the	DET
fnp-5643	34	7	question	question	NOUN
fnp-5643	34	8	of	of	ADP
fnp-5643	34	9	the	the	DET
fnp-5643	34	10	utility	utility	NOUN
fnp-5643	34	11	of	of	ADP
fnp-5643	34	12	small	small	ADJ
fnp-5643	34	13	-	-	PUNCT
fnp-5643	34	14	sized	sized	ADJ
fnp-5643	34	15	tissue	tissue	NOUN
fnp-5643	34	16	samples	sample	NOUN
fnp-5643	34	17	of	of	ADP
fnp-5643	34	18	few	few	ADJ
fnp-5643	34	19	selected	select	VERB
fnp-5643	34	20	brain	brain	NOUN
fnp-5643	34	21	regions	region	NOUN
fnp-5643	34	22	for	for	ADP
fnp-5643	34	23	ndd	ndd	NOUN
fnp-5643	34	24	diagnostics	diagnostic	NOUN
fnp-5643	34	25	.	.	PUNCT
fnp-5643	35	1	venetti	venetti	NOUN
fnp-5643	35	2	et	et	PROPN
fnp-5643	35	3	al	al	PROPN
fnp-5643	35	4	.	.	PROPN
fnp-5643	35	5	performed	perform	VERB
fnp-5643	35	6	simulated	simulated	ADJ
fnp-5643	35	7	brain	brain	NOUN
fnp-5643	35	8	biopsies	biopsy	NOUN
fnp-5643	35	9	on	on	ADP
fnp-5643	35	10	73	73	NUM
fnp-5643	35	11	autopsy	autopsy	ADJ
fnp-5643	35	12	cases	case	NOUN
fnp-5643	35	13	of	of	ADP
fnp-5643	35	14	various	various	ADJ
fnp-5643	35	15	ndd	ndd	NOUN
fnp-5643	35	16	and	and	CCONJ
fnp-5643	35	17	compared	compare	VERB
fnp-5643	35	18	the	the	DET
fnp-5643	35	19	outcome	outcome	NOUN
fnp-5643	35	20	between	between	ADP
fnp-5643	35	21	assessments	assessment	NOUN
fnp-5643	35	22	of	of	ADP
fnp-5643	35	23	the	the	DET
fnp-5643	35	24	mid	mid	ADJ
fnp-5643	35	25	-	-	ADJ
fnp-5643	35	26	frontal	frontal	ADJ
fnp-5643	35	27	cortex	cortex	NOUN
fnp-5643	35	28	alone	alone	ADJ
fnp-5643	35	29	or	or	CCONJ
fnp-5643	35	30	four	four	NUM
fnp-5643	35	31	brain	brain	NOUN
fnp-5643	35	32	regions	region	NOUN
fnp-5643	35	33	(	(	PUNCT
fnp-5643	35	34	frontal	frontal	ADJ
fnp-5643	35	35	,	,	PUNCT
fnp-5643	35	36	temporal	temporal	ADJ
fnp-5643	35	37	,	,	PUNCT
fnp-5643	35	38	parietal	parietal	ADJ
fnp-5643	35	39	cortex	cortex	NOUN
fnp-5643	35	40	and	and	CCONJ
fnp-5643	35	41	basal	basal	ADJ
fnp-5643	35	42	ganglia	ganglia	NOUN
fnp-5643	35	43	)	)	PUNCT
fnp-5643	35	44	to	to	ADP
fnp-5643	35	45	the	the	DET
fnp-5643	35	46	final	final	ADJ
fnp-5643	35	47	autoptic	autoptic	ADJ
fnp-5643	35	48	diagnoses	diagnosis	NOUN
fnp-5643	35	49	[	[	X
fnp-5643	35	50	17	17	NUM
fnp-5643	35	51	]	]	PUNCT
fnp-5643	35	52	.	.	PUNCT
fnp-5643	36	1	considering	consider	VERB
fnp-5643	36	2	solely	solely	ADV
fnp-5643	36	3	the	the	DET
fnp-5643	36	4	frontal	frontal	ADJ
fnp-5643	36	5	sample	sample	NOUN
fnp-5643	36	6	,	,	PUNCT
fnp-5643	36	7	the	the	DET
fnp-5643	36	8	authors	author	NOUN
fnp-5643	36	9	indicate	indicate	VERB
fnp-5643	36	10	an	an	DET
fnp-5643	36	11	average	average	ADJ
fnp-5643	36	12	sensitivity	sensitivity	NOUN
fnp-5643	36	13	of	of	ADP
fnp-5643	36	14	64	64	NUM
fnp-5643	36	15	 	 	SPACE
fnp-5643	36	16	%	%	NOUN
fnp-5643	36	17	and	and	CCONJ
fnp-5643	36	18	a	a	DET
fnp-5643	36	19	specificity	specificity	NOUN
fnp-5643	36	20	of	of	ADP
fnp-5643	36	21	43	43	NUM
fnp-5643	36	22	 	 	SPACE
fnp-5643	36	23	%	%	NOUN
fnp-5643	36	24	,	,	PUNCT
fnp-5643	36	25	and	and	CCONJ
fnp-5643	36	26	92	92	NUM
fnp-5643	36	27	 	 	SPACE
fnp-5643	36	28	%	%	NOUN
fnp-5643	36	29	sensitivity	sensitivity	NOUN
fnp-5643	36	30	and	and	CCONJ
fnp-5643	36	31	71	71	NUM
fnp-5643	36	32	 	 	SPACE
fnp-5643	36	33	%	%	NOUN
fnp-5643	36	34	specificity	specificity	NOUN
fnp-5643	36	35	for	for	ADP
fnp-5643	36	36	all	all	DET
fnp-5643	36	37	four	four	NUM
fnp-5643	36	38	brain	brain	NOUN
fnp-5643	36	39	regions	region	NOUN
fnp-5643	36	40	,	,	PUNCT
fnp-5643	36	41	with	with	ADP
fnp-5643	36	42	the	the	DET
fnp-5643	36	43	highest	high	ADJ
fnp-5643	36	44	sensitivities	sensitivity	NOUN
fnp-5643	36	45	found	find	VERB
fnp-5643	36	46	for	for	ADP
fnp-5643	36	47	ftld	ftld	NOUN
fnp-5643	36	48	with	with	ADP
fnp-5643	36	49	tdp-43	tdp-43	NOUN
fnp-5643	36	50	inclusions	inclusion	NOUN
fnp-5643	36	51	(	(	PUNCT
fnp-5643	36	52	ftld	ftld	ADJ
fnp-5643	36	53	-	-	PUNCT
fnp-5643	36	54	tdp	tdp	NOUN
fnp-5643	36	55	,	,	PUNCT
fnp-5643	36	56	88	88	NUM
fnp-5643	36	57	 	 	SPACE
fnp-5643	36	58	%	%	NOUN
fnp-5643	36	59	)	)	PUNCT
fnp-5643	36	60	and	and	CCONJ
fnp-5643	36	61	ad	ad	NOUN
fnp-5643	36	62	(	(	PUNCT
fnp-5643	36	63	80	80	NUM
fnp-5643	36	64	 	 	SPACE
fnp-5643	36	65	%	%	NOUN
fnp-5643	36	66	)	)	PUNCT
fnp-5643	36	67	and	and	CCONJ
fnp-5643	36	68	the	the	DET
fnp-5643	36	69	lowest	low	ADJ
fnp-5643	36	70	for	for	ADP
fnp-5643	36	71	psp	psp	NOUN
fnp-5643	36	72	(	(	PUNCT
fnp-5643	36	73	0	0	NUM
fnp-5643	36	74	 	 	SPACE
fnp-5643	36	75	%	%	NOUN
fnp-5643	36	76	)	)	PUNCT
fnp-5643	37	1	[	[	X
fnp-5643	37	2	17	17	NUM
fnp-5643	37	3	]	]	PUNCT
fnp-5643	37	4	.	.	PUNCT
fnp-5643	38	1	a	a	DET
fnp-5643	38	2	study	study	NOUN
fnp-5643	38	3	by	by	ADP
fnp-5643	38	4	king	king	PROPN
fnp-5643	38	5	et	et	PROPN
fnp-5643	38	6	al	al	PROPN
fnp-5643	38	7	.	.	PROPN
fnp-5643	38	8	evaluated	evaluate	VERB
fnp-5643	38	9	62	62	NUM
fnp-5643	38	10	ndd	ndd	NOUN
fnp-5643	38	11	cases	case	NOUN
fnp-5643	38	12	using	use	VERB
fnp-5643	38	13	1	1	NUM
fnp-5643	38	14	 	 	SPACE
fnp-5643	38	15	cm3	cm3	NOUN
fnp-5643	38	16	of	of	ADP
fnp-5643	38	17	prefrontal	prefrontal	ADJ
fnp-5643	38	18	and	and	CCONJ
fnp-5643	38	19	middle	middle	ADJ
fnp-5643	38	20	temporal	temporal	ADJ
fnp-5643	38	21	cortex	cortex	NOUN
fnp-5643	38	22	and	and	CCONJ
fnp-5643	38	23	compared	compare	VERB
fnp-5643	38	24	the	the	DET
fnp-5643	38	25	results	result	NOUN
fnp-5643	38	26	with	with	ADP
fnp-5643	38	27	gold	gold	ADJ
fnp-5643	38	28	standard	standard	ADJ
fnp-5643	38	29	autopsy	autopsy	ADJ
fnp-5643	38	30	diagnoses	diagnosis	NOUN
fnp-5643	38	31	[	[	X
fnp-5643	38	32	18	18	NUM
fnp-5643	38	33	]	]	PUNCT
fnp-5643	38	34	.	.	PUNCT
fnp-5643	39	1	the	the	DET
fnp-5643	39	2	sensitivity	sensitivity	NOUN
fnp-5643	39	3	of	of	ADP
fnp-5643	39	4	assessing	assess	VERB
fnp-5643	39	5	the	the	DET
fnp-5643	39	6	frontal	frontal	ADJ
fnp-5643	39	7	lobe	lobe	NOUN
fnp-5643	39	8	alone	alone	ADV
fnp-5643	39	9	was	be	AUX
fnp-5643	39	10	81	81	NUM
fnp-5643	39	11	 	 	SPACE
fnp-5643	39	12	%	%	NOUN
fnp-5643	39	13	and	and	CCONJ
fnp-5643	39	14	the	the	DET
fnp-5643	39	15	specificity	specificity	NOUN
fnp-5643	39	16	79	79	NUM
fnp-5643	39	17	 	 	SPACE
fnp-5643	39	18	%	%	NOUN
fnp-5643	39	19	[	[	X
fnp-5643	39	20	18	18	NUM
fnp-5643	39	21	]	]	PUNCT
fnp-5643	39	22	.	.	PUNCT
fnp-5643	40	1	these	these	DET
fnp-5643	40	2	figures	figure	NOUN
fnp-5643	40	3	increased	increase	VERB
fnp-5643	40	4	to	to	ADP
fnp-5643	40	5	a	a	DET
fnp-5643	40	6	sensitivity	sensitivity	NOUN
fnp-5643	40	7	of	of	ADP
fnp-5643	40	8	85	85	NUM
fnp-5643	40	9	 	 	SPACE
fnp-5643	40	10	%	%	NOUN
fnp-5643	40	11	and	and	CCONJ
fnp-5643	40	12	a	a	DET
fnp-5643	40	13	specificity	specificity	NOUN
fnp-5643	40	14	of	of	ADP
fnp-5643	40	15	83	83	NUM
fnp-5643	40	16	 	 	SPACE
fnp-5643	40	17	%	%	NOUN
fnp-5643	40	18	when	when	SCONJ
fnp-5643	40	19	taking	take	VERB
fnp-5643	40	20	both	both	DET
fnp-5643	40	21	regions	region	NOUN
fnp-5643	40	22	into	into	ADP
fnp-5643	40	23	account	account	NOUN
fnp-5643	40	24	[	[	X
fnp-5643	40	25	18	18	NUM
fnp-5643	40	26	]	]	PUNCT
fnp-5643	40	27	.	.	PUNCT
fnp-5643	41	1	the	the	DET
fnp-5643	41	2	diagnostic	diagnostic	ADJ
fnp-5643	41	3	accuracy	accuracy	NOUN
fnp-5643	41	4	of	of	ADP
fnp-5643	41	5	evaluating	evaluate	VERB
fnp-5643	41	6	frontal	frontal	ADJ
fnp-5643	41	7	lobe	lobe	ADJ
fnp-5643	41	8	specimens	specimen	NOUN
fnp-5643	41	9	was	be	AUX
fnp-5643	41	10	high	high	ADJ
fnp-5643	41	11	e.g.	e.g.	ADV
fnp-5643	41	12	in	in	ADP
fnp-5643	41	13	ad	ad	NOUN
fnp-5643	41	14	,	,	PUNCT
fnp-5643	41	15	cbd	cbd	NOUN
fnp-5643	41	16	and	and	CCONJ
fnp-5643	41	17	msa	msa	PROPN
fnp-5643	41	18	(	(	PUNCT
fnp-5643	41	19	100	100	NUM
fnp-5643	41	20	 	 	SPACE
fnp-5643	41	21	%	%	NOUN
fnp-5643	41	22	of	of	ADP
fnp-5643	41	23	correct	correct	ADJ
fnp-5643	41	24	diagnoses	diagnosis	NOUN
fnp-5643	41	25	)	)	PUNCT
fnp-5643	41	26	and	and	CCONJ
fnp-5643	41	27	low	low	ADJ
fnp-5643	41	28	in	in	ADP
fnp-5643	41	29	psp	psp	NOUN
fnp-5643	41	30	(	(	PUNCT
fnp-5643	41	31	0	0	NUM
fnp-5643	41	32	 	 	SPACE
fnp-5643	41	33	%	%	NOUN
fnp-5643	41	34	)	)	PUNCT
fnp-5643	41	35	,	,	PUNCT
fnp-5643	41	36	ascribed	ascribe	VERB
fnp-5643	41	37	by	by	ADP
fnp-5643	41	38	the	the	DET
fnp-5643	41	39	authors	author	NOUN
fnp-5643	41	40	to	to	PART
fnp-5643	41	41	sparse	sparse	VERB
fnp-5643	41	42	expression	expression	NOUN
fnp-5643	41	43	of	of	ADP
fnp-5643	41	44	tau	tau	NOUN
fnp-5643	41	45	-	-	PUNCT
fnp-5643	41	46	positive	positive	ADJ
fnp-5643	41	47	psp	psp	NOUN
fnp-5643	41	48	lesions	lesion	NOUN
fnp-5643	41	49	in	in	ADP
fnp-5643	41	50	the	the	DET
fnp-5643	41	51	neocortex	neocortex	NOUN
fnp-5643	41	52	[	[	X
fnp-5643	41	53	18	18	NUM
fnp-5643	41	54	]	]	PUNCT
fnp-5643	41	55	.	.	PUNCT
fnp-5643	42	1	we	we	PRON
fnp-5643	42	2	use	use	VERB
fnp-5643	42	3	the	the	DET
fnp-5643	42	4	below	below	ADV
fnp-5643	42	5	-	-	PUNCT
fnp-5643	42	6	described	describe	VERB
fnp-5643	42	7	protocol	protocol	NOUN
fnp-5643	42	8	for	for	ADP
fnp-5643	42	9	screening	screen	VERB
fnp-5643	42	10	not	not	PART
fnp-5643	42	11	only	only	ADV
fnp-5643	42	12	to	to	PART
fnp-5643	42	13	obtain	obtain	VERB
fnp-5643	42	14	a	a	DET
fnp-5643	42	15	rather	rather	ADV
fnp-5643	42	16	quick	quick	ADJ
fnp-5643	42	17	working	working	NOUN
fnp-5643	42	18	diagnosis	diagnosis	NOUN
fnp-5643	42	19	that	that	PRON
fnp-5643	42	20	allows	allow	VERB
fnp-5643	42	21	to	to	PART
fnp-5643	42	22	diagnose	diagnose	VERB
fnp-5643	42	23	more	more	ADJ
fnp-5643	42	24	than	than	ADP
fnp-5643	42	25	96	96	NUM
fnp-5643	42	26	 	 	SPACE
fnp-5643	42	27	%	%	NOUN
fnp-5643	42	28	of	of	ADP
fnp-5643	42	29	ndds	ndd	NOUN
fnp-5643	42	30	but	but	CCONJ
fnp-5643	42	31	also	also	ADV
fnp-5643	42	32	to	to	PART
fnp-5643	42	33	protect	protect	VERB
fnp-5643	42	34	laboratory	laboratory	NOUN
fnp-5643	42	35	personnel	personnel	NOUN
fnp-5643	42	36	from	from	ADP
fnp-5643	42	37	extensive	extensive	ADJ
fnp-5643	42	38	contact	contact	NOUN
fnp-5643	42	39	with	with	ADP
fnp-5643	42	40	potentially	potentially	ADV
fnp-5643	42	41	prion	prion	NOUN
fnp-5643	42	42	-	-	PUNCT
fnp-5643	42	43	infected	infect	VERB
fnp-5643	42	44	tissue	tissue	NOUN
fnp-5643	42	45	.	.	PUNCT
fnp-5643	43	1	material	material	NOUN
fnp-5643	43	2	and	and	CCONJ
fnp-5643	43	3	methods	method	NOUN
fnp-5643	43	4	in	in	ADP
fnp-5643	43	5	our	our	PRON
fnp-5643	43	6	study	study	NOUN
fnp-5643	43	7	we	we	PRON
fnp-5643	43	8	included	include	VERB
fnp-5643	43	9	133	133	NUM
fnp-5643	43	10	cases	case	NOUN
fnp-5643	43	11	who	who	PRON
fnp-5643	43	12	underwent	undergo	VERB
fnp-5643	43	13	neuropathological	neuropathological	ADJ
fnp-5643	43	14	assessment	assessment	NOUN
fnp-5643	43	15	as	as	ADP
fnp-5643	43	16	brain	brain	NOUN
fnp-5643	43	17	donors	donor	NOUN
fnp-5643	43	18	to	to	ADP
fnp-5643	43	19	the	the	DET
fnp-5643	43	20	neurobiobank	neurobiobank	PROPN
fnp-5643	43	21	munich	munich	PROPN
fnp-5643	43	22	(	(	PUNCT
fnp-5643	43	23	nbm	nbm	PROPN
fnp-5643	43	24	)	)	PUNCT
fnp-5643	43	25	,	,	PUNCT
fnp-5643	43	26	located	locate	VERB
fnp-5643	43	27	at	at	ADP
fnp-5643	43	28	the	the	DET
fnp-5643	43	29	centre	centre	NOUN
fnp-5643	43	30	for	for	ADP
fnp-5643	43	31	neuropathology	neuropathology	NOUN
fnp-5643	43	32	and	and	CCONJ
fnp-5643	43	33	prion	prion	NOUN
fnp-5643	43	34	research	research	NOUN
fnp-5643	43	35	,	,	PUNCT
fnp-5643	43	36	ludwig	ludwig	PROPN
fnp-5643	43	37	-	-	PUNCT
fnp-5643	43	38	maximilians	maximilians	PROPN
fnp-5643	43	39	-	-	PUNCT
fnp-5643	43	40	university	university	NOUN
fnp-5643	43	41	(	(	PUNCT
fnp-5643	43	42	lmu	lmu	PROPN
fnp-5643	43	43	)	)	PUNCT
fnp-5643	43	44	,	,	PUNCT
fnp-5643	43	45	munich	munich	PROPN
fnp-5643	43	46	,	,	PUNCT
fnp-5643	43	47	germany	germany	PROPN
fnp-5643	43	48	.	.	PUNCT
fnp-5643	44	1	the	the	DET
fnp-5643	44	2	collection	collection	NOUN
fnp-5643	44	3	of	of	ADP
fnp-5643	44	4	tissue	tissue	NOUN
fnp-5643	44	5	for	for	ADP
fnp-5643	44	6	the	the	DET
fnp-5643	44	7	nbm	nbm	PROPN
fnp-5643	44	8	was	be	AUX
fnp-5643	44	9	approved	approve	VERB
fnp-5643	44	10	by	by	ADP
fnp-5643	44	11	the	the	DET
fnp-5643	44	12	ethics	ethic	NOUN
fnp-5643	44	13	committee	committee	PROPN
fnp-5643	44	14	of	of	ADP
fnp-5643	44	15	the	the	DET
fnp-5643	44	16	medical	medical	ADJ
fnp-5643	44	17	faculty	faculty	NOUN
fnp-5643	44	18	of	of	ADP
fnp-5643	44	19	the	the	DET
fnp-5643	44	20	lmu	lmu	NOUN
fnp-5643	44	21	(	(	PUNCT
fnp-5643	44	22	no	no	INTJ
fnp-5643	44	23	.	.	PUNCT
fnp-5643	44	24	345‑13	345‑13	NUM
fnp-5643	44	25	)	)	PUNCT
fnp-5643	44	26	.	.	PUNCT
fnp-5643	45	1	after	after	SCONJ
fnp-5643	45	2	the	the	DET
fnp-5643	45	3	brain	brain	NOUN
fnp-5643	45	4	had	have	AUX
fnp-5643	45	5	been	be	AUX
fnp-5643	45	6	removed	remove	VERB
fnp-5643	45	7	,	,	PUNCT
fnp-5643	45	8	one	one	NUM
fnp-5643	45	9	hemisphere	hemisphere	ADV
fnp-5643	45	10	was	be	AUX
fnp-5643	45	11	cryopreserved	cryopreserve	VERB
fnp-5643	45	12	while	while	SCONJ
fnp-5643	45	13	the	the	DET
fnp-5643	45	14	other	other	ADJ
fnp-5643	45	15	hemisphere	hemisphere	NOUN
fnp-5643	45	16	was	be	AUX
fnp-5643	45	17	fixed	fix	VERB
fnp-5643	45	18	for	for	ADP
fnp-5643	45	19	at	at	ADV
fnp-5643	45	20	least	least	ADV
fnp-5643	45	21	two	two	NUM
fnp-5643	45	22	weeks	week	NOUN
fnp-5643	45	23	in	in	ADP
fnp-5643	45	24	4	4	NUM
fnp-5643	45	25	 	 	SPACE
fnp-5643	45	26	%	%	NOUN
fnp-5643	45	27	buffered	buffer	VERB
fnp-5643	45	28	formalin	formalin	NOUN
fnp-5643	45	29	.	.	PUNCT
fnp-5643	46	1	after	after	ADP
fnp-5643	46	2	sufficient	sufficient	ADJ
fnp-5643	46	3	fixation	fixation	NOUN
fnp-5643	46	4	,	,	PUNCT
fnp-5643	46	5	small	small	ADJ
fnp-5643	46	6	tissue	tissue	NOUN
fnp-5643	46	7	specimens	specimen	NOUN
fnp-5643	46	8	(	(	PUNCT
fnp-5643	46	9	1	1	NUM
fnp-5643	46	10	 	 	SPACE
fnp-5643	46	11	x	x	NOUN
fnp-5643	46	12	 	 	SPACE
fnp-5643	46	13	1	1	NUM
fnp-5643	46	14	 	 	SPACE
fnp-5643	46	15	x	x	NOUN
fnp-5643	46	16	 	 	SPACE
fnp-5643	46	17	0.5	0.5	NUM
fnp-5643	46	18	 	 	SPACE
fnp-5643	46	19	cm	cm	NOUN
fnp-5643	46	20	)	)	PUNCT
fnp-5643	46	21	from	from	ADP
fnp-5643	46	22	the	the	DET
fnp-5643	46	23	superior	superior	ADJ
fnp-5643	46	24	frontal	frontal	ADJ
fnp-5643	46	25	gyrus	gyrus	NOUN
fnp-5643	46	26	(	(	PUNCT
fnp-5643	46	27	approximately	approximately	ADV
fnp-5643	46	28	ba	ba	PROPN
fnp-5643	46	29	8)	8)	NUM
fnp-5643	46	30	and	and	CCONJ
fnp-5643	46	31	the	the	DET
fnp-5643	46	32	cerebellum	cerebellum	ADJ
fnp-5643	46	33	(	(	PUNCT
fnp-5643	46	34	lateral	lateral	ADJ
fnp-5643	46	35	cerebellar	cerebellar	ADJ
fnp-5643	46	36	cortex	cortex	NOUN
fnp-5643	46	37	)	)	PUNCT
fnp-5643	46	38	were	be	AUX
fnp-5643	46	39	sampled	sample	VERB
fnp-5643	46	40	,	,	PUNCT
fnp-5643	46	41	treated	treat	VERB
fnp-5643	46	42	with	with	ADP
fnp-5643	46	43	100	100	NUM
fnp-5643	46	44	 	 	SPACE
fnp-5643	46	45	%	%	NOUN
fnp-5643	46	46	formic	formic	ADJ
fnp-5643	46	47	acid	acid	NOUN
fnp-5643	46	48	for	for	ADP
fnp-5643	46	49	one	one	NUM
fnp-5643	46	50	hour	hour	NOUN
fnp-5643	46	51	[	[	X
fnp-5643	46	52	19	19	NUM
fnp-5643	46	53	]	]	PUNCT
fnp-5643	46	54	,	,	PUNCT
fnp-5643	46	55	rinsed	rinse	VERB
fnp-5643	46	56	with	with	ADP
fnp-5643	46	57	water	water	NOUN
fnp-5643	46	58	,	,	PUNCT
fnp-5643	46	59	fixed	fix	VERB
fnp-5643	46	60	in	in	ADP
fnp-5643	46	61	formalin	formalin	NOUN
fnp-5643	46	62	for	for	ADP
fnp-5643	46	63	half	half	DET
fnp-5643	46	64	a	a	DET
fnp-5643	46	65	day	day	NOUN
fnp-5643	46	66	and	and	CCONJ
fnp-5643	46	67	embedded	embed	VERB
fnp-5643	46	68	into	into	ADP
fnp-5643	46	69	the	the	DET
fnp-5643	46	70	same	same	ADJ
fnp-5643	46	71	paraffin	paraffin	NOUN
fnp-5643	46	72	block	block	NOUN
fnp-5643	46	73	.	.	PUNCT
fnp-5643	47	1	tissue	tissue	NOUN
fnp-5643	47	2	sections	section	NOUN
fnp-5643	47	3	were	be	AUX
fnp-5643	47	4	cut	cut	VERB
fnp-5643	47	5	and	and	CCONJ
fnp-5643	47	6	stained	stain	VERB
fnp-5643	47	7	with	with	ADP
fnp-5643	47	8	h&e	h&e	PROPN
fnp-5643	47	9	and	and	CCONJ
fnp-5643	47	10	subjected	subject	VERB
fnp-5643	47	11	to	to	ADP
fnp-5643	47	12	six	six	NUM
fnp-5643	47	13	immunohistochemical	immunohistochemical	ADJ
fnp-5643	47	14	stainings	staining	NOUN
fnp-5643	47	15	for	for	ADP
fnp-5643	47	16	prion	prion	NOUN
fnp-5643	47	17	protein	protein	NOUN
fnp-5643	47	18	(	(	PUNCT
fnp-5643	47	19	clone	clone	NOUN
fnp-5643	47	20	l42	l42	NOUN
fnp-5643	47	21	,	,	PUNCT
fnp-5643	47	22	targeting	target	VERB
fnp-5643	47	23	an	an	DET
fnp-5643	47	24	epitope	epitope	NOUN
fnp-5643	47	25	on	on	ADP
fnp-5643	47	26	the	the	DET
fnp-5643	47	27	first	first	ADJ
fnp-5643	47	28	alpha	alpha	NOUN
fnp-5643	47	29	helix	helix	NOUN
fnp-5643	47	30	[	[	X
fnp-5643	47	31	20	20	NUM
fnp-5643	47	32	]	]	PUNCT
fnp-5643	47	33	,	,	PUNCT
fnp-5643	47	34	1	1	NUM
fnp-5643	47	35	 	 	SPACE
fnp-5643	47	36	:	:	PUNCT
fnp-5643	47	37	 	 	SPACE
fnp-5643	47	38	50	50	NUM
fnp-5643	47	39	 	 	SPACE
fnp-5643	47	40	-	-	PUNCT
fnp-5643	47	41	 	 	SPACE
fnp-5643	47	42	1	1	NUM
fnp-5643	47	43	 	 	SPACE
fnp-5643	47	44	:	:	PUNCT
fnp-5643	47	45	 	 	SPACE
fnp-5643	47	46	100	100	NUM
fnp-5643	47	47	,	,	PUNCT
fnp-5643	47	48	pre	pre	ADJ
fnp-5643	47	49	-	-	NOUN
fnp-5643	47	50	treatment	treatment	NOUN
fnp-5643	47	51	with	with	ADP
fnp-5643	47	52	proteinase	proteinase	PROPN
fnp-5643	47	53	k	k	PROPN
fnp-5643	47	54	,	,	PUNCT
fnp-5643	47	55	own	own	ADJ
fnp-5643	47	56	)	)	PUNCT
fnp-5643	47	57	,	,	PUNCT
fnp-5643	47	58	α	α	X
fnp-5643	47	59	-	-	PUNCT
fnp-5643	47	60	synuclein	synuclein	NOUN
fnp-5643	47	61	(	(	PUNCT
fnp-5643	47	62	clone	clone	NOUN
fnp-5643	47	63	42	42	NUM
fnp-5643	47	64	,	,	PUNCT
fnp-5643	47	65	1	1	NUM
fnp-5643	47	66	 	 	SPACE
fnp-5643	47	67	:	:	PUNCT
fnp-5643	47	68	 	 	SPACE
fnp-5643	47	69	2000	2000	NUM
fnp-5643	47	70	,	,	PUNCT
fnp-5643	47	71	bd	bd	PROPN
fnp-5643	47	72	transduction	transduction	NOUN
fnp-5643	47	73	laboratories	laboratory	NOUN
fnp-5643	47	74	)	)	PUNCT
fnp-5643	47	75	;	;	PUNCT
fnp-5643	48	1	β	β	X
fnp-5643	48	2	-	-	PUNCT
fnp-5643	48	3	amyloid	amyloid	NOUN
fnp-5643	48	4	(	(	PUNCT
fnp-5643	48	5	clone	clone	NOUN
fnp-5643	48	6	4g8	4g8	NUM
fnp-5643	48	7	,	,	PUNCT
fnp-5643	48	8	1	1	NUM
fnp-5643	48	9	 	 	SPACE
fnp-5643	48	10	:	:	PUNCT
fnp-5643	48	11	 	 	SPACE
fnp-5643	48	12	2000	2000	NUM
fnp-5643	48	13	,	,	PUNCT
fnp-5643	48	14	covance	covance	NOUN
fnp-5643	48	15	)	)	PUNCT
fnp-5643	48	16	;	;	PUNCT
fnp-5643	48	17	phospho	phospho	NOUN
fnp-5643	48	18	-	-	PUNCT
fnp-5643	48	19	tau	tau	PROPN
fnp-5643	48	20	(	(	PUNCT
fnp-5643	48	21	clone	clone	PROPN
fnp-5643	48	22	at8	at8	PROPN
fnp-5643	48	23	,	,	PUNCT
fnp-5643	48	24	1	1	NUM
fnp-5643	48	25	 	 	SPACE
fnp-5643	48	26	:	:	PUNCT
fnp-5643	48	27	 	 	SPACE
fnp-5643	48	28	200	200	NUM
fnp-5643	48	29	,	,	PUNCT
fnp-5643	48	30	thermofisher	thermofisher	ADJ
fnp-5643	48	31	scientific	scientific	NOUN
fnp-5643	48	32	)	)	PUNCT
fnp-5643	48	33	;	;	PUNCT
fnp-5643	48	34	phospho	phospho	ADJ
fnp-5643	48	35	-	-	PUNCT
fnp-5643	48	36	tdp-43	tdp-43	NOUN
fnp-5643	48	37	(	(	PUNCT
fnp-5643	48	38	clone	clone	NOUN
fnp-5643	48	39	1d3	1d3	NUM
fnp-5643	48	40	,	,	PUNCT
fnp-5643	48	41	1	1	NUM
fnp-5643	48	42	 	 	SPACE
fnp-5643	48	43	:	:	PUNCT
fnp-5643	48	44	 	 	SPACE
fnp-5643	48	45	50	50	NUM
fnp-5643	48	46	,	,	PUNCT
fnp-5643	48	47	own	own	ADJ
fnp-5643	48	48	)	)	PUNCT
fnp-5643	48	49	;	;	PUNCT
fnp-5643	48	50	p62	p62	NOUN
fnp-5643	48	51	(	(	PUNCT
fnp-5643	48	52	clone	clone	NOUN
fnp-5643	48	53	3	3	NUM
fnp-5643	48	54	/	/	SYM
fnp-5643	48	55	p62	p62	NOUN
fnp-5643	48	56	lck	lck	NOUN
fnp-5643	48	57	ligand	ligand	NOUN
fnp-5643	48	58	,	,	PUNCT
fnp-5643	48	59	1	1	NUM
fnp-5643	48	60	 	 	SPACE
fnp-5643	48	61	:	:	PUNCT
fnp-5643	48	62	 	 	SPACE
fnp-5643	48	63	100	100	NUM
fnp-5643	48	64	,	,	PUNCT
fnp-5643	48	65	bd	bd	PROPN
fnp-5643	48	66	transduction	transduction	NOUN
fnp-5643	48	67	laboratories	laboratory	NOUN
fnp-5643	48	68	)	)	PUNCT
fnp-5643	48	69	)	)	PUNCT
fnp-5643	48	70	.	.	PUNCT
fnp-5643	49	1	stainings	staining	NOUN
fnp-5643	49	2	were	be	AUX
fnp-5643	49	3	performed	perform	VERB
fnp-5643	49	4	using	use	VERB
fnp-5643	49	5	an	an	DET
fnp-5643	49	6	automatic	automatic	ADJ
fnp-5643	49	7	staining	stain	VERB
fnp-5643	49	8	system	system	NOUN
fnp-5643	49	9	(	(	PUNCT
fnp-5643	49	10	roche	roche	PROPN
fnp-5643	49	11	,	,	PUNCT
fnp-5643	49	12	ventana	ventana	PROPN
fnp-5643	49	13	benchmark	benchmark	PROPN
fnp-5643	49	14	ultra	ultra	PROPN
fnp-5643	49	15	)	)	PUNCT
fnp-5643	49	16	.	.	PUNCT
fnp-5643	50	1	if	if	SCONJ
fnp-5643	50	2	required	require	VERB
fnp-5643	50	3	and	and	CCONJ
fnp-5643	50	4	in	in	ADP
fnp-5643	50	5	accordance	accordance	NOUN
fnp-5643	50	6	with	with	ADP
fnp-5643	50	7	the	the	DET
fnp-5643	50	8	respective	respective	ADJ
fnp-5643	50	9	clinical	clinical	ADJ
fnp-5643	50	10	diagnosis	diagnosis	NOUN
fnp-5643	50	11	,	,	PUNCT
fnp-5643	50	12	various	various	ADJ
fnp-5643	50	13	other	other	ADJ
fnp-5643	50	14	immunostainings	immunostaining	NOUN
fnp-5643	50	15	(	(	PUNCT
fnp-5643	50	16	e.g.	e.g.	ADV
fnp-5643	50	17	fus	fus	ADJ
fnp-5643	50	18	,	,	PUNCT
fnp-5643	50	19	3	3	NUM
fnp-5643	50	20	-	-	PUNCT
fnp-5643	50	21	repeat	repeat	NOUN
fnp-5643	50	22	tau	tau	NOUN
fnp-5643	50	23	)	)	PUNCT
fnp-5643	50	24	or	or	CCONJ
fnp-5643	50	25	silver	silver	NOUN
fnp-5643	50	26	impregnation	impregnation	NOUN
fnp-5643	50	27	techniques	technique	NOUN
fnp-5643	50	28	(	(	PUNCT
fnp-5643	50	29	bielschowsky	bielschowsky	NOUN
fnp-5643	50	30	,	,	PUNCT
fnp-5643	50	31	gallyas	gallyas	NOUN
fnp-5643	50	32	)	)	PUNCT
fnp-5643	50	33	were	be	AUX
fnp-5643	50	34	occasionally	occasionally	ADV
fnp-5643	50	35	performed	perform	VERB
fnp-5643	50	36	.	.	PUNCT
fnp-5643	51	1	a	a	DET
fnp-5643	51	2	schematic	schematic	ADJ
fnp-5643	51	3	overview	overview	NOUN
fnp-5643	51	4	of	of	ADP
fnp-5643	51	5	the	the	DET
fnp-5643	51	6	work	work	NOUN
fnp-5643	51	7	-	-	PUNCT
fnp-5643	51	8	up	up	NOUN
fnp-5643	51	9	is	be	AUX
fnp-5643	51	10	presented	present	VERB
fnp-5643	51	11	in	in	ADP
fnp-5643	51	12	figure	figure	NOUN
fnp-5643	51	13	 	 	SPACE
fnp-5643	51	14	1	1	NUM
fnp-5643	51	15	.	.	PUNCT
fnp-5643	52	1	firstly	firstly	ADV
fnp-5643	52	2	,	,	PUNCT
fnp-5643	52	3	we	we	PRON
fnp-5643	52	4	assessed	assess	VERB
fnp-5643	52	5	the	the	DET
fnp-5643	52	6	h&e	h&e	PROPN
fnp-5643	52	7	stain	stain	NOUN
fnp-5643	52	8	for	for	ADP
fnp-5643	52	9	the	the	DET
fnp-5643	52	10	presence	presence	NOUN
fnp-5643	52	11	of	of	ADP
fnp-5643	52	12	general	general	ADJ
fnp-5643	52	13	neurodegenerative	neurodegenerative	ADJ
fnp-5643	52	14	features	feature	NOUN
fnp-5643	52	15	(	(	PUNCT
fnp-5643	52	16	atrophy	atrophy	NOUN
fnp-5643	52	17	,	,	PUNCT
fnp-5643	52	18	neuronal	neuronal	ADJ
fnp-5643	52	19	loss	loss	NOUN
fnp-5643	52	20	,	,	PUNCT
fnp-5643	52	21	spongiosis	spongiosis	NOUN
fnp-5643	52	22	,	,	PUNCT
fnp-5643	52	23	gliosis	gliosis	NOUN
fnp-5643	52	24	)	)	PUNCT
fnp-5643	52	25	and	and	CCONJ
fnp-5643	52	26	various	various	ADJ
fnp-5643	52	27	other	other	ADJ
fnp-5643	52	28	pathological	pathological	ADJ
fnp-5643	52	29	alterations	alteration	NOUN
fnp-5643	52	30	such	such	ADJ
fnp-5643	52	31	as	as	ADP
fnp-5643	52	32	tissue	tissue	NOUN
fnp-5643	52	33	ischemia	ischemia	NOUN
fnp-5643	52	34	/	/	SYM
fnp-5643	52	35	hypoxia	hypoxia	NOUN
fnp-5643	52	36	,	,	PUNCT
fnp-5643	52	37	haemorrhage	haemorrhage	NOUN
fnp-5643	52	38	,	,	PUNCT
fnp-5643	52	39	inflammation	inflammation	NOUN
fnp-5643	52	40	or	or	CCONJ
fnp-5643	52	41	neoplasms	neoplasm	NOUN
fnp-5643	52	42	as	as	ADV
fnp-5643	52	43	well	well	ADV
fnp-5643	52	44	as	as	ADP
fnp-5643	52	45	vascular	vascular	ADJ
fnp-5643	52	46	pathologies	pathology	NOUN
fnp-5643	52	47	.	.	PUNCT
fnp-5643	53	1	furthermore	furthermore	ADV
fnp-5643	53	2	,	,	PUNCT
fnp-5643	53	3	disease	disease	NOUN
fnp-5643	53	4	specific	specific	ADJ
fnp-5643	53	5	alterations	alteration	NOUN
fnp-5643	53	6	e.g.	e.g.	ADV
fnp-5643	53	7	senile	senile	ADJ
fnp-5643	53	8	plaques	plaque	NOUN
fnp-5643	53	9	in	in	ADP
fnp-5643	53	10	ad	ad	NOUN
fnp-5643	53	11	or	or	CCONJ
fnp-5643	53	12	ballooned	balloon	VERB
fnp-5643	53	13	neurons	neuron	NOUN
fnp-5643	53	14	in	in	ADP
fnp-5643	53	15	cbd	cbd	NOUN
fnp-5643	53	16	were	be	AUX
fnp-5643	53	17	examined	examine	VERB
fnp-5643	53	18	on	on	ADP
fnp-5643	53	19	an	an	DET
fnp-5643	53	20	h&e	h&e	PROPN
fnp-5643	53	21	stain	stain	NOUN
fnp-5643	53	22	[	[	X
fnp-5643	53	23	21,22	21,22	NOUN
fnp-5643	53	24	]	]	X
fnp-5643	53	25	.	.	PUNCT
fnp-5643	54	1	figure	figure	NOUN
fnp-5643	54	2	1	1	NUM
fnp-5643	54	3	:	:	PUNCT
fnp-5643	54	4	process	process	NOUN
fnp-5643	54	5	flow	flow	NOUN
fnp-5643	54	6	of	of	ADP
fnp-5643	54	7	fast	fast	ADJ
fnp-5643	54	8	-	-	PUNCT
fnp-5643	54	9	track	track	NOUN
fnp-5643	54	10	screening	screen	VERB
fnp-5643	54	11	histology	histology	NOUN
fnp-5643	54	12	for	for	ADP
fnp-5643	54	13	further	further	ADJ
fnp-5643	54	14	neuropathological	neuropathological	ADJ
fnp-5643	54	15	diagnosis	diagnosis	NOUN
fnp-5643	54	16	,	,	PUNCT
fnp-5643	54	17	we	we	PRON
fnp-5643	54	18	evaluated	evaluate	VERB
fnp-5643	54	19	the	the	DET
fnp-5643	54	20	presence	presence	NOUN
fnp-5643	54	21	of	of	ADP
fnp-5643	54	22	the	the	DET
fnp-5643	54	23	following	follow	VERB
fnp-5643	54	24	morphological	morphological	ADJ
fnp-5643	54	25	features	feature	NOUN
fnp-5643	54	26	by	by	ADP
fnp-5643	54	27	immunohistochemistry	immunohistochemistry	NOUN
fnp-5643	54	28	.	.	PUNCT
fnp-5643	55	1	prion	prion	NOUN
fnp-5643	55	2	protein	protein	NOUN
fnp-5643	55	3	immunoreactive	immunoreactive	ADJ
fnp-5643	55	4	structures	structure	NOUN
fnp-5643	55	5	in	in	ADP
fnp-5643	55	6	a	a	DET
fnp-5643	55	7	synaptic	synaptic	ADJ
fnp-5643	55	8	,	,	PUNCT
fnp-5643	55	9	vacuolar	vacuolar	ADJ
fnp-5643	55	10	,	,	PUNCT
fnp-5643	55	11	laminar	laminar	ADJ
fnp-5643	55	12	cortical	cortical	ADJ
fnp-5643	55	13	or	or	CCONJ
fnp-5643	55	14	coarse	coarse	NOUN
fnp-5643	55	15	pattern	pattern	NOUN
fnp-5643	55	16	,	,	PUNCT
fnp-5643	55	17	plaque	plaque	NOUN
fnp-5643	55	18	-	-	PUNCT
fnp-5643	55	19	like	like	ADJ
fnp-5643	55	20	focal	focal	ADJ
fnp-5643	55	21	deposits	deposit	NOUN
fnp-5643	55	22	or	or	CCONJ
fnp-5643	55	23	amyloid	amyloid	NOUN
fnp-5643	55	24	-	-	PUNCT
fnp-5643	55	25	kuru	kuru	NOUN
fnp-5643	55	26	plaques	plaque	NOUN
fnp-5643	55	27	were	be	AUX
fnp-5643	55	28	searched	search	VERB
fnp-5643	55	29	to	to	PART
fnp-5643	55	30	diagnose	diagnose	VERB
fnp-5643	55	31	prion	prion	NOUN
fnp-5643	55	32	disease	disease	NOUN
fnp-5643	55	33	[	[	X
fnp-5643	55	34	23	23	NUM
fnp-5643	55	35	]	]	PUNCT
fnp-5643	55	36	.	.	PUNCT
fnp-5643	56	1	4g8	4g8	NUM
fnp-5643	56	2	-	-	ADJ
fnp-5643	56	3	positive	positive	ADJ
fnp-5643	56	4	amyloid	amyloid	NOUN
fnp-5643	56	5	β	β	X
fnp-5643	56	6	(	(	PUNCT
fnp-5643	56	7	aβ	aβ	NOUN
fnp-5643	56	8	)	)	PUNCT
fnp-5643	56	9	plaques	plaque	NOUN
fnp-5643	56	10	,	,	PUNCT
fnp-5643	56	11	tau	tau	NOUN
fnp-5643	56	12	-	-	PUNCT
fnp-5643	56	13	immunoreactive	immunoreactive	ADJ
fnp-5643	56	14	neurofibrillary	neurofibrillary	ADJ
fnp-5643	56	15	tangles	tangle	NOUN
fnp-5643	56	16	(	(	PUNCT
fnp-5643	56	17	nft	nft	PROPN
fnp-5643	56	18	)	)	PUNCT
fnp-5643	56	19	,	,	PUNCT
fnp-5643	56	20	neuropil	neuropil	NOUN
fnp-5643	56	21	threads	thread	NOUN
fnp-5643	56	22	(	(	PUNCT
fnp-5643	56	23	nt	not	PART
fnp-5643	56	24	)	)	PUNCT
fnp-5643	56	25	and	and	CCONJ
fnp-5643	56	26	neuritic	neuritic	ADJ
fnp-5643	56	27	plaques	plaque	NOUN
fnp-5643	56	28	(	(	PUNCT
fnp-5643	56	29	np	np	X
fnp-5643	56	30	)	)	PUNCT
fnp-5643	56	31	were	be	AUX
fnp-5643	56	32	used	use	VERB
fnp-5643	56	33	for	for	ADP
fnp-5643	56	34	the	the	DET
fnp-5643	56	35	fast	fast	ADJ
fnp-5643	56	36	-	-	PUNCT
fnp-5643	56	37	track	track	NOUN
fnp-5643	56	38	diagnosis	diagnosis	NOUN
fnp-5643	56	39	of	of	ADP
fnp-5643	56	40	higher	high	ADJ
fnp-5643	56	41	stages	stage	NOUN
fnp-5643	56	42	of	of	ADP
fnp-5643	56	43	ad	ad	NOUN
fnp-5643	56	44	associated	associate	VERB
fnp-5643	56	45	pathology	pathology	NOUN
fnp-5643	56	46	[	[	X
fnp-5643	56	47	9,24	9,24	X
fnp-5643	56	48	]	]	X
fnp-5643	56	49	.	.	PUNCT
fnp-5643	57	1	the	the	DET
fnp-5643	57	2	diagnosis	diagnosis	NOUN
fnp-5643	57	3	of	of	ADP
fnp-5643	57	4	psp	psp	NOUN
fnp-5643	57	5	was	be	AUX
fnp-5643	57	6	made	make	VERB
fnp-5643	57	7	when	when	SCONJ
fnp-5643	57	8	nt	not	PART
fnp-5643	57	9	,	,	PUNCT
fnp-5643	57	10	nft	nft	PROPN
fnp-5643	57	11	,	,	PUNCT
fnp-5643	57	12	neuronal	neuronal	ADJ
fnp-5643	57	13	cytoplasmic	cytoplasmic	ADJ
fnp-5643	57	14	inclusions	inclusion	NOUN
fnp-5643	57	15	(	(	PUNCT
fnp-5643	57	16	nci	nci	PROPN
fnp-5643	57	17	)	)	PUNCT
fnp-5643	57	18	,	,	PUNCT
fnp-5643	57	19	tufted	tufte	VERB
fnp-5643	57	20	astrocytes	astrocyte	NOUN
fnp-5643	57	21	(	(	PUNCT
fnp-5643	57	22	ta	ta	NOUN
fnp-5643	57	23	)	)	PUNCT
fnp-5643	57	24	and	and	CCONJ
fnp-5643	57	25	oligodendroglial	oligodendroglial	ADJ
fnp-5643	57	26	coiled	coil	VERB
fnp-5643	57	27	bodies	body	NOUN
fnp-5643	57	28	(	(	PUNCT
fnp-5643	57	29	cb	cb	NOUN
fnp-5643	57	30	)	)	PUNCT
fnp-5643	57	31	were	be	AUX
fnp-5643	57	32	visible	visible	ADJ
fnp-5643	57	33	[	[	X
fnp-5643	57	34	25,26,27	25,26,27	NUM
fnp-5643	57	35	]	]	X
fnp-5643	57	36	.	.	PUNCT
fnp-5643	58	1	nci	nci	PROPN
fnp-5643	58	2	,	,	PUNCT
fnp-5643	58	3	nt	not	PART
fnp-5643	58	4	,	,	PUNCT
fnp-5643	58	5	cb	cb	PROPN
fnp-5643	58	6	and	and	CCONJ
fnp-5643	58	7	most	most	ADV
fnp-5643	58	8	notably	notably	ADV
fnp-5643	58	9	astrocytic	astrocytic	ADJ
fnp-5643	58	10	plaques	plaque	NOUN
fnp-5643	58	11	(	(	PUNCT
fnp-5643	58	12	ap	ap	PROPN
fnp-5643	58	13	)	)	PUNCT
fnp-5643	58	14	were	be	AUX
fnp-5643	58	15	highly	highly	ADV
fnp-5643	58	16	suggestive	suggestive	ADJ
fnp-5643	58	17	for	for	ADP
fnp-5643	58	18	cbd	cbd	NOUN
fnp-5643	58	19	[	[	X
fnp-5643	58	20	27,28	27,28	NOUN
fnp-5643	58	21	]	]	X
fnp-5643	58	22	.	.	PUNCT
fnp-5643	59	1	pick	pick	VERB
fnp-5643	59	2	bodies	body	NOUN
fnp-5643	59	3	(	(	PUNCT
fnp-5643	59	4	pib	pib	NOUN
fnp-5643	59	5	)	)	PUNCT
fnp-5643	59	6	were	be	AUX
fnp-5643	59	7	the	the	DET
fnp-5643	59	8	characteristic	characteristic	ADJ
fnp-5643	59	9	hallmark	hallmark	NOUN
fnp-5643	59	10	of	of	ADP
fnp-5643	59	11	pid	pid	NOUN
fnp-5643	60	1	[	[	X
fnp-5643	60	2	29	29	NUM
fnp-5643	60	3	]	]	PUNCT
fnp-5643	60	4	.	.	PUNCT
fnp-5643	61	1	intraneuronal	intraneuronal	PROPN
fnp-5643	61	2	α	α	PROPN
fnp-5643	61	3	-	-	PUNCT
fnp-5643	61	4	synuclein	synuclein	ADJ
fnp-5643	61	5	positive	positive	ADJ
fnp-5643	61	6	lewy	lewy	ADJ
fnp-5643	61	7	bodies	body	NOUN
fnp-5643	61	8	(	(	PUNCT
fnp-5643	61	9	lb	lb	NOUN
fnp-5643	61	10	)	)	PUNCT
fnp-5643	61	11	,	,	PUNCT
fnp-5643	61	12	extracellular	extracellular	ADJ
fnp-5643	61	13	lewy	lewy	ADJ
fnp-5643	61	14	body	body	NOUN
fnp-5643	61	15	-	-	PUNCT
fnp-5643	61	16	like	like	ADJ
fnp-5643	61	17	inclusions	inclusion	NOUN
fnp-5643	61	18	,	,	PUNCT
fnp-5643	61	19	lewy	lewy	PROPN
fnp-5643	61	20	neurites	neurites	PROPN
fnp-5643	61	21	(	(	PUNCT
fnp-5643	61	22	ln	ln	ADJ
fnp-5643	61	23	)	)	PUNCT
fnp-5643	61	24	and	and	CCONJ
fnp-5643	61	25	grain	grain	NOUN
fnp-5643	61	26	-	-	PUNCT
fnp-5643	61	27	like	like	ADJ
fnp-5643	61	28	cytoplasmic	cytoplasmic	ADJ
fnp-5643	61	29	inclusions	inclusion	NOUN
fnp-5643	61	30	are	be	AUX
fnp-5643	61	31	present	present	ADJ
fnp-5643	61	32	in	in	ADP
fnp-5643	61	33	lbd	lbd	PROPN
fnp-5643	61	34	[	[	X
fnp-5643	61	35	30	30	NUM
fnp-5643	61	36	]	]	PUNCT
fnp-5643	61	37	.	.	PUNCT
fnp-5643	62	1	given	give	VERB
fnp-5643	62	2	the	the	DET
fnp-5643	62	3	overlapping	overlapping	NOUN
fnp-5643	62	4	and	and	CCONJ
fnp-5643	62	5	,	,	PUNCT
fnp-5643	62	6	if	if	SCONJ
fnp-5643	62	7	at	at	ADV
fnp-5643	62	8	all	all	ADV
fnp-5643	62	9	,	,	PUNCT
fnp-5643	62	10	not	not	PART
fnp-5643	62	11	readily	readily	ADV
fnp-5643	62	12	distinguishable	distinguishable	ADJ
fnp-5643	62	13	neuropathological	neuropathological	ADJ
fnp-5643	62	14	features	feature	NOUN
fnp-5643	62	15	of	of	ADP
fnp-5643	62	16	pd	pd	PROPN
fnp-5643	62	17	,	,	PUNCT
fnp-5643	62	18	dlb	dlb	NOUN
fnp-5643	62	19	and	and	CCONJ
fnp-5643	62	20	parkinson	parkinson	NOUN
fnp-5643	62	21	’s	’s	PART
fnp-5643	62	22	disease	disease	NOUN
fnp-5643	62	23	dementia	dementia	NOUN
fnp-5643	62	24	[	[	X
fnp-5643	62	25	31,32	31,32	NUM
fnp-5643	62	26	]	]	PUNCT
fnp-5643	62	27	,	,	PUNCT
fnp-5643	62	28	we	we	PRON
fnp-5643	62	29	summarized	summarize	VERB
fnp-5643	62	30	these	these	DET
fnp-5643	62	31	three	three	NUM
fnp-5643	62	32	entities	entity	NOUN
fnp-5643	62	33	under	under	ADP
fnp-5643	62	34	the	the	DET
fnp-5643	62	35	umbrella	umbrella	NOUN
fnp-5643	62	36	term	term	NOUN
fnp-5643	62	37	lbd	lbd	PROPN
fnp-5643	62	38	.	.	PUNCT
fnp-5643	63	1	msa	msa	PROPN
fnp-5643	63	2	is	be	AUX
fnp-5643	63	3	characterised	characterise	VERB
fnp-5643	63	4	by	by	ADP
fnp-5643	63	5	α	α	NOUN
fnp-5643	63	6	-	-	PUNCT
fnp-5643	63	7	synuclein	synuclein	X
fnp-5643	63	8	immunoreactive	immunoreactive	ADJ
fnp-5643	63	9	glial	glial	ADJ
fnp-5643	63	10	cytoplasmic	cytoplasmic	ADJ
fnp-5643	63	11	inclusions	inclusion	NOUN
fnp-5643	63	12	(	(	PUNCT
fnp-5643	63	13	gci	gci	X
fnp-5643	63	14	)	)	PUNCT
fnp-5643	64	1	[	[	X
fnp-5643	64	2	3	3	NUM
fnp-5643	64	3	]	]	PUNCT
fnp-5643	64	4	.	.	PUNCT
fnp-5643	65	1	phospho	phospho	ADJ
fnp-5643	65	2	-	-	PUNCT
fnp-5643	65	3	tdp-43	tdp-43	NOUN
fnp-5643	65	4	positive	positive	ADJ
fnp-5643	65	5	neuronal	neuronal	ADJ
fnp-5643	65	6	and	and	CCONJ
fnp-5643	65	7	glial	glial	ADJ
fnp-5643	65	8	intracytoplasmic	intracytoplasmic	ADJ
fnp-5643	65	9	inclusions	inclusion	NOUN
fnp-5643	65	10	as	as	ADV
fnp-5643	65	11	well	well	ADV
fnp-5643	65	12	as	as	ADP
fnp-5643	65	13	dystrophic	dystrophic	ADJ
fnp-5643	65	14	neurites	neurite	NOUN
fnp-5643	65	15	can	can	AUX
fnp-5643	65	16	be	be	AUX
fnp-5643	65	17	found	find	VERB
fnp-5643	65	18	in	in	ADP
fnp-5643	65	19	ftld	ftld	ADJ
fnp-5643	65	20	-	-	PUNCT
fnp-5643	65	21	tdp	tdp	NOUN
fnp-5643	65	22	[	[	X
fnp-5643	65	23	34	34	NUM
fnp-5643	65	24	]	]	PUNCT
fnp-5643	65	25	.	.	PUNCT
fnp-5643	66	1	for	for	ADP
fnp-5643	66	2	ftld	ftld	ADJ
fnp-5643	66	3	cases	case	NOUN
fnp-5643	66	4	without	without	ADP
fnp-5643	66	5	tauor	tauor	NOUN
fnp-5643	66	6	tdp-43	tdp-43	NOUN
fnp-5643	66	7	-	-	PUNCT
fnp-5643	66	8	positive	positive	ADJ
fnp-5643	66	9	inclusions	inclusion	NOUN
fnp-5643	66	10	,	,	PUNCT
fnp-5643	66	11	immunostaining	immunostaine	VERB
fnp-5643	66	12	for	for	ADP
fnp-5643	66	13	the	the	DET
fnp-5643	66	14	ubiquitin	ubiquitin	ADJ
fnp-5643	66	15	binding	bind	VERB
fnp-5643	66	16	protein	protein	NOUN
fnp-5643	66	17	p62	p62	NOUN
fnp-5643	66	18	detecting	detect	VERB
fnp-5643	66	19	cytoplasmic	cytoplasmic	ADJ
fnp-5643	66	20	glial	glial	ADJ
fnp-5643	66	21	/	/	SYM
fnp-5643	66	22	neuronal	neuronal	ADJ
fnp-5643	66	23	inclusions	inclusion	NOUN
fnp-5643	66	24	,	,	PUNCT
fnp-5643	66	25	neuronal	neuronal	ADJ
fnp-5643	66	26	nuclear	nuclear	ADJ
fnp-5643	66	27	inclusions	inclusion	NOUN
fnp-5643	66	28	,	,	PUNCT
fnp-5643	66	29	threads	thread	NOUN
fnp-5643	66	30	provides	provide	VERB
fnp-5643	66	31	a	a	DET
fnp-5643	66	32	valuable	valuable	ADJ
fnp-5643	66	33	tool	tool	NOUN
fnp-5643	66	34	prompting	prompt	VERB
fnp-5643	66	35	further	further	ADJ
fnp-5643	66	36	immunohistochemical	immunohistochemical	ADJ
fnp-5643	66	37	characterisation	characterisation	NOUN
fnp-5643	66	38	[	[	X
fnp-5643	66	39	34,35	34,35	NOUN
fnp-5643	66	40	]	]	PUNCT
fnp-5643	66	41	.	.	PUNCT
fnp-5643	67	1	representative	representative	ADJ
fnp-5643	67	2	micrographs	micrograph	NOUN
fnp-5643	67	3	of	of	ADP
fnp-5643	67	4	characteristic	characteristic	ADJ
fnp-5643	67	5	histomorphological	histomorphological	ADJ
fnp-5643	67	6	findings	finding	NOUN
fnp-5643	67	7	and	and	CCONJ
fnp-5643	67	8	protein	protein	NOUN
fnp-5643	67	9	deposits	deposit	NOUN
fnp-5643	67	10	are	be	AUX
fnp-5643	67	11	shown	show	VERB
fnp-5643	67	12	in	in	ADP
fnp-5643	67	13	figure	figure	NOUN
fnp-5643	67	14	 	 	SPACE
fnp-5643	67	15	2	2	NUM
fnp-5643	67	16	.	.	PUNCT
fnp-5643	68	1	a	a	DET
fnp-5643	68	2	decision	decision	NOUN
fnp-5643	68	3	diagram	diagram	NOUN
fnp-5643	68	4	showing	show	VERB
fnp-5643	68	5	a	a	DET
fnp-5643	68	6	representative	representative	ADJ
fnp-5643	68	7	guide	guide	NOUN
fnp-5643	68	8	to	to	PART
fnp-5643	68	9	make	make	VERB
fnp-5643	68	10	a	a	DET
fnp-5643	68	11	screening	screening	NOUN
fnp-5643	68	12	diagnosis	diagnosis	NOUN
fnp-5643	68	13	according	accord	VERB
fnp-5643	68	14	to	to	ADP
fnp-5643	68	15	characteristic	characteristic	ADJ
fnp-5643	68	16	histological	histological	ADJ
fnp-5643	68	17	findings	finding	NOUN
fnp-5643	68	18	is	be	AUX
fnp-5643	68	19	shown	show	VERB
fnp-5643	68	20	in	in	ADP
fnp-5643	68	21	figure	figure	NOUN
fnp-5643	68	22	 	 	SPACE
fnp-5643	68	23	3	3	NUM
fnp-5643	68	24	.	.	PUNCT
fnp-5643	68	25	figure	figure	NOUN
fnp-5643	68	26	2	2	NUM
fnp-5643	68	27	:	:	PUNCT
fnp-5643	68	28	representative	representative	ADJ
fnp-5643	68	29	micrographs	micrograph	NOUN
fnp-5643	68	30	of	of	ADP
fnp-5643	68	31	characteristic	characteristic	ADJ
fnp-5643	68	32	histological	histological	ADJ
fnp-5643	68	33	findings	finding	NOUN
fnp-5643	68	34	.	.	PUNCT
fnp-5643	69	1	a1	a1	NOUN
fnp-5643	69	2	:	:	PUNCT
fnp-5643	69	3	eosinophilic	eosinophilic	ADJ
fnp-5643	69	4	plaque	plaque	NOUN
fnp-5643	69	5	in	in	ADP
fnp-5643	69	6	ad	ad	NOUN
fnp-5643	69	7	.	.	PUNCT
fnp-5643	70	1	a2	a2	PROPN
fnp-5643	70	2	:	:	PUNCT
fnp-5643	70	3	strongly	strongly	ADV
fnp-5643	70	4	stained	stain	VERB
fnp-5643	70	5	neuropil	neuropil	NOUN
fnp-5643	70	6	(	(	PUNCT
fnp-5643	70	7	at8	at8	PROPN
fnp-5643	70	8	)	)	PUNCT
fnp-5643	70	9	with	with	ADP
fnp-5643	70	10	numerous	numerous	ADJ
fnp-5643	70	11	intraneuronal	intraneuronal	ADJ
fnp-5643	70	12	inclusions	inclusion	NOUN
fnp-5643	70	13	ad	ad	NOUN
fnp-5643	70	14	.	.	PUNCT
fnp-5643	70	15	a3	a3	PROPN
fnp-5643	70	16	:	:	PUNCT
fnp-5643	71	1	at8	at8	NOUN
fnp-5643	71	2	-	-	ADJ
fnp-5643	71	3	positive	positive	ADJ
fnp-5643	71	4	neuronal	neuronal	ADJ
fnp-5643	71	5	inclusion	inclusion	NOUN
fnp-5643	71	6	(	(	PUNCT
fnp-5643	71	7	star	star	NOUN
fnp-5643	71	8	)	)	PUNCT
fnp-5643	71	9	,	,	PUNCT
fnp-5643	71	10	neuropil	neuropil	NOUN
fnp-5643	71	11	thread	thread	NOUN
fnp-5643	71	12	(	(	PUNCT
fnp-5643	71	13	arrowhead	arrowhead	NOUN
fnp-5643	71	14	)	)	PUNCT
fnp-5643	71	15	and	and	CCONJ
fnp-5643	71	16	a	a	DET
fnp-5643	71	17	neuritic	neuritic	ADJ
fnp-5643	71	18	plaque	plaque	NOUN
fnp-5643	71	19	(	(	PUNCT
fnp-5643	71	20	arrow	arrow	NOUN
fnp-5643	71	21	)	)	PUNCT
fnp-5643	71	22	in	in	ADP
fnp-5643	71	23	ad	ad	NOUN
fnp-5643	71	24	.	.	PUNCT
fnp-5643	72	1	a4	a4	NUM
fnp-5643	72	2	:	:	PUNCT
fnp-5643	72	3	cored	core	VERB
fnp-5643	72	4	(	(	PUNCT
fnp-5643	72	5	arrows	arrow	NOUN
fnp-5643	72	6	)	)	PUNCT
fnp-5643	72	7	and	and	CCONJ
fnp-5643	72	8	diffuse	diffuse	VERB
fnp-5643	72	9	aβ	aβ	NOUN
fnp-5643	72	10	-	-	NOUN
fnp-5643	72	11	plaques	plaque	NOUN
fnp-5643	72	12	in	in	ADP
fnp-5643	72	13	ad	ad	NOUN
fnp-5643	72	14	.	.	PUNCT
fnp-5643	73	1	a5	a5	NOUN
fnp-5643	73	2	:	:	PUNCT
fnp-5643	73	3	parenchymal	parenchymal	ADJ
fnp-5643	73	4	and	and	CCONJ
fnp-5643	73	5	leptomeningeal	leptomeningeal	ADJ
fnp-5643	73	6	amyloid	amyloid	NOUN
fnp-5643	73	7	deposits	deposit	NOUN
fnp-5643	73	8	in	in	ADP
fnp-5643	73	9	vessel	vessel	ADJ
fnp-5643	73	10	walls	wall	NOUN
fnp-5643	73	11	(	(	PUNCT
fnp-5643	73	12	cerebral	cerebral	ADJ
fnp-5643	73	13	amyloid	amyloid	NOUN
fnp-5643	73	14	angiopathy	angiopathy	NOUN
fnp-5643	73	15	,	,	PUNCT
fnp-5643	73	16	arrows	arrow	NOUN
fnp-5643	73	17	)	)	PUNCT
fnp-5643	73	18	in	in	ADP
fnp-5643	73	19	an	an	DET
fnp-5643	73	20	ad	ad	NOUN
fnp-5643	73	21	patient	patient	NOUN
fnp-5643	73	22	.	.	PUNCT
fnp-5643	74	1	a6	a6	NOUN
fnp-5643	74	2	:	:	PUNCT
fnp-5643	74	3	signs	sign	NOUN
fnp-5643	74	4	of	of	ADP
fnp-5643	74	5	aging	age	VERB
fnp-5643	74	6	-	-	PUNCT
fnp-5643	74	7	related	relate	VERB
fnp-5643	74	8	tau	tau	NOUN
fnp-5643	74	9	astrogliopathy	astrogliopathy	ADJ
fnp-5643	74	10	with	with	ADP
fnp-5643	74	11	perivascular	perivascular	ADJ
fnp-5643	74	12	accentuation	accentuation	NOUN
fnp-5643	74	13	(	(	PUNCT
fnp-5643	74	14	inset	inset	NOUN
fnp-5643	74	15	with	with	ADP
fnp-5643	74	16	higher	high	ADJ
fnp-5643	74	17	magnification	magnification	NOUN
fnp-5643	74	18	)	)	PUNCT
fnp-5643	74	19	as	as	ADP
fnp-5643	74	20	common	common	ADJ
fnp-5643	74	21	co	co	NOUN
fnp-5643	74	22	-	-	NOUN
fnp-5643	74	23	pathology	pathology	NOUN
fnp-5643	74	24	in	in	ADP
fnp-5643	74	25	ad	ad	NOUN
fnp-5643	74	26	.	.	PUNCT
fnp-5643	75	1	b1	b1	PROPN
fnp-5643	75	2	,	,	PUNCT
fnp-5643	75	3	b2	b2	NOUN
fnp-5643	75	4	,	,	PUNCT
fnp-5643	75	5	b3	b3	PROPN
fnp-5643	75	6	:	:	PUNCT
fnp-5643	75	7	psp	psp	NOUN
fnp-5643	75	8	with	with	ADP
fnp-5643	75	9	less	less	ADV
fnp-5643	75	10	pronounced	pronounced	ADJ
fnp-5643	75	11	positivity	positivity	NOUN
fnp-5643	75	12	of	of	ADP
fnp-5643	75	13	the	the	DET
fnp-5643	75	14	neuropil	neuropil	NOUN
fnp-5643	75	15	,	,	PUNCT
fnp-5643	75	16	frequent	frequent	ADJ
fnp-5643	75	17	ta	ta	PROPN
fnp-5643	75	18	(	(	PUNCT
fnp-5643	75	19	arrows	arrow	NOUN
fnp-5643	75	20	)	)	PUNCT
fnp-5643	75	21	,	,	PUNCT
fnp-5643	75	22	nft	nft	PROPN
fnp-5643	75	23	(	(	PUNCT
fnp-5643	75	24	arrowhead	arrowhead	NOUN
fnp-5643	75	25	)	)	PUNCT
fnp-5643	75	26	and	and	CCONJ
fnp-5643	75	27	oligodendroglial	oligodendroglial	ADJ
fnp-5643	75	28	cb	cb	PROPN
fnp-5643	75	29	(	(	PUNCT
fnp-5643	75	30	stars	star	NOUN
fnp-5643	75	31	)	)	PUNCT
fnp-5643	75	32	.	.	PUNCT
fnp-5643	76	1	c1	c1	NOUN
fnp-5643	76	2	:	:	PUNCT
fnp-5643	76	3	ballooned	balloon	VERB
fnp-5643	76	4	neuron	neuron	NOUN
fnp-5643	76	5	in	in	ADP
fnp-5643	76	6	cbd	cbd	PROPN
fnp-5643	76	7	.	.	PUNCT
fnp-5643	77	1	c2	c2	PROPN
fnp-5643	77	2	,	,	PUNCT
fnp-5643	77	3	c3	c3	PROPN
fnp-5643	77	4	:	:	PUNCT
fnp-5643	77	5	overview	overview	NOUN
fnp-5643	77	6	of	of	ADP
fnp-5643	77	7	a	a	DET
fnp-5643	77	8	cbd	cbd	NOUN
fnp-5643	77	9	case	case	NOUN
fnp-5643	77	10	showing	show	VERB
fnp-5643	77	11	moderate	moderate	ADJ
fnp-5643	77	12	nt	not	PART
fnp-5643	77	13	,	,	PUNCT
fnp-5643	77	14	neuronal	neuronal	ADJ
fnp-5643	77	15	inclusions	inclusion	NOUN
fnp-5643	77	16	and	and	CCONJ
fnp-5643	77	17	ap	ap	PROPN
fnp-5643	77	18	(	(	PUNCT
fnp-5643	77	19	c3	c3	PROPN
fnp-5643	77	20	)	)	PUNCT
fnp-5643	77	21	.	.	PUNCT
fnp-5643	78	1	hallmarks	hallmark	NOUN
fnp-5643	78	2	of	of	ADP
fnp-5643	78	3	pid	pid	NOUN
fnp-5643	78	4	include	include	VERB
fnp-5643	78	5	a	a	DET
fnp-5643	78	6	ballooned	balloon	VERB
fnp-5643	78	7	neuron	neuron	NOUN
fnp-5643	78	8	(	(	PUNCT
fnp-5643	78	9	d1	d1	PROPN
fnp-5643	78	10	)	)	PUNCT
fnp-5643	78	11	,	,	PUNCT
fnp-5643	78	12	at8	at8	PROPN
fnp-5643	78	13	-	-	ADJ
fnp-5643	78	14	positive	positive	ADJ
fnp-5643	78	15	pick	pick	NOUN
fnp-5643	78	16	bodies	body	NOUN
fnp-5643	78	17	(	(	PUNCT
fnp-5643	78	18	d2	d2	PROPN
fnp-5643	78	19	,	,	PUNCT
fnp-5643	78	20	arrowheads	arrowhead	NOUN
fnp-5643	78	21	)	)	PUNCT
fnp-5643	78	22	as	as	ADV
fnp-5643	78	23	well	well	ADV
fnp-5643	78	24	as	as	ADP
fnp-5643	78	25	a	a	DET
fnp-5643	78	26	ramified	ramified	ADJ
fnp-5643	78	27	astrocyte	astrocyte	NOUN
fnp-5643	78	28	(	(	PUNCT
fnp-5643	78	29	d3	d3	PROPN
fnp-5643	78	30	)	)	PUNCT
fnp-5643	78	31	.	.	PUNCT
fnp-5643	79	1	e1	e1	PROPN
fnp-5643	79	2	,	,	PUNCT
fnp-5643	79	3	e2	e2	PROPN
fnp-5643	79	4	:	:	PUNCT
fnp-5643	79	5	lewy	lewy	PROPN
fnp-5643	79	6	bodies	body	NOUN
fnp-5643	79	7	in	in	ADP
fnp-5643	79	8	ldb	ldb	PROPN
fnp-5643	79	9	(	(	PUNCT
fnp-5643	79	10	arrowhead	arrowhead	NOUN
fnp-5643	79	11	,	,	PUNCT
fnp-5643	79	12	stars	star	NOUN
fnp-5643	79	13	;	;	PUNCT
fnp-5643	79	14	rarely	rarely	ADV
fnp-5643	79	15	visible	visible	ADJ
fnp-5643	79	16	in	in	ADP
fnp-5643	79	17	he	he	PRON
fnp-5643	79	18	-	-	PUNCT
fnp-5643	79	19	stain	stain	NOUN
fnp-5643	79	20	)	)	PUNCT
fnp-5643	79	21	.	.	PUNCT
fnp-5643	80	1	f	f	X
fnp-5643	80	2	:	:	PUNCT
fnp-5643	80	3	numerous	numerous	ADJ
fnp-5643	80	4	cerebellar	cerebellar	ADJ
fnp-5643	80	5	gci	gci	PROPN
fnp-5643	80	6	in	in	ADP
fnp-5643	80	7	msa	msa	PROPN
fnp-5643	80	8	.	.	PUNCT
fnp-5643	80	9	g1	g1	PROPN
fnp-5643	80	10	,	,	PUNCT
fnp-5643	80	11	g2	g2	PROPN
fnp-5643	80	12	,	,	PUNCT
fnp-5643	80	13	g3	g3	PROPN
fnp-5643	80	14	:	:	PUNCT
fnp-5643	80	15	various	various	ADJ
fnp-5643	80	16	ptdp-43	ptdp-43	ADJ
fnp-5643	80	17	-	-	PUNCT
fnp-5643	80	18	positive	positive	ADJ
fnp-5643	80	19	dystrophic	dystrophic	ADJ
fnp-5643	80	20	neurites	neurite	NOUN
fnp-5643	80	21	(	(	PUNCT
fnp-5643	80	22	g1	g1	PROPN
fnp-5643	80	23	)	)	PUNCT
fnp-5643	80	24	,	,	PUNCT
fnp-5643	80	25	compact	compact	ADJ
fnp-5643	80	26	neuronal	neuronal	ADJ
fnp-5643	80	27	(	(	PUNCT
fnp-5643	80	28	g2	g2	PROPN
fnp-5643	80	29	)	)	PUNCT
fnp-5643	80	30	and	and	CCONJ
fnp-5643	80	31	neuronal	neuronal	ADJ
fnp-5643	80	32	cat	cat	NOUN
fnp-5643	80	33	-	-	PUNCT
fnp-5643	80	34	eye	eye	NOUN
fnp-5643	80	35	shaped	shape	VERB
fnp-5643	80	36	(	(	PUNCT
fnp-5643	80	37	g3	g3	NOUN
fnp-5643	80	38	)	)	PUNCT
fnp-5643	80	39	inclusions	inclusion	NOUN
fnp-5643	80	40	in	in	ADP
fnp-5643	80	41	ftld	ftld	ADJ
fnp-5643	80	42	-	-	PUNCT
fnp-5643	80	43	tdp	tdp	NOUN
fnp-5643	80	44	.	.	PUNCT
fnp-5643	81	1	g4	g4	NOUN
fnp-5643	81	2	:	:	PUNCT
fnp-5643	81	3	tdp-43	tdp-43	NOUN
fnp-5643	81	4	-	-	PUNCT
fnp-5643	81	5	negative	negative	ADJ
fnp-5643	81	6	,	,	PUNCT
fnp-5643	81	7	p62	p62	NOUN
fnp-5643	81	8	-	-	PUNCT
fnp-5643	81	9	positive	positive	ADJ
fnp-5643	81	10	globular	globular	ADJ
fnp-5643	81	11	inclusion	inclusion	NOUN
fnp-5643	81	12	in	in	ADP
fnp-5643	81	13	ftld	ftld	ADJ
fnp-5643	81	14	-	-	PUNCT
fnp-5643	81	15	fus	fus	PROPN
fnp-5643	81	16	(	(	PUNCT
fnp-5643	81	17	arrowhead	arrowhead	NOUN
fnp-5643	81	18	)	)	PUNCT
fnp-5643	81	19	.	.	PUNCT
fnp-5643	82	1	g5	g5	NOUN
fnp-5643	82	2	:	:	PUNCT
fnp-5643	82	3	typical	typical	ADJ
fnp-5643	82	4	star	star	NOUN
fnp-5643	82	5	-	-	PUNCT
fnp-5643	82	6	shaped	shape	VERB
fnp-5643	82	7	p62	p62	NOUN
fnp-5643	82	8	-	-	PUNCT
fnp-5643	82	9	positive	positive	ADJ
fnp-5643	82	10	inclusion	inclusion	NOUN
fnp-5643	82	11	in	in	ADP
fnp-5643	82	12	ftld	ftld	ADJ
fnp-5643	82	13	-	-	PUNCT
fnp-5643	82	14	tdp	tdp	NOUN
fnp-5643	82	15	with	with	ADP
fnp-5643	82	16	c9orf72	c9orf72	PROPN
fnp-5643	82	17	mutation	mutation	NOUN
fnp-5643	82	18	.	.	PUNCT
fnp-5643	83	1	h	h	NOUN
fnp-5643	83	2	:	:	PUNCT
fnp-5643	83	3	deposits	deposit	NOUN
fnp-5643	83	4	of	of	ADP
fnp-5643	83	5	prion	prion	NOUN
fnp-5643	83	6	protein	protein	NOUN
fnp-5643	83	7	in	in	ADP
fnp-5643	83	8	creutzfeldt	creutzfeldt	ADJ
fnp-5643	83	9	-	-	ADJ
fnp-5643	83	10	jakob	jakob	ADJ
fnp-5643	83	11	disease	disease	NOUN
fnp-5643	83	12	.	.	PUNCT
fnp-5643	84	1	images	image	NOUN
fnp-5643	84	2	show	show	VERB
fnp-5643	84	3	stainings	staining	NOUN
fnp-5643	84	4	with	with	ADP
fnp-5643	84	5	he	he	PRON
fnp-5643	84	6	and	and	CCONJ
fnp-5643	84	7	with	with	ADP
fnp-5643	84	8	antibodies	antibody	NOUN
fnp-5643	84	9	against	against	ADP
fnp-5643	84	10	β	β	NOUN
fnp-5643	84	11	-	-	NOUN
fnp-5643	84	12	amyloid	amyloid	NOUN
fnp-5643	84	13	(	(	PUNCT
fnp-5643	84	14	aβ	aβ	NOUN
fnp-5643	84	15	)	)	PUNCT
fnp-5643	84	16	,	,	PUNCT
fnp-5643	84	17	phospho	phospho	NOUN
fnp-5643	84	18	-	-	PUNCT
fnp-5643	84	19	tau	tau	PROPN
fnp-5643	84	20	(	(	PUNCT
fnp-5643	84	21	at8	at8	PROPN
fnp-5643	84	22	)	)	PUNCT
fnp-5643	84	23	,	,	PUNCT
fnp-5643	84	24	α	α	X
fnp-5643	84	25	-	-	PUNCT
fnp-5643	84	26	synuclein	synuclein	NOUN
fnp-5643	84	27	(	(	PUNCT
fnp-5643	84	28	αsyn	αsyn	PROPN
fnp-5643	84	29	)	)	PUNCT
fnp-5643	84	30	,	,	PUNCT
fnp-5643	84	31	phospho	phospho	NOUN
fnp-5643	84	32	-	-	PUNCT
fnp-5643	84	33	tdp43	tdp43	NOUN
fnp-5643	84	34	(	(	PUNCT
fnp-5643	84	35	ptdp	ptdp	NOUN
fnp-5643	84	36	)	)	PUNCT
fnp-5643	84	37	,	,	PUNCT
fnp-5643	84	38	p62	p62	NOUN
fnp-5643	84	39	and	and	CCONJ
fnp-5643	84	40	prion	prion	NOUN
fnp-5643	84	41	protein	protein	NOUN
fnp-5643	84	42	(	(	PUNCT
fnp-5643	84	43	prp	prp	PROPN
fnp-5643	84	44	)	)	PUNCT
fnp-5643	84	45	.	.	PUNCT
fnp-5643	85	1	scale	scale	NOUN
fnp-5643	85	2	bars	bar	NOUN
fnp-5643	85	3	:	:	PUNCT
fnp-5643	85	4	c1	c1	NOUN
fnp-5643	85	5	,	,	PUNCT
fnp-5643	85	6	d1	d1	PROPN
fnp-5643	85	7	,	,	PUNCT
fnp-5643	85	8	d3	d3	PROPN
fnp-5643	85	9	,	,	PUNCT
fnp-5643	85	10	g5	g5	NOUN
fnp-5643	85	11	:	:	PUNCT
fnp-5643	85	12	5	5	NUM
fnp-5643	85	13	 	 	SPACE
fnp-5643	85	14	μm	μm	NUM
fnp-5643	85	15	;	;	PUNCT
fnp-5643	85	16	a1	a1	NOUN
fnp-5643	85	17	,	,	PUNCT
fnp-5643	85	18	e1	e1	NOUN
fnp-5643	85	19	,	,	PUNCT
fnp-5643	85	20	g1	g1	NOUN
fnp-5643	85	21	,	,	PUNCT
fnp-5643	85	22	g4	g4	NOUN
fnp-5643	85	23	:	:	PUNCT
fnp-5643	85	24	10	10	NUM
fnp-5643	85	25	 	 	SPACE
fnp-5643	85	26	μm	μm	NUM
fnp-5643	85	27	;	;	PUNCT
fnp-5643	85	28	a3	a3	NOUN
fnp-5643	85	29	,	,	PUNCT
fnp-5643	85	30	a4	a4	NOUN
fnp-5643	85	31	a6	a6	NOUN
fnp-5643	85	32	(	(	PUNCT
fnp-5643	85	33	inset	inset	NOUN
fnp-5643	85	34	)	)	PUNCT
fnp-5643	85	35	,	,	PUNCT
fnp-5643	85	36	b2	b2	NOUN
fnp-5643	85	37	,	,	PUNCT
fnp-5643	85	38	b3	b3	PROPN
fnp-5643	85	39	,	,	PUNCT
fnp-5643	85	40	c3	c3	PROPN
fnp-5643	85	41	,	,	PUNCT
fnp-5643	85	42	d2	d2	PROPN
fnp-5643	85	43	,	,	PUNCT
fnp-5643	85	44	e2	e2	PROPN
fnp-5643	85	45	,	,	PUNCT
fnp-5643	85	46	g2	g2	PROPN
fnp-5643	85	47	,	,	PUNCT
fnp-5643	85	48	g3	g3	PROPN
fnp-5643	85	49	:	:	PUNCT
fnp-5643	85	50	20	20	NUM
fnp-5643	85	51	 	 	SPACE
fnp-5643	85	52	μm	μm	NUM
fnp-5643	85	53	;	;	PUNCT
fnp-5643	85	54	a2	a2	PROPN
fnp-5643	85	55	,	,	PUNCT
fnp-5643	85	56	a5	a5	NOUN
fnp-5643	85	57	,	,	PUNCT
fnp-5643	85	58	b1	b1	PROPN
fnp-5643	85	59	,	,	PUNCT
fnp-5643	85	60	c2	c2	PROPN
fnp-5643	85	61	,	,	PUNCT
fnp-5643	85	62	f	f	PROPN
fnp-5643	85	63	,	,	PUNCT
fnp-5643	85	64	h	h	NOUN
fnp-5643	85	65	:	:	PUNCT
fnp-5643	85	66	50	50	NUM
fnp-5643	85	67	 	 	SPACE
fnp-5643	85	68	μm	μm	NUM
fnp-5643	85	69	;	;	PUNCT
fnp-5643	85	70	a6	a6	NOUN
fnp-5643	85	71	:	:	PUNCT
fnp-5643	85	72	200	200	NUM
fnp-5643	85	73	 	 	SPACE
fnp-5643	85	74	μm	μm	NOUN
fnp-5643	85	75	.	.	PUNCT
fnp-5643	85	76	figure	figure	NOUN
fnp-5643	85	77	3	3	NUM
fnp-5643	85	78	:	:	PUNCT
fnp-5643	85	79	decision	decision	NOUN
fnp-5643	85	80	diagram	diagram	NOUN
fnp-5643	85	81	guiding	guide	VERB
fnp-5643	85	82	the	the	DET
fnp-5643	85	83	investigator	investigator	NOUN
fnp-5643	85	84	to	to	PART
fnp-5643	85	85	establish	establish	VERB
fnp-5643	85	86	a	a	DET
fnp-5643	85	87	screening	screening	NOUN
fnp-5643	85	88	diagnosis	diagnosis	NOUN
fnp-5643	85	89	based	base	VERB
fnp-5643	85	90	on	on	ADP
fnp-5643	85	91	characteristic	characteristic	ADJ
fnp-5643	85	92	histological	histological	ADJ
fnp-5643	85	93	findings	finding	NOUN
fnp-5643	85	94	.	.	PUNCT
fnp-5643	86	1	prp	prp	NOUN
fnp-5643	86	2	:	:	PUNCT
fnp-5643	86	3	prion	prion	NOUN
fnp-5643	86	4	protein	protein	NOUN
fnp-5643	86	5	,	,	PUNCT
fnp-5643	86	6	at8	at8	PROPN
fnp-5643	86	7	:	:	PUNCT
fnp-5643	86	8	phospho	phospho	NOUN
fnp-5643	86	9	-	-	PUNCT
fnp-5643	86	10	tau	tau	PROPN
fnp-5643	86	11	,	,	PUNCT
fnp-5643	86	12	nft	nft	PROPN
fnp-5643	86	13	:	:	PUNCT
fnp-5643	86	14	neurofibrillary	neurofibrillary	ADJ
fnp-5643	86	15	tangles	tangle	NOUN
fnp-5643	86	16	,	,	PUNCT
fnp-5643	86	17	nci	nci	NOUN
fnp-5643	86	18	:	:	PUNCT
fnp-5643	86	19	neuronal	neuronal	ADJ
fnp-5643	86	20	cytoplasmic	cytoplasmic	ADJ
fnp-5643	86	21	inclusions	inclusion	NOUN
fnp-5643	86	22	,	,	PUNCT
fnp-5643	86	23	ta	ta	X
fnp-5643	86	24	:	:	PUNCT
fnp-5643	86	25	tufted	tufte	VERB
fnp-5643	86	26	astrocytes	astrocyte	NOUN
fnp-5643	86	27	,	,	PUNCT
fnp-5643	86	28	cb	cb	PROPN
fnp-5643	86	29	:	:	PUNCT
fnp-5643	86	30	coiled	coil	VERB
fnp-5643	86	31	bodies	body	NOUN
fnp-5643	86	32	,	,	PUNCT
fnp-5643	86	33	ap	ap	ADJ
fnp-5643	86	34	:	:	PUNCT
fnp-5643	86	35	astrocytic	astrocytic	ADJ
fnp-5643	86	36	plaques	plaque	NOUN
fnp-5643	86	37	,	,	PUNCT
fnp-5643	86	38	pib	pib	ADJ
fnp-5643	86	39	:	:	PUNCT
fnp-5643	86	40	pick	pick	VERB
fnp-5643	86	41	bodies	body	NOUN
fnp-5643	86	42	,	,	PUNCT
fnp-5643	86	43	np	np	INTJ
fnp-5643	86	44	:	:	PUNCT
fnp-5643	86	45	neuritic	neuritic	ADJ
fnp-5643	86	46	plaques	plaque	NOUN
fnp-5643	86	47	,	,	PUNCT
fnp-5643	86	48	nt	not	PART
fnp-5643	86	49	:	:	PUNCT
fnp-5643	86	50	neuropil	neuropil	NOUN
fnp-5643	86	51	threads	thread	NOUN
fnp-5643	86	52	,	,	PUNCT
fnp-5643	86	53	aβ	aβ	NOUN
fnp-5643	86	54	:	:	PUNCT
fnp-5643	86	55	β	β	NOUN
fnp-5643	86	56	-	-	NOUN
fnp-5643	86	57	amyloid	amyloid	NOUN
fnp-5643	86	58	,	,	PUNCT
fnp-5643	86	59	αsyn	αsyn	NOUN
fnp-5643	86	60	:	:	PUNCT
fnp-5643	86	61	α	α	NUM
fnp-5643	86	62	-	-	PUNCT
fnp-5643	86	63	synuclein	synuclein	NOUN
fnp-5643	86	64	,	,	PUNCT
fnp-5643	86	65	lb	lb	X
fnp-5643	86	66	:	:	PUNCT
fnp-5643	86	67	lewy	lewy	ADJ
fnp-5643	86	68	bodies	body	NOUN
fnp-5643	86	69	,	,	PUNCT
fnp-5643	86	70	ln	ln	ADJ
fnp-5643	86	71	:	:	PUNCT
fnp-5643	86	72	lewy	lewy	PROPN
fnp-5643	86	73	neurites	neurites	PROPN
fnp-5643	86	74	,	,	PUNCT
fnp-5643	86	75	gci	gci	NOUN
fnp-5643	86	76	:	:	PUNCT
fnp-5643	86	77	glial	glial	ADJ
fnp-5643	86	78	cytoplasmic	cytoplasmic	ADJ
fnp-5643	86	79	inclusions	inclusion	NOUN
fnp-5643	86	80	,	,	PUNCT
fnp-5643	86	81	psp	psp	NOUN
fnp-5643	86	82	:	:	PUNCT
fnp-5643	86	83	progressive	progressive	ADJ
fnp-5643	86	84	supranuclear	supranuclear	ADJ
fnp-5643	86	85	palsy	palsy	ADJ
fnp-5643	86	86	,	,	PUNCT
fnp-5643	86	87	cbd	cbd	NOUN
fnp-5643	86	88	:	:	PUNCT
fnp-5643	86	89	corticobasal	corticobasal	NOUN
fnp-5643	86	90	degeneration	degeneration	NOUN
fnp-5643	86	91	,	,	PUNCT
fnp-5643	86	92	pid	pid	NOUN
fnp-5643	86	93	:	:	PUNCT
fnp-5643	86	94	pick	pick	VERB
fnp-5643	86	95	’s	’s	PART
fnp-5643	86	96	disease	disease	NOUN
fnp-5643	86	97	,	,	PUNCT
fnp-5643	86	98	ad	ad	NOUN
fnp-5643	86	99	:	:	PUNCT
fnp-5643	86	100	alzheimer	alzheimer	PROPN
fnp-5643	86	101	’s	’s	PART
fnp-5643	86	102	disease	disease	PROPN
fnp-5643	86	103	,	,	PUNCT
fnp-5643	86	104	lbd	lbd	PROPN
fnp-5643	86	105	:	:	PUNCT
fnp-5643	86	106	lewy	lewy	PROPN
fnp-5643	86	107	body	body	NOUN
fnp-5643	86	108	disease	disease	NOUN
fnp-5643	86	109	,	,	PUNCT
fnp-5643	86	110	msa	msa	PROPN
fnp-5643	86	111	:	:	PUNCT
fnp-5643	86	112	multiple	multiple	ADJ
fnp-5643	86	113	system	system	NOUN
fnp-5643	86	114	atrophy	atrophy	NOUN
fnp-5643	86	115	,	,	PUNCT
fnp-5643	86	116	ftld	ftld	ADJ
fnp-5643	86	117	:	:	PUNCT
fnp-5643	86	118	frontotemporal	frontotemporal	ADJ
fnp-5643	86	119	lobar	lobar	ADJ
fnp-5643	86	120	degeneration	degeneration	NOUN
fnp-5643	86	121	.	.	PUNCT
fnp-5643	87	1	a	a	DET
fnp-5643	87	2	limited	limited	ADJ
fnp-5643	87	3	neuropathological	neuropathological	ADJ
fnp-5643	87	4	disease	disease	NOUN
fnp-5643	87	5	staging	staging	NOUN
fnp-5643	87	6	was	be	AUX
fnp-5643	87	7	also	also	ADV
fnp-5643	87	8	performed	perform	VERB
fnp-5643	87	9	.	.	PUNCT
fnp-5643	88	1	a	a	DET
fnp-5643	88	2	thal	thal	NOUN
fnp-5643	88	3	-	-	PUNCT
fnp-5643	88	4	score	score	NOUN
fnp-5643	88	5	for	for	ADP
fnp-5643	88	6	aβ	aβ	PRON
fnp-5643	88	7	deposits	deposit	NOUN
fnp-5643	88	8	was	be	AUX
fnp-5643	88	9	assigned	assign	VERB
fnp-5643	88	10	to	to	ADP
fnp-5643	88	11	a	a	DET
fnp-5643	88	12	stage	stage	NOUN
fnp-5643	88	13	of	of	ADP
fnp-5643	88	14	either	either	CCONJ
fnp-5643	88	15	(	(	PUNCT
fnp-5643	88	16	at	at	ADP
fnp-5643	88	17	least	least	ADJ
fnp-5643	88	18	)	)	PUNCT
fnp-5643	88	19	1	1	NUM
fnp-5643	88	20	(	(	PUNCT
fnp-5643	88	21	frontal	frontal	ADJ
fnp-5643	88	22	beta	beta	ADJ
fnp-5643	88	23	amyloid	amyloid	NOUN
fnp-5643	88	24	plaques	plaque	NOUN
fnp-5643	88	25	)	)	PUNCT
fnp-5643	88	26	or	or	CCONJ
fnp-5643	88	27	5	5	NUM
fnp-5643	88	28	(	(	PUNCT
fnp-5643	88	29	additional	additional	ADJ
fnp-5643	88	30	aβ	aβ	DET
fnp-5643	88	31	plaques	plaque	NOUN
fnp-5643	88	32	detected	detect	VERB
fnp-5643	88	33	in	in	ADP
fnp-5643	88	34	the	the	DET
fnp-5643	88	35	cerebellum	cerebellum	NOUN
fnp-5643	88	36	)	)	PUNCT
fnp-5643	89	1	[	[	X
fnp-5643	89	2	36	36	NUM
fnp-5643	89	3	]	]	PUNCT
fnp-5643	89	4	.	.	PUNCT
fnp-5643	90	1	the	the	DET
fnp-5643	90	2	presence	presence	NOUN
fnp-5643	90	3	of	of	ADP
fnp-5643	90	4	frontal	frontal	ADJ
fnp-5643	90	5	tau	tau	NOUN
fnp-5643	90	6	-	-	PUNCT
fnp-5643	90	7	immunoreactive	immunoreactive	ADJ
fnp-5643	90	8	neurofibrillary	neurofibrillary	ADJ
fnp-5643	90	9	pathology	pathology	NOUN
fnp-5643	90	10	allowed	allow	VERB
fnp-5643	90	11	for	for	ADP
fnp-5643	90	12	assigning	assign	VERB
fnp-5643	90	13	a	a	DET
fnp-5643	90	14	braak	braak	NOUN
fnp-5643	90	15	and	and	CCONJ
fnp-5643	90	16	braak	braak	ADJ
fnp-5643	90	17	stage	stage	NOUN
fnp-5643	90	18	of	of	ADP
fnp-5643	90	19	at	at	ADV
fnp-5643	90	20	least	least	ADJ
fnp-5643	90	21	iv	iv	NOUN
fnp-5643	91	1	[	[	X
fnp-5643	91	2	37	37	NUM
fnp-5643	91	3	]	]	PUNCT
fnp-5643	91	4	.	.	PUNCT
fnp-5643	92	1	recognition	recognition	NOUN
fnp-5643	92	2	and	and	CCONJ
fnp-5643	92	3	staging	staging	NOUN
fnp-5643	92	4	of	of	ADP
fnp-5643	92	5	additional	additional	ADJ
fnp-5643	92	6	caa	caa	NOUN
fnp-5643	92	7	according	accord	VERB
fnp-5643	92	8	to	to	ADP
fnp-5643	92	9	thal	thal	PROPN
fnp-5643	92	10	et	et	PROPN
fnp-5643	92	11	al	al	PROPN
fnp-5643	92	12	.	.	PUNCT
fnp-5643	93	1	[	[	X
fnp-5643	93	2	38	38	NUM
fnp-5643	93	3	]	]	PUNCT
fnp-5643	93	4	is	be	AUX
fnp-5643	93	5	limited	limit	VERB
fnp-5643	93	6	to	to	ADP
fnp-5643	93	7	stages	stage	NOUN
fnp-5643	93	8	1	1	NUM
fnp-5643	93	9	(	(	PUNCT
fnp-5643	93	10	if	if	SCONJ
fnp-5643	93	11	frontal	frontal	ADJ
fnp-5643	93	12	pathology	pathology	NOUN
fnp-5643	93	13	is	be	AUX
fnp-5643	93	14	present	present	ADJ
fnp-5643	93	15	)	)	PUNCT
fnp-5643	93	16	or	or	CCONJ
fnp-5643	93	17	(	(	PUNCT
fnp-5643	93	18	at	at	ADP
fnp-5643	93	19	least	least	ADJ
fnp-5643	93	20	)	)	PUNCT
fnp-5643	93	21	2	2	NUM
fnp-5643	93	22	(	(	PUNCT
fnp-5643	93	23	with	with	ADP
fnp-5643	93	24	cerebellar	cerebellar	ADJ
fnp-5643	93	25	amyloid	amyloid	NOUN
fnp-5643	93	26	angiopathy	angiopathy	NOUN
fnp-5643	93	27	)	)	PUNCT
fnp-5643	93	28	.	.	PUNCT
fnp-5643	94	1	frontal	frontal	ADJ
fnp-5643	94	2	α	α	NOUN
fnp-5643	94	3	-	-	PUNCT
fnp-5643	94	4	synuclein	synuclein	ADJ
fnp-5643	94	5	inclusions	inclusion	NOUN
fnp-5643	94	6	lead	lead	VERB
fnp-5643	94	7	to	to	ADP
fnp-5643	94	8	designation	designation	NOUN
fnp-5643	94	9	of	of	ADP
fnp-5643	94	10	a	a	DET
fnp-5643	94	11	braak	braak	NOUN
fnp-5643	94	12	stage	stage	NOUN
fnp-5643	94	13	of	of	ADP
fnp-5643	94	14	6	6	NUM
fnp-5643	94	15	[	[	SYM
fnp-5643	94	16	39	39	NUM
fnp-5643	94	17	]	]	PUNCT
fnp-5643	94	18	.	.	PUNCT
fnp-5643	95	1	a	a	DET
fnp-5643	95	2	full	full	ADJ
fnp-5643	95	3	histological	histological	ADJ
fnp-5643	95	4	work	work	NOUN
fnp-5643	95	5	-	-	PUNCT
fnp-5643	95	6	up	up	NOUN
fnp-5643	95	7	according	accord	VERB
fnp-5643	95	8	to	to	ADP
fnp-5643	95	9	a	a	DET
fnp-5643	95	10	standardized	standardized	ADJ
fnp-5643	95	11	,	,	PUNCT
fnp-5643	95	12	well	well	ADV
fnp-5643	95	13	-	-	PUNCT
fnp-5643	95	14	established	establish	VERB
fnp-5643	95	15	nbm	nbm	PROPN
fnp-5643	95	16	protocol	protocol	NOUN
fnp-5643	95	17	was	be	AUX
fnp-5643	95	18	performed	perform	VERB
fnp-5643	95	19	on	on	ADP
fnp-5643	95	20	formalin	formalin	NOUN
fnp-5643	95	21	-	-	PUNCT
fnp-5643	95	22	fixed	fix	VERB
fnp-5643	95	23	hemispheres	hemisphere	NOUN
fnp-5643	95	24	after	after	ADP
fnp-5643	95	25	complete	complete	ADJ
fnp-5643	95	26	fixation	fixation	NOUN
fnp-5643	95	27	,	,	PUNCT
fnp-5643	95	28	taking	take	VERB
fnp-5643	95	29	both	both	CCONJ
fnp-5643	95	30	the	the	DET
fnp-5643	95	31	working	work	VERB
fnp-5643	95	32	diagnosis	diagnosis	NOUN
fnp-5643	95	33	obtained	obtain	VERB
fnp-5643	95	34	by	by	ADP
fnp-5643	95	35	screening	screen	VERB
fnp-5643	95	36	histology	histology	NOUN
fnp-5643	95	37	and	and	CCONJ
fnp-5643	95	38	the	the	DET
fnp-5643	95	39	deceased	deceased	ADJ
fnp-5643	95	40	's	's	PART
fnp-5643	95	41	medical	medical	ADJ
fnp-5643	95	42	history	history	NOUN
fnp-5643	95	43	into	into	ADP
fnp-5643	95	44	account	account	NOUN
fnp-5643	95	45	for	for	ADP
fnp-5643	95	46	a	a	DET
fnp-5643	95	47	more	more	ADV
fnp-5643	95	48	targeted	target	VERB
fnp-5643	95	49	evaluation	evaluation	NOUN
fnp-5643	95	50	.	.	PUNCT
fnp-5643	96	1	the	the	DET
fnp-5643	96	2	final	final	ADJ
fnp-5643	96	3	neuropathological	neuropathological	ADJ
fnp-5643	96	4	diagnoses	diagnosis	NOUN
fnp-5643	96	5	were	be	AUX
fnp-5643	96	6	made	make	VERB
fnp-5643	96	7	in	in	ADP
fnp-5643	96	8	accordance	accordance	NOUN
fnp-5643	96	9	with	with	ADP
fnp-5643	96	10	established	establish	VERB
fnp-5643	96	11	guidelines	guideline	NOUN
fnp-5643	96	12	for	for	ADP
fnp-5643	96	13	the	the	DET
fnp-5643	96	14	histological	histological	ADJ
fnp-5643	96	15	diagnosis	diagnosis	NOUN
fnp-5643	96	16	of	of	ADP
fnp-5643	96	17	ndd	ndd	PROPN
fnp-5643	96	18	[	[	X
fnp-5643	96	19	9,24,25,30,33,40,41,42	9,24,25,30,33,40,41,42	NOUN
fnp-5643	96	20	]	]	PUNCT
fnp-5643	96	21	.	.	PUNCT
fnp-5643	97	1	point	point	NOUN
fnp-5643	97	2	estimates	estimate	NOUN
fnp-5643	97	3	and	and	CCONJ
fnp-5643	97	4	95	95	NUM
fnp-5643	97	5	 	 	SPACE
fnp-5643	97	6	%	%	NOUN
fnp-5643	97	7	confidence	confidence	NOUN
fnp-5643	97	8	intervals	interval	NOUN
fnp-5643	97	9	(	(	PUNCT
fnp-5643	97	10	ci	ci	NOUN
fnp-5643	97	11	)	)	PUNCT
fnp-5643	97	12	for	for	ADP
fnp-5643	97	13	sensitivity	sensitivity	NOUN
fnp-5643	97	14	and	and	CCONJ
fnp-5643	97	15	specificity	specificity	NOUN
fnp-5643	97	16	comparing	compare	VERB
fnp-5643	97	17	fast	fast	ADJ
fnp-5643	97	18	-	-	PUNCT
fnp-5643	97	19	track	track	NOUN
fnp-5643	97	20	to	to	ADP
fnp-5643	97	21	final	final	ADJ
fnp-5643	97	22	diagnoses	diagnosis	NOUN
fnp-5643	97	23	were	be	AUX
fnp-5643	97	24	calculated	calculate	VERB
fnp-5643	97	25	for	for	ADP
fnp-5643	97	26	each	each	DET
fnp-5643	97	27	disease	disease	NOUN
fnp-5643	97	28	group	group	NOUN
fnp-5643	97	29	using	use	VERB
fnp-5643	97	30	graphpad	graphpad	NOUN
fnp-5643	97	31	prism	prism	NOUN
fnp-5643	97	32	version	version	NOUN
fnp-5643	97	33	9.4.1	9.4.1	NUM
fnp-5643	97	34	,	,	PUNCT
fnp-5643	97	35	graphpad	graphpad	NOUN
fnp-5643	97	36	software	software	NOUN
fnp-5643	97	37	,	,	PUNCT
fnp-5643	97	38	san	san	PROPN
fnp-5643	97	39	diego	diego	PROPN
fnp-5643	97	40	,	,	PUNCT
fnp-5643	97	41	california	california	PROPN
fnp-5643	97	42	,	,	PUNCT
fnp-5643	97	43	usa	usa	PROPN
fnp-5643	97	44	.	.	PROPN
fnp-5643	97	45	statistical	statistical	ADJ
fnp-5643	97	46	significance	significance	NOUN
fnp-5643	97	47	was	be	AUX
fnp-5643	97	48	set	set	VERB
fnp-5643	97	49	at	at	ADP
fnp-5643	97	50	the	the	DET
fnp-5643	97	51	0.05	0.05	NUM
fnp-5643	97	52	level	level	NOUN
fnp-5643	97	53	(	(	PUNCT
fnp-5643	97	54	fisher	fisher	PROPN
fnp-5643	97	55	’s	’s	PART
fnp-5643	97	56	exact	exact	ADJ
fnp-5643	97	57	test	test	NOUN
fnp-5643	97	58	)	)	PUNCT
fnp-5643	97	59	.	.	PUNCT
fnp-5643	98	1	kappa	kappa	PROPN
fnp-5643	98	2	coefficients	coefficient	NOUN
fnp-5643	98	3	for	for	ADP
fnp-5643	98	4	inter	inter	ADJ
fnp-5643	98	5	-	-	ADJ
fnp-5643	98	6	rater	rater	ADJ
fnp-5643	98	7	variability	variability	NOUN
fnp-5643	98	8	between	between	ADP
fnp-5643	98	9	fast	fast	ADJ
fnp-5643	98	10	-	-	PUNCT
fnp-5643	98	11	track	track	NOUN
fnp-5643	98	12	and	and	CCONJ
fnp-5643	98	13	final	final	ADJ
fnp-5643	98	14	diagnoses	diagnosis	NOUN
fnp-5643	98	15	were	be	AUX
fnp-5643	98	16	calculated	calculate	VERB
fnp-5643	98	17	with	with	ADP
fnp-5643	98	18	a	a	DET
fnp-5643	98	19	graphpad	graphpad	NOUN
fnp-5643	98	20	online	online	NOUN
fnp-5643	98	21	tool	tool	NOUN
fnp-5643	98	22	(	(	PUNCT
fnp-5643	98	23	https://www.graphpad.com/quickcalcs/kappa1/	https://www.graphpad.com/quickcalcs/kappa1/	PROPN
fnp-5643	98	24	)	)	PUNCT
fnp-5643	98	25	.	.	PUNCT
fnp-5643	99	1	according	accord	VERB
fnp-5643	99	2	to	to	ADP
fnp-5643	99	3	the	the	DET
fnp-5643	99	4	kappa	kappa	ADJ
fnp-5643	99	5	values	value	NOUN
fnp-5643	99	6	the	the	DET
fnp-5643	99	7	agreement	agreement	NOUN
fnp-5643	99	8	was	be	AUX
fnp-5643	99	9	considered	consider	VERB
fnp-5643	99	10	as	as	ADP
fnp-5643	99	11	poor	poor	ADJ
fnp-5643	99	12	(	(	PUNCT
fnp-5643	99	13	kappa	kappa	ADJ
fnp-5643	99	14	 	 	SPACE
fnp-5643	99	15	=	=	NOUN
fnp-5643	99	16	 	 	SPACE
fnp-5643	99	17	0	0	NUM
fnp-5643	99	18	)	)	PUNCT
fnp-5643	99	19	,	,	PUNCT
fnp-5643	99	20	slight	slight	ADJ
fnp-5643	99	21	(	(	PUNCT
fnp-5643	99	22	0	0	NUM
fnp-5643	99	23	 	 	SPACE
fnp-5643	99	24	-	-	PUNCT
fnp-5643	99	25	 	 	SPACE
fnp-5643	99	26	0.2	0.2	NUM
fnp-5643	99	27	)	)	PUNCT
fnp-5643	99	28	,	,	PUNCT
fnp-5643	99	29	fair	fair	ADJ
fnp-5643	99	30	(	(	PUNCT
fnp-5643	99	31	0.21	0.21	NUM
fnp-5643	99	32	 	 	SPACE
fnp-5643	99	33	-	-	PUNCT
fnp-5643	99	34	 	 	SPACE
fnp-5643	99	35	0.4	0.4	NUM
fnp-5643	99	36	)	)	PUNCT
fnp-5643	99	37	,	,	PUNCT
fnp-5643	99	38	moderate	moderate	ADJ
fnp-5643	99	39	(	(	PUNCT
fnp-5643	99	40	0.41	0.41	NUM
fnp-5643	99	41	 	 	SPACE
fnp-5643	99	42	-	-	PUNCT
fnp-5643	99	43	 	 	SPACE
fnp-5643	99	44	0.6	0.6	NUM
fnp-5643	99	45	)	)	PUNCT
fnp-5643	99	46	substantial	substantial	ADJ
fnp-5643	99	47	(	(	PUNCT
fnp-5643	99	48	0.61	0.61	NUM
fnp-5643	99	49	 	 	SPACE
fnp-5643	99	50	-	-	PUNCT
fnp-5643	99	51	 	 	SPACE
fnp-5643	99	52	0.8	0.8	NUM
fnp-5643	99	53	)	)	PUNCT
fnp-5643	99	54	or	or	CCONJ
fnp-5643	99	55	almost	almost	ADV
fnp-5643	99	56	perfect	perfect	ADJ
fnp-5643	99	57	(	(	PUNCT
fnp-5643	99	58	0.81	0.81	NUM
fnp-5643	99	59	 	 	SPACE
fnp-5643	99	60	-	-	PUNCT
fnp-5643	99	61	 	 	SPACE
fnp-5643	99	62	1.0	1.0	NUM
fnp-5643	99	63	)	)	PUNCT
fnp-5643	99	64	[	[	X
fnp-5643	99	65	43	43	NUM
fnp-5643	99	66	]	]	PUNCT
fnp-5643	99	67	.	.	PUNCT
fnp-5643	100	1	results	result	VERB
fnp-5643	100	2	fast	fast	ADJ
fnp-5643	100	3	-	-	PUNCT
fnp-5643	100	4	track	track	NOUN
fnp-5643	100	5	histology	histology	NOUN
fnp-5643	100	6	was	be	AUX
fnp-5643	100	7	analysed	analyse	VERB
fnp-5643	100	8	in	in	ADP
fnp-5643	100	9	133	133	NUM
fnp-5643	100	10	cases	case	NOUN
fnp-5643	100	11	(	(	PUNCT
fnp-5643	100	12	58	58	NUM
fnp-5643	100	13	females	female	NOUN
fnp-5643	100	14	,	,	PUNCT
fnp-5643	100	15	75	75	NUM
fnp-5643	100	16	males	male	NOUN
fnp-5643	100	17	,	,	PUNCT
fnp-5643	100	18	median	median	ADJ
fnp-5643	100	19	age	age	NOUN
fnp-5643	100	20	at	at	ADP
fnp-5643	100	21	death	death	NOUN
fnp-5643	100	22	:	:	PUNCT
fnp-5643	100	23	71.1	71.1	NUM
fnp-5643	100	24	years	year	NOUN
fnp-5643	100	25	;	;	PUNCT
fnp-5643	100	26	age	age	NOUN
fnp-5643	100	27	range	range	NOUN
fnp-5643	100	28	:	:	PUNCT
fnp-5643	100	29	38.7	38.7	NUM
fnp-5643	100	30	 	 	SPACE
fnp-5643	100	31	-	-	PUNCT
fnp-5643	100	32	 	 	SPACE
fnp-5643	100	33	95.1	95.1	NUM
fnp-5643	100	34	years	year	NOUN
fnp-5643	100	35	)	)	PUNCT
fnp-5643	100	36	which	which	PRON
fnp-5643	100	37	were	be	AUX
fnp-5643	100	38	enrolled	enrol	VERB
fnp-5643	100	39	in	in	ADP
fnp-5643	100	40	a	a	DET
fnp-5643	100	41	brain	brain	NOUN
fnp-5643	100	42	donation	donation	NOUN
fnp-5643	100	43	program	program	NOUN
fnp-5643	100	44	for	for	ADP
fnp-5643	100	45	brain	brain	NOUN
fnp-5643	100	46	banking	banking	NOUN
fnp-5643	100	47	and	and	CCONJ
fnp-5643	100	48	thus	thus	ADV
fnp-5643	100	49	underwent	underwent	ADJ
fnp-5643	100	50	brain	brain	NOUN
fnp-5643	100	51	autopsy	autopsy	ADJ
fnp-5643	100	52	at	at	ADP
fnp-5643	100	53	nbm	nbm	PROPN
fnp-5643	100	54	between	between	ADP
fnp-5643	100	55	march	march	PROPN
fnp-5643	100	56	2015	2015	NUM
fnp-5643	100	57	and	and	CCONJ
fnp-5643	100	58	december	december	PROPN
fnp-5643	100	59	2020	2020	NUM
fnp-5643	100	60	.	.	PUNCT
fnp-5643	101	1	from	from	ADP
fnp-5643	101	2	156	156	NUM
fnp-5643	101	3	cases	case	NOUN
fnp-5643	101	4	initially	initially	ADV
fnp-5643	101	5	selected	select	VERB
fnp-5643	101	6	,	,	PUNCT
fnp-5643	101	7	we	we	PRON
fnp-5643	101	8	excluded	exclude	VERB
fnp-5643	101	9	15	15	NUM
fnp-5643	101	10	cases	case	NOUN
fnp-5643	101	11	because	because	SCONJ
fnp-5643	101	12	of	of	ADP
fnp-5643	101	13	suspected	suspect	VERB
fnp-5643	101	14	motor	motor	NOUN
fnp-5643	101	15	neuron	neuron	NOUN
fnp-5643	101	16	disease	disease	NOUN
fnp-5643	101	17	(	(	PUNCT
fnp-5643	101	18	mnd)/amyotrophic	mnd)/amyotrophic	ADJ
fnp-5643	101	19	lateral	lateral	ADJ
fnp-5643	101	20	sclerosis	sclerosis	NOUN
fnp-5643	101	21	(	(	PUNCT
fnp-5643	101	22	since	since	SCONJ
fnp-5643	101	23	spinal	spinal	ADJ
fnp-5643	101	24	samples	sample	NOUN
fnp-5643	101	25	were	be	AUX
fnp-5643	101	26	not	not	PART
fnp-5643	101	27	assessed	assess	VERB
fnp-5643	101	28	on	on	ADP
fnp-5643	101	29	screening	screen	VERB
fnp-5643	101	30	histology	histology	NOUN
fnp-5643	101	31	)	)	PUNCT
fnp-5643	101	32	,	,	PUNCT
fnp-5643	101	33	three	three	NUM
fnp-5643	101	34	cases	case	NOUN
fnp-5643	101	35	with	with	ADP
fnp-5643	101	36	clinical	clinical	ADJ
fnp-5643	101	37	restless	restless	ADJ
fnp-5643	101	38	legs	leg	NOUN
fnp-5643	101	39	syndrome	syndrome	NOUN
fnp-5643	101	40	,	,	PUNCT
fnp-5643	101	41	one	one	NUM
fnp-5643	101	42	case	case	NOUN
fnp-5643	101	43	with	with	ADP
fnp-5643	101	44	suspected	suspect	VERB
fnp-5643	101	45	fahr	fahr	PROPN
fnp-5643	101	46	’s	’s	PART
fnp-5643	101	47	disease	disease	NOUN
fnp-5643	101	48	and	and	CCONJ
fnp-5643	101	49	four	four	NUM
fnp-5643	101	50	cases	case	NOUN
fnp-5643	101	51	with	with	ADP
fnp-5643	101	52	huntington	huntington	PROPN
fnp-5643	101	53	’s	’s	PART
fnp-5643	101	54	disease	disease	NOUN
fnp-5643	101	55	already	already	ADV
fnp-5643	101	56	genetically	genetically	ADV
fnp-5643	101	57	confirmed	confirm	VERB
fnp-5643	101	58	during	during	ADP
fnp-5643	101	59	lifetime	lifetime	NOUN
fnp-5643	101	60	.	.	PUNCT
fnp-5643	102	1	the	the	DET
fnp-5643	102	2	main	main	ADJ
fnp-5643	102	3	histological	histological	ADJ
fnp-5643	102	4	ndd	ndd	NOUN
fnp-5643	102	5	diagnoses	diagnosis	NOUN
fnp-5643	102	6	without	without	ADP
fnp-5643	102	7	consideration	consideration	NOUN
fnp-5643	102	8	of	of	ADP
fnp-5643	102	9	additional	additional	ADJ
fnp-5643	102	10	pathology	pathology	NOUN
fnp-5643	102	11	besides	besides	SCONJ
fnp-5643	102	12	lbd	lbd	PROPN
fnp-5643	102	13	pathology	pathology	PROPN
fnp-5643	102	14	in	in	ADP
fnp-5643	102	15	ad	ad	NOUN
fnp-5643	102	16	shown	show	VERB
fnp-5643	102	17	in	in	ADP
fnp-5643	102	18	table	table	NOUN
fnp-5643	102	19	 	 	SPACE
fnp-5643	102	20	1	1	NUM
fnp-5643	102	21	were	be	AUX
fnp-5643	102	22	:	:	PUNCT
fnp-5643	102	23	psp	psp	NOUN
fnp-5643	102	24	(	(	PUNCT
fnp-5643	102	25	n	n	CCONJ
fnp-5643	102	26	 	 	SPACE
fnp-5643	102	27	=	=	NOUN
fnp-5643	102	28	 	 	SPACE
fnp-5643	102	29	26	26	NUM
fnp-5643	102	30	,	,	PUNCT
fnp-5643	102	31	19.5	19.5	NUM
fnp-5643	102	32	 	 	SPACE
fnp-5643	102	33	%	%	NOUN
fnp-5643	102	34	)	)	PUNCT
fnp-5643	102	35	,	,	PUNCT
fnp-5643	102	36	ad	ad	NOUN
fnp-5643	102	37	without	without	ADP
fnp-5643	102	38	lbd	lbd	PROPN
fnp-5643	102	39	pathology	pathology	PROPN
fnp-5643	102	40	(	(	PUNCT
fnp-5643	102	41	n	n	CCONJ
fnp-5643	102	42	 	 	SPACE
fnp-5643	102	43	=	=	NOUN
fnp-5643	102	44	 	 	SPACE
fnp-5643	102	45	24	24	NUM
fnp-5643	102	46	,	,	PUNCT
fnp-5643	102	47	18.05	18.05	NUM
fnp-5643	102	48	 	 	SPACE
fnp-5643	102	49	%	%	NOUN
fnp-5643	102	50	)	)	PUNCT
fnp-5643	102	51	,	,	PUNCT
fnp-5643	102	52	lbd	lbd	PROPN
fnp-5643	102	53	(	(	PUNCT
fnp-5643	102	54	n	n	CCONJ
fnp-5643	102	55	 	 	SPACE
fnp-5643	102	56	=	=	NOUN
fnp-5643	102	57	 	 	SPACE
fnp-5643	102	58	22	22	NUM
fnp-5643	102	59	,	,	PUNCT
fnp-5643	102	60	16.5	16.5	NUM
fnp-5643	102	61	 	 	SPACE
fnp-5643	102	62	%	%	NOUN
fnp-5643	102	63	)	)	PUNCT
fnp-5643	102	64	,	,	PUNCT
fnp-5643	102	65	ad	ad	NOUN
fnp-5643	102	66	with	with	ADP
fnp-5643	102	67	lbd	lbd	PROPN
fnp-5643	102	68	(	(	PUNCT
fnp-5643	102	69	n	n	CCONJ
fnp-5643	102	70	 	 	SPACE
fnp-5643	102	71	=	=	NOUN
fnp-5643	102	72	 	 	SPACE
fnp-5643	102	73	13	13	NUM
fnp-5643	102	74	,	,	PUNCT
fnp-5643	102	75	9.77	9.77	NUM
fnp-5643	102	76	 	 	SPACE
fnp-5643	102	77	%	%	NOUN
fnp-5643	102	78	)	)	PUNCT
fnp-5643	102	79	,	,	PUNCT
fnp-5643	102	80	cbd	cbd	NOUN
fnp-5643	102	81	(	(	PUNCT
fnp-5643	102	82	n	n	CCONJ
fnp-5643	102	83	 	 	SPACE
fnp-5643	102	84	=	=	NOUN
fnp-5643	102	85	 	 	SPACE
fnp-5643	102	86	14	14	NUM
fnp-5643	102	87	,	,	PUNCT
fnp-5643	102	88	10.5	10.5	NUM
fnp-5643	102	89	 	 	SPACE
fnp-5643	102	90	%	%	NOUN
fnp-5643	102	91	)	)	PUNCT
fnp-5643	102	92	,	,	PUNCT
fnp-5643	102	93	msa	msa	PROPN
fnp-5643	102	94	(	(	PUNCT
fnp-5643	102	95	n	n	CCONJ
fnp-5643	102	96	 	 	SPACE
fnp-5643	102	97	=	=	NOUN
fnp-5643	102	98	 	 	SPACE
fnp-5643	102	99	14	14	NUM
fnp-5643	102	100	,	,	PUNCT
fnp-5643	102	101	10.5	10.5	NUM
fnp-5643	102	102	 	 	SPACE
fnp-5643	102	103	%	%	NOUN
fnp-5643	102	104	)	)	PUNCT
fnp-5643	102	105	non	non	ADJ
fnp-5643	102	106	-	-	ADJ
fnp-5643	102	107	tau	tau	ADJ
fnp-5643	102	108	ftld	ftld	ADJ
fnp-5643	102	109	(	(	PUNCT
fnp-5643	102	110	ftld	ftld	ADJ
fnp-5643	102	111	-	-	PUNCT
fnp-5643	102	112	tdp	tdp	NOUN
fnp-5643	102	113	,	,	PUNCT
fnp-5643	102	114	ftld	ftld	NOUN
fnp-5643	102	115	-	-	PUNCT
fnp-5643	102	116	fus	fus	NOUN
fnp-5643	102	117	;	;	PUNCT
fnp-5643	102	118	n	n	CCONJ
fnp-5643	102	119	 	 	SPACE
fnp-5643	102	120	=	=	VERB
fnp-5643	102	121	 	 	SPACE
fnp-5643	102	122	9	9	NUM
fnp-5643	102	123	,	,	PUNCT
fnp-5643	102	124	6.7	6.7	NUM
fnp-5643	102	125	 	 	SPACE
fnp-5643	102	126	%	%	NOUN
fnp-5643	102	127	)	)	PUNCT
fnp-5643	102	128	,	,	PUNCT
fnp-5643	102	129	prion	prion	NOUN
fnp-5643	102	130	disease	disease	NOUN
fnp-5643	102	131	(	(	PUNCT
fnp-5643	102	132	n	n	CCONJ
fnp-5643	102	133	 	 	SPACE
fnp-5643	102	134	=	=	NOUN
fnp-5643	102	135	 	 	SPACE
fnp-5643	102	136	4	4	NUM
fnp-5643	102	137	,	,	PUNCT
fnp-5643	102	138	3	3	NUM
fnp-5643	102	139	 	 	SPACE
fnp-5643	102	140	%	%	NOUN
fnp-5643	102	141	)	)	PUNCT
fnp-5643	102	142	,	,	PUNCT
fnp-5643	102	143	pid	pid	NOUN
fnp-5643	102	144	(	(	PUNCT
fnp-5643	102	145	n	n	CCONJ
fnp-5643	102	146	 	 	SPACE
fnp-5643	102	147	=	=	NOUN
fnp-5643	102	148	 	 	SPACE
fnp-5643	102	149	3	3	NUM
fnp-5643	102	150	,	,	PUNCT
fnp-5643	102	151	2.3	2.3	NUM
fnp-5643	102	152	 	 	SPACE
fnp-5643	102	153	%	%	NOUN
fnp-5643	102	154	)	)	PUNCT
fnp-5643	102	155	.	.	PUNCT
fnp-5643	103	1	in	in	ADP
fnp-5643	103	2	four	four	NUM
fnp-5643	103	3	cases	case	NOUN
fnp-5643	103	4	(	(	PUNCT
fnp-5643	103	5	3	3	NUM
fnp-5643	103	6	 	 	SPACE
fnp-5643	103	7	%	%	NOUN
fnp-5643	103	8	)	)	PUNCT
fnp-5643	103	9	,	,	PUNCT
fnp-5643	103	10	no	no	DET
fnp-5643	103	11	diagnosis	diagnosis	NOUN
fnp-5643	103	12	could	could	AUX
fnp-5643	103	13	be	be	AUX
fnp-5643	103	14	made	make	VERB
fnp-5643	103	15	using	use	VERB
fnp-5643	103	16	fast	fast	ADJ
fnp-5643	103	17	-	-	PUNCT
fnp-5643	103	18	track	track	NOUN
fnp-5643	103	19	histology	histology	NOUN
fnp-5643	103	20	and	and	CCONJ
fnp-5643	103	21	additional	additional	ADJ
fnp-5643	103	22	histological	histological	ADJ
fnp-5643	103	23	work	work	NOUN
fnp-5643	103	24	-	-	PUNCT
fnp-5643	103	25	up	up	NOUN
fnp-5643	103	26	was	be	AUX
fnp-5643	103	27	hence	hence	ADV
fnp-5643	103	28	required	require	VERB
fnp-5643	103	29	for	for	ADP
fnp-5643	103	30	neuropathological	neuropathological	ADJ
fnp-5643	103	31	diagnosis	diagnosis	NOUN
fnp-5643	103	32	.	.	PUNCT
fnp-5643	104	1	those	those	DET
fnp-5643	104	2	cases	case	NOUN
fnp-5643	104	3	were	be	AUX
fnp-5643	104	4	later	later	ADV
fnp-5643	104	5	classified	classify	VERB
fnp-5643	104	6	as	as	ADP
fnp-5643	104	7	psp	psp	NOUN
fnp-5643	104	8	(	(	PUNCT
fnp-5643	104	9	two	two	NUM
fnp-5643	104	10	cases	case	NOUN
fnp-5643	104	11	)	)	PUNCT
fnp-5643	104	12	,	,	PUNCT
fnp-5643	104	13	ftld	ftld	ADJ
fnp-5643	104	14	non	non	PROPN
fnp-5643	104	15	-	-	PROPN
fnp-5643	104	16	tau	tau	PROPN
fnp-5643	104	17	and	and	CCONJ
fnp-5643	104	18	lbd	lbd	PROPN
fnp-5643	104	19	(	(	PUNCT
fnp-5643	104	20	one	one	NUM
fnp-5643	104	21	case	case	NOUN
fnp-5643	104	22	each	each	PRON
fnp-5643	104	23	)	)	PUNCT
fnp-5643	104	24	.	.	PUNCT
fnp-5643	105	1	in	in	ADP
fnp-5643	105	2	80	80	NUM
fnp-5643	105	3	cases	case	NOUN
fnp-5643	105	4	(	(	PUNCT
fnp-5643	105	5	60.2	60.2	NUM
fnp-5643	105	6	 	 	SPACE
fnp-5643	105	7	%	%	NOUN
fnp-5643	105	8	)	)	PUNCT
fnp-5643	105	9	,	,	PUNCT
fnp-5643	105	10	the	the	DET
fnp-5643	105	11	suspected	suspect	VERB
fnp-5643	105	12	clinical	clinical	ADJ
fnp-5643	105	13	diagnosis	diagnosis	NOUN
fnp-5643	105	14	could	could	AUX
fnp-5643	105	15	be	be	AUX
fnp-5643	105	16	confirmed	confirm	VERB
fnp-5643	105	17	by	by	ADP
fnp-5643	105	18	fast	fast	ADJ
fnp-5643	105	19	-	-	PUNCT
fnp-5643	105	20	track	track	NOUN
fnp-5643	105	21	histology	histology	NOUN
fnp-5643	105	22	,	,	PUNCT
fnp-5643	105	23	whereas	whereas	SCONJ
fnp-5643	105	24	in	in	ADP
fnp-5643	105	25	49	49	NUM
fnp-5643	105	26	(	(	PUNCT
fnp-5643	105	27	39.8	39.8	NUM
fnp-5643	105	28	 	 	SPACE
fnp-5643	105	29	%	%	NOUN
fnp-5643	105	30	)	)	PUNCT
fnp-5643	106	1	the	the	DET
fnp-5643	106	2	clinical	clinical	ADJ
fnp-5643	106	3	diagnosis	diagnosis	NOUN
fnp-5643	106	4	was	be	AUX
fnp-5643	106	5	either	either	CCONJ
fnp-5643	106	6	ambiguous	ambiguous	ADJ
fnp-5643	106	7	or	or	CCONJ
fnp-5643	106	8	different	different	ADJ
fnp-5643	106	9	from	from	ADP
fnp-5643	106	10	the	the	DET
fnp-5643	106	11	histopathological	histopathological	ADJ
fnp-5643	106	12	diagnosis	diagnosis	NOUN
fnp-5643	106	13	.	.	PUNCT
fnp-5643	107	1	when	when	SCONJ
fnp-5643	107	2	comparing	compare	VERB
fnp-5643	107	3	the	the	DET
fnp-5643	107	4	initial	initial	ADJ
fnp-5643	107	5	fast	fast	ADJ
fnp-5643	107	6	-	-	PUNCT
fnp-5643	107	7	track	track	NOUN
fnp-5643	107	8	diagnosis	diagnosis	NOUN
fnp-5643	107	9	to	to	ADP
fnp-5643	107	10	the	the	DET
fnp-5643	107	11	diagnosis	diagnosis	NOUN
fnp-5643	107	12	made	make	VERB
fnp-5643	107	13	after	after	ADP
fnp-5643	107	14	subsequent	subsequent	ADJ
fnp-5643	107	15	conventional	conventional	ADJ
fnp-5643	107	16	pathological	pathological	ADJ
fnp-5643	107	17	work	work	NOUN
fnp-5643	107	18	-	-	PUNCT
fnp-5643	107	19	up	up	NOUN
fnp-5643	107	20	of	of	ADP
fnp-5643	107	21	the	the	DET
fnp-5643	107	22	brain	brain	NOUN
fnp-5643	107	23	,	,	PUNCT
fnp-5643	107	24	it	it	PRON
fnp-5643	107	25	became	become	VERB
fnp-5643	107	26	evident	evident	ADJ
fnp-5643	107	27	that	that	SCONJ
fnp-5643	107	28	in	in	ADP
fnp-5643	107	29	128	128	NUM
fnp-5643	107	30	cases	case	NOUN
fnp-5643	107	31	(	(	PUNCT
fnp-5643	107	32	96.2	96.2	NUM
fnp-5643	107	33	 	 	SPACE
fnp-5643	107	34	%	%	NOUN
fnp-5643	107	35	)	)	PUNCT
fnp-5643	107	36	the	the	DET
fnp-5643	107	37	ndd	ndd	PROPN
fnp-5643	107	38	entity	entity	NOUN
fnp-5643	107	39	determined	determine	VERB
fnp-5643	107	40	by	by	ADP
fnp-5643	107	41	fast	fast	ADJ
fnp-5643	107	42	-	-	PUNCT
fnp-5643	107	43	track	track	NOUN
fnp-5643	107	44	diagnosis	diagnosis	NOUN
fnp-5643	107	45	was	be	AUX
fnp-5643	107	46	correct	correct	ADJ
fnp-5643	107	47	and	and	CCONJ
fnp-5643	107	48	only	only	ADV
fnp-5643	107	49	co	co	NOUN
fnp-5643	107	50	-	-	NOUN
fnp-5643	107	51	pathologies	pathology	NOUN
fnp-5643	107	52	or	or	CCONJ
fnp-5643	107	53	correct	correct	ADJ
fnp-5643	107	54	disease	disease	NOUN
fnp-5643	107	55	staging	staging	NOUN
fnp-5643	107	56	needed	need	VERB
fnp-5643	107	57	to	to	PART
fnp-5643	107	58	be	be	AUX
fnp-5643	107	59	determined	determine	VERB
fnp-5643	107	60	.	.	PUNCT
fnp-5643	108	1	the	the	DET
fnp-5643	108	2	fast	fast	ADJ
fnp-5643	108	3	-	-	PUNCT
fnp-5643	108	4	track	track	NOUN
fnp-5643	108	5	diagnosis	diagnosis	NOUN
fnp-5643	108	6	needed	need	VERB
fnp-5643	108	7	revision	revision	NOUN
fnp-5643	108	8	in	in	ADP
fnp-5643	108	9	only	only	ADV
fnp-5643	108	10	one	one	NUM
fnp-5643	108	11	case	case	NOUN
fnp-5643	108	12	of	of	ADP
fnp-5643	108	13	an	an	DET
fnp-5643	108	14	unusual	unusual	ADJ
fnp-5643	108	15	tauopathy	tauopathy	NOUN
fnp-5643	108	16	initially	initially	ADV
fnp-5643	108	17	classified	classify	VERB
fnp-5643	108	18	as	as	ADP
fnp-5643	108	19	psp	psp	NOUN
fnp-5643	108	20	(	(	PUNCT
fnp-5643	108	21	3	3	NUM
fnp-5643	108	22	 	 	SPACE
fnp-5643	108	23	%	%	NOUN
fnp-5643	108	24	)	)	PUNCT
fnp-5643	108	25	.	.	PUNCT
fnp-5643	109	1	in	in	ADP
fnp-5643	109	2	four	four	NUM
fnp-5643	109	3	cases	case	NOUN
fnp-5643	109	4	,	,	PUNCT
fnp-5643	109	5	the	the	DET
fnp-5643	109	6	analysis	analysis	NOUN
fnp-5643	109	7	of	of	ADP
fnp-5643	109	8	additional	additional	ADJ
fnp-5643	109	9	brain	brain	NOUN
fnp-5643	109	10	regions	region	NOUN
fnp-5643	109	11	after	after	ADP
fnp-5643	109	12	fast	fast	ADJ
fnp-5643	109	13	-	-	PUNCT
fnp-5643	109	14	track	track	NOUN
fnp-5643	109	15	histology	histology	NOUN
fnp-5643	109	16	was	be	AUX
fnp-5643	109	17	required	require	VERB
fnp-5643	109	18	to	to	PART
fnp-5643	109	19	reach	reach	VERB
fnp-5643	109	20	a	a	DET
fnp-5643	109	21	conclusive	conclusive	ADJ
fnp-5643	109	22	histopathological	histopathological	ADJ
fnp-5643	109	23	diagnosis	diagnosis	NOUN
fnp-5643	109	24	,	,	PUNCT
fnp-5643	109	25	as	as	SCONJ
fnp-5643	109	26	mentioned	mention	VERB
fnp-5643	109	27	above	above	ADV
fnp-5643	109	28	.	.	PUNCT
fnp-5643	110	1	there	there	PRON
fnp-5643	110	2	was	be	VERB
fnp-5643	110	3	a	a	DET
fnp-5643	110	4	high	high	ADJ
fnp-5643	110	5	sensitivity	sensitivity	NOUN
fnp-5643	110	6	for	for	ADP
fnp-5643	110	7	the	the	DET
fnp-5643	110	8	diagnosis	diagnosis	NOUN
fnp-5643	110	9	,	,	PUNCT
fnp-5643	110	10	considering	consider	VERB
fnp-5643	110	11	only	only	ADV
fnp-5643	110	12	the	the	DET
fnp-5643	110	13	main	main	ADJ
fnp-5643	110	14	pathology	pathology	NOUN
fnp-5643	110	15	without	without	ADP
fnp-5643	110	16	additional	additional	ADJ
fnp-5643	110	17	pathology	pathology	NOUN
fnp-5643	110	18	,	,	PUNCT
fnp-5643	110	19	for	for	ADP
fnp-5643	110	20	ad	ad	NOUN
fnp-5643	110	21	,	,	PUNCT
fnp-5643	110	22	braak	braak	NOUN
fnp-5643	110	23	and	and	CCONJ
fnp-5643	110	24	braak	braak	NOUN
fnp-5643	110	25	stage	stage	VERB
fnp-5643	110	26	5	5	NUM
fnp-5643	110	27	or	or	CCONJ
fnp-5643	110	28	6	6	NUM
fnp-5643	110	29	(	(	PUNCT
fnp-5643	110	30	1.0	1.0	NUM
fnp-5643	110	31	,	,	PUNCT
fnp-5643	110	32	ci	ci	NOUN
fnp-5643	110	33	 	 	SPACE
fnp-5643	110	34	=	=	NOUN
fnp-5643	110	35	 	 	SPACE
fnp-5643	110	36	0.9059	0.9059	NUM
fnp-5643	110	37	 	 	SPACE
fnp-5643	110	38	-	-	PUNCT
fnp-5643	110	39	 	 	SPACE
fnp-5643	110	40	1.00	1.00	NUM
fnp-5643	110	41	,	,	PUNCT
fnp-5643	110	42	p	p	X
fnp-5643	110	43	 	 	SPACE
fnp-5643	110	44	<	<	X
fnp-5643	110	45	 	 	SPACE
fnp-5643	110	46	0.0001	0.0001	NUM
fnp-5643	110	47	)	)	PUNCT
fnp-5643	110	48	,	,	PUNCT
fnp-5643	110	49	cbd	cbd	NOUN
fnp-5643	110	50	(	(	PUNCT
fnp-5643	110	51	1.0	1.0	NUM
fnp-5643	110	52	,	,	PUNCT
fnp-5643	110	53	ci	ci	NOUN
fnp-5643	110	54	 	 	SPACE
fnp-5643	110	55	=	=	NOUN
fnp-5643	110	56	 	 	SPACE
fnp-5643	110	57	0.7847	0.7847	NUM
fnp-5643	110	58	 	 	SPACE
fnp-5643	110	59	-	-	PUNCT
fnp-5643	110	60	 	 	SPACE
fnp-5643	110	61	1.00	1.00	NUM
fnp-5643	110	62	,	,	PUNCT
fnp-5643	110	63	p	p	X
fnp-5643	110	64	 	 	SPACE
fnp-5643	110	65	<	<	X
fnp-5643	110	66	 	 	SPACE
fnp-5643	110	67	0.0001	0.0001	NUM
fnp-5643	110	68	)	)	PUNCT
fnp-5643	110	69	,	,	PUNCT
fnp-5643	110	70	lbd	lbd	PROPN
fnp-5643	110	71	(	(	PUNCT
fnp-5643	110	72	1.0	1.0	NUM
fnp-5643	110	73	,	,	PUNCT
fnp-5643	110	74	ci	ci	NOUN
fnp-5643	110	75	 	 	SPACE
fnp-5643	110	76	=	=	NOUN
fnp-5643	110	77	 	 	SPACE
fnp-5643	110	78	0.8513	0.8513	NUM
fnp-5643	110	79	 	 	SPACE
fnp-5643	110	80	-	-	PUNCT
fnp-5643	110	81	 	 	SPACE
fnp-5643	110	82	1.00	1.00	NUM
fnp-5643	110	83	,	,	PUNCT
fnp-5643	110	84	p	p	X
fnp-5643	110	85	 	 	SPACE
fnp-5643	110	86	<	<	X
fnp-5643	110	87	 	 	SPACE
fnp-5643	110	88	0.0001	0.0001	NUM
fnp-5643	110	89	)	)	PUNCT
fnp-5643	110	90	,	,	PUNCT
fnp-5643	110	91	pid	pid	NOUN
fnp-5643	110	92	(	(	PUNCT
fnp-5643	110	93	1.0	1.0	NUM
fnp-5643	110	94	,	,	PUNCT
fnp-5643	110	95	ci	ci	NOUN
fnp-5643	110	96	 	 	SPACE
fnp-5643	110	97	=	=	NOUN
fnp-5643	110	98	 	 	SPACE
fnp-5643	110	99	0.4385	0.4385	NUM
fnp-5643	110	100	 	 	SPACE
fnp-5643	110	101	-	-	PUNCT
fnp-5643	110	102	 	 	SPACE
fnp-5643	110	103	1.00	1.00	NUM
fnp-5643	110	104	,	,	PUNCT
fnp-5643	110	105	p	p	X
fnp-5643	110	106	 	 	SPACE
fnp-5643	110	107	<	<	X
fnp-5643	110	108	 	 	SPACE
fnp-5643	110	109	0.0001	0.0001	NUM
fnp-5643	110	110	)	)	PUNCT
fnp-5643	110	111	,	,	PUNCT
fnp-5643	110	112	msa	msa	PROPN
fnp-5643	110	113	(	(	PUNCT
fnp-5643	110	114	1.0	1.0	NUM
fnp-5643	110	115	,	,	PUNCT
fnp-5643	110	116	ci	ci	NOUN
fnp-5643	110	117	 	 	SPACE
fnp-5643	110	118	=	=	NOUN
fnp-5643	110	119	 	 	SPACE
fnp-5643	110	120	0.7847	0.7847	NUM
fnp-5643	110	121	 	 	SPACE
fnp-5643	110	122	-	-	PUNCT
fnp-5643	110	123	 	 	SPACE
fnp-5643	110	124	1.00	1.00	NUM
fnp-5643	110	125	,	,	PUNCT
fnp-5643	110	126	p	p	X
fnp-5643	110	127	 	 	SPACE
fnp-5643	110	128	<	<	X
fnp-5643	110	129	 	 	SPACE
fnp-5643	110	130	0.0001	0.0001	NUM
fnp-5643	110	131	)	)	PUNCT
fnp-5643	110	132	and	and	CCONJ
fnp-5643	110	133	ftld	ftld	ADJ
fnp-5643	110	134	non	non	PROPN
fnp-5643	110	135	-	-	PROPN
fnp-5643	110	136	tau	tau	PROPN
fnp-5643	110	137	(	(	PUNCT
fnp-5643	110	138	1.0	1.0	NUM
fnp-5643	110	139	,	,	PUNCT
fnp-5643	110	140	ci	ci	NOUN
fnp-5643	110	141	 	 	SPACE
fnp-5643	110	142	=	=	NOUN
fnp-5643	110	143	 	 	SPACE
fnp-5643	110	144	0.7009	0.7009	NUM
fnp-5643	110	145	 	 	SPACE
fnp-5643	110	146	-	-	PUNCT
fnp-5643	110	147	 	 	SPACE
fnp-5643	110	148	1.00	1.00	NUM
fnp-5643	110	149	,	,	PUNCT
fnp-5643	110	150	p	p	X
fnp-5643	110	151	 	 	SPACE
fnp-5643	110	152	<	<	X
fnp-5643	110	153	 	 	SPACE
fnp-5643	110	154	0.0001	0.0001	NUM
fnp-5643	110	155	)	)	PUNCT
fnp-5643	110	156	.	.	PUNCT
fnp-5643	111	1	the	the	DET
fnp-5643	111	2	sensitivity	sensitivity	NOUN
fnp-5643	111	3	for	for	ADP
fnp-5643	111	4	the	the	DET
fnp-5643	111	5	diagnosis	diagnosis	NOUN
fnp-5643	111	6	of	of	ADP
fnp-5643	111	7	psp	psp	NOUN
fnp-5643	111	8	was	be	AUX
fnp-5643	111	9	0.96	0.96	NUM
fnp-5643	111	10	(	(	PUNCT
fnp-5643	111	11	ci	ci	NOUN
fnp-5643	111	12	 	 	SPACE
fnp-5643	111	13	=	=	NOUN
fnp-5643	111	14	 	 	SPACE
fnp-5643	111	15	0.8046	0.8046	NUM
fnp-5643	111	16	 	 	SPACE
fnp-5643	111	17	-	-	PUNCT
fnp-5643	111	18	 	 	SPACE
fnp-5643	111	19	0.9979	0.9979	NUM
fnp-5643	111	20	,	,	PUNCT
fnp-5643	111	21	p	p	X
fnp-5643	111	22	 	 	SPACE
fnp-5643	111	23	<	<	X
fnp-5643	111	24	 	 	SPACE
fnp-5643	111	25	0.0001	0.0001	NUM
fnp-5643	111	26	)	)	PUNCT
fnp-5643	111	27	.	.	PUNCT
fnp-5643	112	1	the	the	DET
fnp-5643	112	2	respective	respective	ADJ
fnp-5643	112	3	specificity	specificity	NOUN
fnp-5643	112	4	was	be	AUX
fnp-5643	112	5	for	for	ADP
fnp-5643	112	6	ad	ad	NOUN
fnp-5643	112	7	1.0	1.0	NUM
fnp-5643	112	8	(	(	PUNCT
fnp-5643	112	9	ci	ci	NOUN
fnp-5643	112	10	 	 	SPACE
fnp-5643	112	11	=	=	NOUN
fnp-5643	112	12	 	 	SPACE
fnp-5643	112	13	0.9615	0.9615	NUM
fnp-5643	112	14	 	 	SPACE
fnp-5643	112	15	-	-	PUNCT
fnp-5643	112	16	 	 	SPACE
fnp-5643	112	17	0	0	NUM
fnp-5643	112	18	,	,	PUNCT
fnp-5643	112	19	p	p	X
fnp-5643	112	20	 	 	SPACE
fnp-5643	112	21	<	<	X
fnp-5643	112	22	 	 	SPACE
fnp-5643	112	23	0.0001	0.0001	NUM
fnp-5643	112	24	)	)	PUNCT
fnp-5643	112	25	,	,	PUNCT
fnp-5643	112	26	for	for	ADP
fnp-5643	112	27	cbd	cbd	NOUN
fnp-5643	112	28	1.0	1.0	NUM
fnp-5643	112	29	(	(	PUNCT
fnp-5643	112	30	ci	ci	NOUN
fnp-5643	112	31	 	 	SPACE
fnp-5643	112	32	=	=	NOUN
fnp-5643	112	33	 	 	SPACE
fnp-5643	112	34	0.9687	0.9687	NUM
fnp-5643	112	35	 	 	SPACE
fnp-5643	112	36	-	-	PUNCT
fnp-5643	112	37	 	 	SPACE
fnp-5643	112	38	1.0	1.0	NUM
fnp-5643	112	39	,	,	PUNCT
fnp-5643	112	40	p	p	X
fnp-5643	112	41	 	 	SPACE
fnp-5643	112	42	<	<	X
fnp-5643	112	43	 	 	SPACE
fnp-5643	112	44	0.0001	0.0001	NUM
fnp-5643	112	45	)	)	PUNCT
fnp-5643	112	46	,	,	PUNCT
fnp-5643	112	47	for	for	ADP
fnp-5643	112	48	lbd	lbd	PROPN
fnp-5643	112	49	0.9910	0.9910	NUM
fnp-5643	112	50	(	(	PUNCT
fnp-5643	112	51	ci	ci	NOUN
fnp-5643	112	52	 	 	SPACE
fnp-5643	112	53	=	=	NOUN
fnp-5643	112	54	 	 	SPACE
fnp-5643	112	55	0.9507	0.9507	NUM
fnp-5643	112	56	 	 	SPACE
fnp-5643	112	57	-	-	PUNCT
fnp-5643	112	58	 	 	SPACE
fnp-5643	112	59	0.9995	0.9995	NUM
fnp-5643	112	60	,	,	PUNCT
fnp-5643	112	61	p	p	X
fnp-5643	112	62	 	 	SPACE
fnp-5643	112	63	<	<	X
fnp-5643	112	64	 	 	SPACE
fnp-5643	112	65	0.0001	0.0001	NUM
fnp-5643	112	66	)	)	PUNCT
fnp-5643	112	67	,	,	PUNCT
fnp-5643	112	68	for	for	ADP
fnp-5643	112	69	pid	pid	NOUN
fnp-5643	112	70	1.0	1.0	NUM
fnp-5643	112	71	(	(	PUNCT
fnp-5643	112	72	ci	ci	NOUN
fnp-5643	112	73	 	 	SPACE
fnp-5643	112	74	=	=	NOUN
fnp-5643	112	75	 	 	SPACE
fnp-5643	112	76	0.9713	0.9713	NUM
fnp-5643	112	77	 	 	SPACE
fnp-5643	112	78	-	-	PUNCT
fnp-5643	112	79	 	 	SPACE
fnp-5643	112	80	1.0	1.0	NUM
fnp-5643	112	81	,	,	PUNCT
fnp-5643	112	82	p	p	X
fnp-5643	112	83	 	 	SPACE
fnp-5643	112	84	<	<	X
fnp-5643	112	85	 	 	SPACE
fnp-5643	112	86	0.0001	0.0001	NUM
fnp-5643	112	87	)	)	PUNCT
fnp-5643	112	88	,	,	PUNCT
fnp-5643	112	89	for	for	ADP
fnp-5643	112	90	msa	msa	PROPN
fnp-5643	112	91	1.0	1.0	NUM
fnp-5643	112	92	(	(	PUNCT
fnp-5643	112	93	ci	ci	NOUN
fnp-5643	112	94	 	 	SPACE
fnp-5643	112	95	=	=	NOUN
fnp-5643	112	96	 	 	SPACE
fnp-5643	112	97	0.9687	0.9687	NUM
fnp-5643	112	98	 	 	SPACE
fnp-5643	112	99	-	-	PUNCT
fnp-5643	112	100	 	 	SPACE
fnp-5643	112	101	1.0	1.0	NUM
fnp-5643	112	102	,	,	PUNCT
fnp-5643	112	103	p	p	X
fnp-5643	112	104	 	 	SPACE
fnp-5643	112	105	<	<	X
fnp-5643	112	106	 	 	SPACE
fnp-5643	112	107	0.0001	0.0001	NUM
fnp-5643	112	108	)	)	PUNCT
fnp-5643	112	109	,	,	PUNCT
fnp-5643	112	110	for	for	ADP
fnp-5643	112	111	ftld	ftld	ADJ
fnp-5643	112	112	non	non	ADJ
fnp-5643	112	113	-	-	ADJ
fnp-5643	112	114	tau	tau	ADJ
fnp-5643	112	115	0.9919	0.9919	NUM
fnp-5643	112	116	(	(	PUNCT
fnp-5643	112	117	ci	ci	NOUN
fnp-5643	112	118	 	 	SPACE
fnp-5643	112	119	=	=	NOUN
fnp-5643	112	120	 	 	SPACE
fnp-5643	112	121	0.9557	0.9557	NUM
fnp-5643	112	122	 	 	SPACE
fnp-5643	112	123	-	-	PUNCT
fnp-5643	112	124	 	 	SPACE
fnp-5643	112	125	0.9996	0.9996	NUM
fnp-5643	112	126	,	,	PUNCT
fnp-5643	112	127	p	p	X
fnp-5643	112	128	 	 	SPACE
fnp-5643	112	129	<	<	X
fnp-5643	112	130	 	 	SPACE
fnp-5643	112	131	0.0001	0.0001	NUM
fnp-5643	112	132	)	)	PUNCT
fnp-5643	112	133	and	and	CCONJ
fnp-5643	112	134	for	for	ADP
fnp-5643	112	135	psp	psp	NOUN
fnp-5643	112	136	0.9815	0.9815	NUM
fnp-5643	112	137	(	(	PUNCT
fnp-5643	112	138	ci	ci	NOUN
fnp-5643	112	139	 	 	SPACE
fnp-5643	112	140	=	=	NOUN
fnp-5643	112	141	 	 	SPACE
fnp-5643	112	142	0.9350	0.9350	NUM
fnp-5643	112	143	 	 	SPACE
fnp-5643	112	144	-	-	PUNCT
fnp-5643	112	145	 	 	SPACE
fnp-5643	112	146	0.9967	0.9967	NUM
fnp-5643	112	147	,	,	PUNCT
fnp-5643	112	148	p	p	X
fnp-5643	112	149	 	 	SPACE
fnp-5643	112	150	<	<	X
fnp-5643	112	151	 	 	SPACE
fnp-5643	112	152	0.0001	0.0001	NUM
fnp-5643	112	153	)	)	PUNCT
fnp-5643	112	154	.	.	PUNCT
fnp-5643	113	1	leading	lead	VERB
fnp-5643	113	2	diagnosis	diagnosis	NOUN
fnp-5643	113	3	on	on	ADP
fnp-5643	113	4	screening	screen	VERB
fnp-5643	113	5	histology	histology	NOUN
fnp-5643	113	6	confirmation	confirmation	NOUN
fnp-5643	113	7	by	by	ADP
fnp-5643	113	8	full	full	ADJ
fnp-5643	113	9	histology	histology	NOUN
fnp-5643	113	10	ad	ad	NOUN
fnp-5643	113	11	without	without	ADP
fnp-5643	113	12	lbd	lbd	PROPN
fnp-5643	113	13	(	(	PUNCT
fnp-5643	113	14	n	n	CCONJ
fnp-5643	113	15	 	 	SPACE
fnp-5643	113	16	=	=	NOUN
fnp-5643	113	17	 	 	SPACE
fnp-5643	113	18	24	24	NUM
fnp-5643	113	19	)	)	PUNCT
fnp-5643	113	20	91.67	91.67	NUM
fnp-5643	113	21	 	 	SPACE
fnp-5643	113	22	%	%	NOUN
fnp-5643	113	23	*	*	PUNCT
fnp-5643	113	24	ad	ad	NOUN
fnp-5643	113	25	with	with	ADP
fnp-5643	113	26	lbd	lbd	PROPN
fnp-5643	113	27	(	(	PUNCT
fnp-5643	113	28	n	n	CCONJ
fnp-5643	113	29	 	 	SPACE
fnp-5643	113	30	=	=	NOUN
fnp-5643	113	31	 	 	SPACE
fnp-5643	113	32	13	13	NUM
fnp-5643	113	33	)	)	PUNCT
fnp-5643	113	34	100	100	NUM
fnp-5643	113	35	 	 	SPACE
fnp-5643	113	36	%	%	NOUN
fnp-5643	113	37	psp	psp	NOUN
fnp-5643	113	38	(	(	PUNCT
fnp-5643	113	39	n	n	CCONJ
fnp-5643	113	40	 	 	SPACE
fnp-5643	113	41	=	=	NOUN
fnp-5643	113	42	 	 	SPACE
fnp-5643	113	43	26	26	NUM
fnp-5643	113	44	)	)	PUNCT
fnp-5643	113	45	96.15	96.15	NUM
fnp-5643	113	46	 	 	SPACE
fnp-5643	113	47	%	%	NOUN
fnp-5643	113	48	cbd	cbd	NOUN
fnp-5643	113	49	(	(	PUNCT
fnp-5643	113	50	n	n	CCONJ
fnp-5643	113	51	 	 	SPACE
fnp-5643	113	52	=	=	NOUN
fnp-5643	113	53	 	 	SPACE
fnp-5643	113	54	14	14	NUM
fnp-5643	113	55	)	)	PUNCT
fnp-5643	113	56	100	100	NUM
fnp-5643	113	57	 	 	SPACE
fnp-5643	113	58	%	%	NOUN
fnp-5643	113	59	pid	pid	NOUN
fnp-5643	113	60	(	(	PUNCT
fnp-5643	113	61	n	n	CCONJ
fnp-5643	113	62	 	 	SPACE
fnp-5643	113	63	=	=	NOUN
fnp-5643	113	64	 	 	SPACE
fnp-5643	113	65	3	3	NUM
fnp-5643	113	66	)	)	PUNCT
fnp-5643	113	67	100	100	NUM
fnp-5643	113	68	 	 	SPACE
fnp-5643	113	69	%	%	NOUN
fnp-5643	113	70	non	non	ADJ
fnp-5643	113	71	-	-	ADJ
fnp-5643	113	72	tau	tau	ADJ
fnp-5643	113	73	ftld	ftld	ADJ
fnp-5643	113	74	(	(	PUNCT
fnp-5643	113	75	n	n	CCONJ
fnp-5643	113	76	 	 	SPACE
fnp-5643	113	77	=	=	NOUN
fnp-5643	113	78	 	 	SPACE
fnp-5643	113	79	9	9	NUM
fnp-5643	113	80	)	)	PUNCT
fnp-5643	113	81	100	100	NUM
fnp-5643	113	82	 	 	SPACE
fnp-5643	113	83	%	%	NOUN
fnp-5643	113	84	lbd	lbd	PROPN
fnp-5643	113	85	(	(	PUNCT
fnp-5643	113	86	n	n	CCONJ
fnp-5643	113	87	 	 	SPACE
fnp-5643	113	88	=	=	NOUN
fnp-5643	113	89	 	 	SPACE
fnp-5643	113	90	22	22	NUM
fnp-5643	113	91	)	)	PUNCT
fnp-5643	113	92	100	100	NUM
fnp-5643	113	93	 	 	SPACE
fnp-5643	113	94	%	%	NOUN
fnp-5643	113	95	msa	msa	PROPN
fnp-5643	113	96	(	(	PUNCT
fnp-5643	113	97	n	n	CCONJ
fnp-5643	113	98	 	 	SPACE
fnp-5643	113	99	=	=	NOUN
fnp-5643	113	100	 	 	SPACE
fnp-5643	113	101	14	14	NUM
fnp-5643	113	102	)	)	PUNCT
fnp-5643	113	103	100	100	NUM
fnp-5643	113	104	 	 	SPACE
fnp-5643	113	105	%	%	NOUN
fnp-5643	113	106	prion	prion	NOUN
fnp-5643	113	107	disease	disease	NOUN
fnp-5643	113	108	(	(	PUNCT
fnp-5643	113	109	n	n	CCONJ
fnp-5643	113	110	 	 	SPACE
fnp-5643	113	111	=	=	NOUN
fnp-5643	113	112	 	 	SPACE
fnp-5643	113	113	4	4	NUM
fnp-5643	113	114	)	)	PUNCT
fnp-5643	113	115	100	100	NUM
fnp-5643	113	116	 	 	SPACE
fnp-5643	113	117	%	%	NOUN
fnp-5643	114	1	no	no	DET
fnp-5643	114	2	diagnosis	diagnosis	NOUN
fnp-5643	114	3	possible	possible	ADJ
fnp-5643	114	4	(	(	PUNCT
fnp-5643	114	5	n	n	CCONJ
fnp-5643	114	6	 	 	SPACE
fnp-5643	114	7	=	=	NOUN
fnp-5643	114	8	 	 	SPACE
fnp-5643	114	9	4	4	NUM
fnp-5643	114	10	)	)	PUNCT
fnp-5643	114	11	table	table	NOUN
fnp-5643	114	12	1	1	NUM
fnp-5643	114	13	:	:	PUNCT
fnp-5643	114	14	histopathological	histopathological	ADJ
fnp-5643	114	15	diagnoses	diagnosis	NOUN
fnp-5643	114	16	obtained	obtain	VERB
fnp-5643	114	17	by	by	ADP
fnp-5643	114	18	fast	fast	ADJ
fnp-5643	114	19	-	-	PUNCT
fnp-5643	114	20	track	track	NOUN
fnp-5643	114	21	screening	screen	VERB
fnp-5643	114	22	histology	histology	NOUN
fnp-5643	114	23	and	and	CCONJ
fnp-5643	114	24	their	their	PRON
fnp-5643	114	25	confirmation	confirmation	NOUN
fnp-5643	114	26	by	by	ADP
fnp-5643	114	27	final	final	ADJ
fnp-5643	114	28	histology	histology	NOUN
fnp-5643	114	29	in	in	ADP
fnp-5643	114	30	percentage	percentage	NOUN
fnp-5643	114	31	of	of	ADP
fnp-5643	114	32	cases	case	NOUN
fnp-5643	114	33	.	.	PUNCT
fnp-5643	115	1	the	the	DET
fnp-5643	115	2	diagnoses	diagnosis	NOUN
fnp-5643	115	3	are	be	AUX
fnp-5643	115	4	arranged	arrange	VERB
fnp-5643	115	5	according	accord	VERB
fnp-5643	115	6	to	to	ADP
fnp-5643	115	7	the	the	DET
fnp-5643	115	8	predominant	predominant	ADJ
fnp-5643	115	9	protein	protein	NOUN
fnp-5643	115	10	deposit	deposit	NOUN
fnp-5643	115	11	:	:	PUNCT
fnp-5643	115	12	ad	ad	NOUN
fnp-5643	115	13	without	without	ADP
fnp-5643	115	14	(	(	PUNCT
fnp-5643	115	15	green	green	ADJ
fnp-5643	115	16	)	)	PUNCT
fnp-5643	115	17	and	and	CCONJ
fnp-5643	115	18	with	with	ADP
fnp-5643	115	19	(	(	PUNCT
fnp-5643	115	20	light	light	ADJ
fnp-5643	115	21	brown	brown	PROPN
fnp-5643	115	22	)	)	PUNCT
fnp-5643	115	23	lbd	lbd	PROPN
fnp-5643	115	24	,	,	PUNCT
fnp-5643	115	25	primary	primary	ADJ
fnp-5643	115	26	tauopathies	tauopathie	NOUN
fnp-5643	115	27	(	(	PUNCT
fnp-5643	115	28	blue	blue	ADJ
fnp-5643	115	29	)	)	PUNCT
fnp-5643	115	30	,	,	PUNCT
fnp-5643	115	31	tdp-43	tdp-43	NOUN
fnp-5643	115	32	or	or	CCONJ
fnp-5643	115	33	other	other	ADJ
fnp-5643	115	34	proteins	protein	NOUN
fnp-5643	115	35	in	in	ADP
fnp-5643	115	36	non	non	ADJ
fnp-5643	115	37	-	-	ADJ
fnp-5643	115	38	tau	tau	ADJ
fnp-5643	115	39	ftld	ftld	ADJ
fnp-5643	115	40	(	(	PUNCT
fnp-5643	115	41	purple	purple	ADJ
fnp-5643	115	42	)	)	PUNCT
fnp-5643	115	43	,	,	PUNCT
fnp-5643	115	44	synucleinopathies	synucleinopathie	NOUN
fnp-5643	115	45	(	(	PUNCT
fnp-5643	115	46	red	red	ADJ
fnp-5643	115	47	)	)	PUNCT
fnp-5643	115	48	,	,	PUNCT
fnp-5643	115	49	prion	prion	NOUN
fnp-5643	115	50	disease	disease	NOUN
fnp-5643	115	51	(	(	PUNCT
fnp-5643	115	52	black	black	NOUN
fnp-5643	115	53	)	)	PUNCT
fnp-5643	115	54	.	.	PUNCT
fnp-5643	116	1	*	*	PUNCT
fnp-5643	116	2	 	 	SPACE
fnp-5643	116	3	ad	ad	NOUN
fnp-5643	116	4	was	be	AUX
fnp-5643	116	5	confirmed	confirm	VERB
fnp-5643	116	6	in	in	ADP
fnp-5643	116	7	all	all	DET
fnp-5643	116	8	24	24	NUM
fnp-5643	116	9	cases	case	NOUN
fnp-5643	116	10	,	,	PUNCT
fnp-5643	116	11	however	however	ADV
fnp-5643	116	12	,	,	PUNCT
fnp-5643	116	13	two	two	NUM
fnp-5643	116	14	showed	show	VERB
fnp-5643	116	15	additional	additional	ADJ
fnp-5643	116	16	lbd	lbd	PROPN
fnp-5643	116	17	pathology	pathology	NOUN
fnp-5643	116	18	(	(	PUNCT
fnp-5643	116	19	one	one	NUM
fnp-5643	116	20	olfactory	olfactory	NOUN
fnp-5643	116	21	bulb	bulb	NOUN
fnp-5643	116	22	only	only	ADV
fnp-5643	116	23	,	,	PUNCT
fnp-5643	116	24	one	one	NUM
fnp-5643	116	25	lbd	lbd	PROPN
fnp-5643	116	26	braak	braak	PROPN
fnp-5643	116	27	stage	stage	VERB
fnp-5643	116	28	5	5	NUM
fnp-5643	116	29	)	)	PUNCT
fnp-5643	116	30	and	and	CCONJ
fnp-5643	116	31	were	be	AUX
fnp-5643	116	32	thus	thus	ADV
fnp-5643	116	33	classified	classify	VERB
fnp-5643	116	34	as	as	ADP
fnp-5643	116	35	ad	ad	NOUN
fnp-5643	116	36	with	with	ADP
fnp-5643	116	37	lbd	lbd	PROPN
fnp-5643	116	38	cases	case	NOUN
fnp-5643	116	39	.	.	PUNCT
fnp-5643	117	1	the	the	DET
fnp-5643	117	2	kappa	kappa	PROPN
fnp-5643	117	3	coefficient	coefficient	NOUN
fnp-5643	117	4	for	for	ADP
fnp-5643	117	5	inter	inter	ADJ
fnp-5643	117	6	-	-	ADJ
fnp-5643	117	7	rater	rater	ADJ
fnp-5643	117	8	variability	variability	NOUN
fnp-5643	117	9	comparing	compare	VERB
fnp-5643	117	10	fast	fast	ADJ
fnp-5643	117	11	-	-	PUNCT
fnp-5643	117	12	track	track	NOUN
fnp-5643	117	13	and	and	CCONJ
fnp-5643	117	14	final	final	ADJ
fnp-5643	117	15	histology	histology	NOUN
fnp-5643	117	16	was	be	AUX
fnp-5643	117	17	as	as	SCONJ
fnp-5643	117	18	follows	follow	VERB
fnp-5643	117	19	:	:	PUNCT
fnp-5643	117	20	ad	ad	NOUN
fnp-5643	117	21	1.0	1.0	NUM
fnp-5643	117	22	(	(	PUNCT
fnp-5643	117	23	ci	ci	NOUN
fnp-5643	117	24	 	 	SPACE
fnp-5643	117	25	=	=	NOUN
fnp-5643	117	26	 	 	SPACE
fnp-5643	117	27	1.0	1.0	NUM
fnp-5643	117	28	 	 	SPACE
fnp-5643	117	29	-	-	PUNCT
fnp-5643	117	30	 	 	SPACE
fnp-5643	117	31	1.0	1.0	NUM
fnp-5643	117	32	)	)	PUNCT
fnp-5643	117	33	,	,	PUNCT
fnp-5643	117	34	cbd	cbd	NOUN
fnp-5643	117	35	1.0	1.0	NUM
fnp-5643	117	36	(	(	PUNCT
fnp-5643	117	37	ci	ci	NOUN
fnp-5643	117	38	 	 	SPACE
fnp-5643	117	39	=	=	NOUN
fnp-5643	117	40	 	 	SPACE
fnp-5643	117	41	1.0	1.0	NUM
fnp-5643	117	42	 	 	SPACE
fnp-5643	117	43	-	-	PUNCT
fnp-5643	117	44	 	 	SPACE
fnp-5643	117	45	1.0	1.0	NUM
fnp-5643	117	46	)	)	PUNCT
fnp-5643	117	47	,	,	PUNCT
fnp-5643	117	48	pid	pid	NOUN
fnp-5643	117	49	1.0	1.0	NUM
fnp-5643	117	50	(	(	PUNCT
fnp-5643	117	51	ci	ci	NOUN
fnp-5643	117	52	 	 	SPACE
fnp-5643	117	53	=	=	NOUN
fnp-5643	117	54	 	 	SPACE
fnp-5643	117	55	1.0	1.0	NUM
fnp-5643	117	56	 	 	SPACE
fnp-5643	117	57	-	-	PUNCT
fnp-5643	117	58	 	 	SPACE
fnp-5643	117	59	1.0	1.0	NUM
fnp-5643	117	60	)	)	PUNCT
fnp-5643	117	61	,	,	PUNCT
fnp-5643	117	62	msa	msa	PROPN
fnp-5643	117	63	1.0	1.0	NUM
fnp-5643	117	64	(	(	PUNCT
fnp-5643	117	65	ci	ci	NOUN
fnp-5643	117	66	 	 	SPACE
fnp-5643	117	67	=	=	NOUN
fnp-5643	117	68	 	 	SPACE
fnp-5643	117	69	1.0	1.0	NUM
fnp-5643	117	70	 	 	SPACE
fnp-5643	117	71	-	-	PUNCT
fnp-5643	117	72	 	 	SPACE
fnp-5643	117	73	1.0	1.0	NUM
fnp-5643	117	74	)	)	PUNCT
fnp-5643	117	75	,	,	PUNCT
fnp-5643	117	76	ftld	ftld	ADJ
fnp-5643	117	77	non	non	PROPN
fnp-5643	117	78	-	-	NOUN
fnp-5643	117	79	tau	tau	ADJ
fnp-5643	117	80	0.943	0.943	NUM
fnp-5643	117	81	(	(	PUNCT
fnp-5643	117	82	ci	ci	NOUN
fnp-5643	117	83	 	 	SPACE
fnp-5643	117	84	=	=	NOUN
fnp-5643	117	85	 	 	SPACE
fnp-5643	117	86	0.833	0.833	NUM
fnp-5643	117	87	 	 	SPACE
fnp-5643	117	88	-	-	PUNCT
fnp-5643	117	89	 	 	SPACE
fnp-5643	117	90	1.0	1.0	NUM
fnp-5643	117	91	)	)	PUNCT
fnp-5643	117	92	,	,	PUNCT
fnp-5643	117	93	lbd	lbd	PROPN
fnp-5643	117	94	0.973	0.973	NUM
fnp-5643	117	95	(	(	PUNCT
fnp-5643	117	96	ci	ci	NOUN
fnp-5643	117	97	 	 	SPACE
fnp-5643	117	98	=	=	NOUN
fnp-5643	117	99	 	 	SPACE
fnp-5643	117	100	0.921	0.921	NUM
fnp-5643	117	101	 	 	SPACE
fnp-5643	117	102	-	-	PUNCT
fnp-5643	117	103	 	 	SPACE
fnp-5643	117	104	1.0	1.0	NUM
fnp-5643	117	105	)	)	PUNCT
fnp-5643	117	106	,	,	PUNCT
fnp-5643	117	107	psp	psp	NOUN
fnp-5643	117	108	0.927	0.927	NUM
fnp-5643	117	109	(	(	PUNCT
fnp-5643	117	110	ci	ci	NOUN
fnp-5643	117	111	 	 	SPACE
fnp-5643	117	112	=	=	NOUN
fnp-5643	117	113	 	 	SPACE
fnp-5643	117	114	0.846	0.846	NUM
fnp-5643	117	115	 	 	SPACE
fnp-5643	117	116	-	-	PUNCT
fnp-5643	117	117	 	 	SPACE
fnp-5643	117	118	1.0	1.0	NUM
fnp-5643	117	119	)	)	PUNCT
fnp-5643	117	120	.	.	PUNCT
fnp-5643	118	1	among	among	ADP
fnp-5643	118	2	the	the	DET
fnp-5643	118	3	cases	case	NOUN
fnp-5643	118	4	referred	refer	VERB
fnp-5643	118	5	to	to	ADP
fnp-5643	118	6	our	our	PRON
fnp-5643	118	7	brain	brain	NOUN
fnp-5643	118	8	bank	bank	NOUN
fnp-5643	118	9	with	with	ADP
fnp-5643	118	10	various	various	ADJ
fnp-5643	118	11	clinical	clinical	ADJ
fnp-5643	118	12	diagnoses	diagnosis	NOUN
fnp-5643	118	13	such	such	ADJ
fnp-5643	118	14	as	as	ADP
fnp-5643	118	15	atypical	atypical	ADJ
fnp-5643	118	16	parkinsonian	parkinsonian	ADJ
fnp-5643	118	17	disorder	disorder	NOUN
fnp-5643	118	18	,	,	PUNCT
fnp-5643	118	19	movement	movement	NOUN
fnp-5643	118	20	disorder	disorder	NOUN
fnp-5643	118	21	of	of	ADP
fnp-5643	118	22	unknown	unknown	ADJ
fnp-5643	118	23	aetiology	aetiology	NOUN
fnp-5643	118	24	or	or	CCONJ
fnp-5643	118	25	behavioural	behavioural	ADJ
fnp-5643	118	26	variant	variant	ADJ
fnp-5643	118	27	frontotemporal	frontotemporal	ADJ
fnp-5643	118	28	dementia	dementia	NOUN
fnp-5643	118	29	(	(	PUNCT
fnp-5643	118	30	bv	bv	PROPN
fnp-5643	118	31	-	-	PUNCT
fnp-5643	118	32	ftd	ftd	NOUN
fnp-5643	118	33	)	)	PUNCT
fnp-5643	118	34	,	,	PUNCT
fnp-5643	118	35	four	four	NUM
fnp-5643	118	36	cases	case	NOUN
fnp-5643	118	37	(	(	PUNCT
fnp-5643	118	38	3	3	NUM
fnp-5643	118	39	 	 	SPACE
fnp-5643	118	40	%	%	NOUN
fnp-5643	118	41	)	)	PUNCT
fnp-5643	118	42	showed	show	VERB
fnp-5643	118	43	positive	positive	ADJ
fnp-5643	118	44	staining	staining	NOUN
fnp-5643	118	45	for	for	ADP
fnp-5643	118	46	prion	prion	NOUN
fnp-5643	118	47	protein	protein	NOUN
fnp-5643	118	48	.	.	PUNCT
fnp-5643	119	1	among	among	ADP
fnp-5643	119	2	neuropathologically	neuropathologically	ADV
fnp-5643	119	3	classified	classify	VERB
fnp-5643	119	4	non	non	ADJ
fnp-5643	119	5	-	-	ADJ
fnp-5643	119	6	tau	tau	ADJ
fnp-5643	119	7	ftld	ftld	ADJ
fnp-5643	119	8	cases	case	NOUN
fnp-5643	119	9	(	(	PUNCT
fnp-5643	119	10	nine	nine	NUM
fnp-5643	119	11	on	on	ADP
fnp-5643	119	12	fast	fast	ADJ
fnp-5643	119	13	-	-	PUNCT
fnp-5643	119	14	track	track	NOUN
fnp-5643	119	15	,	,	PUNCT
fnp-5643	119	16	ten	ten	NUM
fnp-5643	119	17	in	in	ADP
fnp-5643	119	18	total	total	NOUN
fnp-5643	119	19	)	)	PUNCT
fnp-5643	119	20	,	,	PUNCT
fnp-5643	119	21	one	one	NUM
fnp-5643	119	22	had	have	VERB
fnp-5643	119	23	the	the	DET
fnp-5643	119	24	clinical	clinical	ADJ
fnp-5643	119	25	diagnosis	diagnosis	NOUN
fnp-5643	119	26	of	of	ADP
fnp-5643	119	27	cbd	cbd	NOUN
fnp-5643	119	28	,	,	PUNCT
fnp-5643	119	29	one	one	NUM
fnp-5643	119	30	of	of	ADP
fnp-5643	119	31	lbd	lbd	PROPN
fnp-5643	119	32	,	,	PUNCT
fnp-5643	119	33	one	one	NUM
fnp-5643	119	34	of	of	ADP
fnp-5643	119	35	pid	pid	NOUN
fnp-5643	119	36	and	and	CCONJ
fnp-5643	119	37	of	of	ADP
fnp-5643	119	38	unclassified	unclassified	ADJ
fnp-5643	119	39	dementia	dementia	NOUN
fnp-5643	119	40	with	with	ADP
fnp-5643	119	41	oral	oral	ADJ
fnp-5643	119	42	facial	facial	ADJ
fnp-5643	119	43	dystonia	dystonia	NOUN
fnp-5643	119	44	.	.	PUNCT
fnp-5643	120	1	the	the	DET
fnp-5643	120	2	remaining	remain	VERB
fnp-5643	120	3	cases	case	NOUN
fnp-5643	120	4	were	be	AUX
fnp-5643	120	5	clinically	clinically	ADV
fnp-5643	120	6	classified	classify	VERB
fnp-5643	120	7	as	as	ADP
fnp-5643	120	8	frontotemporal	frontotemporal	ADJ
fnp-5643	120	9	dementia	dementia	NOUN
fnp-5643	120	10	(	(	PUNCT
fnp-5643	120	11	four	four	NUM
fnp-5643	120	12	cases	case	NOUN
fnp-5643	120	13	)	)	PUNCT
fnp-5643	120	14	,	,	PUNCT
fnp-5643	120	15	suspected	suspect	VERB
fnp-5643	120	16	bv	bv	PROPN
fnp-5643	120	17	-	-	PUNCT
fnp-5643	120	18	ftd	ftd	NOUN
fnp-5643	120	19	or	or	CCONJ
fnp-5643	120	20	psp	psp	NOUN
fnp-5643	120	21	(	(	PUNCT
fnp-5643	120	22	one	one	NUM
fnp-5643	120	23	case	case	NOUN
fnp-5643	120	24	)	)	PUNCT
fnp-5643	120	25	and	and	CCONJ
fnp-5643	120	26	primary	primary	ADJ
fnp-5643	120	27	progressive	progressive	ADJ
fnp-5643	120	28	aphasia	aphasia	NOUN
fnp-5643	120	29	(	(	PUNCT
fnp-5643	120	30	one	one	NUM
fnp-5643	120	31	case	case	NOUN
fnp-5643	120	32	)	)	PUNCT
fnp-5643	120	33	.	.	PUNCT
fnp-5643	121	1	the	the	DET
fnp-5643	121	2	case	case	NOUN
fnp-5643	121	3	with	with	ADP
fnp-5643	121	4	clinically	clinically	ADV
fnp-5643	121	5	suspected	suspect	VERB
fnp-5643	121	6	lbd	lbd	PROPN
fnp-5643	121	7	showed	show	VERB
fnp-5643	121	8	a	a	DET
fnp-5643	121	9	peculiar	peculiar	ADJ
fnp-5643	121	10	immunostaining	immunostaine	VERB
fnp-5643	121	11	with	with	ADP
fnp-5643	121	12	tdp-43	tdp-43	NUM
fnp-5643	121	13	negative	negative	ADJ
fnp-5643	121	14	sequestome-1	sequestome-1	PROPN
fnp-5643	121	15	(	(	PUNCT
fnp-5643	121	16	p62	p62	NOUN
fnp-5643	121	17	)	)	PUNCT
fnp-5643	121	18	positive	positive	ADJ
fnp-5643	121	19	inclusions	inclusion	NOUN
fnp-5643	121	20	typical	typical	ADJ
fnp-5643	121	21	for	for	ADP
fnp-5643	121	22	c9orf72	c9orf72	ADJ
fnp-5643	121	23	hexanucleotide	hexanucleotide	ADJ
fnp-5643	121	24	expansion	expansion	NOUN
fnp-5643	121	25	-	-	PUNCT
fnp-5643	121	26	related	relate	VERB
fnp-5643	121	27	ftld	ftld	ADJ
fnp-5643	121	28	cases	case	NOUN
fnp-5643	121	29	[	[	X
fnp-5643	121	30	4	4	NUM
fnp-5643	121	31	]	]	NUM
fnp-5643	121	32	)	)	PUNCT
fnp-5643	121	33	,	,	PUNCT
fnp-5643	121	34	which	which	PRON
fnp-5643	121	35	prompted	prompt	VERB
fnp-5643	121	36	us	we	PRON
fnp-5643	121	37	to	to	ADP
fnp-5643	121	38	further	further	ADJ
fnp-5643	121	39	assessment	assessment	NOUN
fnp-5643	121	40	and	and	CCONJ
fnp-5643	121	41	final	final	ADJ
fnp-5643	121	42	classification	classification	NOUN
fnp-5643	121	43	as	as	ADP
fnp-5643	121	44	ftld	ftld	ADJ
fnp-5643	121	45	-	-	PUNCT
fnp-5643	121	46	tdp	tdp	NOUN
fnp-5643	121	47	.	.	PUNCT
fnp-5643	122	1	additional	additional	ADJ
fnp-5643	122	2	cerebral	cerebral	ADJ
fnp-5643	122	3	amyloid	amyloid	NOUN
fnp-5643	122	4	angiopathy	angiopathy	ADJ
fnp-5643	122	5	(	(	PUNCT
fnp-5643	122	6	caa	caa	NOUN
fnp-5643	122	7	)	)	PUNCT
fnp-5643	122	8	occurred	occur	VERB
fnp-5643	122	9	in	in	ADP
fnp-5643	122	10	50	50	NUM
fnp-5643	122	11	cases	case	NOUN
fnp-5643	122	12	(	(	PUNCT
fnp-5643	122	13	37.6	37.6	NUM
fnp-5643	122	14	 	 	SPACE
fnp-5643	122	15	%	%	NOUN
fnp-5643	122	16	)	)	PUNCT
fnp-5643	122	17	.	.	PUNCT
fnp-5643	123	1	we	we	PRON
fnp-5643	123	2	detected	detect	VERB
fnp-5643	123	3	caa	caa	NOUN
fnp-5643	123	4	on	on	ADP
fnp-5643	123	5	screening	screen	VERB
fnp-5643	123	6	histology	histology	NOUN
fnp-5643	123	7	already	already	ADV
fnp-5643	123	8	in	in	ADP
fnp-5643	123	9	46	46	NUM
fnp-5643	123	10	cases	case	NOUN
fnp-5643	123	11	(	(	PUNCT
fnp-5643	123	12	92	92	NUM
fnp-5643	123	13	 	 	SPACE
fnp-5643	123	14	%	%	NOUN
fnp-5643	123	15	)	)	PUNCT
fnp-5643	123	16	.	.	PUNCT
fnp-5643	124	1	we	we	PRON
fnp-5643	124	2	found	find	VERB
fnp-5643	124	3	lbd	lbd	PROPN
fnp-5643	124	4	co	co	PROPN
fnp-5643	124	5	-	-	NOUN
fnp-5643	124	6	pathology	pathology	NOUN
fnp-5643	124	7	in	in	ADP
fnp-5643	124	8	15	15	NUM
fnp-5643	124	9	out	out	ADP
fnp-5643	124	10	of	of	ADP
fnp-5643	124	11	37	37	NUM
fnp-5643	124	12	ad	ad	NOUN
fnp-5643	124	13	cases	case	NOUN
fnp-5643	124	14	(	(	PUNCT
fnp-5643	124	15	40.5	40.5	NUM
fnp-5643	124	16	 	 	SPACE
fnp-5643	124	17	%	%	NOUN
fnp-5643	124	18	)	)	PUNCT
fnp-5643	124	19	among	among	ADP
fnp-5643	124	20	which	which	PRON
fnp-5643	124	21	13	13	NUM
fnp-5643	124	22	cases	case	NOUN
fnp-5643	124	23	where	where	SCONJ
fnp-5643	124	24	lbd	lbd	PROPN
fnp-5643	124	25	co	co	NOUN
fnp-5643	124	26	-	-	PROPN
fnp-5643	124	27	pathology	pathology	NOUN
fnp-5643	124	28	had	have	AUX
fnp-5643	124	29	already	already	ADV
fnp-5643	124	30	been	be	AUX
fnp-5643	124	31	seen	see	VERB
fnp-5643	124	32	on	on	ADP
fnp-5643	124	33	fast	fast	ADJ
fnp-5643	124	34	-	-	PUNCT
fnp-5643	124	35	track	track	NOUN
fnp-5643	124	36	histology	histology	NOUN
fnp-5643	124	37	.	.	PUNCT
fnp-5643	125	1	another	another	DET
fnp-5643	125	2	frequent	frequent	ADJ
fnp-5643	125	3	finding	finding	NOUN
fnp-5643	125	4	(	(	PUNCT
fnp-5643	125	5	12	12	NUM
fnp-5643	125	6	 	 	SPACE
fnp-5643	125	7	/	/	SYM
fnp-5643	125	8	 	 	SPACE
fnp-5643	125	9	37	37	NUM
fnp-5643	125	10	cases	case	NOUN
fnp-5643	125	11	,	,	PUNCT
fnp-5643	125	12	32.4	32.4	NUM
fnp-5643	125	13	 	 	SPACE
fnp-5643	125	14	%	%	NOUN
fnp-5643	125	15	in	in	ADP
fnp-5643	125	16	our	our	PRON
fnp-5643	125	17	study	study	NOUN
fnp-5643	125	18	)	)	PUNCT
fnp-5643	125	19	in	in	ADP
fnp-5643	125	20	ad	ad	NOUN
fnp-5643	125	21	is	be	AUX
fnp-5643	125	22	tdp-43	tdp-43	PROPN
fnp-5643	125	23	pathology	pathology	PROPN
fnp-5643	125	24	,	,	PUNCT
fnp-5643	125	25	which	which	PRON
fnp-5643	125	26	was	be	AUX
fnp-5643	125	27	only	only	ADV
fnp-5643	125	28	identified	identify	VERB
fnp-5643	125	29	after	after	ADP
fnp-5643	125	30	complete	complete	ADJ
fnp-5643	125	31	histopathological	histopathological	ADJ
fnp-5643	125	32	work	work	NOUN
fnp-5643	125	33	-	-	PUNCT
fnp-5643	125	34	up	up	NOUN
fnp-5643	125	35	in	in	ADP
fnp-5643	125	36	seven	seven	NUM
fnp-5643	125	37	cases	case	NOUN
fnp-5643	125	38	.	.	PUNCT
fnp-5643	126	1	final	final	ADJ
fnp-5643	126	2	histology	histology	NOUN
fnp-5643	126	3	revealed	reveal	VERB
fnp-5643	126	4	the	the	DET
fnp-5643	126	5	presence	presence	NOUN
fnp-5643	126	6	of	of	ADP
fnp-5643	126	7	ad	ad	NOUN
fnp-5643	126	8	-	-	PUNCT
fnp-5643	126	9	associated	associate	VERB
fnp-5643	126	10	alterations	alteration	NOUN
fnp-5643	126	11	(	(	PUNCT
fnp-5643	126	12	aβ	aβ	ADP
fnp-5643	126	13	plaques	plaque	NOUN
fnp-5643	126	14	and	and	CCONJ
fnp-5643	126	15	 	 	SPACE
fnp-5643	126	16	/	/	SYM
fnp-5643	126	17	 	 	SPACE
fnp-5643	126	18	or	or	CCONJ
fnp-5643	126	19	ad	ad	NOUN
fnp-5643	126	20	-	-	PUNCT
fnp-5643	126	21	type	type	NOUN
fnp-5643	126	22	tau	tau	NOUN
fnp-5643	126	23	deposits	deposit	NOUN
fnp-5643	126	24	)	)	PUNCT
fnp-5643	126	25	in	in	ADP
fnp-5643	126	26	15	15	NUM
fnp-5643	126	27	 	 	SPACE
fnp-5643	126	28	/	/	SYM
fnp-5643	126	29	 	 	SPACE
fnp-5643	126	30	23	23	NUM
fnp-5643	126	31	lbd	lbd	NOUN
fnp-5643	126	32	cases	case	NOUN
fnp-5643	126	33	(	(	PUNCT
fnp-5643	126	34	65.2	65.2	NUM
fnp-5643	126	35	 	 	SPACE
fnp-5643	126	36	%	%	NOUN
fnp-5643	126	37	)	)	PUNCT
fnp-5643	126	38	,	,	PUNCT
fnp-5643	126	39	3/14	3/14	NUM
fnp-5643	126	40	cbd	cbd	NOUN
fnp-5643	126	41	cases	case	NOUN
fnp-5643	126	42	(	(	PUNCT
fnp-5643	126	43	21.4	21.4	NUM
fnp-5643	126	44	 	 	SPACE
fnp-5643	126	45	%	%	NOUN
fnp-5643	126	46	)	)	PUNCT
fnp-5643	126	47	,	,	PUNCT
fnp-5643	126	48	4	4	NUM
fnp-5643	126	49	 	 	SPACE
fnp-5643	126	50	/	/	SYM
fnp-5643	126	51	 	 	SPACE
fnp-5643	126	52	10	10	NUM
fnp-5643	126	53	non	non	ADJ
fnp-5643	126	54	-	-	ADJ
fnp-5643	126	55	tau	tau	ADJ
fnp-5643	126	56	ftld	ftld	ADJ
fnp-5643	126	57	cases	case	NOUN
fnp-5643	126	58	(	(	PUNCT
fnp-5643	126	59	40	40	NUM
fnp-5643	126	60	 	 	SPACE
fnp-5643	126	61	%	%	NOUN
fnp-5643	126	62	)	)	PUNCT
fnp-5643	126	63	,	,	PUNCT
fnp-5643	126	64	9	9	NUM
fnp-5643	126	65	 	 	SPACE
fnp-5643	126	66	/	/	SYM
fnp-5643	126	67	 	 	SPACE
fnp-5643	126	68	14	14	NUM
fnp-5643	126	69	msa	msa	PROPN
fnp-5643	126	70	cases	case	NOUN
fnp-5643	126	71	(	(	PUNCT
fnp-5643	126	72	64.3	64.3	NUM
fnp-5643	126	73	 	 	SPACE
fnp-5643	126	74	%	%	NOUN
fnp-5643	126	75	)	)	PUNCT
fnp-5643	126	76	,	,	PUNCT
fnp-5643	126	77	7	7	NUM
fnp-5643	126	78	 	 	SPACE
fnp-5643	126	79	/	/	SYM
fnp-5643	126	80	 	 	SPACE
fnp-5643	126	81	27	27	NUM
fnp-5643	126	82	psp	psp	NOUN
fnp-5643	126	83	cases	case	NOUN
fnp-5643	126	84	(	(	PUNCT
fnp-5643	126	85	25.9	25.9	NUM
fnp-5643	126	86	 	 	SPACE
fnp-5643	126	87	%	%	NOUN
fnp-5643	126	88	)	)	PUNCT
fnp-5643	126	89	.	.	PUNCT
fnp-5643	127	1	we	we	PRON
fnp-5643	127	2	detected	detect	VERB
fnp-5643	127	3	signs	sign	NOUN
fnp-5643	127	4	of	of	ADP
fnp-5643	127	5	aging	age	VERB
fnp-5643	127	6	-	-	PUNCT
fnp-5643	127	7	related	relate	VERB
fnp-5643	127	8	tau	tau	PROPN
fnp-5643	127	9	astrogliopathy	astrogliopathy	ADJ
fnp-5643	127	10	(	(	PUNCT
fnp-5643	127	11	artag	artag	ADJ
fnp-5643	127	12	)	)	PUNCT
fnp-5643	127	13	in	in	ADP
fnp-5643	127	14	seven	seven	NUM
fnp-5643	127	15	lbd	lbd	NOUN
fnp-5643	127	16	,	,	PUNCT
fnp-5643	127	17	three	three	NUM
fnp-5643	127	18	ad	ad	NOUN
fnp-5643	127	19	,	,	PUNCT
fnp-5643	127	20	three	three	NUM
fnp-5643	127	21	psp	psp	NOUN
fnp-5643	127	22	,	,	PUNCT
fnp-5643	127	23	two	two	NUM
fnp-5643	127	24	ftld	ftld	ADJ
fnp-5643	127	25	non	non	NOUN
fnp-5643	127	26	-	-	NOUN
fnp-5643	127	27	tau	tau	PROPN
fnp-5643	127	28	and	and	CCONJ
fnp-5643	127	29	one	one	NUM
fnp-5643	127	30	cbd	cbd	NOUN
fnp-5643	127	31	case	case	NOUN
fnp-5643	127	32	.	.	PUNCT
fnp-5643	128	1	we	we	PRON
fnp-5643	128	2	reported	report	VERB
fnp-5643	128	3	artag	artag	ADJ
fnp-5643	128	4	in	in	ADP
fnp-5643	128	5	five	five	NUM
fnp-5643	128	6	cases	case	NOUN
fnp-5643	128	7	(	(	PUNCT
fnp-5643	128	8	3.8	3.8	NUM
fnp-5643	128	9	 	 	SPACE
fnp-5643	128	10	%	%	NOUN
fnp-5643	128	11	)	)	PUNCT
fnp-5643	128	12	on	on	ADP
fnp-5643	128	13	screening	screen	VERB
fnp-5643	128	14	histology	histology	NOUN
fnp-5643	128	15	.	.	PUNCT
fnp-5643	129	1	two	two	NUM
fnp-5643	129	2	ad	ad	NOUN
fnp-5643	129	3	,	,	PUNCT
fnp-5643	129	4	two	two	NUM
fnp-5643	129	5	cbd	cbd	NOUN
fnp-5643	129	6	,	,	PUNCT
fnp-5643	129	7	eight	eight	NUM
fnp-5643	129	8	lbd	lbd	NOUN
fnp-5643	129	9	,	,	PUNCT
fnp-5643	129	10	one	one	NUM
fnp-5643	129	11	non	non	ADJ
fnp-5643	129	12	-	-	ADJ
fnp-5643	129	13	tau	tau	ADJ
fnp-5643	129	14	ftld	ftld	NOUN
fnp-5643	129	15	and	and	CCONJ
fnp-5643	129	16	one	one	NUM
fnp-5643	129	17	msa	msa	PROPN
fnp-5643	129	18	case	case	NOUN
fnp-5643	129	19	showed	show	VERB
fnp-5643	129	20	signs	sign	NOUN
fnp-5643	129	21	of	of	ADP
fnp-5643	129	22	argyrophilic	argyrophilic	ADJ
fnp-5643	129	23	grain	grain	NOUN
fnp-5643	129	24	disease	disease	NOUN
fnp-5643	129	25	(	(	PUNCT
fnp-5643	129	26	agd	agd	PROPN
fnp-5643	129	27	)	)	PUNCT
fnp-5643	129	28	on	on	ADP
fnp-5643	129	29	final	final	ADJ
fnp-5643	129	30	histology	histology	NOUN
fnp-5643	129	31	.	.	PUNCT
fnp-5643	130	1	additional	additional	ADJ
fnp-5643	130	2	lbd	lbd	PROPN
fnp-5643	130	3	pathology	pathology	PROPN
fnp-5643	130	4	was	be	AUX
fnp-5643	130	5	present	present	ADJ
fnp-5643	130	6	in	in	ADP
fnp-5643	130	7	one	one	NUM
fnp-5643	130	8	psp	psp	NOUN
fnp-5643	130	9	and	and	CCONJ
fnp-5643	130	10	15	15	NUM
fnp-5643	130	11	ad	ad	NOUN
fnp-5643	130	12	cases	case	NOUN
fnp-5643	130	13	upon	upon	SCONJ
fnp-5643	130	14	examination	examination	NOUN
fnp-5643	130	15	of	of	ADP
fnp-5643	130	16	one	one	NUM
fnp-5643	130	17	hemisphere	hemisphere	ADV
fnp-5643	130	18	.	.	PUNCT
fnp-5643	131	1	except	except	SCONJ
fnp-5643	131	2	for	for	ADP
fnp-5643	131	3	two	two	NUM
fnp-5643	131	4	cases	case	NOUN
fnp-5643	131	5	(	(	PUNCT
fnp-5643	131	6	one	one	NUM
fnp-5643	131	7	with	with	ADP
fnp-5643	131	8	lbd	lbd	PROPN
fnp-5643	131	9	braak	braak	PROPN
fnp-5643	131	10	stage	stage	VERB
fnp-5643	131	11	5	5	NUM
fnp-5643	131	12	and	and	CCONJ
fnp-5643	131	13	one	one	NUM
fnp-5643	131	14	with	with	ADP
fnp-5643	131	15	sole	sole	ADJ
fnp-5643	131	16	olfactory	olfactory	NOUN
fnp-5643	131	17	bulb	bulb	NOUN
fnp-5643	131	18	pathology	pathology	NOUN
fnp-5643	131	19	)	)	PUNCT
fnp-5643	131	20	,	,	PUNCT
fnp-5643	131	21	all	all	DET
fnp-5643	131	22	cases	case	NOUN
fnp-5643	131	23	showed	show	VERB
fnp-5643	131	24	a	a	DET
fnp-5643	131	25	braak	braak	NOUN
fnp-5643	131	26	lbd	lbd	PROPN
fnp-5643	131	27	stage	stage	NOUN
fnp-5643	131	28	6	6	NUM
fnp-5643	131	29	and	and	CCONJ
fnp-5643	131	30	could	could	AUX
fnp-5643	131	31	therefore	therefore	ADV
fnp-5643	131	32	be	be	AUX
fnp-5643	131	33	identified	identify	VERB
fnp-5643	131	34	already	already	ADV
fnp-5643	131	35	on	on	ADP
fnp-5643	131	36	screening	screen	VERB
fnp-5643	131	37	histology	histology	NOUN
fnp-5643	131	38	.	.	PUNCT
fnp-5643	132	1	discussion	discussion	NOUN
fnp-5643	132	2	in	in	ADP
fnp-5643	132	3	our	our	PRON
fnp-5643	132	4	study	study	NOUN
fnp-5643	132	5	we	we	PRON
fnp-5643	132	6	demonstrated	demonstrate	VERB
fnp-5643	132	7	that	that	SCONJ
fnp-5643	132	8	a	a	DET
fnp-5643	132	9	reliable	reliable	ADJ
fnp-5643	132	10	,	,	PUNCT
fnp-5643	132	11	preliminary	preliminary	ADJ
fnp-5643	132	12	main	main	ADJ
fnp-5643	132	13	diagnosis	diagnosis	NOUN
fnp-5643	132	14	in	in	ADP
fnp-5643	132	15	patients	patient	NOUN
fnp-5643	132	16	with	with	ADP
fnp-5643	132	17	a	a	DET
fnp-5643	132	18	suspected	suspect	VERB
fnp-5643	132	19	neurodegenerative	neurodegenerative	ADJ
fnp-5643	132	20	disease	disease	NOUN
fnp-5643	132	21	can	can	AUX
fnp-5643	132	22	be	be	AUX
fnp-5643	132	23	achieved	achieve	VERB
fnp-5643	132	24	in	in	ADP
fnp-5643	132	25	over	over	ADP
fnp-5643	132	26	96	96	NUM
fnp-5643	132	27	 	 	SPACE
fnp-5643	132	28	%	%	NOUN
fnp-5643	132	29	of	of	ADP
fnp-5643	132	30	the	the	DET
fnp-5643	132	31	cases	case	NOUN
fnp-5643	132	32	within	within	ADP
fnp-5643	132	33	a	a	DET
fnp-5643	132	34	few	few	ADJ
fnp-5643	132	35	days	day	NOUN
fnp-5643	132	36	using	use	VERB
fnp-5643	132	37	histological	histological	ADJ
fnp-5643	132	38	and	and	CCONJ
fnp-5643	132	39	immunohistochemical	immunohistochemical	ADJ
fnp-5643	132	40	screening	screening	NOUN
fnp-5643	132	41	of	of	ADP
fnp-5643	132	42	two	two	NUM
fnp-5643	132	43	selected	select	VERB
fnp-5643	132	44	,	,	PUNCT
fnp-5643	132	45	easily	easily	ADV
fnp-5643	132	46	accessible	accessible	ADJ
fnp-5643	132	47	brain	brain	NOUN
fnp-5643	132	48	regions	region	NOUN
fnp-5643	132	49	(	(	PUNCT
fnp-5643	132	50	superior	superior	ADJ
fnp-5643	132	51	frontal	frontal	ADJ
fnp-5643	132	52	gyrus	gyrus	NOUN
fnp-5643	132	53	and	and	CCONJ
fnp-5643	132	54	cerebellum	cerebellum	NOUN
fnp-5643	132	55	)	)	PUNCT
fnp-5643	132	56	embedded	embed	VERB
fnp-5643	132	57	into	into	ADP
fnp-5643	132	58	one	one	NUM
fnp-5643	132	59	paraffin	paraffin	NOUN
fnp-5643	132	60	block	block	NOUN
fnp-5643	132	61	.	.	PUNCT
fnp-5643	133	1	considering	consider	VERB
fnp-5643	133	2	the	the	DET
fnp-5643	133	3	rapid	rapid	ADJ
fnp-5643	133	4	workflow	workflow	NOUN
fnp-5643	133	5	,	,	PUNCT
fnp-5643	133	6	a	a	DET
fnp-5643	133	7	prompt	prompt	ADJ
fnp-5643	133	8	response	response	NOUN
fnp-5643	133	9	from	from	ADP
fnp-5643	133	10	the	the	DET
fnp-5643	133	11	neuropathologist	neuropathologist	NOUN
fnp-5643	133	12	to	to	ADP
fnp-5643	133	13	the	the	DET
fnp-5643	133	14	clinician	clinician	NOUN
fnp-5643	133	15	might	might	AUX
fnp-5643	133	16	improve	improve	VERB
fnp-5643	133	17	the	the	DET
fnp-5643	133	18	accuracy	accuracy	NOUN
fnp-5643	133	19	of	of	ADP
fnp-5643	133	20	clinical	clinical	ADJ
fnp-5643	133	21	diagnosis	diagnosis	NOUN
fnp-5643	133	22	in	in	ADP
fnp-5643	133	23	other	other	ADJ
fnp-5643	133	24	patients	patient	NOUN
fnp-5643	133	25	.	.	PUNCT
fnp-5643	134	1	furthermore	furthermore	ADV
fnp-5643	134	2	,	,	PUNCT
fnp-5643	134	3	performing	perform	VERB
fnp-5643	134	4	a	a	DET
fnp-5643	134	5	screening	screening	NOUN
fnp-5643	134	6	approach	approach	NOUN
fnp-5643	134	7	might	might	AUX
fnp-5643	134	8	also	also	ADV
fnp-5643	134	9	be	be	AUX
fnp-5643	134	10	feasible	feasible	ADJ
fnp-5643	134	11	in	in	ADP
fnp-5643	134	12	places	place	NOUN
fnp-5643	134	13	with	with	ADP
fnp-5643	134	14	limited	limited	ADJ
fnp-5643	134	15	resources	resource	NOUN
fnp-5643	134	16	and	and	CCONJ
fnp-5643	134	17	could	could	AUX
fnp-5643	134	18	also	also	ADV
fnp-5643	134	19	be	be	AUX
fnp-5643	134	20	performed	perform	VERB
fnp-5643	134	21	by	by	ADP
fnp-5643	134	22	general	general	ADJ
fnp-5643	134	23	or	or	CCONJ
fnp-5643	134	24	forensic	forensic	ADJ
fnp-5643	134	25	pathologists	pathologist	NOUN
fnp-5643	134	26	,	,	PUNCT
fnp-5643	134	27	perhaps	perhaps	ADV
fnp-5643	134	28	with	with	ADP
fnp-5643	134	29	the	the	DET
fnp-5643	134	30	aid	aid	NOUN
fnp-5643	134	31	of	of	ADP
fnp-5643	134	32	online	online	ADJ
fnp-5643	134	33	consultation	consultation	NOUN
fnp-5643	134	34	using	use	VERB
fnp-5643	134	35	digitalized	digitalize	VERB
fnp-5643	134	36	micrographs	micrograph	NOUN
fnp-5643	134	37	.	.	PUNCT
fnp-5643	135	1	the	the	DET
fnp-5643	135	2	fast	fast	ADJ
fnp-5643	135	3	-	-	PUNCT
fnp-5643	135	4	track	track	NOUN
fnp-5643	135	5	diagnosis	diagnosis	NOUN
fnp-5643	135	6	may	may	AUX
fnp-5643	135	7	also	also	ADV
fnp-5643	135	8	have	have	VERB
fnp-5643	135	9	consequences	consequence	NOUN
fnp-5643	135	10	for	for	ADP
fnp-5643	135	11	relatives	relative	NOUN
fnp-5643	135	12	and	and	CCONJ
fnp-5643	135	13	lead	lead	VERB
fnp-5643	135	14	to	to	ADP
fnp-5643	135	15	genetic	genetic	ADJ
fnp-5643	135	16	counselling	counselling	NOUN
fnp-5643	135	17	.	.	PUNCT
fnp-5643	136	1	however	however	ADV
fnp-5643	136	2	,	,	PUNCT
fnp-5643	136	3	our	our	PRON
fnp-5643	136	4	approach	approach	NOUN
fnp-5643	136	5	can	can	AUX
fnp-5643	136	6	not	not	PART
fnp-5643	136	7	supersede	supersede	VERB
fnp-5643	136	8	a	a	DET
fnp-5643	136	9	thorough	thorough	ADJ
fnp-5643	136	10	macroand	macroand	NOUN
fnp-5643	136	11	microscopic	microscopic	ADJ
fnp-5643	136	12	examination	examination	NOUN
fnp-5643	136	13	with	with	ADP
fnp-5643	136	14	sampling	sampling	NOUN
fnp-5643	136	15	of	of	ADP
fnp-5643	136	16	various	various	ADJ
fnp-5643	136	17	other	other	ADJ
fnp-5643	136	18	brain	brain	NOUN
fnp-5643	136	19	regions	region	NOUN
fnp-5643	136	20	,	,	PUNCT
fnp-5643	136	21	given	give	VERB
fnp-5643	136	22	the	the	DET
fnp-5643	136	23	multitude	multitude	NOUN
fnp-5643	136	24	of	of	ADP
fnp-5643	136	25	possible	possible	ADJ
fnp-5643	136	26	proteinopathic	proteinopathic	NOUN
fnp-5643	136	27	and	and	CCONJ
fnp-5643	136	28	vascular	vascular	ADJ
fnp-5643	136	29	co	co	NOUN
fnp-5643	136	30	-	-	NOUN
fnp-5643	136	31	pathologies	pathology	NOUN
fnp-5643	136	32	,	,	PUNCT
fnp-5643	136	33	potential	potential	ADJ
fnp-5643	136	34	extraordinarily	extraordinarily	ADV
fnp-5643	136	35	rare	rare	ADJ
fnp-5643	136	36	ndd	ndd	NOUN
fnp-5643	136	37	and	and	CCONJ
fnp-5643	136	38	alterations	alteration	NOUN
fnp-5643	136	39	relevant	relevant	ADJ
fnp-5643	136	40	for	for	ADP
fnp-5643	136	41	disease	disease	NOUN
fnp-5643	136	42	staging	staging	NOUN
fnp-5643	136	43	.	.	PUNCT
fnp-5643	137	1	by	by	ADP
fnp-5643	137	2	way	way	NOUN
fnp-5643	137	3	of	of	ADP
fnp-5643	137	4	example	example	NOUN
fnp-5643	137	5	,	,	PUNCT
fnp-5643	137	6	our	our	PRON
fnp-5643	137	7	approach	approach	NOUN
fnp-5643	137	8	neither	neither	CCONJ
fnp-5643	137	9	allows	allow	VERB
fnp-5643	137	10	for	for	ADP
fnp-5643	137	11	classification	classification	NOUN
fnp-5643	137	12	into	into	ADP
fnp-5643	137	13	brainstem	brainstem	NOUN
fnp-5643	137	14	-	-	PUNCT
fnp-5643	137	15	predominant	predominant	ADJ
fnp-5643	137	16	,	,	PUNCT
fnp-5643	137	17	limbic	limbic	ADJ
fnp-5643	137	18	or	or	CCONJ
fnp-5643	137	19	diffuse	diffuse	VERB
fnp-5643	137	20	neocortical	neocortical	ADJ
fnp-5643	137	21	lb	lb	ADJ
fnp-5643	137	22	pathology	pathology	NOUN
fnp-5643	137	23	according	accord	VERB
fnp-5643	137	24	to	to	ADP
fnp-5643	137	25	the	the	DET
fnp-5643	137	26	consensus	consensus	NOUN
fnp-5643	137	27	report	report	NOUN
fnp-5643	137	28	nor	nor	CCONJ
fnp-5643	137	29	for	for	ADP
fnp-5643	137	30	determination	determination	NOUN
fnp-5643	137	31	of	of	ADP
fnp-5643	137	32	olfactory	olfactory	ADJ
fnp-5643	137	33	bulb	bulb	NOUN
fnp-5643	137	34	only	only	ADV
fnp-5643	137	35	or	or	CCONJ
fnp-5643	137	36	amygdala	amygdala	NOUN
fnp-5643	137	37	predominant	predominant	ADJ
fnp-5643	137	38	pathology	pathology	NOUN
fnp-5643	138	1	[	[	X
fnp-5643	138	2	40,45,46	40,45,46	X
fnp-5643	138	3	]	]	X
fnp-5643	138	4	.	.	PUNCT
fnp-5643	139	1	due	due	ADP
fnp-5643	139	2	to	to	ADP
fnp-5643	139	3	the	the	DET
fnp-5643	139	4	heterogeneous	heterogeneous	ADJ
fnp-5643	139	5	spatial	spatial	ADJ
fnp-5643	139	6	distribution	distribution	NOUN
fnp-5643	139	7	pattern	pattern	NOUN
fnp-5643	139	8	of	of	ADP
fnp-5643	139	9	subpial	subpial	ADJ
fnp-5643	139	10	,	,	PUNCT
fnp-5643	139	11	subependymal	subependymal	ADJ
fnp-5643	139	12	,	,	PUNCT
fnp-5643	139	13	perivascular	perivascular	ADJ
fnp-5643	139	14	,	,	PUNCT
fnp-5643	139	15	white	white	ADJ
fnp-5643	139	16	matter	matter	NOUN
fnp-5643	139	17	and	and	CCONJ
fnp-5643	139	18	gray	gray	ADJ
fnp-5643	139	19	matter	matter	NOUN
fnp-5643	139	20	artag	artag	ADJ
fnp-5643	140	1	[	[	X
fnp-5643	140	2	47	47	NUM
fnp-5643	140	3	]	]	PUNCT
fnp-5643	140	4	,	,	PUNCT
fnp-5643	140	5	it	it	PRON
fnp-5643	140	6	is	be	AUX
fnp-5643	140	7	possible	possible	ADJ
fnp-5643	140	8	that	that	SCONJ
fnp-5643	140	9	artag	artag	ADJ
fnp-5643	140	10	pathology	pathology	NOUN
fnp-5643	140	11	will	will	AUX
fnp-5643	140	12	be	be	AUX
fnp-5643	140	13	missed	miss	VERB
fnp-5643	140	14	or	or	CCONJ
fnp-5643	140	15	not	not	PART
fnp-5643	140	16	fully	fully	ADV
fnp-5643	140	17	assessed	assess	VERB
fnp-5643	140	18	by	by	ADP
fnp-5643	140	19	screening	screen	VERB
fnp-5643	140	20	histology	histology	NOUN
fnp-5643	140	21	.	.	PUNCT
fnp-5643	141	1	given	give	VERB
fnp-5643	141	2	the	the	DET
fnp-5643	141	3	anatomical	anatomical	ADJ
fnp-5643	141	4	distribution	distribution	NOUN
fnp-5643	141	5	of	of	ADP
fnp-5643	141	6	argyrophilic	argyrophilic	ADJ
fnp-5643	141	7	grain	grain	NOUN
fnp-5643	141	8	disease	disease	NOUN
fnp-5643	141	9	(	(	PUNCT
fnp-5643	141	10	agd	agd	PROPN
fnp-5643	141	11	)	)	PUNCT
fnp-5643	141	12	,	,	PUNCT
fnp-5643	141	13	often	often	ADV
fnp-5643	141	14	limited	limit	VERB
fnp-5643	141	15	to	to	ADP
fnp-5643	141	16	the	the	DET
fnp-5643	141	17	limbic	limbic	ADJ
fnp-5643	141	18	system	system	NOUN
fnp-5643	141	19	[	[	X
fnp-5643	141	20	48	48	NUM
fnp-5643	141	21	]	]	PUNCT
fnp-5643	141	22	,	,	PUNCT
fnp-5643	141	23	assessment	assessment	NOUN
fnp-5643	141	24	of	of	ADP
fnp-5643	141	25	this	this	DET
fnp-5643	141	26	disease	disease	NOUN
fnp-5643	141	27	occurring	occur	VERB
fnp-5643	141	28	frequently	frequently	ADV
fnp-5643	141	29	with	with	ADP
fnp-5643	141	30	concomitant	concomitant	ADJ
fnp-5643	141	31	ndd	ndd	PROPN
fnp-5643	141	32	is	be	AUX
fnp-5643	141	33	limited	limit	VERB
fnp-5643	141	34	with	with	ADP
fnp-5643	141	35	our	our	PRON
fnp-5643	141	36	method	method	NOUN
fnp-5643	141	37	.	.	PUNCT
fnp-5643	142	1	this	this	PRON
fnp-5643	142	2	also	also	ADV
fnp-5643	142	3	holds	hold	VERB
fnp-5643	142	4	true	true	ADJ
fnp-5643	142	5	for	for	ADP
fnp-5643	142	6	the	the	DET
fnp-5643	142	7	diagnosis	diagnosis	NOUN
fnp-5643	142	8	of	of	ADP
fnp-5643	142	9	primary	primary	ADJ
fnp-5643	142	10	age	age	NOUN
fnp-5643	142	11	-	-	PUNCT
fnp-5643	142	12	related	relate	VERB
fnp-5643	142	13	tauopathy	tauopathy	NOUN
fnp-5643	142	14	(	(	PUNCT
fnp-5643	142	15	part	part	NOUN
fnp-5643	142	16	)	)	PUNCT
fnp-5643	142	17	and	and	CCONJ
fnp-5643	142	18	late	late	PROPN
fnp-5643	142	19	-	-	PUNCT
fnp-5643	142	20	nc	nc	PROPN
fnp-5643	142	21	which	which	PRON
fnp-5643	142	22	usually	usually	ADV
fnp-5643	142	23	affects	affect	VERB
fnp-5643	142	24	the	the	DET
fnp-5643	142	25	middle	middle	ADJ
fnp-5643	142	26	frontal	frontal	ADJ
fnp-5643	142	27	gyrus	gyrus	NOUN
fnp-5643	142	28	in	in	ADP
fnp-5643	142	29	later	later	ADJ
fnp-5643	142	30	stages	stage	NOUN
fnp-5643	142	31	[	[	X
fnp-5643	142	32	49,50	49,50	X
fnp-5643	142	33	]	]	PUNCT
fnp-5643	142	34	.	.	PUNCT
fnp-5643	143	1	furthermore	furthermore	ADV
fnp-5643	143	2	,	,	PUNCT
fnp-5643	143	3	staging	stage	VERB
fnp-5643	143	4	tdp-43	tdp-43	PROPN
fnp-5643	143	5	co	co	NOUN
fnp-5643	143	6	-	-	NOUN
fnp-5643	143	7	pathology	pathology	NOUN
fnp-5643	143	8	in	in	ADP
fnp-5643	143	9	ad	ad	NOUN
fnp-5643	143	10	according	accord	VERB
fnp-5643	143	11	to	to	ADP
fnp-5643	143	12	josephs	josephs	PROPN
fnp-5643	143	13	et	et	PROPN
fnp-5643	143	14	al	al	PROPN
fnp-5643	143	15	.	.	PUNCT
fnp-5643	144	1	[	[	X
fnp-5643	144	2	51	51	NUM
fnp-5643	144	3	]	]	PUNCT
fnp-5643	144	4	is	be	AUX
fnp-5643	144	5	not	not	PART
fnp-5643	144	6	possible	possible	ADJ
fnp-5643	144	7	in	in	ADP
fnp-5643	144	8	our	our	PRON
fnp-5643	144	9	rapid	rapid	ADJ
fnp-5643	144	10	screening	screening	NOUN
fnp-5643	144	11	approach	approach	NOUN
fnp-5643	144	12	.	.	PUNCT
fnp-5643	145	1	independent	independent	ADJ
fnp-5643	145	2	from	from	ADP
fnp-5643	145	3	its	its	PRON
fnp-5643	145	4	diagnostic	diagnostic	ADJ
fnp-5643	145	5	benefit	benefit	NOUN
fnp-5643	145	6	,	,	PUNCT
fnp-5643	145	7	our	our	PRON
fnp-5643	145	8	procedure	procedure	NOUN
fnp-5643	145	9	enhances	enhance	VERB
fnp-5643	145	10	laboratory	laboratory	NOUN
fnp-5643	145	11	safety	safety	NOUN
fnp-5643	145	12	by	by	ADP
fnp-5643	145	13	detecting	detect	VERB
fnp-5643	145	14	unexpected	unexpected	ADJ
fnp-5643	145	15	prion	prion	NOUN
fnp-5643	145	16	protein	protein	NOUN
fnp-5643	145	17	aggregates	aggregate	NOUN
fnp-5643	145	18	before	before	ADP
fnp-5643	145	19	a	a	DET
fnp-5643	145	20	complete	complete	ADJ
fnp-5643	145	21	work	work	NOUN
fnp-5643	145	22	-	-	PUNCT
fnp-5643	145	23	up	up	NOUN
fnp-5643	145	24	of	of	ADP
fnp-5643	145	25	the	the	DET
fnp-5643	145	26	brain	brain	NOUN
fnp-5643	145	27	,	,	PUNCT
fnp-5643	145	28	as	as	SCONJ
fnp-5643	145	29	seen	see	VERB
fnp-5643	145	30	in	in	ADP
fnp-5643	145	31	four	four	NUM
fnp-5643	145	32	cases	case	NOUN
fnp-5643	145	33	analysed	analyse	VERB
fnp-5643	145	34	.	.	PUNCT
fnp-5643	146	1	since	since	SCONJ
fnp-5643	146	2	up	up	ADP
fnp-5643	146	3	-	-	PUNCT
fnp-5643	146	4	to	to	ADP
fnp-5643	146	5	-	-	PUNCT
fnp-5643	146	6	date	date	NOUN
fnp-5643	146	7	cerebrospinal	cerebrospinal	ADJ
fnp-5643	146	8	fluid	fluid	NOUN
fnp-5643	146	9	based	base	VERB
fnp-5643	146	10	real	real	ADJ
fnp-5643	146	11	-	-	PUNCT
fnp-5643	146	12	time	time	NOUN
fnp-5643	146	13	quaking	quake	VERB
fnp-5643	146	14	-	-	PUNCT
fnp-5643	146	15	induced	induced	ADJ
fnp-5643	146	16	conversion	conversion	NOUN
fnp-5643	146	17	(	(	PUNCT
fnp-5643	146	18	rt	rt	NOUN
fnp-5643	146	19	-	-	PUNCT
fnp-5643	146	20	quic	quic	NOUN
fnp-5643	146	21	)	)	PUNCT
fnp-5643	146	22	has	have	VERB
fnp-5643	146	23	high	high	ADJ
fnp-5643	146	24	sensitivity	sensitivity	NOUN
fnp-5643	146	25	(	(	PUNCT
fnp-5643	146	26	>	>	X
fnp-5643	146	27	 	 	SPACE
fnp-5643	146	28	90	90	NUM
fnp-5643	146	29	 	 	SPACE
fnp-5643	146	30	%	%	NOUN
fnp-5643	146	31	)	)	PUNCT
fnp-5643	146	32	and	and	CCONJ
fnp-5643	146	33	specificity	specificity	NOUN
fnp-5643	146	34	(	(	PUNCT
fnp-5643	146	35	up	up	ADP
fnp-5643	146	36	to	to	PART
fnp-5643	146	37	100	100	NUM
fnp-5643	146	38	 	 	SPACE
fnp-5643	146	39	%	%	NOUN
fnp-5643	146	40	)	)	PUNCT
fnp-5643	146	41	for	for	ADP
fnp-5643	146	42	the	the	DET
fnp-5643	146	43	detection	detection	NOUN
fnp-5643	146	44	of	of	ADP
fnp-5643	146	45	prion	prion	NOUN
fnp-5643	146	46	disease	disease	NOUN
fnp-5643	147	1	[	[	X
fnp-5643	147	2	52,53,54,55	52,53,54,55	NUM
fnp-5643	147	3	]	]	PUNCT
fnp-5643	147	4	,	,	PUNCT
fnp-5643	147	5	an	an	DET
fnp-5643	147	6	intravitam	intravitam	ADJ
fnp-5643	147	7	diagnosis	diagnosis	NOUN
fnp-5643	147	8	in	in	ADP
fnp-5643	147	9	patients	patient	NOUN
fnp-5643	147	10	with	with	ADP
fnp-5643	147	11	suspected	suspect	VERB
fnp-5643	147	12	prion	prion	NOUN
fnp-5643	147	13	disease	disease	NOUN
fnp-5643	147	14	is	be	AUX
fnp-5643	147	15	possible	possible	ADJ
fnp-5643	147	16	.	.	PUNCT
fnp-5643	148	1	yet	yet	ADV
fnp-5643	148	2	,	,	PUNCT
fnp-5643	148	3	rt	rt	PROPN
fnp-5643	148	4	-	-	PUNCT
fnp-5643	148	5	quic	quic	PROPN
fnp-5643	148	6	might	might	AUX
fnp-5643	148	7	give	give	VERB
fnp-5643	148	8	false	false	ADJ
fnp-5643	148	9	negative	negative	ADJ
fnp-5643	148	10	results	result	NOUN
fnp-5643	148	11	as	as	SCONJ
fnp-5643	148	12	documented	document	VERB
fnp-5643	148	13	for	for	ADP
fnp-5643	148	14	instance	instance	NOUN
fnp-5643	148	15	in	in	ADP
fnp-5643	148	16	sporadic	sporadic	ADJ
fnp-5643	148	17	cjd	cjd	NOUN
fnp-5643	148	18	cases	case	NOUN
fnp-5643	148	19	at	at	ADP
fnp-5643	148	20	younger	young	ADJ
fnp-5643	148	21	age	age	NOUN
fnp-5643	148	22	or	or	CCONJ
fnp-5643	148	23	cases	case	NOUN
fnp-5643	148	24	with	with	ADP
fnp-5643	148	25	vv1	vv1	NOUN
fnp-5643	148	26	or	or	CCONJ
fnp-5643	148	27	mm2	mm2	NOUN
fnp-5643	148	28	molecular	molecular	ADJ
fnp-5643	148	29	subtype	subtype	NOUN
fnp-5643	149	1	[	[	X
fnp-5643	149	2	52,56	52,56	NOUN
fnp-5643	149	3	]	]	PUNCT
fnp-5643	149	4	.	.	PUNCT
fnp-5643	150	1	patients	patient	NOUN
fnp-5643	150	2	with	with	ADP
fnp-5643	150	3	negative	negative	ADJ
fnp-5643	150	4	rt	rt	PROPN
fnp-5643	150	5	-	-	PUNCT
fnp-5643	150	6	quic	quic	PROPN
fnp-5643	150	7	are	be	AUX
fnp-5643	150	8	also	also	ADV
fnp-5643	150	9	more	more	ADV
fnp-5643	150	10	likely	likely	ADJ
fnp-5643	150	11	to	to	PART
fnp-5643	150	12	present	present	VERB
fnp-5643	150	13	with	with	ADP
fnp-5643	150	14	motor	motor	NOUN
fnp-5643	150	15	symptoms	symptom	NOUN
fnp-5643	150	16	or	or	CCONJ
fnp-5643	150	17	gait	gait	ADJ
fnp-5643	150	18	difficulties	difficulty	NOUN
fnp-5643	150	19	at	at	ADP
fnp-5643	150	20	initial	initial	ADJ
fnp-5643	150	21	presentation	presentation	NOUN
fnp-5643	150	22	[	[	X
fnp-5643	150	23	56	56	NUM
fnp-5643	150	24	]	]	PUNCT
fnp-5643	150	25	.	.	PUNCT
fnp-5643	151	1	additionally	additionally	ADV
fnp-5643	151	2	,	,	PUNCT
fnp-5643	151	3	implementing	implement	VERB
fnp-5643	151	4	rt	rt	NOUN
fnp-5643	151	5	-	-	PUNCT
fnp-5643	151	6	quic	quic	NOUN
fnp-5643	151	7	assays	assay	NOUN
fnp-5643	151	8	is	be	AUX
fnp-5643	151	9	difficult	difficult	ADJ
fnp-5643	151	10	and	and	CCONJ
fnp-5643	151	11	therefore	therefore	ADV
fnp-5643	151	12	often	often	ADV
fnp-5643	151	13	only	only	ADV
fnp-5643	151	14	a	a	DET
fnp-5643	151	15	limited	limited	ADJ
fnp-5643	151	16	number	number	NOUN
fnp-5643	151	17	of	of	ADP
fnp-5643	151	18	laboratories	laboratory	NOUN
fnp-5643	151	19	offer	offer	VERB
fnp-5643	151	20	it	it	PRON
fnp-5643	151	21	[	[	X
fnp-5643	151	22	57	57	NUM
fnp-5643	151	23	]	]	PUNCT
fnp-5643	151	24	.	.	PUNCT
fnp-5643	152	1	of	of	ADP
fnp-5643	152	2	note	note	NOUN
fnp-5643	152	3	,	,	PUNCT
fnp-5643	152	4	absence	absence	NOUN
fnp-5643	152	5	of	of	ADP
fnp-5643	152	6	prion	prion	NOUN
fnp-5643	152	7	protein	protein	NOUN
fnp-5643	152	8	immunoreactivity	immunoreactivity	NOUN
fnp-5643	152	9	in	in	ADP
fnp-5643	152	10	the	the	DET
fnp-5643	152	11	fontal	fontal	ADJ
fnp-5643	152	12	cortex	cortex	NOUN
fnp-5643	152	13	and	and	CCONJ
fnp-5643	152	14	cerebellum	cerebellum	NOUN
fnp-5643	152	15	does	do	AUX
fnp-5643	152	16	not	not	PART
fnp-5643	152	17	entirely	entirely	ADV
fnp-5643	152	18	rule	rule	VERB
fnp-5643	152	19	out	out	ADP
fnp-5643	152	20	the	the	DET
fnp-5643	152	21	possibility	possibility	NOUN
fnp-5643	152	22	of	of	ADP
fnp-5643	152	23	a	a	DET
fnp-5643	152	24	prion	prion	NOUN
fnp-5643	152	25	disease	disease	NOUN
fnp-5643	152	26	since	since	SCONJ
fnp-5643	152	27	thalamic	thalamic	ADJ
fnp-5643	152	28	forms	form	NOUN
fnp-5643	152	29	of	of	ADP
fnp-5643	152	30	creutzfeldt	creutzfeldt	ADJ
fnp-5643	152	31	-	-	ADJ
fnp-5643	152	32	jakob	jakob	ADJ
fnp-5643	152	33	disease	disease	NOUN
fnp-5643	152	34	or	or	CCONJ
fnp-5643	152	35	fatal	fatal	ADJ
fnp-5643	152	36	familial	familial	ADJ
fnp-5643	152	37	insomnia	insomnia	NOUN
fnp-5643	152	38	might	might	AUX
fnp-5643	152	39	not	not	PART
fnp-5643	152	40	exhibit	exhibit	VERB
fnp-5643	152	41	pathological	pathological	ADJ
fnp-5643	152	42	prion	prion	NOUN
fnp-5643	152	43	protein	protein	NOUN
fnp-5643	152	44	aggregates	aggregate	NOUN
fnp-5643	152	45	in	in	ADP
fnp-5643	152	46	the	the	DET
fnp-5643	152	47	frontal	frontal	ADJ
fnp-5643	152	48	cortex	cortex	NOUN
fnp-5643	152	49	or	or	CCONJ
fnp-5643	152	50	cerebellum	cerebellum	ADJ
fnp-5643	152	51	[	[	X
fnp-5643	152	52	23,58	23,58	NOUN
fnp-5643	152	53	]	]	PUNCT
fnp-5643	152	54	.	.	PUNCT
fnp-5643	153	1	finally	finally	ADV
fnp-5643	153	2	,	,	PUNCT
fnp-5643	153	3	in	in	ADP
fnp-5643	153	4	a	a	DET
fnp-5643	153	5	different	different	ADJ
fnp-5643	153	6	brain	brain	NOUN
fnp-5643	153	7	bank	bank	NOUN
fnp-5643	153	8	cohort	cohort	NOUN
fnp-5643	153	9	,	,	PUNCT
fnp-5643	153	10	the	the	DET
fnp-5643	153	11	use	use	NOUN
fnp-5643	153	12	of	of	ADP
fnp-5643	153	13	two	two	NUM
fnp-5643	153	14	brain	brain	NOUN
fnp-5643	153	15	regions	region	NOUN
fnp-5643	153	16	(	(	PUNCT
fnp-5643	153	17	frontal	frontal	ADJ
fnp-5643	153	18	cortex	cortex	NOUN
fnp-5643	153	19	and	and	CCONJ
fnp-5643	153	20	cerebellum	cerebellum	NOUN
fnp-5643	153	21	)	)	PUNCT
fnp-5643	153	22	has	have	AUX
fnp-5643	153	23	been	be	AUX
fnp-5643	153	24	considered	consider	VERB
fnp-5643	153	25	sufficient	sufficient	ADJ
fnp-5643	153	26	for	for	ADP
fnp-5643	153	27	the	the	DET
fnp-5643	153	28	surveillance	surveillance	NOUN
fnp-5643	153	29	of	of	ADP
fnp-5643	153	30	prion	prion	NOUN
fnp-5643	153	31	disease	disease	NOUN
fnp-5643	153	32	[	[	X
fnp-5643	153	33	59	59	NUM
fnp-5643	153	34	]	]	PUNCT
fnp-5643	153	35	.	.	PUNCT
fnp-5643	154	1	the	the	DET
fnp-5643	154	2	diagnostic	diagnostic	ADJ
fnp-5643	154	3	accuracy	accuracy	NOUN
fnp-5643	154	4	of	of	ADP
fnp-5643	154	5	fast	fast	ADJ
fnp-5643	154	6	-	-	PUNCT
fnp-5643	154	7	track	track	NOUN
fnp-5643	154	8	histology	histology	NOUN
fnp-5643	154	9	might	might	AUX
fnp-5643	154	10	even	even	ADV
fnp-5643	154	11	be	be	AUX
fnp-5643	154	12	higher	high	ADJ
fnp-5643	154	13	by	by	ADP
fnp-5643	154	14	including	include	VERB
fnp-5643	154	15	temporomesial	temporomesial	ADJ
fnp-5643	154	16	structures	structure	NOUN
fnp-5643	154	17	(	(	PUNCT
fnp-5643	154	18	hippocampus	hippocampus	NOUN
fnp-5643	154	19	,	,	PUNCT
fnp-5643	154	20	amygdala	amygdala	NOUN
fnp-5643	154	21	)	)	PUNCT
fnp-5643	154	22	or	or	CCONJ
fnp-5643	154	23	thalamus	thalamus	NOUN
fnp-5643	154	24	(	(	PUNCT
fnp-5643	154	25	e.g.	e.g.	ADV
fnp-5643	154	26	for	for	ADP
fnp-5643	154	27	the	the	DET
fnp-5643	154	28	detection	detection	NOUN
fnp-5643	154	29	of	of	ADP
fnp-5643	154	30	rare	rare	ADJ
fnp-5643	154	31	prion	prion	NOUN
fnp-5643	154	32	disease	disease	NOUN
fnp-5643	154	33	variants	variant	NOUN
fnp-5643	154	34	)	)	PUNCT
fnp-5643	154	35	.	.	PUNCT
fnp-5643	155	1	diagnosing	diagnose	VERB
fnp-5643	155	2	part	part	NOUN
fnp-5643	155	3	,	,	PUNCT
fnp-5643	155	4	as	as	SCONJ
fnp-5643	155	5	defined	define	VERB
fnp-5643	155	6	by	by	ADP
fnp-5643	155	7	tau	tau	PROPN
fnp-5643	155	8	nft	nft	PROPN
fnp-5643	155	9	pathology	pathology	PROPN
fnp-5643	155	10	with	with	ADP
fnp-5643	155	11	a	a	DET
fnp-5643	155	12	braak	braak	NOUN
fnp-5643	155	13	and	and	CCONJ
fnp-5643	155	14	braak	braak	NOUN
fnp-5643	155	15	stage	stage	NOUN
fnp-5643	155	16	<	<	X
fnp-5643	155	17	 	 	SPACE
fnp-5643	155	18	iv	iv	NUM
fnp-5643	155	19	and	and	CCONJ
fnp-5643	155	20	thal	thal	ADJ
fnp-5643	155	21	plaque	plaque	NOUN
fnp-5643	155	22	phases	phase	NOUN
fnp-5643	155	23	0	0	NUM
fnp-5643	155	24	 	 	SPACE
fnp-5643	155	25	-	-	PUNCT
fnp-5643	155	26	 	 	SPACE
fnp-5643	155	27	2	2	NUM
fnp-5643	156	1	[	[	X
fnp-5643	156	2	49	49	NUM
fnp-5643	156	3	]	]	PUNCT
fnp-5643	156	4	,	,	PUNCT
fnp-5643	156	5	would	would	AUX
fnp-5643	156	6	require	require	VERB
fnp-5643	156	7	sampling	sampling	NOUN
fnp-5643	156	8	of	of	ADP
fnp-5643	156	9	hippocampal	hippocampal	ADJ
fnp-5643	156	10	structures	structure	NOUN
fnp-5643	156	11	including	include	VERB
fnp-5643	156	12	entorhinal	entorhinal	ADJ
fnp-5643	156	13	and	and	CCONJ
fnp-5643	156	14	transentorhinal	transentorhinal	ADJ
fnp-5643	156	15	cortices	cortex	NOUN
fnp-5643	156	16	as	as	ADV
fnp-5643	156	17	well	well	ADV
fnp-5643	156	18	as	as	ADP
fnp-5643	156	19	adjacent	adjacent	ADJ
fnp-5643	156	20	temporal	temporal	ADJ
fnp-5643	156	21	neocortex	neocortex	NOUN
fnp-5643	156	22	.	.	PUNCT
fnp-5643	157	1	in	in	ADP
fnp-5643	157	2	particular	particular	ADJ
fnp-5643	157	3	,	,	PUNCT
fnp-5643	157	4	fast	fast	ADJ
fnp-5643	157	5	-	-	PUNCT
fnp-5643	157	6	track	track	NOUN
fnp-5643	157	7	histology	histology	NOUN
fnp-5643	157	8	might	might	AUX
fnp-5643	157	9	enhance	enhance	VERB
fnp-5643	157	10	the	the	DET
fnp-5643	157	11	recognition	recognition	NOUN
fnp-5643	157	12	of	of	ADP
fnp-5643	157	13	common	common	ADJ
fnp-5643	157	14	co	co	NOUN
fnp-5643	157	15	-	-	NOUN
fnp-5643	157	16	pathologies	pathology	NOUN
fnp-5643	157	17	,	,	PUNCT
fnp-5643	157	18	such	such	ADJ
fnp-5643	157	19	as	as	ADP
fnp-5643	157	20	agd	agd	PROPN
fnp-5643	157	21	,	,	PUNCT
fnp-5643	157	22	artag	artag	ADJ
fnp-5643	157	23	or	or	CCONJ
fnp-5643	157	24	late	late	ADV
fnp-5643	157	25	-	-	PUNCT
fnp-5643	157	26	nc	nc	PROPN
fnp-5643	157	27	which	which	PRON
fnp-5643	157	28	typically	typically	ADV
fnp-5643	157	29	or	or	CCONJ
fnp-5643	157	30	often	often	ADV
fnp-5643	157	31	initiate	initiate	VERB
fnp-5643	157	32	in	in	ADP
fnp-5643	157	33	the	the	DET
fnp-5643	157	34	limbic	limbic	ADJ
fnp-5643	157	35	structures	structure	NOUN
fnp-5643	157	36	of	of	ADP
fnp-5643	157	37	the	the	DET
fnp-5643	157	38	medial	medial	ADJ
fnp-5643	157	39	temporal	temporal	ADJ
fnp-5643	157	40	lobe	lobe	NOUN
fnp-5643	157	41	[	[	X
fnp-5643	157	42	47,48,50	47,48,50	NUM
fnp-5643	157	43	]	]	X
fnp-5643	157	44	.	.	PUNCT
fnp-5643	158	1	in	in	ADP
fnp-5643	158	2	our	our	PRON
fnp-5643	158	3	study	study	NOUN
fnp-5643	158	4	however	however	ADV
fnp-5643	158	5	,	,	PUNCT
fnp-5643	158	6	handling	handling	NOUN
fnp-5643	158	7	and	and	CCONJ
fnp-5643	158	8	cutting	cutting	NOUN
fnp-5643	158	9	of	of	ADP
fnp-5643	158	10	the	the	DET
fnp-5643	158	11	brain	brain	NOUN
fnp-5643	158	12	was	be	AUX
fnp-5643	158	13	limited	limit	VERB
fnp-5643	158	14	to	to	ADP
fnp-5643	158	15	a	a	DET
fnp-5643	158	16	minimum	minimum	NOUN
fnp-5643	158	17	for	for	ADP
fnp-5643	158	18	the	the	DET
fnp-5643	158	19	sake	sake	NOUN
fnp-5643	158	20	of	of	ADP
fnp-5643	158	21	safety	safety	NOUN
fnp-5643	158	22	in	in	ADP
fnp-5643	158	23	respect	respect	NOUN
fnp-5643	158	24	to	to	ADP
fnp-5643	158	25	prion	prion	NOUN
fnp-5643	158	26	transmission	transmission	NOUN
fnp-5643	158	27	and	and	CCONJ
fnp-5643	158	28	hence	hence	ADV
fnp-5643	158	29	focused	focus	VERB
fnp-5643	158	30	only	only	ADV
fnp-5643	158	31	on	on	ADP
fnp-5643	158	32	two	two	NUM
fnp-5643	158	33	easily	easily	ADV
fnp-5643	158	34	accessible	accessible	ADJ
fnp-5643	158	35	brain	brain	NOUN
fnp-5643	158	36	regions	region	NOUN
fnp-5643	158	37	.	.	PUNCT
fnp-5643	159	1	furthermore	furthermore	ADV
fnp-5643	159	2	,	,	PUNCT
fnp-5643	159	3	our	our	PRON
fnp-5643	159	4	study	study	NOUN
fnp-5643	159	5	was	be	AUX
fnp-5643	159	6	performed	perform	VERB
fnp-5643	159	7	in	in	ADP
fnp-5643	159	8	a	a	DET
fnp-5643	159	9	brain	brain	NOUN
fnp-5643	159	10	bank	bank	NOUN
fnp-5643	159	11	setting	setting	NOUN
fnp-5643	159	12	and	and	CCONJ
fnp-5643	159	13	all	all	DET
fnp-5643	159	14	cases	case	NOUN
fnp-5643	159	15	hence	hence	ADV
fnp-5643	159	16	underwent	undergo	VERB
fnp-5643	159	17	a	a	DET
fnp-5643	159	18	thorough	thorough	ADJ
fnp-5643	159	19	neuropathological	neuropathological	ADJ
fnp-5643	159	20	evaluation	evaluation	NOUN
fnp-5643	159	21	after	after	ADP
fnp-5643	159	22	screening	screen	VERB
fnp-5643	159	23	histology	histology	NOUN
fnp-5643	159	24	,	,	PUNCT
fnp-5643	159	25	covering	cover	VERB
fnp-5643	159	26	the	the	DET
fnp-5643	159	27	aforementioned	aforementioned	ADJ
fnp-5643	159	28	disease	disease	NOUN
fnp-5643	159	29	entities	entity	NOUN
fnp-5643	159	30	as	as	ADV
fnp-5643	159	31	well	well	ADV
fnp-5643	159	32	.	.	PUNCT
fnp-5643	160	1	compared	compare	VERB
fnp-5643	160	2	to	to	ADP
fnp-5643	160	3	the	the	DET
fnp-5643	160	4	study	study	NOUN
fnp-5643	160	5	by	by	ADP
fnp-5643	160	6	venneti	venneti	NOUN
fnp-5643	160	7	et	et	PROPN
fnp-5643	160	8	al	al	PROPN
fnp-5643	160	9	.	.	PUNCT
fnp-5643	161	1	[	[	X
fnp-5643	161	2	17	17	NUM
fnp-5643	161	3	]	]	PUNCT
fnp-5643	161	4	which	which	PRON
fnp-5643	161	5	assessed	assess	VERB
fnp-5643	161	6	mid	mid	ADJ
fnp-5643	161	7	-	-	ADJ
fnp-5643	161	8	frontal	frontal	ADJ
fnp-5643	161	9	cortex	cortex	NOUN
fnp-5643	161	10	(	(	PUNCT
fnp-5643	161	11	and	and	CCONJ
fnp-5643	161	12	additional	additional	ADJ
fnp-5643	161	13	cortical	cortical	ADJ
fnp-5643	161	14	regions	region	NOUN
fnp-5643	161	15	as	as	ADV
fnp-5643	161	16	well	well	ADV
fnp-5643	161	17	as	as	ADP
fnp-5643	161	18	basal	basal	ADJ
fnp-5643	161	19	ganglia	ganglia	NOUN
fnp-5643	161	20	)	)	PUNCT
fnp-5643	161	21	we	we	PRON
fnp-5643	161	22	achieved	achieve	VERB
fnp-5643	161	23	a	a	DET
fnp-5643	161	24	higher	high	ADJ
fnp-5643	161	25	diagnostic	diagnostic	ADJ
fnp-5643	161	26	sensitivity	sensitivity	NOUN
fnp-5643	161	27	.	.	PUNCT
fnp-5643	162	1	remarkably	remarkably	ADV
fnp-5643	162	2	that	that	DET
fnp-5643	162	3	study	study	NOUN
fnp-5643	162	4	[	[	X
fnp-5643	162	5	17	17	NUM
fnp-5643	162	6	]	]	PUNCT
fnp-5643	162	7	showed	show	VERB
fnp-5643	162	8	0	0	NUM
fnp-5643	162	9	 	 	SPACE
fnp-5643	162	10	%	%	NOUN
fnp-5643	162	11	sensitivity	sensitivity	NOUN
fnp-5643	162	12	for	for	ADP
fnp-5643	162	13	the	the	DET
fnp-5643	162	14	diagnosis	diagnosis	NOUN
fnp-5643	162	15	of	of	ADP
fnp-5643	162	16	psp	psp	NOUN
fnp-5643	162	17	by	by	ADP
fnp-5643	162	18	applying	apply	VERB
fnp-5643	162	19	only	only	ADV
fnp-5643	162	20	a	a	DET
fnp-5643	162	21	frontal	frontal	ADJ
fnp-5643	162	22	lobe	lobe	NOUN
fnp-5643	162	23	specimen	speciman	NOUN
fnp-5643	162	24	,	,	PUNCT
fnp-5643	162	25	whereas	whereas	SCONJ
fnp-5643	162	26	we	we	PRON
fnp-5643	162	27	reached	reach	VERB
fnp-5643	162	28	a	a	DET
fnp-5643	162	29	sensitivity	sensitivity	NOUN
fnp-5643	162	30	of	of	ADP
fnp-5643	162	31	96	96	NUM
fnp-5643	162	32	 	 	SPACE
fnp-5643	162	33	%	%	NOUN
fnp-5643	162	34	.	.	PUNCT
fnp-5643	163	1	in	in	ADP
fnp-5643	163	2	the	the	DET
fnp-5643	163	3	study	study	NOUN
fnp-5643	163	4	by	by	ADP
fnp-5643	163	5	king	king	PROPN
fnp-5643	163	6	et	et	PROPN
fnp-5643	163	7	al	al	PROPN
fnp-5643	163	8	.	.	PUNCT
fnp-5643	164	1	[	[	X
fnp-5643	164	2	18	18	NUM
fnp-5643	164	3	]	]	PUNCT
fnp-5643	164	4	,	,	PUNCT
fnp-5643	164	5	the	the	DET
fnp-5643	164	6	sensitivity	sensitivity	NOUN
fnp-5643	164	7	for	for	ADP
fnp-5643	164	8	the	the	DET
fnp-5643	164	9	diagnosis	diagnosis	NOUN
fnp-5643	164	10	of	of	ADP
fnp-5643	164	11	ad	ad	NOUN
fnp-5643	164	12	,	,	PUNCT
fnp-5643	164	13	cbd	cbd	NOUN
fnp-5643	164	14	and	and	CCONJ
fnp-5643	164	15	msa	msa	PROPN
fnp-5643	164	16	was	be	AUX
fnp-5643	164	17	100	100	NUM
fnp-5643	164	18	 	 	SPACE
fnp-5643	164	19	%	%	NOUN
fnp-5643	164	20	for	for	ADP
fnp-5643	164	21	frontal	frontal	ADJ
fnp-5643	164	22	specimens	specimen	NOUN
fnp-5643	164	23	and	and	CCONJ
fnp-5643	164	24	frontal	frontal	ADJ
fnp-5643	164	25	/	/	SYM
fnp-5643	164	26	temporal	temporal	ADJ
fnp-5643	164	27	specimens	specimen	NOUN
fnp-5643	164	28	combined	combine	VERB
fnp-5643	164	29	,	,	PUNCT
fnp-5643	164	30	which	which	PRON
fnp-5643	164	31	is	be	AUX
fnp-5643	164	32	as	as	ADV
fnp-5643	164	33	high	high	ADJ
fnp-5643	164	34	as	as	ADP
fnp-5643	164	35	in	in	ADP
fnp-5643	164	36	our	our	PRON
fnp-5643	164	37	study	study	NOUN
fnp-5643	164	38	.	.	PUNCT
fnp-5643	165	1	however	however	ADV
fnp-5643	165	2	,	,	PUNCT
fnp-5643	165	3	we	we	PRON
fnp-5643	165	4	reached	reach	VERB
fnp-5643	165	5	a	a	DET
fnp-5643	165	6	higher	high	ADJ
fnp-5643	165	7	sensitivity	sensitivity	NOUN
fnp-5643	165	8	for	for	ADP
fnp-5643	165	9	the	the	DET
fnp-5643	165	10	diagnosis	diagnosis	NOUN
fnp-5643	165	11	of	of	ADP
fnp-5643	165	12	psp	psp	NOUN
fnp-5643	165	13	(	(	PUNCT
fnp-5643	165	14	96	96	NUM
fnp-5643	165	15	 	 	SPACE
fnp-5643	165	16	%	%	NOUN
fnp-5643	165	17	vs.	vs.	ADP
fnp-5643	165	18	0	0	NUM
fnp-5643	165	19	 	 	SPACE
fnp-5643	165	20	%	%	NOUN
fnp-5643	165	21	)	)	PUNCT
fnp-5643	165	22	,	,	PUNCT
fnp-5643	165	23	lbd	lbd	PROPN
fnp-5643	165	24	(	(	PUNCT
fnp-5643	165	25	100	100	NUM
fnp-5643	165	26	 	 	SPACE
fnp-5643	165	27	%	%	NOUN
fnp-5643	165	28	vs.	vs.	ADP
fnp-5643	165	29	60	60	NUM
fnp-5643	165	30	 	 	SPACE
fnp-5643	165	31	%	%	NOUN
fnp-5643	165	32	)	)	PUNCT
fnp-5643	165	33	and	and	CCONJ
fnp-5643	165	34	ftld	ftld	ADJ
fnp-5643	165	35	non	non	PROPN
fnp-5643	165	36	-	-	PROPN
fnp-5643	165	37	tau	tau	PROPN
fnp-5643	165	38	(	(	PUNCT
fnp-5643	165	39	100	100	NUM
fnp-5643	165	40	 	 	SPACE
fnp-5643	165	41	%	%	NOUN
fnp-5643	165	42	vs.	vs.	ADP
fnp-5643	165	43	83	83	NUM
fnp-5643	165	44	 	 	SPACE
fnp-5643	165	45	%	%	NOUN
fnp-5643	165	46	(	(	PUNCT
fnp-5643	165	47	combined	combine	VERB
fnp-5643	165	48	)	)	PUNCT
fnp-5643	165	49	respectively	respectively	ADV
fnp-5643	165	50	67	67	NUM
fnp-5643	165	51	 	 	SPACE
fnp-5643	165	52	%	%	NOUN
fnp-5643	165	53	(	(	PUNCT
fnp-5643	165	54	fontal	fontal	ADJ
fnp-5643	165	55	sample	sample	NOUN
fnp-5643	165	56	alone	alone	ADV
fnp-5643	165	57	)	)	PUNCT
fnp-5643	165	58	.	.	PUNCT
fnp-5643	166	1	the	the	DET
fnp-5643	166	2	authors	author	NOUN
fnp-5643	166	3	of	of	ADP
fnp-5643	166	4	both	both	DET
fnp-5643	166	5	previous	previous	ADJ
fnp-5643	166	6	studies	study	NOUN
fnp-5643	166	7	[	[	X
fnp-5643	166	8	17,18	17,18	X
fnp-5643	166	9	]	]	PUNCT
fnp-5643	166	10	mention	mention	VERB
fnp-5643	166	11	the	the	DET
fnp-5643	166	12	sparse	sparse	ADJ
fnp-5643	166	13	occurrence	occurrence	NOUN
fnp-5643	166	14	of	of	ADP
fnp-5643	166	15	frontal	frontal	ADJ
fnp-5643	166	16	tau	tau	PROPN
fnp-5643	166	17	pathology	pathology	NOUN
fnp-5643	166	18	in	in	ADP
fnp-5643	166	19	psp	psp	NOUN
fnp-5643	166	20	and	and	CCONJ
fnp-5643	166	21	thus	thus	ADV
fnp-5643	166	22	diagnostic	diagnostic	ADJ
fnp-5643	166	23	difficulties	difficulty	NOUN
fnp-5643	166	24	.	.	PUNCT
fnp-5643	167	1	on	on	ADP
fnp-5643	167	2	the	the	DET
fnp-5643	167	3	contrary	contrary	NOUN
fnp-5643	167	4	,	,	PUNCT
fnp-5643	167	5	we	we	PRON
fnp-5643	167	6	found	find	VERB
fnp-5643	167	7	frontal	frontal	ADJ
fnp-5643	167	8	tufted	tufte	VERB
fnp-5643	167	9	astrocytes	astrocyte	NOUN
fnp-5643	167	10	in	in	ADP
fnp-5643	167	11	all	all	DET
fnp-5643	167	12	cases	case	NOUN
fnp-5643	167	13	and	and	CCONJ
fnp-5643	167	14	frontal	frontal	ADJ
fnp-5643	167	15	coiled	coil	VERB
fnp-5643	167	16	bodies	body	NOUN
fnp-5643	167	17	in	in	ADP
fnp-5643	167	18	all	all	PRON
fnp-5643	167	19	but	but	SCONJ
fnp-5643	167	20	one	one	NUM
fnp-5643	167	21	case	case	NOUN
fnp-5643	167	22	classified	classify	VERB
fnp-5643	167	23	as	as	ADP
fnp-5643	167	24	psp	psp	NOUN
fnp-5643	167	25	on	on	ADP
fnp-5643	167	26	screening	screen	VERB
fnp-5643	167	27	histology	histology	NOUN
fnp-5643	167	28	.	.	PUNCT
fnp-5643	168	1	since	since	SCONJ
fnp-5643	168	2	neuronal	neuronal	ADJ
fnp-5643	168	3	,	,	PUNCT
fnp-5643	168	4	astrocytic	astrocytic	ADJ
fnp-5643	168	5	and	and	CCONJ
fnp-5643	168	6	oligodendroglial	oligodendroglial	ADJ
fnp-5643	168	7	tau	tau	PROPN
fnp-5643	168	8	accumulation	accumulation	NOUN
fnp-5643	168	9	in	in	ADP
fnp-5643	168	10	the	the	DET
fnp-5643	168	11	frontal	frontal	ADJ
fnp-5643	168	12	cortex	cortex	NOUN
fnp-5643	168	13	precedes	precede	VERB
fnp-5643	168	14	pathology	pathology	NOUN
fnp-5643	168	15	in	in	ADP
fnp-5643	168	16	other	other	ADJ
fnp-5643	168	17	neocortical	neocortical	ADJ
fnp-5643	168	18	areas	area	NOUN
fnp-5643	168	19	[	[	X
fnp-5643	168	20	60	60	NUM
fnp-5643	168	21	]	]	PUNCT
fnp-5643	168	22	,	,	PUNCT
fnp-5643	168	23	we	we	PRON
fnp-5643	168	24	consider	consider	VERB
fnp-5643	168	25	assessment	assessment	NOUN
fnp-5643	168	26	of	of	ADP
fnp-5643	168	27	the	the	DET
fnp-5643	168	28	superior	superior	ADJ
fnp-5643	168	29	frontal	frontal	ADJ
fnp-5643	168	30	gyrus	gyrus	NOUN
fnp-5643	168	31	as	as	ADP
fnp-5643	168	32	useful	useful	ADJ
fnp-5643	168	33	for	for	ADP
fnp-5643	168	34	an	an	DET
fnp-5643	168	35	orientating	orientating	NOUN
fnp-5643	168	36	diagnosis	diagnosis	NOUN
fnp-5643	168	37	of	of	ADP
fnp-5643	168	38	psp	psp	NOUN
fnp-5643	168	39	.	.	PUNCT
fnp-5643	169	1	in	in	ADP
fnp-5643	169	2	a	a	DET
fnp-5643	169	3	proposed	propose	VERB
fnp-5643	169	4	stepwise	stepwise	ADJ
fnp-5643	169	5	distribution	distribution	NOUN
fnp-5643	169	6	model	model	NOUN
fnp-5643	169	7	of	of	ADP
fnp-5643	169	8	psp	psp	NOUN
fnp-5643	169	9	,	,	PUNCT
fnp-5643	169	10	frontal	frontal	ADJ
fnp-5643	169	11	tau	tau	PROPN
fnp-5643	169	12	can	can	AUX
fnp-5643	169	13	already	already	ADV
fnp-5643	169	14	be	be	AUX
fnp-5643	169	15	detected	detect	VERB
fnp-5643	169	16	at	at	ADP
fnp-5643	169	17	stage	stage	NOUN
fnp-5643	169	18	 	 	SPACE
fnp-5643	169	19	3	3	NUM
fnp-5643	169	20	,	,	PUNCT
fnp-5643	169	21	temporally	temporally	ADV
fnp-5643	169	22	just	just	ADV
fnp-5643	169	23	after	after	ADP
fnp-5643	169	24	anatomically	anatomically	ADV
fnp-5643	169	25	less	less	ADV
fnp-5643	169	26	easily	easily	ADV
fnp-5643	169	27	accessible	accessible	ADJ
fnp-5643	169	28	regions	region	NOUN
fnp-5643	169	29	of	of	ADP
fnp-5643	169	30	the	the	DET
fnp-5643	169	31	subthalamic	subthalamic	ADJ
fnp-5643	169	32	nucleus	nucleus	NOUN
fnp-5643	169	33	and	and	CCONJ
fnp-5643	169	34	basal	basal	ADJ
fnp-5643	169	35	ganglia	ganglion	NOUN
fnp-5643	170	1	[	[	X
fnp-5643	170	2	60	60	NUM
fnp-5643	170	3	]	]	PUNCT
fnp-5643	170	4	.	.	PUNCT
fnp-5643	171	1	of	of	ADP
fnp-5643	171	2	note	note	NOUN
fnp-5643	171	3	,	,	PUNCT
fnp-5643	171	4	we	we	PRON
fnp-5643	171	5	assessed	assess	VERB
fnp-5643	171	6	brain	brain	NOUN
fnp-5643	171	7	tissue	tissue	NOUN
fnp-5643	171	8	of	of	ADP
fnp-5643	171	9	participants	participant	NOUN
fnp-5643	171	10	in	in	ADP
fnp-5643	171	11	the	the	DET
fnp-5643	171	12	frame	frame	NOUN
fnp-5643	171	13	of	of	ADP
fnp-5643	171	14	a	a	DET
fnp-5643	171	15	brain	brain	NOUN
fnp-5643	171	16	bank	bank	NOUN
fnp-5643	171	17	program	program	NOUN
fnp-5643	171	18	,	,	PUNCT
fnp-5643	171	19	essentially	essentially	ADV
fnp-5643	171	20	recruiting	recruit	VERB
fnp-5643	171	21	patients	patient	NOUN
fnp-5643	171	22	with	with	ADP
fnp-5643	171	23	a	a	DET
fnp-5643	171	24	known	know	VERB
fnp-5643	171	25	history	history	NOUN
fnp-5643	171	26	of	of	ADP
fnp-5643	171	27	a	a	DET
fnp-5643	171	28	ndd	ndd	NOUN
fnp-5643	171	29	and	and	CCONJ
fnp-5643	171	30	therefore	therefore	ADV
fnp-5643	171	31	often	often	ADV
fnp-5643	171	32	presenting	present	VERB
fnp-5643	171	33	with	with	ADP
fnp-5643	171	34	advanced	advanced	ADJ
fnp-5643	171	35	disease	disease	NOUN
fnp-5643	171	36	and	and	CCONJ
fnp-5643	171	37	widespread	widespread	ADJ
fnp-5643	171	38	pathology	pathology	NOUN
fnp-5643	171	39	.	.	PUNCT
fnp-5643	172	1	this	this	PRON
fnp-5643	172	2	might	might	AUX
fnp-5643	172	3	for	for	ADP
fnp-5643	172	4	instance	instance	NOUN
fnp-5643	172	5	account	account	VERB
fnp-5643	172	6	for	for	ADP
fnp-5643	172	7	the	the	DET
fnp-5643	172	8	high	high	ADJ
fnp-5643	172	9	number	number	NOUN
fnp-5643	172	10	of	of	ADP
fnp-5643	172	11	lbd	lbd	PROPN
fnp-5643	172	12	cases	case	NOUN
fnp-5643	172	13	showing	show	VERB
fnp-5643	172	14	frontal	frontal	ADJ
fnp-5643	172	15	pathology	pathology	NOUN
fnp-5643	172	16	.	.	PUNCT
fnp-5643	173	1	conclusion	conclusion	NOUN
fnp-5643	173	2	we	we	PRON
fnp-5643	173	3	here	here	ADV
fnp-5643	173	4	developed	develop	VERB
fnp-5643	173	5	a	a	DET
fnp-5643	173	6	diagnostic	diagnostic	ADJ
fnp-5643	173	7	algorithm	algorithm	NOUN
fnp-5643	173	8	based	base	VERB
fnp-5643	173	9	on	on	ADP
fnp-5643	173	10	the	the	DET
fnp-5643	173	11	histomorphological	histomorphological	ADJ
fnp-5643	173	12	assessment	assessment	NOUN
fnp-5643	173	13	of	of	ADP
fnp-5643	173	14	two	two	NUM
fnp-5643	173	15	easily	easily	ADV
fnp-5643	173	16	accessible	accessible	ADJ
fnp-5643	173	17	brain	brain	NOUN
fnp-5643	173	18	regions	region	NOUN
fnp-5643	173	19	to	to	PART
fnp-5643	173	20	obtain	obtain	VERB
fnp-5643	173	21	a	a	DET
fnp-5643	173	22	working	work	VERB
fnp-5643	173	23	diagnosis	diagnosis	NOUN
fnp-5643	173	24	for	for	ADP
fnp-5643	173	25	the	the	DET
fnp-5643	173	26	commonest	commonest	NOUN
fnp-5643	173	27	ndd	ndd	NOUN
fnp-5643	173	28	.	.	PUNCT
fnp-5643	174	1	our	our	PRON
fnp-5643	174	2	diagnostic	diagnostic	ADJ
fnp-5643	174	3	algorithm	algorithm	NOUN
fnp-5643	174	4	is	be	AUX
fnp-5643	174	5	highly	highly	ADV
fnp-5643	174	6	reliable	reliable	ADJ
fnp-5643	174	7	with	with	ADP
fnp-5643	174	8	an	an	DET
fnp-5643	174	9	over	over	ADP
fnp-5643	174	10	96	96	NUM
fnp-5643	174	11	 	 	SPACE
fnp-5643	174	12	%	%	NOUN
fnp-5643	174	13	concordance	concordance	NOUN
fnp-5643	174	14	between	between	ADP
fnp-5643	174	15	the	the	DET
fnp-5643	174	16	screening	screening	NOUN
fnp-5643	174	17	and	and	CCONJ
fnp-5643	174	18	final	final	ADJ
fnp-5643	174	19	neuropathological	neuropathological	ADJ
fnp-5643	174	20	diagnoses	diagnosis	NOUN
fnp-5643	174	21	.	.	PUNCT
fnp-5643	175	1	in	in	ADP
fnp-5643	175	2	addition	addition	NOUN
fnp-5643	175	3	,	,	PUNCT
fnp-5643	175	4	it	it	PRON
fnp-5643	175	5	enhances	enhance	VERB
fnp-5643	175	6	the	the	DET
fnp-5643	175	7	safety	safety	NOUN
fnp-5643	175	8	of	of	ADP
fnp-5643	175	9	laboratory	laboratory	NOUN
fnp-5643	175	10	personnel	personnel	NOUN
fnp-5643	175	11	by	by	ADP
fnp-5643	175	12	excluding	exclude	VERB
fnp-5643	175	13	prion	prion	NOUN
fnp-5643	175	14	diseases	disease	NOUN
fnp-5643	175	15	before	before	ADP
fnp-5643	175	16	exhaustive	exhaustive	ADJ
fnp-5643	175	17	manipulation	manipulation	NOUN
fnp-5643	175	18	of	of	ADP
fnp-5643	175	19	the	the	DET
fnp-5643	175	20	brain	brain	NOUN
fnp-5643	175	21	.	.	PUNCT
fnp-5643	176	1	furthermore	furthermore	ADV
fnp-5643	176	2	,	,	PUNCT
fnp-5643	176	3	our	our	PRON
fnp-5643	176	4	diagnostic	diagnostic	ADJ
fnp-5643	176	5	algorithm	algorithm	NOUN
fnp-5643	176	6	allows	allow	VERB
fnp-5643	176	7	for	for	ADP
fnp-5643	176	8	a	a	DET
fnp-5643	176	9	prompt	prompt	ADJ
fnp-5643	176	10	feedback	feedback	NOUN
fnp-5643	176	11	to	to	ADP
fnp-5643	176	12	the	the	DET
fnp-5643	176	13	treating	treat	VERB
fnp-5643	176	14	physicians	physician	NOUN
fnp-5643	176	15	.	.	PUNCT
fnp-5643	177	1	in	in	ADP
fnp-5643	177	2	conjunction	conjunction	NOUN
fnp-5643	177	3	with	with	ADP
fnp-5643	177	4	the	the	DET
fnp-5643	177	5	clinical	clinical	ADJ
fnp-5643	177	6	history	history	NOUN
fnp-5643	177	7	,	,	PUNCT
fnp-5643	177	8	our	our	PRON
fnp-5643	177	9	screening	screening	NOUN
fnp-5643	177	10	diagnosis	diagnosis	NOUN
fnp-5643	177	11	might	might	AUX
fnp-5643	177	12	foster	foster	VERB
fnp-5643	177	13	a	a	DET
fnp-5643	177	14	targeted	targeted	ADJ
fnp-5643	177	15	evaluation	evaluation	NOUN
fnp-5643	177	16	of	of	ADP
fnp-5643	177	17	the	the	DET
fnp-5643	177	18	fixed	fix	VERB
fnp-5643	177	19	brain	brain	NOUN
fnp-5643	177	20	tissue	tissue	NOUN
fnp-5643	177	21	.	.	PUNCT
fnp-5643	178	1	finally	finally	ADV
fnp-5643	178	2	,	,	PUNCT
fnp-5643	178	3	the	the	DET
fnp-5643	178	4	approach	approach	NOUN
fnp-5643	178	5	presented	present	VERB
fnp-5643	178	6	here	here	ADV
fnp-5643	178	7	might	might	AUX
fnp-5643	178	8	be	be	AUX
fnp-5643	178	9	feasible	feasible	ADJ
fnp-5643	178	10	in	in	ADP
fnp-5643	178	11	future	future	ADJ
fnp-5643	178	12	biopsy	biopsy	NOUN
fnp-5643	178	13	diagnostics	diagnostic	NOUN
fnp-5643	178	14	of	of	ADP
fnp-5643	178	15	ndd	ndd	PROPN
fnp-5643	178	16	and	and	CCONJ
fnp-5643	178	17	thereby	thereby	ADV
fnp-5643	178	18	enhance	enhance	VERB
fnp-5643	178	19	the	the	DET
fnp-5643	178	20	diagnostic	diagnostic	ADJ
fnp-5643	178	21	rapidity	rapidity	NOUN
fnp-5643	178	22	of	of	ADP
fnp-5643	178	23	postmortem	postmortem	NOUN
fnp-5643	178	24	ndd	ndd	NOUN
fnp-5643	178	25	diagnostics	diagnostic	NOUN
fnp-5643	178	26	.	.	PUNCT
fnp-5643	179	1	some	some	DET
fnp-5643	179	2	caution	caution	NOUN
fnp-5643	179	3	is	be	AUX
fnp-5643	179	4	however	however	ADV
fnp-5643	179	5	warranted	warrant	VERB
fnp-5643	179	6	since	since	SCONJ
fnp-5643	179	7	our	our	PRON
fnp-5643	179	8	approach	approach	NOUN
fnp-5643	179	9	does	do	AUX
fnp-5643	179	10	not	not	PART
fnp-5643	179	11	appreciate	appreciate	VERB
fnp-5643	179	12	the	the	DET
fnp-5643	179	13	manifold	manifold	ADJ
fnp-5643	179	14	co	co	NOUN
fnp-5643	179	15	-	-	NOUN
fnp-5643	179	16	pathologies	pathology	NOUN
fnp-5643	179	17	that	that	PRON
fnp-5643	179	18	may	may	AUX
fnp-5643	179	19	be	be	AUX
fnp-5643	179	20	present	present	ADJ
fnp-5643	179	21	in	in	ADP
fnp-5643	179	22	ndd	ndd	PROPN
fnp-5643	179	23	and	and	CCONJ
fnp-5643	179	24	since	since	SCONJ
fnp-5643	179	25	it	it	PRON
fnp-5643	179	26	has	have	VERB
fnp-5643	179	27	limited	limit	VERB
fnp-5643	179	28	value	value	NOUN
fnp-5643	179	29	for	for	ADP
fnp-5643	179	30	disease	disease	NOUN
fnp-5643	179	31	staging	staging	NOUN
fnp-5643	179	32	.	.	PUNCT
fnp-5643	180	1	therefore	therefore	ADV
fnp-5643	180	2	,	,	PUNCT
fnp-5643	180	3	subsequent	subsequent	ADJ
fnp-5643	180	4	thorough	thorough	ADJ
fnp-5643	180	5	analysis	analysis	NOUN
fnp-5643	180	6	of	of	ADP
fnp-5643	180	7	various	various	ADJ
fnp-5643	180	8	brain	brain	NOUN
fnp-5643	180	9	specimens	specimen	NOUN
fnp-5643	180	10	is	be	AUX
fnp-5643	180	11	still	still	ADV
fnp-5643	180	12	required	require	VERB
fnp-5643	180	13	,	,	PUNCT
fnp-5643	180	14	especially	especially	ADV
fnp-5643	180	15	in	in	ADP
fnp-5643	180	16	a	a	DET
fnp-5643	180	17	brain	brain	NOUN
fnp-5643	180	18	bank	bank	NOUN
fnp-5643	180	19	setting	setting	NOUN
fnp-5643	180	20	.	.	PUNCT
fnp-5643	181	1	acknowledgements	acknowledgement	NOUN
fnp-5643	181	2	we	we	PRON
fnp-5643	181	3	thank	thank	VERB
fnp-5643	181	4	all	all	DET
fnp-5643	181	5	brain	brain	NOUN
fnp-5643	181	6	donors	donor	NOUN
fnp-5643	181	7	and	and	CCONJ
fnp-5643	181	8	their	their	PRON
fnp-5643	181	9	relatives	relative	NOUN
fnp-5643	181	10	as	as	ADV
fnp-5643	181	11	well	well	ADV
fnp-5643	181	12	as	as	ADP
fnp-5643	181	13	the	the	DET
fnp-5643	181	14	(	(	PUNCT
fnp-5643	181	15	neuro)pathologists	neuro)pathologist	NOUN
fnp-5643	181	16	involved	involve	VERB
fnp-5643	181	17	in	in	ADP
fnp-5643	181	18	tissue	tissue	NOUN
fnp-5643	181	19	asservation	asservation	NOUN
fnp-5643	181	20	all	all	ADV
fnp-5643	181	21	over	over	ADP
fnp-5643	181	22	germany	germany	PROPN
fnp-5643	181	23	for	for	ADP
fnp-5643	181	24	enabling	enable	VERB
fnp-5643	181	25	this	this	DET
fnp-5643	181	26	study	study	NOUN
fnp-5643	181	27	.	.	PUNCT
fnp-5643	182	1	we	we	PRON
fnp-5643	182	2	further	far	ADV
fnp-5643	182	3	thank	thank	VERB
fnp-5643	182	4	mr	mr	PROPN
fnp-5643	182	5	.	.	PROPN
fnp-5643	182	6	michael	michael	PROPN
fnp-5643	182	7	schmidt	schmidt	PROPN
fnp-5643	182	8	for	for	ADP
fnp-5643	182	9	excellent	excellent	ADJ
fnp-5643	182	10	technical	technical	ADJ
fnp-5643	182	11	assistance	assistance	NOUN
fnp-5643	182	12	.	.	PUNCT
fnp-5643	183	1	conflicts	conflict	NOUN
fnp-5643	183	2	of	of	ADP
fnp-5643	183	3	interest	interest	NOUN
fnp-5643	183	4	statement	statement	NOUN
fnp-5643	183	5	all	all	DET
fnp-5643	183	6	authors	author	NOUN
fnp-5643	183	7	do	do	AUX
fnp-5643	183	8	not	not	PART
fnp-5643	183	9	disclose	disclose	VERB
fnp-5643	183	10	any	any	DET
fnp-5643	183	11	conflict	conflict	NOUN
fnp-5643	183	12	of	of	ADP
fnp-5643	183	13	interest	interest	NOUN
fnp-5643	183	14	.	.	PUNCT
fnp-5643	184	1	funding	funding	NOUN
fnp-5643	184	2	statement	statement	NOUN
fnp-5643	184	3	no	no	DET
fnp-5643	184	4	funding	funding	NOUN
fnp-5643	184	5	was	be	AUX
fnp-5643	184	6	received	receive	VERB
fnp-5643	184	7	to	to	PART
fnp-5643	184	8	help	help	VERB
fnp-5643	184	9	prepare	prepare	VERB
fnp-5643	184	10	this	this	DET
fnp-5643	184	11	manuscript	manuscript	NOUN
fnp-5643	184	12	.	.	PUNCT
fnp-5643	185	1	references	reference	NOUN
fnp-5643	185	2	1	1	NUM
fnp-5643	185	3	.	.	PUNCT
fnp-5643	186	1	tamsen	tamsen	PROPN
fnp-5643	186	2	,	,	PUNCT
fnp-5643	186	3	f.	f.	PROPN
fnp-5643	186	4	and	and	CCONJ
fnp-5643	186	5	i.	i.	PROPN
fnp-5643	186	6	alafuzoff	alafuzoff	PROPN
fnp-5643	186	7	,	,	PUNCT
fnp-5643	186	8	when	when	SCONJ
fnp-5643	186	9	is	be	AUX
fnp-5643	186	10	a	a	DET
fnp-5643	186	11	postmortem	postmortem	NOUN
fnp-5643	186	12	examination	examination	NOUN
fnp-5643	186	13	carried	carry	VERB
fnp-5643	186	14	out	out	ADP
fnp-5643	186	15	?	?	PUNCT
fnp-5643	187	1	a	a	DET
fnp-5643	187	2	retrospective	retrospective	ADJ
fnp-5643	187	3	analysis	analysis	NOUN
fnp-5643	187	4	of	of	ADP
fnp-5643	187	5	all	all	DET
fnp-5643	187	6	swedish	swedish	ADJ
fnp-5643	187	7	deaths	death	NOUN
fnp-5643	187	8	1999	1999	NUM
fnp-5643	187	9	-	-	SYM
fnp-5643	187	10	2018	2018	NUM
fnp-5643	187	11	.	.	PUNCT
fnp-5643	188	1	virchows	virchow	NOUN
fnp-5643	188	2	arch	arch	VERB
fnp-5643	188	3	,	,	PUNCT
fnp-5643	188	4	2023	2023	NUM
fnp-5643	188	5	.	.	PUNCT
fnp-5643	189	1	482(4	482(4	NUM
fnp-5643	189	2	):	):	PUNCT
fnp-5643	190	1	p.	p.	NOUN
fnp-5643	190	2	721	721	NUM
fnp-5643	190	3	-	-	SYM
fnp-5643	190	4	727	727	NUM
fnp-5643	190	5	.	.	PUNCT
fnp-5643	191	1	doi	doi	NOUN
fnp-5643	191	2	:	:	PUNCT
fnp-5643	191	3	https://doi.org/10.1007/s00428-022-03462-w	https://doi.org/10.1007/s00428-022-03462-w	PROPN
fnp-5643	191	4	2	2	NUM
fnp-5643	191	5	.	.	PUNCT
fnp-5643	191	6	selvackadunco	selvackadunco	PROPN
fnp-5643	191	7	,	,	PUNCT
fnp-5643	191	8	s.	s.	PROPN
fnp-5643	191	9	,	,	PUNCT
fnp-5643	191	10	et	et	PROPN
fnp-5643	191	11	al	al	PROPN
fnp-5643	191	12	.	.	PROPN
fnp-5643	191	13	,	,	PUNCT
fnp-5643	191	14	comparison	comparison	NOUN
fnp-5643	191	15	of	of	ADP
fnp-5643	191	16	clinical	clinical	ADJ
fnp-5643	191	17	and	and	CCONJ
fnp-5643	191	18	neuropathological	neuropathological	ADJ
fnp-5643	191	19	diagnoses	diagnosis	NOUN
fnp-5643	191	20	of	of	ADP
fnp-5643	191	21	neurodegenerative	neurodegenerative	ADJ
fnp-5643	191	22	diseases	disease	NOUN
fnp-5643	191	23	in	in	ADP
fnp-5643	191	24	two	two	NUM
fnp-5643	191	25	centres	centre	NOUN
fnp-5643	191	26	from	from	ADP
fnp-5643	191	27	the	the	DET
fnp-5643	191	28	brains	brain	NOUN
fnp-5643	191	29	for	for	ADP
fnp-5643	191	30	dementia	dementia	NOUN
fnp-5643	191	31	research	research	NOUN
fnp-5643	191	32	(	(	PUNCT
fnp-5643	191	33	bdr	bdr	NOUN
fnp-5643	191	34	)	)	PUNCT
fnp-5643	191	35	cohort	cohort	NOUN
fnp-5643	191	36	.	.	PUNCT
fnp-5643	192	1	j	j	PROPN
fnp-5643	192	2	neural	neural	ADJ
fnp-5643	192	3	transm	transm	PROPN
fnp-5643	192	4	(	(	PUNCT
fnp-5643	192	5	vienna	vienna	PROPN
fnp-5643	192	6	)	)	PUNCT
fnp-5643	192	7	,	,	PUNCT
fnp-5643	192	8	2019	2019	NUM
fnp-5643	192	9	.	.	PUNCT
fnp-5643	193	1	126(3	126(3	NUM
fnp-5643	193	2	):	):	PUNCT
fnp-5643	193	3	p.	p.	NOUN
fnp-5643	193	4	327	327	NUM
fnp-5643	193	5	-	-	SYM
fnp-5643	193	6	337	337	NUM
fnp-5643	193	7	.	.	PUNCT
fnp-5643	194	1	doi	doi	NOUN
fnp-5643	194	2	:	:	PUNCT
fnp-5643	194	3	https://doi.org/10.1007/s00702-018-01967-w	https://doi.org/10.1007/s00702-018-01967-w	PROPN
fnp-5643	194	4	3	3	NUM
fnp-5643	194	5	.	.	X
fnp-5643	194	6	brunnstrom	brunnstrom	NOUN
fnp-5643	194	7	,	,	PUNCT
fnp-5643	194	8	h.	h.	PROPN
fnp-5643	194	9	and	and	CCONJ
fnp-5643	194	10	e.	e.	PROPN
fnp-5643	194	11	englund	englund	PROPN
fnp-5643	194	12	,	,	PUNCT
fnp-5643	194	13	clinicopathological	clinicopathological	ADJ
fnp-5643	194	14	concordance	concordance	NOUN
fnp-5643	194	15	in	in	ADP
fnp-5643	194	16	dementia	dementia	NOUN
fnp-5643	194	17	diagnostics	diagnostic	NOUN
fnp-5643	194	18	.	.	PUNCT
fnp-5643	195	1	am	be	AUX
fnp-5643	195	2	j	j	PROPN
fnp-5643	195	3	geriatr	geriatr	ADJ
fnp-5643	195	4	psychiatry	psychiatry	NOUN
fnp-5643	195	5	,	,	PUNCT
fnp-5643	195	6	2009	2009	NUM
fnp-5643	195	7	.	.	PUNCT
fnp-5643	196	1	17(8	17(8	NUM
fnp-5643	196	2	):	):	PUNCT
fnp-5643	196	3	p.	p.	NOUN
fnp-5643	196	4	664	664	NUM
fnp-5643	196	5	-	-	SYM
fnp-5643	196	6	70	70	NUM
fnp-5643	196	7	.	.	PUNCT
fnp-5643	197	1	doi	doi	NOUN
fnp-5643	197	2	:	:	PUNCT
fnp-5643	197	3	https://doi.org/10.1097/jgp.0b013e3181a6516e	https://doi.org/10.1097/jgp.0b013e3181a6516e	PROPN
fnp-5643	197	4	4	4	NUM
fnp-5643	197	5	.	.	PUNCT
fnp-5643	198	1	shim	shim	NOUN
fnp-5643	198	2	,	,	PUNCT
fnp-5643	198	3	y.s	y.s	PROPN
fnp-5643	198	4	.	.	PROPN
fnp-5643	198	5	,	,	PUNCT
fnp-5643	198	6	et	et	PROPN
fnp-5643	198	7	al	al	PROPN
fnp-5643	198	8	.	.	PROPN
fnp-5643	198	9	,	,	PUNCT
fnp-5643	198	10	clinicopathologic	clinicopathologic	ADJ
fnp-5643	198	11	study	study	NOUN
fnp-5643	198	12	of	of	ADP
fnp-5643	198	13	alzheimer	alzheimer	PROPN
fnp-5643	198	14	's	's	PART
fnp-5643	198	15	disease	disease	NOUN
fnp-5643	198	16	:	:	PUNCT
fnp-5643	198	17	alzheimer	alzheimer	PROPN
fnp-5643	198	18	mimics	mimic	VERB
fnp-5643	198	19	.	.	PUNCT
fnp-5643	199	1	j	j	PROPN
fnp-5643	199	2	alzheimers	alzheimers	PROPN
fnp-5643	199	3	dis	dis	PROPN
fnp-5643	199	4	,	,	PUNCT
fnp-5643	199	5	2013	2013	NUM
fnp-5643	199	6	.	.	PUNCT
fnp-5643	200	1	35(4	35(4	NUM
fnp-5643	200	2	):	):	PUNCT
fnp-5643	200	3	p.	p.	NOUN
fnp-5643	200	4	799	799	NUM
fnp-5643	200	5	-	-	SYM
fnp-5643	200	6	811	811	NUM
fnp-5643	200	7	.	.	PUNCT
fnp-5643	201	1	doi	doi	NOUN
fnp-5643	201	2	:	:	PUNCT
fnp-5643	201	3	https://doi.org/10.3233/jad-121594	https://doi.org/10.3233/jad-121594	PROPN
fnp-5643	201	4	5	5	X
fnp-5643	201	5	.	.	X
fnp-5643	201	6	osaki	osaki	PROPN
fnp-5643	201	7	,	,	PUNCT
fnp-5643	201	8	y.	y.	PROPN
fnp-5643	201	9	,	,	PUNCT
fnp-5643	201	10	et	et	PROPN
fnp-5643	201	11	al	al	PROPN
fnp-5643	201	12	.	.	PROPN
fnp-5643	201	13	,	,	PUNCT
fnp-5643	201	14	accuracy	accuracy	NOUN
fnp-5643	201	15	of	of	ADP
fnp-5643	201	16	clinical	clinical	ADJ
fnp-5643	201	17	diagnosis	diagnosis	NOUN
fnp-5643	201	18	of	of	ADP
fnp-5643	201	19	progressive	progressive	ADJ
fnp-5643	201	20	supranuclear	supranuclear	ADJ
fnp-5643	201	21	palsy	palsy	ADJ
fnp-5643	201	22	.	.	PUNCT
fnp-5643	202	1	mov	mov	NOUN
fnp-5643	202	2	disord	disord	NOUN
fnp-5643	202	3	,	,	PUNCT
fnp-5643	202	4	2004	2004	NUM
fnp-5643	202	5	.	.	PUNCT
fnp-5643	203	1	19(2	19(2	NUM
fnp-5643	203	2	):	):	PUNCT
fnp-5643	204	1	p.	p.	NOUN
fnp-5643	204	2	181	181	NUM
fnp-5643	204	3	-	-	SYM
fnp-5643	204	4	9	9	NUM
fnp-5643	204	5	.	.	PUNCT
fnp-5643	204	6	doi	doi	NOUN
fnp-5643	204	7	:	:	PUNCT
fnp-5643	204	8	https://doi.org/10.1002/mds.10680	https://doi.org/10.1002/mds.10680	PROPN
fnp-5643	204	9	6	6	NUM
fnp-5643	204	10	.	.	PUNCT
fnp-5643	205	1	el	el	PROPN
fnp-5643	205	2	tawil	tawil	PROPN
fnp-5643	205	3	,	,	PUNCT
fnp-5643	205	4	s.	s.	PROPN
fnp-5643	205	5	,	,	PUNCT
fnp-5643	205	6	et	et	PROPN
fnp-5643	205	7	al	al	PROPN
fnp-5643	205	8	.	.	PROPN
fnp-5643	205	9	,	,	PUNCT
fnp-5643	205	10	variant	variant	ADJ
fnp-5643	205	11	creutzfeldt	creutzfeldt	ADJ
fnp-5643	205	12	-	-	PUNCT
fnp-5643	205	13	jakob	jakob	ADJ
fnp-5643	205	14	disease	disease	NOUN
fnp-5643	205	15	in	in	ADP
fnp-5643	205	16	older	old	ADJ
fnp-5643	205	17	patients	patient	NOUN
fnp-5643	205	18	.	.	PUNCT
fnp-5643	206	1	j	j	PROPN
fnp-5643	206	2	neurol	neurol	PROPN
fnp-5643	206	3	neurosurg	neurosurg	PROPN
fnp-5643	206	4	psychiatry	psychiatry	PROPN
fnp-5643	206	5	,	,	PUNCT
fnp-5643	206	6	2015	2015	NUM
fnp-5643	206	7	.	.	PUNCT
fnp-5643	207	1	86(11	86(11	NUM
fnp-5643	207	2	):	):	PUNCT
fnp-5643	207	3	p.	p.	NOUN
fnp-5643	207	4	1279	1279	NUM
fnp-5643	207	5	-	-	SYM
fnp-5643	207	6	80	80	NUM
fnp-5643	207	7	.	.	PUNCT
fnp-5643	208	1	doi	doi	NOUN
fnp-5643	208	2	:	:	PUNCT
fnp-5643	208	3	https://doi.org/10.1136/jnnp-2014-309397	https://doi.org/10.1136/jnnp-2014-309397	NOUN
fnp-5643	208	4	7	7	NUM
fnp-5643	208	5	.	.	PUNCT
fnp-5643	208	6	xiong	xiong	PROPN
fnp-5643	208	7	,	,	PUNCT
fnp-5643	208	8	x.	x.	PROPN
fnp-5643	208	9	,	,	PUNCT
fnp-5643	208	10	et	et	PROPN
fnp-5643	208	11	al	al	PROPN
fnp-5643	208	12	.	.	PROPN
fnp-5643	208	13	,	,	PUNCT
fnp-5643	208	14	alzheimer	alzheimer	PROPN
fnp-5643	208	15	's	's	PART
fnp-5643	208	16	disease	disease	NOUN
fnp-5643	208	17	diagnostic	diagnostic	ADJ
fnp-5643	208	18	accuracy	accuracy	NOUN
fnp-5643	208	19	by	by	ADP
fnp-5643	208	20	fluid	fluid	NOUN
fnp-5643	208	21	and	and	CCONJ
fnp-5643	208	22	neuroimaging	neuroimage	VERB
fnp-5643	208	23	atn	atn	NOUN
fnp-5643	208	24	framework	framework	NOUN
fnp-5643	208	25	.	.	PUNCT
fnp-5643	209	1	cns	cns	PROPN
fnp-5643	209	2	neurosci	neurosci	PROPN
fnp-5643	209	3	ther	ther	ADV
fnp-5643	209	4	,	,	PUNCT
fnp-5643	209	5	2023	2023	NUM
fnp-5643	209	6	.	.	PUNCT
fnp-5643	210	1	doi	doi	NOUN
fnp-5643	210	2	:	:	PUNCT
fnp-5643	210	3	https://doi.org/10.1111/cns.14357	https://doi.org/10.1111/cns.14357	PROPN
fnp-5643	210	4	8	8	NUM
fnp-5643	210	5	.	.	PUNCT
fnp-5643	211	1	kovacs	kovacs	PROPN
fnp-5643	211	2	,	,	PUNCT
fnp-5643	211	3	g.g	g.g	PROPN
fnp-5643	211	4	.	.	PROPN
fnp-5643	211	5	and	and	CCONJ
fnp-5643	211	6	h.	h.	PROPN
fnp-5643	211	7	budka	budka	PROPN
fnp-5643	211	8	,	,	PUNCT
fnp-5643	211	9	current	current	ADJ
fnp-5643	211	10	concepts	concept	NOUN
fnp-5643	211	11	of	of	ADP
fnp-5643	211	12	neuropathological	neuropathological	ADJ
fnp-5643	211	13	diagnostics	diagnostic	NOUN
fnp-5643	211	14	in	in	ADP
fnp-5643	211	15	practice	practice	NOUN
fnp-5643	211	16	:	:	PUNCT
fnp-5643	211	17	neurodegenerative	neurodegenerative	ADJ
fnp-5643	211	18	diseases	disease	NOUN
fnp-5643	211	19	.	.	PUNCT
fnp-5643	212	1	clin	clin	PROPN
fnp-5643	212	2	neuropathol	neuropathol	PROPN
fnp-5643	212	3	,	,	PUNCT
fnp-5643	212	4	2010	2010	NUM
fnp-5643	212	5	.	.	PUNCT
fnp-5643	213	1	29(5	29(5	NUM
fnp-5643	213	2	):	):	PUNCT
fnp-5643	213	3	p.	p.	NOUN
fnp-5643	213	4	271	271	NUM
fnp-5643	213	5	-	-	SYM
fnp-5643	213	6	88	88	NUM
fnp-5643	213	7	.	.	PUNCT
fnp-5643	214	1	doi	doi	NOUN
fnp-5643	214	2	:	:	PUNCT
fnp-5643	214	3	https://doi.org/10.5414/npp29271	https://doi.org/10.5414/npp29271	NOUN
fnp-5643	214	4	9	9	NUM
fnp-5643	214	5	.	.	X
fnp-5643	214	6	montine	montine	PROPN
fnp-5643	214	7	,	,	PUNCT
fnp-5643	214	8	t.j	t.j	PROPN
fnp-5643	214	9	.	.	PROPN
fnp-5643	214	10	,	,	PUNCT
fnp-5643	214	11	et	et	PROPN
fnp-5643	214	12	al	al	PROPN
fnp-5643	214	13	.	.	PROPN
fnp-5643	214	14	,	,	PUNCT
fnp-5643	214	15	national	national	PROPN
fnp-5643	214	16	institute	institute	NOUN
fnp-5643	214	17	on	on	ADP
fnp-5643	214	18	aging	age	VERB
fnp-5643	214	19	-	-	PUNCT
fnp-5643	214	20	alzheimer	alzheimer	NOUN
fnp-5643	214	21	's	's	PART
fnp-5643	214	22	association	association	NOUN
fnp-5643	214	23	guidelines	guideline	NOUN
fnp-5643	214	24	for	for	ADP
fnp-5643	214	25	the	the	DET
fnp-5643	214	26	neuropathologic	neuropathologic	ADJ
fnp-5643	214	27	assessment	assessment	NOUN
fnp-5643	214	28	of	of	ADP
fnp-5643	214	29	alzheimer	alzheimer	PROPN
fnp-5643	214	30	's	's	PART
fnp-5643	214	31	disease	disease	NOUN
fnp-5643	214	32	:	:	PUNCT
fnp-5643	214	33	a	a	DET
fnp-5643	214	34	practical	practical	ADJ
fnp-5643	214	35	approach	approach	NOUN
fnp-5643	214	36	.	.	PUNCT
fnp-5643	215	1	acta	acta	PROPN
fnp-5643	215	2	neuropathol	neuropathol	PROPN
fnp-5643	215	3	,	,	PUNCT
fnp-5643	215	4	2012	2012	NUM
fnp-5643	215	5	.	.	PUNCT
fnp-5643	216	1	123(1	123(1	NUM
fnp-5643	216	2	):	):	PUNCT
fnp-5643	217	1	p.	p.	NOUN
fnp-5643	217	2	1	1	NUM
fnp-5643	217	3	-	-	SYM
fnp-5643	217	4	11	11	NUM
fnp-5643	217	5	.	.	PUNCT
fnp-5643	218	1	doi	doi	NOUN
fnp-5643	218	2	:	:	PUNCT
fnp-5643	218	3	https://doi.org/10.1007/s00401-011-0910-3	https://doi.org/10.1007/s00401-011-0910-3	NUM
fnp-5643	218	4	10	10	NUM
fnp-5643	218	5	.	.	PUNCT
fnp-5643	219	1	flanagan	flanagan	PROPN
fnp-5643	219	2	,	,	PUNCT
fnp-5643	219	3	m.e	m.e	PROPN
fnp-5643	219	4	.	.	PROPN
fnp-5643	219	5	,	,	PUNCT
fnp-5643	219	6	et	et	PROPN
fnp-5643	219	7	al	al	PROPN
fnp-5643	219	8	.	.	PROPN
fnp-5643	219	9	,	,	PUNCT
fnp-5643	219	10	performance	performance	NOUN
fnp-5643	219	11	of	of	ADP
fnp-5643	219	12	a	a	DET
fnp-5643	219	13	condensed	condense	VERB
fnp-5643	219	14	protocol	protocol	NOUN
fnp-5643	219	15	that	that	PRON
fnp-5643	219	16	reduces	reduce	VERB
fnp-5643	219	17	effort	effort	NOUN
fnp-5643	219	18	and	and	CCONJ
fnp-5643	219	19	cost	cost	NOUN
fnp-5643	219	20	of	of	ADP
fnp-5643	219	21	nia	nia	PROPN
fnp-5643	219	22	-	-	PUNCT
fnp-5643	219	23	aa	aa	PROPN
fnp-5643	219	24	guidelines	guideline	NOUN
fnp-5643	219	25	for	for	ADP
fnp-5643	219	26	neuropathologic	neuropathologic	ADJ
fnp-5643	219	27	assessment	assessment	NOUN
fnp-5643	219	28	of	of	ADP
fnp-5643	219	29	alzheimer	alzheimer	PROPN
fnp-5643	219	30	disease	disease	PROPN
fnp-5643	219	31	.	.	PUNCT
fnp-5643	220	1	j	j	PROPN
fnp-5643	220	2	neuropathol	neuropathol	PROPN
fnp-5643	220	3	exp	exp	PROPN
fnp-5643	220	4	neurol	neurol	NOUN
fnp-5643	220	5	,	,	PUNCT
fnp-5643	220	6	2017	2017	NUM
fnp-5643	220	7	.	.	PUNCT
fnp-5643	221	1	76(1	76(1	NOUN
fnp-5643	221	2	):	):	PUNCT
fnp-5643	221	3	p.	p.	NOUN
fnp-5643	221	4	39	39	NUM
fnp-5643	221	5	-	-	SYM
fnp-5643	221	6	43	43	NUM
fnp-5643	221	7	.	.	PUNCT
fnp-5643	222	1	doi	doi	NOUN
fnp-5643	222	2	:	:	PUNCT
fnp-5643	222	3	https://doi.org/10.1093/jnen/nlw104	https://doi.org/10.1093/jnen/nlw104	PROPN
fnp-5643	222	4	11	11	NUM
fnp-5643	222	5	.	.	PUNCT
fnp-5643	223	1	clement	clement	PROPN
fnp-5643	223	2	,	,	PUNCT
fnp-5643	223	3	n.f	n.f	PROPN
fnp-5643	223	4	.	.	PROPN
fnp-5643	223	5	,	,	PUNCT
fnp-5643	223	6	et	et	PROPN
fnp-5643	223	7	al	al	PROPN
fnp-5643	223	8	.	.	PROPN
fnp-5643	223	9	,	,	PUNCT
fnp-5643	223	10	a	a	DET
fnp-5643	223	11	simplified	simplified	ADJ
fnp-5643	223	12	brain	brain	NOUN
fnp-5643	223	13	blocking	block	VERB
fnp-5643	223	14	protocol	protocol	NOUN
fnp-5643	223	15	optimized	optimize	VERB
fnp-5643	223	16	for	for	ADP
fnp-5643	223	17	the	the	DET
fnp-5643	223	18	diagnosis	diagnosis	NOUN
fnp-5643	223	19	of	of	ADP
fnp-5643	223	20	neurodegenerative	neurodegenerative	ADJ
fnp-5643	223	21	disease	disease	NOUN
fnp-5643	223	22	saves	save	VERB
fnp-5643	223	23	time	time	NOUN
fnp-5643	223	24	and	and	CCONJ
fnp-5643	223	25	money	money	NOUN
fnp-5643	223	26	while	while	SCONJ
fnp-5643	223	27	preserving	preserve	VERB
fnp-5643	223	28	anatomic	anatomic	ADJ
fnp-5643	223	29	relationships	relationship	NOUN
fnp-5643	223	30	.	.	PUNCT
fnp-5643	224	1	arch	arch	ADJ
fnp-5643	224	2	pathol	pathol	NOUN
fnp-5643	224	3	lab	lab	NOUN
fnp-5643	224	4	med	me	VERB
fnp-5643	224	5	,	,	PUNCT
fnp-5643	224	6	2021	2021	NUM
fnp-5643	224	7	.	.	PUNCT
fnp-5643	225	1	145(8	145(8	NUM
fnp-5643	225	2	):	):	PUNCT
fnp-5643	225	3	p.	p.	NOUN
fnp-5643	225	4	960	960	NUM
fnp-5643	225	5	-	-	SYM
fnp-5643	225	6	968	968	NUM
fnp-5643	225	7	.	.	PUNCT
fnp-5643	226	1	doi	doi	NOUN
fnp-5643	226	2	:	:	PUNCT
fnp-5643	226	3	https://doi.org/10.5858/arpa.2020-0322-oa	https://doi.org/10.5858/arpa.2020-0322-oa	PROPN
fnp-5643	226	4	12	12	NUM
fnp-5643	226	5	.	.	PUNCT
fnp-5643	227	1	maioli	maioli	NOUN
fnp-5643	227	2	,	,	PUNCT
fnp-5643	227	3	h.	h.	PROPN
fnp-5643	227	4	,	,	PUNCT
fnp-5643	227	5	et	et	PROPN
fnp-5643	227	6	al	al	PROPN
fnp-5643	227	7	.	.	PROPN
fnp-5643	227	8	,	,	PUNCT
fnp-5643	227	9	performance	performance	NOUN
fnp-5643	227	10	of	of	ADP
fnp-5643	227	11	a	a	DET
fnp-5643	227	12	condensed	condense	VERB
fnp-5643	227	13	protocol	protocol	NOUN
fnp-5643	227	14	to	to	PART
fnp-5643	227	15	assess	assess	VERB
fnp-5643	227	16	limbic	limbic	ADJ
fnp-5643	227	17	-	-	PUNCT
fnp-5643	227	18	predominant	predominant	ADJ
fnp-5643	227	19	age	age	NOUN
fnp-5643	227	20	-	-	PUNCT
fnp-5643	227	21	related	relate	VERB
fnp-5643	227	22	tdp-43	tdp-43	NOUN
fnp-5643	227	23	encephalopathy	encephalopathy	ADJ
fnp-5643	227	24	neuropathologic	neuropathologic	ADJ
fnp-5643	227	25	change	change	NOUN
fnp-5643	227	26	.	.	PUNCT
fnp-5643	228	1	j	j	PROPN
fnp-5643	228	2	neuropathol	neuropathol	PROPN
fnp-5643	228	3	exp	exp	PROPN
fnp-5643	228	4	neurol	neurol	NOUN
fnp-5643	228	5	,	,	PUNCT
fnp-5643	228	6	2023	2023	NUM
fnp-5643	228	7	.	.	PUNCT
fnp-5643	229	1	82(7	82(7	NUM
fnp-5643	229	2	):	):	PUNCT
fnp-5643	230	1	p.	p.	NOUN
fnp-5643	230	2	611	611	NUM
fnp-5643	230	3	-	-	SYM
fnp-5643	230	4	619	619	NUM
fnp-5643	230	5	.	.	PUNCT
fnp-5643	231	1	doi	doi	NOUN
fnp-5643	231	2	:	:	PUNCT
fnp-5643	231	3	https://doi.org/10.1093/jnen/nlad035	https://doi.org/10.1093/jnen/nlad035	PROPN
fnp-5643	231	4	13	13	NUM
fnp-5643	231	5	.	.	PUNCT
fnp-5643	231	6	multz	multz	NOUN
fnp-5643	231	7	,	,	PUNCT
fnp-5643	231	8	r.a	r.a	PROPN
fnp-5643	231	9	.	.	PROPN
fnp-5643	231	10	,	,	PUNCT
fnp-5643	231	11	et	et	PROPN
fnp-5643	231	12	al	al	PROPN
fnp-5643	231	13	.	.	PROPN
fnp-5643	231	14	,	,	PUNCT
fnp-5643	231	15	what	what	PRON
fnp-5643	231	16	every	every	DET
fnp-5643	231	17	neuropathologist	neuropathologist	NOUN
fnp-5643	231	18	needs	need	VERB
fnp-5643	231	19	to	to	PART
fnp-5643	231	20	know	know	VERB
fnp-5643	231	21	:	:	PUNCT
fnp-5643	231	22	condensed	condense	VERB
fnp-5643	231	23	protocol	protocol	NOUN
fnp-5643	231	24	work	work	NOUN
fnp-5643	231	25	-	-	PUNCT
fnp-5643	231	26	up	up	NOUN
fnp-5643	231	27	for	for	ADP
fnp-5643	231	28	clinical	clinical	ADJ
fnp-5643	231	29	dementia	dementia	NOUN
fnp-5643	231	30	syndromes	syndrome	NOUN
fnp-5643	231	31	.	.	PUNCT
fnp-5643	232	1	j	j	PROPN
fnp-5643	232	2	neuropathol	neuropathol	PROPN
fnp-5643	232	3	exp	exp	PROPN
fnp-5643	232	4	neurol	neurol	NOUN
fnp-5643	232	5	,	,	PUNCT
fnp-5643	232	6	2023	2023	NUM
fnp-5643	232	7	.	.	PUNCT
fnp-5643	232	8	82(2	82(2	NUM
fnp-5643	232	9	):	):	PUNCT
fnp-5643	232	10	p.	p.	NOUN
fnp-5643	232	11	103	103	NUM
fnp-5643	232	12	-	-	SYM
fnp-5643	232	13	109	109	NUM
fnp-5643	232	14	.	.	PUNCT
fnp-5643	233	1	doi	doi	PROPN
fnp-5643	233	2	:	:	PUNCT
fnp-5643	233	3	https://doi.org/10.1093/jnen/nlac114	https://doi.org/10.1093/jnen/nlac114	PROPN
fnp-5643	233	4	14	14	NUM
fnp-5643	233	5	.	.	PUNCT
fnp-5643	234	1	bharadwaj	bharadwaj	PROPN
fnp-5643	234	2	,	,	PUNCT
fnp-5643	234	3	r.	r.	PROPN
fnp-5643	234	4	,	,	PUNCT
fnp-5643	234	5	et	et	PROPN
fnp-5643	234	6	al	al	PROPN
fnp-5643	234	7	.	.	PROPN
fnp-5643	234	8	,	,	PUNCT
fnp-5643	234	9	application	application	NOUN
fnp-5643	234	10	of	of	ADP
fnp-5643	234	11	the	the	DET
fnp-5643	234	12	condensed	condense	VERB
fnp-5643	234	13	protocol	protocol	NOUN
fnp-5643	234	14	for	for	ADP
fnp-5643	234	15	the	the	DET
fnp-5643	234	16	nia	nia	PROPN
fnp-5643	234	17	-	-	PUNCT
fnp-5643	234	18	aa	aa	NOUN
fnp-5643	234	19	guidelines	guideline	NOUN
fnp-5643	234	20	for	for	ADP
fnp-5643	234	21	the	the	DET
fnp-5643	234	22	neuropathological	neuropathological	ADJ
fnp-5643	234	23	assessment	assessment	NOUN
fnp-5643	234	24	of	of	ADP
fnp-5643	234	25	alzheimer	alzheimer	PROPN
fnp-5643	234	26	's	's	PART
fnp-5643	234	27	disease	disease	NOUN
fnp-5643	234	28	in	in	ADP
fnp-5643	234	29	an	an	DET
fnp-5643	234	30	academic	academic	ADJ
fnp-5643	234	31	clinical	clinical	ADJ
fnp-5643	234	32	practice	practice	NOUN
fnp-5643	234	33	.	.	PUNCT
fnp-5643	235	1	histopathology	histopathology	NOUN
fnp-5643	235	2	,	,	PUNCT
fnp-5643	235	3	2018	2018	NUM
fnp-5643	235	4	.	.	PUNCT
fnp-5643	236	1	72(3	72(3	NUM
fnp-5643	236	2	):	):	PUNCT
fnp-5643	236	3	p.	p.	NOUN
fnp-5643	236	4	433	433	NUM
fnp-5643	236	5	-	-	SYM
fnp-5643	236	6	440	440	NUM
fnp-5643	236	7	.	.	PUNCT
fnp-5643	237	1	doi	doi	NOUN
fnp-5643	237	2	:	:	PUNCT
fnp-5643	237	3	https://doi.org/10.1111/his.13345	https://doi.org/10.1111/his.13345	PROPN
fnp-5643	237	4	15	15	NUM
fnp-5643	237	5	.	.	PUNCT
fnp-5643	238	1	priemer	priemer	PROPN
fnp-5643	238	2	,	,	PUNCT
fnp-5643	238	3	d.s	d.s	PROPN
fnp-5643	238	4	.	.	PROPN
fnp-5643	238	5	and	and	CCONJ
fnp-5643	238	6	r.d	r.d	PROPN
fnp-5643	238	7	.	.	PROPN
fnp-5643	238	8	folkerth	folkerth	PROPN
fnp-5643	238	9	,	,	PUNCT
fnp-5643	238	10	dementia	dementia	NOUN
fnp-5643	238	11	in	in	ADP
fnp-5643	238	12	the	the	DET
fnp-5643	238	13	forensic	forensic	ADJ
fnp-5643	238	14	setting	setting	NOUN
fnp-5643	238	15	:	:	PUNCT
fnp-5643	238	16	diagnoses	diagnosis	NOUN
fnp-5643	238	17	obtained	obtain	VERB
fnp-5643	238	18	using	use	VERB
fnp-5643	238	19	a	a	DET
fnp-5643	238	20	condensed	condense	VERB
fnp-5643	238	21	protocol	protocol	NOUN
fnp-5643	238	22	at	at	ADP
fnp-5643	238	23	the	the	DET
fnp-5643	238	24	office	office	NOUN
fnp-5643	238	25	of	of	ADP
fnp-5643	238	26	chief	chief	ADJ
fnp-5643	238	27	medical	medical	ADJ
fnp-5643	238	28	examiner	examiner	NOUN
fnp-5643	238	29	,	,	PUNCT
fnp-5643	238	30	new	new	PROPN
fnp-5643	238	31	york	york	PROPN
fnp-5643	238	32	city	city	PROPN
fnp-5643	238	33	.	.	PUNCT
fnp-5643	239	1	j	j	PROPN
fnp-5643	239	2	neuropathol	neuropathol	PROPN
fnp-5643	239	3	exp	exp	PROPN
fnp-5643	239	4	neurol	neurol	NOUN
fnp-5643	239	5	,	,	PUNCT
fnp-5643	239	6	2021	2021	NUM
fnp-5643	239	7	.	.	PUNCT
fnp-5643	240	1	80(8	80(8	NOUN
fnp-5643	240	2	):	):	PUNCT
fnp-5643	240	3	p.	p.	NOUN
fnp-5643	240	4	724	724	NUM
fnp-5643	240	5	-	-	SYM
fnp-5643	240	6	730	730	NUM
fnp-5643	240	7	.	.	PUNCT
fnp-5643	241	1	doi	doi	NOUN
fnp-5643	241	2	:	:	PUNCT
fnp-5643	241	3	https://doi.org/10.1093/jnen/nlab059	https://doi.org/10.1093/jnen/nlab059	PROPN
fnp-5643	241	4	16	16	NUM
fnp-5643	241	5	.	.	PUNCT
fnp-5643	242	1	lopez	lopez	PROPN
fnp-5643	242	2	,	,	PUNCT
fnp-5643	242	3	a.	a.	PROPN
fnp-5643	242	4	,	,	PUNCT
fnp-5643	242	5	et	et	PROPN
fnp-5643	242	6	al	al	PROPN
fnp-5643	242	7	.	.	PROPN
fnp-5643	242	8	,	,	PUNCT
fnp-5643	242	9	flanagan	flanagan	PROPN
fnp-5643	242	10	's	's	PART
fnp-5643	242	11	condensed	condense	VERB
fnp-5643	242	12	protocol	protocol	NOUN
fnp-5643	242	13	for	for	ADP
fnp-5643	242	14	neurodegenerative	neurodegenerative	ADJ
fnp-5643	242	15	diseases	disease	NOUN
fnp-5643	242	16	.	.	PUNCT
fnp-5643	243	1	implementation	implementation	NOUN
fnp-5643	243	2	in	in	ADP
fnp-5643	243	3	a	a	DET
fnp-5643	243	4	clinical	clinical	ADJ
fnp-5643	243	5	autopsy	autopsy	ADJ
fnp-5643	243	6	setting	setting	NOUN
fnp-5643	243	7	with	with	ADP
fnp-5643	243	8	partial	partial	ADJ
fnp-5643	243	9	supervision	supervision	NOUN
fnp-5643	243	10	of	of	ADP
fnp-5643	243	11	a	a	DET
fnp-5643	243	12	neuropathologist	neuropathologist	NOUN
fnp-5643	243	13	.	.	PUNCT
fnp-5643	244	1	virchows	virchow	NOUN
fnp-5643	244	2	arch	arch	VERB
fnp-5643	244	3	,	,	PUNCT
fnp-5643	244	4	2024	2024	NUM
fnp-5643	244	5	.	.	PUNCT
fnp-5643	245	1	doi	doi	NOUN
fnp-5643	245	2	:	:	PUNCT
fnp-5643	245	3	https://doi.org/10.1007/s00428-024-03781-0	https://doi.org/10.1007/s00428-024-03781-0	NUM
fnp-5643	245	4	17	17	NUM
fnp-5643	245	5	.	.	PUNCT
fnp-5643	246	1	venneti	venneti	PRON
fnp-5643	246	2	,	,	PUNCT
fnp-5643	246	3	s.	s.	PROPN
fnp-5643	246	4	,	,	PUNCT
fnp-5643	246	5	et	et	PROPN
fnp-5643	246	6	al	al	PROPN
fnp-5643	246	7	.	.	PROPN
fnp-5643	246	8	,	,	PUNCT
fnp-5643	246	9	simulated	simulate	VERB
fnp-5643	246	10	brain	brain	NOUN
fnp-5643	246	11	biopsy	biopsy	NOUN
fnp-5643	246	12	for	for	ADP
fnp-5643	246	13	diagnosing	diagnose	VERB
fnp-5643	246	14	neurodegeneration	neurodegeneration	NOUN
fnp-5643	246	15	using	use	VERB
fnp-5643	246	16	autopsy	autopsy	ADJ
fnp-5643	246	17	-	-	PUNCT
fnp-5643	246	18	confirmed	confirm	VERB
fnp-5643	246	19	cases	case	NOUN
fnp-5643	246	20	.	.	PUNCT
fnp-5643	247	1	acta	acta	PROPN
fnp-5643	247	2	neuropathol	neuropathol	PROPN
fnp-5643	247	3	,	,	PUNCT
fnp-5643	247	4	2011	2011	NUM
fnp-5643	247	5	.	.	PUNCT
fnp-5643	248	1	122(6	122(6	NUM
fnp-5643	248	2	):	):	PUNCT
fnp-5643	249	1	p.	p.	NOUN
fnp-5643	249	2	737	737	NUM
fnp-5643	249	3	-	-	SYM
fnp-5643	249	4	45	45	NUM
fnp-5643	249	5	.	.	PUNCT
fnp-5643	250	1	doi	doi	NOUN
fnp-5643	250	2	:	:	PUNCT
fnp-5643	250	3	https://doi.org/10.1007/s00401-011-0880-5	https://doi.org/10.1007/s00401-011-0880-5	NUM
fnp-5643	250	4	18	18	NUM
fnp-5643	250	5	.	.	PUNCT
fnp-5643	251	1	king	king	PROPN
fnp-5643	251	2	,	,	PUNCT
fnp-5643	251	3	a.	a.	PROPN
fnp-5643	251	4	,	,	PUNCT
fnp-5643	251	5	et	et	PROPN
fnp-5643	251	6	al	al	PROPN
fnp-5643	251	7	.	.	PROPN
fnp-5643	251	8	,	,	PUNCT
fnp-5643	251	9	simulated	simulate	VERB
fnp-5643	251	10	surgical	surgical	ADJ
fnp-5643	251	11	-	-	PUNCT
fnp-5643	251	12	type	type	NOUN
fnp-5643	251	13	cerebral	cerebral	ADJ
fnp-5643	251	14	biopsies	biopsy	NOUN
fnp-5643	251	15	from	from	ADP
fnp-5643	251	16	post	post	ADJ
fnp-5643	251	17	-	-	ADJ
fnp-5643	251	18	mortem	mortem	ADJ
fnp-5643	251	19	brains	brain	NOUN
fnp-5643	251	20	allows	allow	VERB
fnp-5643	251	21	accurate	accurate	ADJ
fnp-5643	251	22	neuropathological	neuropathological	ADJ
fnp-5643	251	23	diagnoses	diagnosis	NOUN
fnp-5643	251	24	in	in	ADP
fnp-5643	251	25	the	the	DET
fnp-5643	251	26	majority	majority	NOUN
fnp-5643	251	27	of	of	ADP
fnp-5643	251	28	neurodegenerative	neurodegenerative	ADJ
fnp-5643	251	29	disease	disease	NOUN
fnp-5643	251	30	groups	group	NOUN
fnp-5643	251	31	.	.	PUNCT
fnp-5643	252	1	acta	acta	PROPN
fnp-5643	252	2	neuropathol	neuropathol	PROPN
fnp-5643	252	3	commun	commun	PROPN
fnp-5643	252	4	,	,	PUNCT
fnp-5643	252	5	2013	2013	NUM
fnp-5643	252	6	.	.	PUNCT
fnp-5643	253	1	1	1	NUM
fnp-5643	253	2	:	:	PUNCT
fnp-5643	253	3	p.	p.	NOUN
fnp-5643	253	4	53	53	NUM
fnp-5643	253	5	.	.	PUNCT
fnp-5643	254	1	doi	doi	PROPN
fnp-5643	254	2	:	:	PUNCT
fnp-5643	254	3	https://doi.org/10.1186/2051-5960-1-53	https://doi.org/10.1186/2051-5960-1-53	PROPN
fnp-5643	254	4	19	19	NUM
fnp-5643	254	5	.	.	PUNCT
fnp-5643	254	6	kitamoto	kitamoto	NOUN
fnp-5643	254	7	,	,	PUNCT
fnp-5643	254	8	t.	t.	PROPN
fnp-5643	254	9	,	,	PUNCT
fnp-5643	254	10	et	et	PROPN
fnp-5643	254	11	al	al	PROPN
fnp-5643	254	12	.	.	PROPN
fnp-5643	254	13	,	,	PUNCT
fnp-5643	254	14	formic	formic	PROPN
fnp-5643	254	15	acid	acid	PROPN
fnp-5643	254	16	pretreatment	pretreatment	NOUN
fnp-5643	254	17	enhances	enhance	VERB
fnp-5643	254	18	immunostaining	immunostaine	VERB
fnp-5643	254	19	of	of	ADP
fnp-5643	254	20	cerebral	cerebral	ADJ
fnp-5643	254	21	and	and	CCONJ
fnp-5643	254	22	systemic	systemic	ADJ
fnp-5643	254	23	amyloids	amyloid	NOUN
fnp-5643	254	24	.	.	PUNCT
fnp-5643	255	1	lab	lab	PROPN
fnp-5643	255	2	invest	invest	PROPN
fnp-5643	255	3	,	,	PUNCT
fnp-5643	255	4	1987	1987	NUM
fnp-5643	255	5	.	.	PUNCT
fnp-5643	256	1	57(2	57(2	NUM
fnp-5643	256	2	):	):	PUNCT
fnp-5643	256	3	p.	p.	NOUN
fnp-5643	256	4	230	230	NUM
fnp-5643	256	5	-	-	SYM
fnp-5643	256	6	6	6	NUM
fnp-5643	256	7	.	.	NOUN
fnp-5643	256	8	20	20	NUM
fnp-5643	256	9	.	.	PUNCT
fnp-5643	257	1	hardt	hardt	PROPN
fnp-5643	257	2	,	,	PUNCT
fnp-5643	257	3	m.	m.	NOUN
fnp-5643	257	4	,	,	PUNCT
fnp-5643	257	5	t.	t.	NOUN
fnp-5643	257	6	baron	baron	NOUN
fnp-5643	257	7	,	,	PUNCT
fnp-5643	257	8	and	and	CCONJ
fnp-5643	257	9	m.h	m.h	PROPN
fnp-5643	257	10	.	.	PROPN
fnp-5643	257	11	groschup	groschup	PROPN
fnp-5643	257	12	,	,	PUNCT
fnp-5643	257	13	a	a	DET
fnp-5643	257	14	comparative	comparative	ADJ
fnp-5643	257	15	study	study	NOUN
fnp-5643	257	16	of	of	ADP
fnp-5643	257	17	immunohistochemical	immunohistochemical	ADJ
fnp-5643	257	18	methods	method	NOUN
fnp-5643	257	19	for	for	ADP
fnp-5643	257	20	detecting	detect	VERB
fnp-5643	257	21	abnormal	abnormal	ADJ
fnp-5643	257	22	prion	prion	NOUN
fnp-5643	257	23	protein	protein	NOUN
fnp-5643	257	24	with	with	ADP
fnp-5643	257	25	monoclonal	monoclonal	NOUN
fnp-5643	257	26	and	and	CCONJ
fnp-5643	257	27	polyclonal	polyclonal	ADJ
fnp-5643	257	28	antibodies	antibodie	VERB
fnp-5643	257	29	.	.	PUNCT
fnp-5643	258	1	j	j	PROPN
fnp-5643	258	2	comp	comp	PROPN
fnp-5643	258	3	pathol	pathol	PROPN
fnp-5643	258	4	,	,	PUNCT
fnp-5643	258	5	2000	2000	NUM
fnp-5643	258	6	.	.	PUNCT
fnp-5643	259	1	122(1	122(1	NUM
fnp-5643	259	2	):	):	PUNCT
fnp-5643	259	3	p.	p.	NOUN
fnp-5643	259	4	43	43	NUM
fnp-5643	259	5	-	-	SYM
fnp-5643	259	6	53	53	NUM
fnp-5643	259	7	.	.	PUNCT
fnp-5643	260	1	doi	doi	NOUN
fnp-5643	260	2	:	:	PUNCT
fnp-5643	260	3	https://doi.org/10.1053/jcpa.1999.0343	https://doi.org/10.1053/jcpa.1999.0343	PROPN
fnp-5643	260	4	21	21	NUM
fnp-5643	260	5	.	.	PUNCT
fnp-5643	261	1	dickson	dickson	PROPN
fnp-5643	261	2	,	,	PUNCT
fnp-5643	261	3	d.w	d.w	PROPN
fnp-5643	261	4	.	.	PROPN
fnp-5643	261	5	,	,	PUNCT
fnp-5643	261	6	et	et	PROPN
fnp-5643	261	7	al	al	PROPN
fnp-5643	261	8	.	.	PROPN
fnp-5643	261	9	,	,	PUNCT
fnp-5643	261	10	office	office	NOUN
fnp-5643	261	11	of	of	ADP
fnp-5643	261	12	rare	rare	ADJ
fnp-5643	261	13	diseases	disease	NOUN
fnp-5643	261	14	neuropathologic	neuropathologic	ADJ
fnp-5643	261	15	criteria	criterion	NOUN
fnp-5643	261	16	for	for	ADP
fnp-5643	261	17	corticobasal	corticobasal	NOUN
fnp-5643	261	18	degeneration	degeneration	NOUN
fnp-5643	261	19	.	.	PUNCT
fnp-5643	262	1	j	j	PROPN
fnp-5643	262	2	neuropathol	neuropathol	PROPN
fnp-5643	262	3	exp	exp	PROPN
fnp-5643	262	4	neurol	neurol	PROPN
fnp-5643	262	5	,	,	PUNCT
fnp-5643	262	6	2002	2002	NUM
fnp-5643	262	7	.	.	PUNCT
fnp-5643	263	1	61(11	61(11	NUM
fnp-5643	263	2	):	):	PUNCT
fnp-5643	263	3	p.	p.	NOUN
fnp-5643	263	4	935	935	NUM
fnp-5643	263	5	-	-	SYM
fnp-5643	263	6	46	46	NUM
fnp-5643	263	7	.	.	PUNCT
fnp-5643	264	1	doi	doi	NOUN
fnp-5643	264	2	:	:	PUNCT
fnp-5643	264	3	https://doi.org/10.1093/jnen/61.11.935	https://doi.org/10.1093/jnen/61.11.935	PROPN
fnp-5643	264	4	22	22	NUM
fnp-5643	264	5	.	.	PUNCT
fnp-5643	265	1	taipa	taipa	PROPN
fnp-5643	265	2	,	,	PUNCT
fnp-5643	265	3	r.	r.	PROPN
fnp-5643	265	4	,	,	PUNCT
fnp-5643	265	5	j.	j.	PROPN
fnp-5643	265	6	pinho	pinho	PROPN
fnp-5643	265	7	,	,	PUNCT
fnp-5643	265	8	and	and	CCONJ
fnp-5643	265	9	m.	m.	NOUN
fnp-5643	265	10	melo	melo	PROPN
fnp-5643	265	11	-	-	PUNCT
fnp-5643	265	12	pires	pire	NOUN
fnp-5643	265	13	,	,	PUNCT
fnp-5643	265	14	clinico	clinico	ADJ
fnp-5643	265	15	-	-	PUNCT
fnp-5643	265	16	pathological	pathological	ADJ
fnp-5643	265	17	correlations	correlation	NOUN
fnp-5643	265	18	of	of	ADP
fnp-5643	265	19	the	the	DET
fnp-5643	265	20	most	most	ADV
fnp-5643	265	21	common	common	ADJ
fnp-5643	265	22	neurodegenerative	neurodegenerative	ADJ
fnp-5643	265	23	dementias	dementia	NOUN
fnp-5643	265	24	.	.	PUNCT
fnp-5643	266	1	front	front	ADJ
fnp-5643	266	2	neurol	neurol	NOUN
fnp-5643	266	3	,	,	PUNCT
fnp-5643	266	4	2012	2012	NUM
fnp-5643	266	5	.	.	PUNCT
fnp-5643	267	1	3	3	NUM
fnp-5643	267	2	:	:	PUNCT
fnp-5643	267	3	p.	p.	NOUN
fnp-5643	267	4	68	68	NUM
fnp-5643	267	5	.	.	PUNCT
fnp-5643	268	1	doi	doi	NOUN
fnp-5643	268	2	:	:	PUNCT
fnp-5643	268	3	https://doi.org/10.3389/fneur.2012.00068	https://doi.org/10.3389/fneur.2012.00068	PROPN
fnp-5643	268	4	23	23	NUM
fnp-5643	268	5	.	.	PUNCT
fnp-5643	269	1	parchi	parchi	NOUN
fnp-5643	269	2	,	,	PUNCT
fnp-5643	269	3	p.	p.	PROPN
fnp-5643	269	4	,	,	PUNCT
fnp-5643	269	5	et	et	PROPN
fnp-5643	269	6	al	al	PROPN
fnp-5643	269	7	.	.	PROPN
fnp-5643	269	8	,	,	PUNCT
fnp-5643	269	9	classification	classification	NOUN
fnp-5643	269	10	of	of	ADP
fnp-5643	269	11	sporadic	sporadic	ADJ
fnp-5643	269	12	creutzfeldt	creutzfeldt	ADJ
fnp-5643	269	13	-	-	PUNCT
fnp-5643	269	14	jakob	jakob	ADJ
fnp-5643	269	15	disease	disease	NOUN
fnp-5643	269	16	based	base	VERB
fnp-5643	269	17	on	on	ADP
fnp-5643	269	18	molecular	molecular	ADJ
fnp-5643	269	19	and	and	CCONJ
fnp-5643	269	20	phenotypic	phenotypic	ADJ
fnp-5643	269	21	analysis	analysis	NOUN
fnp-5643	269	22	of	of	ADP
fnp-5643	269	23	300	300	NUM
fnp-5643	269	24	subjects	subject	NOUN
fnp-5643	269	25	.	.	PUNCT
fnp-5643	270	1	ann	ann	PROPN
fnp-5643	270	2	neurol	neurol	PROPN
fnp-5643	270	3	,	,	PUNCT
fnp-5643	270	4	1999	1999	NUM
fnp-5643	270	5	.	.	PUNCT
fnp-5643	271	1	46(2	46(2	NUM
fnp-5643	271	2	):	):	PUNCT
fnp-5643	272	1	p.	p.	NOUN
fnp-5643	272	2	224	224	NUM
fnp-5643	272	3	-	-	SYM
fnp-5643	272	4	33	33	NUM
fnp-5643	272	5	.	.	PUNCT
fnp-5643	272	6	24	24	NUM
fnp-5643	272	7	.	.	PUNCT
fnp-5643	273	1	hyman	hyman	PROPN
fnp-5643	273	2	,	,	PUNCT
fnp-5643	273	3	b.t	b.t	PROPN
fnp-5643	273	4	.	.	PROPN
fnp-5643	273	5	,	,	PUNCT
fnp-5643	273	6	et	et	PROPN
fnp-5643	273	7	al	al	PROPN
fnp-5643	273	8	.	.	PROPN
fnp-5643	273	9	,	,	PUNCT
fnp-5643	273	10	national	national	PROPN
fnp-5643	273	11	institute	institute	NOUN
fnp-5643	273	12	on	on	ADP
fnp-5643	273	13	aging	age	VERB
fnp-5643	273	14	-	-	PUNCT
fnp-5643	273	15	alzheimer	alzheimer	NOUN
fnp-5643	273	16	's	's	PART
fnp-5643	273	17	association	association	NOUN
fnp-5643	273	18	guidelines	guideline	NOUN
fnp-5643	273	19	for	for	ADP
fnp-5643	273	20	the	the	DET
fnp-5643	273	21	neuropathologic	neuropathologic	ADJ
fnp-5643	273	22	assessment	assessment	NOUN
fnp-5643	273	23	of	of	ADP
fnp-5643	273	24	alzheimer	alzheimer	PROPN
fnp-5643	273	25	's	's	PART
fnp-5643	273	26	disease	disease	NOUN
fnp-5643	273	27	.	.	PUNCT
fnp-5643	274	1	alzheimers	alzheimers	PROPN
fnp-5643	274	2	dement	dement	PROPN
fnp-5643	274	3	,	,	PUNCT
fnp-5643	274	4	2012	2012	NUM
fnp-5643	274	5	.	.	PUNCT
fnp-5643	275	1	8(1	8(1	NOUN
fnp-5643	275	2	):	):	PUNCT
fnp-5643	275	3	p.	p.	NOUN
fnp-5643	275	4	1	1	NUM
fnp-5643	275	5	-	-	SYM
fnp-5643	275	6	13	13	NUM
fnp-5643	275	7	.	.	PUNCT
fnp-5643	276	1	doi	doi	NOUN
fnp-5643	276	2	:	:	PUNCT
fnp-5643	276	3	https://doi.org/10.1016/j.jalz.2011.10.007	https://doi.org/10.1016/j.jalz.2011.10.007	NOUN
fnp-5643	276	4	25	25	NUM
fnp-5643	276	5	.	.	PUNCT
fnp-5643	277	1	hoglinger	hoglinger	NOUN
fnp-5643	277	2	,	,	PUNCT
fnp-5643	277	3	g.u	g.u	PROPN
fnp-5643	277	4	.	.	PROPN
fnp-5643	277	5	,	,	PUNCT
fnp-5643	277	6	et	et	PROPN
fnp-5643	277	7	al	al	PROPN
fnp-5643	277	8	.	.	PROPN
fnp-5643	277	9	,	,	PUNCT
fnp-5643	277	10	clinical	clinical	ADJ
fnp-5643	277	11	diagnosis	diagnosis	NOUN
fnp-5643	277	12	of	of	ADP
fnp-5643	277	13	progressive	progressive	ADJ
fnp-5643	277	14	supranuclear	supranuclear	ADJ
fnp-5643	277	15	palsy	palsy	ADJ
fnp-5643	277	16	:	:	PUNCT
fnp-5643	277	17	the	the	DET
fnp-5643	277	18	movement	movement	NOUN
fnp-5643	277	19	disorder	disorder	NOUN
fnp-5643	277	20	society	society	NOUN
fnp-5643	277	21	criteria	criterion	NOUN
fnp-5643	277	22	.	.	PUNCT
fnp-5643	278	1	mov	mov	NOUN
fnp-5643	278	2	disord	disord	NOUN
fnp-5643	278	3	,	,	PUNCT
fnp-5643	278	4	2017	2017	NUM
fnp-5643	278	5	.	.	PUNCT
fnp-5643	279	1	32(6	32(6	NUM
fnp-5643	279	2	):	):	PUNCT
fnp-5643	279	3	p.	p.	NOUN
fnp-5643	279	4	853	853	NUM
fnp-5643	279	5	-	-	SYM
fnp-5643	279	6	864	864	NUM
fnp-5643	279	7	.	.	PUNCT
fnp-5643	280	1	doi	doi	NOUN
fnp-5643	280	2	:	:	PUNCT
fnp-5643	280	3	https://doi.org/10.1002/mds.26987	https://doi.org/10.1002/mds.26987	PROPN
fnp-5643	280	4	26	26	NUM
fnp-5643	280	5	.	.	PUNCT
fnp-5643	281	1	jecmenica	jecmenica	PROPN
fnp-5643	281	2	lukic	lukic	PROPN
fnp-5643	281	3	,	,	PUNCT
fnp-5643	281	4	m.	m.	NOUN
fnp-5643	281	5	,	,	PUNCT
fnp-5643	281	6	et	et	PROPN
fnp-5643	281	7	al	al	PROPN
fnp-5643	281	8	.	.	PROPN
fnp-5643	281	9	,	,	PUNCT
fnp-5643	281	10	long	long	ADJ
fnp-5643	281	11	-	-	PUNCT
fnp-5643	281	12	duration	duration	NOUN
fnp-5643	281	13	progressive	progressive	ADJ
fnp-5643	281	14	supranuclear	supranuclear	ADJ
fnp-5643	281	15	palsy	palsy	ADJ
fnp-5643	281	16	:	:	PUNCT
fnp-5643	281	17	clinical	clinical	ADJ
fnp-5643	281	18	course	course	NOUN
fnp-5643	281	19	and	and	CCONJ
fnp-5643	281	20	pathological	pathological	ADJ
fnp-5643	281	21	underpinnings	underpinning	NOUN
fnp-5643	281	22	.	.	PUNCT
fnp-5643	282	1	ann	ann	PROPN
fnp-5643	282	2	neurol	neurol	PROPN
fnp-5643	282	3	,	,	PUNCT
fnp-5643	282	4	2022	2022	NUM
fnp-5643	282	5	.	.	PUNCT
fnp-5643	283	1	doi	doi	NOUN
fnp-5643	283	2	:	:	PUNCT
fnp-5643	283	3	https://doi.org/10.1002/ana.26455	https://doi.org/10.1002/ana.26455	PROPN
fnp-5643	283	4	27	27	NUM
fnp-5643	283	5	.	.	PUNCT
fnp-5643	284	1	dickson	dickson	PROPN
fnp-5643	284	2	,	,	PUNCT
fnp-5643	284	3	d.w	d.w	PROPN
fnp-5643	284	4	.	.	PROPN
fnp-5643	284	5	,	,	PUNCT
fnp-5643	284	6	neuropathologic	neuropathologic	ADJ
fnp-5643	284	7	differentiation	differentiation	NOUN
fnp-5643	284	8	of	of	ADP
fnp-5643	284	9	progressive	progressive	ADJ
fnp-5643	284	10	supranuclear	supranuclear	ADJ
fnp-5643	284	11	palsy	palsy	ADJ
fnp-5643	284	12	and	and	CCONJ
fnp-5643	284	13	corticobasal	corticobasal	NOUN
fnp-5643	284	14	degeneration	degeneration	NOUN
fnp-5643	284	15	.	.	PUNCT
fnp-5643	285	1	j	j	PROPN
fnp-5643	285	2	neurol	neurol	PROPN
fnp-5643	285	3	,	,	PUNCT
fnp-5643	285	4	1999	1999	NUM
fnp-5643	285	5	.	.	PUNCT
fnp-5643	286	1	246	246	NUM
fnp-5643	286	2	suppl	suppl	ADJ
fnp-5643	286	3	2	2	NUM
fnp-5643	286	4	:	:	PUNCT
fnp-5643	286	5	p.	p.	NOUN
fnp-5643	286	6	ii6	ii6	PROPN
fnp-5643	286	7	-	-	PUNCT
fnp-5643	286	8	15	15	NUM
fnp-5643	286	9	.	.	PUNCT
fnp-5643	287	1	doi	doi	NOUN
fnp-5643	287	2	:	:	PUNCT
fnp-5643	287	3	https://doi.org/10.1007/bf03161076	https://doi.org/10.1007/bf03161076	PROPN
fnp-5643	287	4	28	28	NUM
fnp-5643	287	5	.	.	PUNCT
fnp-5643	288	1	saranza	saranza	PROPN
fnp-5643	288	2	,	,	PUNCT
fnp-5643	288	3	g.m	g.m	PROPN
fnp-5643	288	4	.	.	PROPN
fnp-5643	288	5	,	,	PUNCT
fnp-5643	288	6	et	et	PROPN
fnp-5643	288	7	al	al	PROPN
fnp-5643	288	8	.	.	PROPN
fnp-5643	288	9	,	,	PUNCT
fnp-5643	288	10	corticobasal	corticobasal	NOUN
fnp-5643	288	11	degeneration	degeneration	NOUN
fnp-5643	288	12	.	.	PUNCT
fnp-5643	289	1	int	int	PROPN
fnp-5643	289	2	rev	rev	PROPN
fnp-5643	289	3	neurobiol	neurobiol	PROPN
fnp-5643	289	4	,	,	PUNCT
fnp-5643	289	5	2019	2019	NUM
fnp-5643	289	6	.	.	PUNCT
fnp-5643	290	1	149	149	NUM
fnp-5643	290	2	:	:	PUNCT
fnp-5643	290	3	p.	p.	NOUN
fnp-5643	290	4	87	87	NUM
fnp-5643	290	5	-	-	SYM
fnp-5643	290	6	136	136	NUM
fnp-5643	290	7	.	.	PUNCT
fnp-5643	291	1	doi	doi	NOUN
fnp-5643	291	2	:	:	PUNCT
fnp-5643	291	3	https://doi.org/10.1016/bs.irn.2019.10.014	https://doi.org/10.1016/bs.irn.2019.10.014	PROPN
fnp-5643	291	4	29	29	NUM
fnp-5643	291	5	.	.	PUNCT
fnp-5643	292	1	uchihara	uchihara	PROPN
fnp-5643	292	2	,	,	PUNCT
fnp-5643	292	3	t.	t.	PROPN
fnp-5643	292	4	and	and	CCONJ
fnp-5643	292	5	k.	k.	PROPN
fnp-5643	292	6	tsuchiya	tsuchiya	PROPN
fnp-5643	292	7	,	,	PUNCT
fnp-5643	292	8	neuropathology	neuropathology	NOUN
fnp-5643	292	9	of	of	ADP
fnp-5643	292	10	pick	pick	VERB
fnp-5643	292	11	body	body	NOUN
fnp-5643	292	12	disease	disease	NOUN
fnp-5643	292	13	.	.	PUNCT
fnp-5643	293	1	handb	handb	PROPN
fnp-5643	293	2	clin	clin	PROPN
fnp-5643	293	3	neurol	neurol	PROPN
fnp-5643	293	4	,	,	PUNCT
fnp-5643	293	5	2008	2008	NUM
fnp-5643	293	6	.	.	PUNCT
fnp-5643	294	1	89	89	NUM
fnp-5643	294	2	:	:	PUNCT
fnp-5643	295	1	p.	p.	NOUN
fnp-5643	295	2	415	415	NUM
fnp-5643	295	3	-	-	SYM
fnp-5643	295	4	30	30	NUM
fnp-5643	295	5	.	.	PUNCT
fnp-5643	296	1	doi	doi	NOUN
fnp-5643	296	2	:	:	PUNCT
fnp-5643	296	3	https://doi.org/10.1016/s0072-9752(07)01238-9	https://doi.org/10.1016/s0072-9752(07)01238-9	NOUN
fnp-5643	296	4	30	30	NUM
fnp-5643	296	5	.	.	PUNCT
fnp-5643	296	6	alafuzoff	alafuzoff	PROPN
fnp-5643	296	7	,	,	PUNCT
fnp-5643	296	8	i.	i.	PROPN
fnp-5643	296	9	,	,	PUNCT
fnp-5643	296	10	et	et	PROPN
fnp-5643	296	11	al	al	PROPN
fnp-5643	296	12	.	.	PROPN
fnp-5643	296	13	,	,	PUNCT
fnp-5643	296	14	staging	stage	VERB
fnp-5643	296	15	/	/	SYM
fnp-5643	296	16	typing	typing	NOUN
fnp-5643	296	17	of	of	ADP
fnp-5643	296	18	lewy	lewy	PROPN
fnp-5643	296	19	body	body	NOUN
fnp-5643	296	20	related	relate	VERB
fnp-5643	296	21	alpha	alpha	NOUN
fnp-5643	296	22	-	-	PUNCT
fnp-5643	296	23	synuclein	synuclein	NOUN
fnp-5643	296	24	pathology	pathology	NOUN
fnp-5643	296	25	:	:	PUNCT
fnp-5643	296	26	a	a	DET
fnp-5643	296	27	study	study	NOUN
fnp-5643	296	28	of	of	ADP
fnp-5643	296	29	the	the	DET
fnp-5643	296	30	brainnet	brainnet	PROPN
fnp-5643	296	31	europe	europe	PROPN
fnp-5643	296	32	consortium	consortium	PROPN
fnp-5643	296	33	.	.	PUNCT
fnp-5643	297	1	acta	acta	PROPN
fnp-5643	297	2	neuropathol	neuropathol	PROPN
fnp-5643	297	3	,	,	PUNCT
fnp-5643	297	4	2009	2009	NUM
fnp-5643	297	5	.	.	PUNCT
fnp-5643	298	1	117(6	117(6	NUM
fnp-5643	298	2	):	):	PUNCT
fnp-5643	298	3	p.	p.	NOUN
fnp-5643	298	4	635	635	NUM
fnp-5643	298	5	-	-	SYM
fnp-5643	298	6	52	52	NUM
fnp-5643	298	7	.	.	PUNCT
fnp-5643	299	1	doi	doi	NOUN
fnp-5643	299	2	:	:	PUNCT
fnp-5643	299	3	https://doi.org/10.1007/s00401-009-0523-2	https://doi.org/10.1007/s00401-009-0523-2	NUM
fnp-5643	299	4	31	31	NUM
fnp-5643	299	5	.	.	PUNCT
fnp-5643	300	1	walker	walker	PROPN
fnp-5643	300	2	,	,	PUNCT
fnp-5643	300	3	l.	l.	PROPN
fnp-5643	300	4	,	,	PUNCT
fnp-5643	300	5	l.	l.	PROPN
fnp-5643	300	6	stefanis	stefanis	PROPN
fnp-5643	300	7	,	,	PUNCT
fnp-5643	300	8	and	and	CCONJ
fnp-5643	300	9	j.	j.	PROPN
fnp-5643	300	10	attems	attems	PROPN
fnp-5643	300	11	,	,	PUNCT
fnp-5643	300	12	clinical	clinical	ADJ
fnp-5643	300	13	and	and	CCONJ
fnp-5643	300	14	neuropathological	neuropathological	ADJ
fnp-5643	300	15	differences	difference	NOUN
fnp-5643	300	16	between	between	ADP
fnp-5643	300	17	parkinson	parkinson	NOUN
fnp-5643	300	18	's	's	PART
fnp-5643	300	19	disease	disease	NOUN
fnp-5643	300	20	,	,	PUNCT
fnp-5643	300	21	parkinson	parkinson	NOUN
fnp-5643	300	22	's	's	PART
fnp-5643	300	23	disease	disease	NOUN
fnp-5643	300	24	dementia	dementia	NOUN
fnp-5643	300	25	and	and	CCONJ
fnp-5643	300	26	dementia	dementia	NOUN
fnp-5643	300	27	with	with	ADP
fnp-5643	300	28	lewy	lewy	PROPN
fnp-5643	300	29	bodies	body	NOUN
fnp-5643	300	30	current	current	ADJ
fnp-5643	300	31	issues	issue	NOUN
fnp-5643	300	32	and	and	CCONJ
fnp-5643	300	33	future	future	ADJ
fnp-5643	300	34	directions	direction	NOUN
fnp-5643	300	35	.	.	PUNCT
fnp-5643	301	1	j	j	PROPN
fnp-5643	301	2	neurochem	neurochem	PROPN
fnp-5643	301	3	,	,	PUNCT
fnp-5643	301	4	2019	2019	NUM
fnp-5643	301	5	.	.	PUNCT
fnp-5643	302	1	150(5	150(5	NUM
fnp-5643	302	2	):	):	PUNCT
fnp-5643	303	1	p.	p.	NOUN
fnp-5643	303	2	467	467	NUM
fnp-5643	303	3	-	-	SYM
fnp-5643	303	4	474	474	NUM
fnp-5643	303	5	.	.	PUNCT
fnp-5643	304	1	doi	doi	NOUN
fnp-5643	304	2	:	:	PUNCT
fnp-5643	304	3	https://doi.org/10.1111/jnc.14698	https://doi.org/10.1111/jnc.14698	NOUN
fnp-5643	304	4	32	32	NUM
fnp-5643	304	5	.	.	PUNCT
fnp-5643	305	1	jellinger	jellinger	PROPN
fnp-5643	305	2	,	,	PUNCT
fnp-5643	305	3	k.a	k.a	PROPN
fnp-5643	305	4	.	.	PROPN
fnp-5643	305	5	and	and	CCONJ
fnp-5643	305	6	a.d	a.d	PROPN
fnp-5643	305	7	.	.	PROPN
fnp-5643	305	8	korczyn	korczyn	PROPN
fnp-5643	305	9	,	,	PUNCT
fnp-5643	305	10	are	be	AUX
fnp-5643	305	11	dementia	dementia	NOUN
fnp-5643	305	12	with	with	ADP
fnp-5643	305	13	lewy	lewy	PROPN
fnp-5643	305	14	bodies	body	NOUN
fnp-5643	305	15	and	and	CCONJ
fnp-5643	305	16	parkinson	parkinson	NOUN
fnp-5643	305	17	's	's	PART
fnp-5643	305	18	disease	disease	NOUN
fnp-5643	305	19	dementia	dementia	NOUN
fnp-5643	305	20	the	the	DET
fnp-5643	305	21	same	same	ADJ
fnp-5643	305	22	disease	disease	NOUN
fnp-5643	305	23	?	?	PUNCT
fnp-5643	306	1	bmc	bmc	PROPN
fnp-5643	306	2	med	med	ADJ
fnp-5643	306	3	,	,	PUNCT
fnp-5643	306	4	2018	2018	NUM
fnp-5643	306	5	.	.	PUNCT
fnp-5643	307	1	16(1	16(1	NUM
fnp-5643	307	2	):	):	PUNCT
fnp-5643	307	3	p.	p.	NOUN
fnp-5643	307	4	34	34	NUM
fnp-5643	307	5	.	.	PUNCT
fnp-5643	308	1	doi	doi	PROPN
fnp-5643	308	2	:	:	PUNCT
fnp-5643	308	3	https://doi.org/10.1186/s12916-018-1016-8	https://doi.org/10.1186/s12916-018-1016-8	NUM
fnp-5643	308	4	33	33	NUM
fnp-5643	308	5	.	.	PUNCT
fnp-5643	309	1	trojanowski	trojanowski	PROPN
fnp-5643	309	2	,	,	PUNCT
fnp-5643	309	3	j.q	j.q	PROPN
fnp-5643	309	4	.	.	PROPN
fnp-5643	309	5	,	,	PUNCT
fnp-5643	309	6	t.	t.	PROPN
fnp-5643	309	7	revesz	revesz	PROPN
fnp-5643	309	8	,	,	PUNCT
fnp-5643	309	9	and	and	CCONJ
fnp-5643	309	10	m.s.a	m.s.a	NOUN
fnp-5643	309	11	.	.	PUNCT
fnp-5643	309	12	neuropathology	neuropathology	NOUN
fnp-5643	309	13	working	working	PROPN
fnp-5643	309	14	group	group	NOUN
fnp-5643	309	15	on	on	ADP
fnp-5643	309	16	,	,	PUNCT
fnp-5643	309	17	proposed	propose	VERB
fnp-5643	309	18	neuropathological	neuropathological	ADJ
fnp-5643	309	19	criteria	criterion	NOUN
fnp-5643	309	20	for	for	ADP
fnp-5643	309	21	the	the	DET
fnp-5643	309	22	post	post	ADJ
fnp-5643	309	23	mortem	mortem	X
fnp-5643	309	24	diagnosis	diagnosis	NOUN
fnp-5643	309	25	of	of	ADP
fnp-5643	309	26	multiple	multiple	ADJ
fnp-5643	309	27	system	system	NOUN
fnp-5643	309	28	atrophy	atrophy	NOUN
fnp-5643	309	29	.	.	PUNCT
fnp-5643	310	1	neuropathol	neuropathol	PROPN
fnp-5643	310	2	appl	appl	PROPN
fnp-5643	310	3	neurobiol	neurobiol	PROPN
fnp-5643	310	4	,	,	PUNCT
fnp-5643	310	5	2007	2007	NUM
fnp-5643	310	6	.	.	PUNCT
fnp-5643	311	1	33(6	33(6	NUM
fnp-5643	311	2	):	):	PUNCT
fnp-5643	312	1	p.	p.	NOUN
fnp-5643	312	2	615	615	NUM
fnp-5643	312	3	-	-	SYM
fnp-5643	312	4	20	20	NUM
fnp-5643	312	5	.	.	PUNCT
fnp-5643	313	1	doi	doi	NOUN
fnp-5643	313	2	:	:	PUNCT
fnp-5643	313	3	https://doi.org/10.1111/j.1365-2990.2007.00907.x	https://doi.org/10.1111/j.1365-2990.2007.00907.x	NOUN
fnp-5643	313	4	34	34	NUM
fnp-5643	313	5	.	.	PUNCT
fnp-5643	314	1	cairns	cairns	PROPN
fnp-5643	314	2	,	,	PUNCT
fnp-5643	314	3	n.j	n.j	PROPN
fnp-5643	314	4	.	.	PROPN
fnp-5643	314	5	,	,	PUNCT
fnp-5643	314	6	et	et	PROPN
fnp-5643	314	7	al	al	PROPN
fnp-5643	314	8	.	.	PROPN
fnp-5643	314	9	,	,	PUNCT
fnp-5643	314	10	neuropathologic	neuropathologic	ADJ
fnp-5643	314	11	diagnostic	diagnostic	ADJ
fnp-5643	314	12	and	and	CCONJ
fnp-5643	314	13	nosologic	nosologic	ADJ
fnp-5643	314	14	criteria	criterion	NOUN
fnp-5643	314	15	for	for	ADP
fnp-5643	314	16	frontotemporal	frontotemporal	ADJ
fnp-5643	314	17	lobar	lobar	ADJ
fnp-5643	314	18	degeneration	degeneration	NOUN
fnp-5643	314	19	:	:	PUNCT
fnp-5643	314	20	consensus	consensus	NOUN
fnp-5643	314	21	of	of	ADP
fnp-5643	314	22	the	the	DET
fnp-5643	314	23	consortium	consortium	NOUN
fnp-5643	314	24	for	for	ADP
fnp-5643	314	25	frontotemporal	frontotemporal	ADJ
fnp-5643	314	26	lobar	lobar	ADJ
fnp-5643	314	27	degeneration	degeneration	NOUN
fnp-5643	314	28	.	.	PUNCT
fnp-5643	315	1	acta	acta	PROPN
fnp-5643	315	2	neuropathol	neuropathol	PROPN
fnp-5643	315	3	,	,	PUNCT
fnp-5643	315	4	2007	2007	NUM
fnp-5643	315	5	.	.	PUNCT
fnp-5643	316	1	114(1	114(1	NUM
fnp-5643	316	2	):	):	PUNCT
fnp-5643	316	3	p.	p.	NOUN
fnp-5643	316	4	5	5	NUM
fnp-5643	316	5	-	-	SYM
fnp-5643	316	6	22	22	NUM
fnp-5643	316	7	.	.	PUNCT
fnp-5643	317	1	doi	doi	NOUN
fnp-5643	317	2	:	:	PUNCT
fnp-5643	317	3	https://doi.org/10.1007/s00401-007-0237-2	https://doi.org/10.1007/s00401-007-0237-2	NUM
fnp-5643	317	4	35	35	NUM
fnp-5643	317	5	.	.	PUNCT
fnp-5643	318	1	pikkarainen	pikkarainen	NOUN
fnp-5643	318	2	,	,	PUNCT
fnp-5643	318	3	m.	m.	NOUN
fnp-5643	318	4	,	,	PUNCT
fnp-5643	318	5	p.	p.	PROPN
fnp-5643	318	6	hartikainen	hartikainen	PROPN
fnp-5643	318	7	,	,	PUNCT
fnp-5643	318	8	and	and	CCONJ
fnp-5643	318	9	i.	i.	PROPN
fnp-5643	318	10	alafuzoff	alafuzoff	PROPN
fnp-5643	318	11	,	,	PUNCT
fnp-5643	318	12	neuropathologic	neuropathologic	ADJ
fnp-5643	318	13	features	feature	NOUN
fnp-5643	318	14	of	of	ADP
fnp-5643	318	15	frontotemporal	frontotemporal	ADJ
fnp-5643	318	16	lobar	lobar	ADJ
fnp-5643	318	17	degeneration	degeneration	NOUN
fnp-5643	318	18	with	with	ADP
fnp-5643	318	19	ubiquitin	ubiquitin	ADJ
fnp-5643	318	20	-	-	PUNCT
fnp-5643	318	21	positive	positive	ADJ
fnp-5643	318	22	inclusions	inclusion	NOUN
fnp-5643	318	23	visualized	visualize	VERB
fnp-5643	318	24	with	with	ADP
fnp-5643	318	25	ubiquitin	ubiquitin	ADJ
fnp-5643	318	26	-	-	PUNCT
fnp-5643	318	27	binding	bind	VERB
fnp-5643	318	28	protein	protein	NOUN
fnp-5643	318	29	p62	p62	NOUN
fnp-5643	318	30	immunohistochemistry	immunohistochemistry	NOUN
fnp-5643	318	31	.	.	PUNCT
fnp-5643	319	1	j	j	PROPN
fnp-5643	319	2	neuropathol	neuropathol	PROPN
fnp-5643	319	3	exp	exp	PROPN
fnp-5643	319	4	neurol	neurol	PROPN
fnp-5643	319	5	,	,	PUNCT
fnp-5643	319	6	2008	2008	NUM
fnp-5643	319	7	.	.	PUNCT
fnp-5643	320	1	67(4	67(4	NUM
fnp-5643	320	2	):	):	PUNCT
fnp-5643	321	1	p.	p.	NOUN
fnp-5643	321	2	280	280	NUM
fnp-5643	321	3	-	-	SYM
fnp-5643	321	4	98	98	NUM
fnp-5643	321	5	.	.	PUNCT
fnp-5643	322	1	doi	doi	NOUN
fnp-5643	322	2	:	:	PUNCT
fnp-5643	322	3	https://doi.org/10.1097/nen.0b013e31816a1da2	https://doi.org/10.1097/nen.0b013e31816a1da2	PROPN
fnp-5643	322	4	36	36	NUM
fnp-5643	322	5	.	.	PUNCT
fnp-5643	323	1	thal	thal	PROPN
fnp-5643	323	2	,	,	PUNCT
fnp-5643	323	3	d.r	d.r	PROPN
fnp-5643	323	4	.	.	PROPN
fnp-5643	323	5	,	,	PUNCT
fnp-5643	323	6	et	et	PROPN
fnp-5643	323	7	al	al	PROPN
fnp-5643	323	8	.	.	PROPN
fnp-5643	323	9	,	,	PUNCT
fnp-5643	323	10	phases	phase	NOUN
fnp-5643	323	11	of	of	ADP
fnp-5643	323	12	a	a	DET
fnp-5643	323	13	beta	beta	NOUN
fnp-5643	323	14	-	-	PUNCT
fnp-5643	323	15	deposition	deposition	NOUN
fnp-5643	323	16	in	in	ADP
fnp-5643	323	17	the	the	DET
fnp-5643	323	18	human	human	ADJ
fnp-5643	323	19	brain	brain	NOUN
fnp-5643	323	20	and	and	CCONJ
fnp-5643	323	21	its	its	PRON
fnp-5643	323	22	relevance	relevance	NOUN
fnp-5643	323	23	for	for	ADP
fnp-5643	323	24	the	the	DET
fnp-5643	323	25	development	development	NOUN
fnp-5643	323	26	of	of	ADP
fnp-5643	323	27	ad	ad	NOUN
fnp-5643	323	28	.	.	PUNCT
fnp-5643	323	29	neurology	neurology	NOUN
fnp-5643	323	30	,	,	PUNCT
fnp-5643	323	31	2002	2002	NUM
fnp-5643	323	32	.	.	PUNCT
fnp-5643	324	1	58(12	58(12	NUM
fnp-5643	324	2	):	):	PUNCT
fnp-5643	324	3	p.	p.	NOUN
fnp-5643	324	4	1791	1791	NUM
fnp-5643	324	5	-	-	SYM
fnp-5643	324	6	800	800	NUM
fnp-5643	324	7	.	.	PUNCT
fnp-5643	325	1	doi	doi	NOUN
fnp-5643	325	2	:	:	PUNCT
fnp-5643	325	3	https://doi.org/10.1212/wnl.58.12.1791	https://doi.org/10.1212/wnl.58.12.1791	PROPN
fnp-5643	325	4	37	37	NUM
fnp-5643	325	5	.	.	PUNCT
fnp-5643	326	1	braak	braak	PROPN
fnp-5643	326	2	,	,	PUNCT
fnp-5643	326	3	h.	h.	PROPN
fnp-5643	326	4	,	,	PUNCT
fnp-5643	326	5	et	et	PROPN
fnp-5643	326	6	al	al	PROPN
fnp-5643	326	7	.	.	PROPN
fnp-5643	326	8	,	,	PUNCT
fnp-5643	326	9	staging	staging	NOUN
fnp-5643	326	10	of	of	ADP
fnp-5643	326	11	alzheimer	alzheimer	PROPN
fnp-5643	326	12	disease	disease	NOUN
fnp-5643	326	13	-	-	PUNCT
fnp-5643	326	14	associated	associate	VERB
fnp-5643	326	15	neurofibrillary	neurofibrillary	ADJ
fnp-5643	326	16	pathology	pathology	NOUN
fnp-5643	326	17	using	use	VERB
fnp-5643	326	18	paraffin	paraffin	NOUN
fnp-5643	326	19	sections	section	NOUN
fnp-5643	326	20	and	and	CCONJ
fnp-5643	326	21	immunocytochemistry	immunocytochemistry	NOUN
fnp-5643	326	22	.	.	PUNCT
fnp-5643	327	1	acta	acta	PROPN
fnp-5643	327	2	neuropathol	neuropathol	PROPN
fnp-5643	327	3	,	,	PUNCT
fnp-5643	327	4	2006	2006	NUM
fnp-5643	327	5	.	.	PUNCT
fnp-5643	328	1	112(4	112(4	NUM
fnp-5643	328	2	):	):	PUNCT
fnp-5643	329	1	p.	p.	NOUN
fnp-5643	329	2	389	389	NUM
fnp-5643	329	3	-	-	SYM
fnp-5643	329	4	404	404	NUM
fnp-5643	329	5	.	.	PUNCT
fnp-5643	330	1	doi	doi	NOUN
fnp-5643	330	2	:	:	PUNCT
fnp-5643	330	3	https://doi.org/10.1007/s00401-006-0127-z	https://doi.org/10.1007/s00401-006-0127-z	PROPN
fnp-5643	330	4	38	38	NUM
fnp-5643	330	5	.	.	PUNCT
fnp-5643	331	1	thal	thal	PROPN
fnp-5643	331	2	,	,	PUNCT
fnp-5643	331	3	d.r	d.r	PROPN
fnp-5643	331	4	.	.	PROPN
fnp-5643	331	5	,	,	PUNCT
fnp-5643	331	6	et	et	PROPN
fnp-5643	331	7	al	al	PROPN
fnp-5643	331	8	.	.	PROPN
fnp-5643	331	9	,	,	PUNCT
fnp-5643	331	10	two	two	NUM
fnp-5643	331	11	types	type	NOUN
fnp-5643	331	12	of	of	ADP
fnp-5643	331	13	sporadic	sporadic	ADJ
fnp-5643	331	14	cerebral	cerebral	ADJ
fnp-5643	331	15	amyloid	amyloid	NOUN
fnp-5643	331	16	angiopathy	angiopathy	NOUN
fnp-5643	331	17	.	.	PUNCT
fnp-5643	332	1	j	j	PROPN
fnp-5643	332	2	neuropathol	neuropathol	PROPN
fnp-5643	332	3	exp	exp	PROPN
fnp-5643	332	4	neurol	neurol	PROPN
fnp-5643	332	5	,	,	PUNCT
fnp-5643	332	6	2002	2002	NUM
fnp-5643	332	7	.	.	PUNCT
fnp-5643	333	1	61(3	61(3	NUM
fnp-5643	333	2	):	):	PUNCT
fnp-5643	334	1	p.	p.	NOUN
fnp-5643	334	2	282	282	NUM
fnp-5643	334	3	-	-	SYM
fnp-5643	334	4	93	93	NUM
fnp-5643	334	5	.	.	PUNCT
fnp-5643	335	1	doi	doi	NOUN
fnp-5643	335	2	:	:	PUNCT
fnp-5643	335	3	https://doi.org/10.1093/jnen/61.3.282	https://doi.org/10.1093/jnen/61.3.282	PROPN
fnp-5643	335	4	39	39	NUM
fnp-5643	335	5	.	.	PUNCT
fnp-5643	336	1	braak	braak	PROPN
fnp-5643	336	2	,	,	PUNCT
fnp-5643	336	3	h.	h.	PROPN
fnp-5643	336	4	,	,	PUNCT
fnp-5643	336	5	et	et	PROPN
fnp-5643	336	6	al	al	PROPN
fnp-5643	336	7	.	.	PROPN
fnp-5643	336	8	,	,	PUNCT
fnp-5643	336	9	staging	staging	NOUN
fnp-5643	336	10	of	of	ADP
fnp-5643	336	11	brain	brain	NOUN
fnp-5643	336	12	pathology	pathology	NOUN
fnp-5643	336	13	related	relate	VERB
fnp-5643	336	14	to	to	ADP
fnp-5643	336	15	sporadic	sporadic	ADJ
fnp-5643	336	16	parkinson	parkinson	NOUN
fnp-5643	336	17	's	's	PART
fnp-5643	336	18	disease	disease	NOUN
fnp-5643	336	19	.	.	PUNCT
fnp-5643	337	1	neurobiol	neurobiol	PROPN
fnp-5643	337	2	aging	aging	NOUN
fnp-5643	337	3	,	,	PUNCT
fnp-5643	337	4	2003	2003	NUM
fnp-5643	337	5	.	.	PUNCT
fnp-5643	338	1	24(2	24(2	NUM
fnp-5643	338	2	):	):	PUNCT
fnp-5643	338	3	p.	p.	NOUN
fnp-5643	338	4	197	197	NUM
fnp-5643	338	5	-	-	SYM
fnp-5643	338	6	211	211	NUM
fnp-5643	338	7	.	.	PUNCT
fnp-5643	339	1	doi	doi	NOUN
fnp-5643	339	2	:	:	PUNCT
fnp-5643	339	3	https://doi.org/10.1016/s0197-4580(02)00065-9	https://doi.org/10.1016/s0197-4580(02)00065-9	PROPN
fnp-5643	339	4	40	40	NUM
fnp-5643	339	5	.	.	PUNCT
fnp-5643	340	1	mckeith	mckeith	PROPN
fnp-5643	340	2	,	,	PUNCT
fnp-5643	340	3	i.g	i.g	PROPN
fnp-5643	340	4	.	.	PROPN
fnp-5643	340	5	,	,	PUNCT
fnp-5643	340	6	et	et	PROPN
fnp-5643	340	7	al	al	PROPN
fnp-5643	340	8	.	.	PROPN
fnp-5643	340	9	,	,	PUNCT
fnp-5643	340	10	diagnosis	diagnosis	NOUN
fnp-5643	340	11	and	and	CCONJ
fnp-5643	340	12	management	management	NOUN
fnp-5643	340	13	of	of	ADP
fnp-5643	340	14	dementia	dementia	NOUN
fnp-5643	340	15	with	with	ADP
fnp-5643	340	16	lewy	lewy	PROPN
fnp-5643	340	17	bodies	body	NOUN
fnp-5643	340	18	:	:	PUNCT
fnp-5643	340	19	fourth	fourth	ADJ
fnp-5643	340	20	consensus	consensus	NOUN
fnp-5643	340	21	report	report	NOUN
fnp-5643	340	22	of	of	ADP
fnp-5643	340	23	the	the	DET
fnp-5643	340	24	dlb	dlb	PROPN
fnp-5643	340	25	consortium	consortium	PROPN
fnp-5643	340	26	.	.	PUNCT
fnp-5643	341	1	neurology	neurology	NOUN
fnp-5643	341	2	,	,	PUNCT
fnp-5643	341	3	2017	2017	NUM
fnp-5643	341	4	.	.	PUNCT
fnp-5643	342	1	89(1	89(1	NUM
fnp-5643	342	2	):	):	PUNCT
fnp-5643	342	3	p.	p.	NOUN
fnp-5643	342	4	88	88	NUM
fnp-5643	342	5	-	-	SYM
fnp-5643	342	6	100	100	NUM
fnp-5643	342	7	.	.	PUNCT
fnp-5643	343	1	doi	doi	NOUN
fnp-5643	343	2	:	:	PUNCT
fnp-5643	343	3	https://doi.org/10.1212/wnl.0000000000004058	https://doi.org/10.1212/wnl.0000000000004058	PROPN
fnp-5643	343	4	41	41	NUM
fnp-5643	343	5	.	.	PUNCT
fnp-5643	344	1	armstrong	armstrong	PROPN
fnp-5643	344	2	,	,	PUNCT
fnp-5643	344	3	m.j	m.j	PROPN
fnp-5643	344	4	.	.	PROPN
fnp-5643	344	5	,	,	PUNCT
fnp-5643	344	6	et	et	PROPN
fnp-5643	344	7	al	al	PROPN
fnp-5643	344	8	.	.	PROPN
fnp-5643	344	9	,	,	PUNCT
fnp-5643	344	10	criteria	criterion	NOUN
fnp-5643	344	11	for	for	ADP
fnp-5643	344	12	the	the	DET
fnp-5643	344	13	diagnosis	diagnosis	NOUN
fnp-5643	344	14	of	of	ADP
fnp-5643	344	15	corticobasal	corticobasal	NOUN
fnp-5643	344	16	degeneration	degeneration	NOUN
fnp-5643	344	17	.	.	PUNCT
fnp-5643	345	1	neurology	neurology	NOUN
fnp-5643	345	2	,	,	PUNCT
fnp-5643	345	3	2013	2013	NUM
fnp-5643	345	4	.	.	PUNCT
fnp-5643	346	1	80(5	80(5	NUM
fnp-5643	346	2	):	):	PUNCT
fnp-5643	346	3	p.	p.	NOUN
fnp-5643	346	4	496	496	NUM
fnp-5643	346	5	-	-	SYM
fnp-5643	346	6	503	503	NUM
fnp-5643	346	7	.	.	PUNCT
fnp-5643	347	1	doi	doi	PROPN
fnp-5643	347	2	:	:	PUNCT
fnp-5643	347	3	https://doi.org/10.1212/wnl.0b013e31827f0fd1	https://doi.org/10.1212/wnl.0b013e31827f0fd1	NOUN
fnp-5643	347	4	42	42	NUM
fnp-5643	347	5	.	.	PUNCT
fnp-5643	348	1	mackenzie	mackenzie	PROPN
fnp-5643	348	2	,	,	PUNCT
fnp-5643	348	3	i.r	i.r	PROPN
fnp-5643	348	4	.	.	PROPN
fnp-5643	348	5	,	,	PUNCT
fnp-5643	348	6	et	et	PROPN
fnp-5643	348	7	al	al	PROPN
fnp-5643	348	8	.	.	PROPN
fnp-5643	348	9	,	,	PUNCT
fnp-5643	348	10	nomenclature	nomenclature	NOUN
fnp-5643	348	11	for	for	ADP
fnp-5643	348	12	neuropathologic	neuropathologic	ADJ
fnp-5643	348	13	subtypes	subtype	NOUN
fnp-5643	348	14	of	of	ADP
fnp-5643	348	15	frontotemporal	frontotemporal	ADJ
fnp-5643	348	16	lobar	lobar	ADJ
fnp-5643	348	17	degeneration	degeneration	NOUN
fnp-5643	348	18	:	:	PUNCT
fnp-5643	348	19	consensus	consensus	NOUN
fnp-5643	348	20	recommendations	recommendation	NOUN
fnp-5643	348	21	.	.	PUNCT
fnp-5643	349	1	acta	acta	PROPN
fnp-5643	349	2	neuropathol	neuropathol	PROPN
fnp-5643	349	3	,	,	PUNCT
fnp-5643	349	4	2009	2009	NUM
fnp-5643	349	5	.	.	PUNCT
fnp-5643	350	1	117(1	117(1	NUM
fnp-5643	350	2	):	):	PUNCT
fnp-5643	350	3	p.	p.	NOUN
fnp-5643	350	4	15	15	NUM
fnp-5643	350	5	-	-	SYM
fnp-5643	350	6	8	8	NUM
fnp-5643	350	7	.	.	PUNCT
fnp-5643	350	8	doi	doi	NOUN
fnp-5643	350	9	:	:	PUNCT
fnp-5643	350	10	https://doi.org/10.1007/s00401-008-0460-5	https://doi.org/10.1007/s00401-008-0460-5	NUM
fnp-5643	350	11	43	43	NUM
fnp-5643	350	12	.	.	PUNCT
fnp-5643	351	1	landis	landis	PROPN
fnp-5643	351	2	,	,	PUNCT
fnp-5643	351	3	j.r	j.r	PROPN
fnp-5643	351	4	.	.	PROPN
fnp-5643	351	5	and	and	CCONJ
fnp-5643	351	6	g.g	g.g	PROPN
fnp-5643	351	7	.	.	PROPN
fnp-5643	351	8	koch	koch	PROPN
fnp-5643	351	9	,	,	PUNCT
fnp-5643	351	10	the	the	DET
fnp-5643	351	11	measurement	measurement	NOUN
fnp-5643	351	12	of	of	ADP
fnp-5643	351	13	observer	observer	NOUN
fnp-5643	351	14	agreement	agreement	NOUN
fnp-5643	351	15	for	for	ADP
fnp-5643	351	16	categorical	categorical	ADJ
fnp-5643	351	17	data	datum	NOUN
fnp-5643	351	18	.	.	PUNCT
fnp-5643	352	1	biometrics	biometric	NOUN
fnp-5643	352	2	,	,	PUNCT
fnp-5643	352	3	1977	1977	NUM
fnp-5643	352	4	.	.	PUNCT
fnp-5643	353	1	33(1	33(1	NUM
fnp-5643	353	2	):	):	PUNCT
fnp-5643	353	3	p.	p.	NOUN
fnp-5643	353	4	159	159	NUM
fnp-5643	353	5	-	-	SYM
fnp-5643	353	6	74	74	NUM
fnp-5643	353	7	44	44	NUM
fnp-5643	353	8	.	.	PUNCT
fnp-5643	354	1	mann	mann	PROPN
fnp-5643	354	2	,	,	PUNCT
fnp-5643	354	3	d.m	d.m	PROPN
fnp-5643	354	4	.	.	PROPN
fnp-5643	354	5	,	,	PUNCT
fnp-5643	354	6	et	et	PROPN
fnp-5643	354	7	al	al	PROPN
fnp-5643	354	8	.	.	PROPN
fnp-5643	354	9	,	,	PUNCT
fnp-5643	354	10	dipeptide	dipeptide	NOUN
fnp-5643	354	11	repeat	repeat	NOUN
fnp-5643	354	12	proteins	protein	NOUN
fnp-5643	354	13	are	be	AUX
fnp-5643	354	14	present	present	ADJ
fnp-5643	354	15	in	in	ADP
fnp-5643	354	16	the	the	DET
fnp-5643	354	17	p62	p62	NOUN
fnp-5643	354	18	positive	positive	ADJ
fnp-5643	354	19	inclusions	inclusion	NOUN
fnp-5643	354	20	in	in	ADP
fnp-5643	354	21	patients	patient	NOUN
fnp-5643	354	22	with	with	ADP
fnp-5643	354	23	frontotemporal	frontotemporal	ADJ
fnp-5643	354	24	lobar	lobar	ADJ
fnp-5643	354	25	degeneration	degeneration	NOUN
fnp-5643	354	26	and	and	CCONJ
fnp-5643	354	27	motor	motor	NOUN
fnp-5643	354	28	neurone	neurone	NOUN
fnp-5643	354	29	disease	disease	NOUN
fnp-5643	354	30	associated	associate	VERB
fnp-5643	354	31	with	with	ADP
fnp-5643	354	32	expansions	expansion	NOUN
fnp-5643	354	33	in	in	ADP
fnp-5643	354	34	c9orf72	c9orf72	PROPN
fnp-5643	354	35	.	.	PUNCT
fnp-5643	355	1	acta	acta	PROPN
fnp-5643	355	2	neuropathol	neuropathol	PROPN
fnp-5643	355	3	commun	commun	PROPN
fnp-5643	355	4	,	,	PUNCT
fnp-5643	355	5	2013	2013	NUM
fnp-5643	355	6	.	.	PUNCT
fnp-5643	356	1	1	1	NUM
fnp-5643	356	2	:	:	PUNCT
fnp-5643	356	3	p.	p.	NOUN
fnp-5643	356	4	68	68	NUM
fnp-5643	356	5	.	.	PUNCT
fnp-5643	357	1	doi	doi	NOUN
fnp-5643	357	2	:	:	PUNCT
fnp-5643	357	3	https://doi.org/10.1186/2051-5960-1-68	https://doi.org/10.1186/2051-5960-1-68	ADV
fnp-5643	357	4	45	45	NUM
fnp-5643	357	5	.	.	PUNCT
fnp-5643	358	1	mckeith	mckeith	PROPN
fnp-5643	358	2	,	,	PUNCT
fnp-5643	358	3	i.g	i.g	PROPN
fnp-5643	358	4	.	.	PROPN
fnp-5643	358	5	,	,	PUNCT
fnp-5643	358	6	et	et	PROPN
fnp-5643	358	7	al	al	PROPN
fnp-5643	358	8	.	.	PROPN
fnp-5643	358	9	,	,	PUNCT
fnp-5643	358	10	diagnosis	diagnosis	NOUN
fnp-5643	358	11	and	and	CCONJ
fnp-5643	358	12	management	management	NOUN
fnp-5643	358	13	of	of	ADP
fnp-5643	358	14	dementia	dementia	NOUN
fnp-5643	358	15	with	with	ADP
fnp-5643	358	16	lewy	lewy	PROPN
fnp-5643	358	17	bodies	body	NOUN
fnp-5643	358	18	:	:	PUNCT
fnp-5643	358	19	third	third	ADJ
fnp-5643	358	20	report	report	NOUN
fnp-5643	358	21	of	of	ADP
fnp-5643	358	22	the	the	DET
fnp-5643	358	23	dlb	dlb	PROPN
fnp-5643	358	24	consortium	consortium	PROPN
fnp-5643	358	25	.	.	PUNCT
fnp-5643	359	1	neurology	neurology	NOUN
fnp-5643	359	2	,	,	PUNCT
fnp-5643	359	3	2005	2005	NUM
fnp-5643	359	4	.	.	PUNCT
fnp-5643	360	1	65(12	65(12	NUM
fnp-5643	360	2	):	):	PUNCT
fnp-5643	360	3	p.	p.	NOUN
fnp-5643	360	4	1863	1863	NUM
fnp-5643	360	5	-	-	SYM
fnp-5643	360	6	72	72	NUM
fnp-5643	360	7	.	.	PUNCT
fnp-5643	361	1	doi	doi	NOUN
fnp-5643	361	2	:	:	PUNCT
fnp-5643	361	3	https://doi.org/10.1212/01.wnl.0000187889.17253.b1	https://doi.org/10.1212/01.wnl.0000187889.17253.b1	PROPN
fnp-5643	361	4	46	46	NUM
fnp-5643	361	5	.	.	PUNCT
fnp-5643	361	6	beach	beach	PROPN
fnp-5643	361	7	,	,	PUNCT
fnp-5643	361	8	t.g	t.g	PROPN
fnp-5643	361	9	.	.	PROPN
fnp-5643	361	10	,	,	PUNCT
fnp-5643	361	11	et	et	PROPN
fnp-5643	361	12	al	al	PROPN
fnp-5643	361	13	.	.	PROPN
fnp-5643	361	14	,	,	PUNCT
fnp-5643	361	15	unified	unified	ADJ
fnp-5643	361	16	staging	staging	NOUN
fnp-5643	361	17	system	system	NOUN
fnp-5643	361	18	for	for	ADP
fnp-5643	361	19	lewy	lewy	ADJ
fnp-5643	361	20	body	body	NOUN
fnp-5643	361	21	disorders	disorder	NOUN
fnp-5643	361	22	:	:	PUNCT
fnp-5643	361	23	correlation	correlation	NOUN
fnp-5643	361	24	with	with	ADP
fnp-5643	361	25	nigrostriatal	nigrostriatal	ADJ
fnp-5643	361	26	degeneration	degeneration	NOUN
fnp-5643	361	27	,	,	PUNCT
fnp-5643	361	28	cognitive	cognitive	ADJ
fnp-5643	361	29	impairment	impairment	NOUN
fnp-5643	361	30	and	and	CCONJ
fnp-5643	361	31	motor	motor	NOUN
fnp-5643	361	32	dysfunction	dysfunction	NOUN
fnp-5643	361	33	.	.	PUNCT
fnp-5643	362	1	acta	acta	PROPN
fnp-5643	362	2	neuropathol	neuropathol	PROPN
fnp-5643	362	3	,	,	PUNCT
fnp-5643	362	4	2009	2009	NUM
fnp-5643	362	5	.	.	PUNCT
fnp-5643	363	1	117(6	117(6	NUM
fnp-5643	363	2	):	):	PUNCT
fnp-5643	364	1	p.	p.	NOUN
fnp-5643	364	2	613	613	NUM
fnp-5643	364	3	-	-	SYM
fnp-5643	364	4	34	34	NUM
fnp-5643	364	5	.	.	PUNCT
fnp-5643	365	1	doi	doi	PROPN
fnp-5643	365	2	:	:	PUNCT
fnp-5643	365	3	https://doi.org/10.1007/s00401-009-0538-8	https://doi.org/10.1007/s00401-009-0538-8	NUM
fnp-5643	365	4	47	47	NUM
fnp-5643	365	5	.	.	PUNCT
fnp-5643	366	1	kovacs	kovacs	PROPN
fnp-5643	366	2	,	,	PUNCT
fnp-5643	366	3	g.g	g.g	PROPN
fnp-5643	366	4	.	.	PROPN
fnp-5643	366	5	,	,	PUNCT
fnp-5643	366	6	et	et	PROPN
fnp-5643	366	7	al	al	PROPN
fnp-5643	366	8	.	.	PROPN
fnp-5643	366	9	,	,	PUNCT
fnp-5643	366	10	sequential	sequential	ADJ
fnp-5643	366	11	stages	stage	NOUN
fnp-5643	366	12	and	and	CCONJ
fnp-5643	366	13	distribution	distribution	NOUN
fnp-5643	366	14	patterns	pattern	NOUN
fnp-5643	366	15	of	of	ADP
fnp-5643	366	16	aging	age	VERB
fnp-5643	366	17	-	-	PUNCT
fnp-5643	366	18	related	relate	VERB
fnp-5643	366	19	tau	tau	PROPN
fnp-5643	366	20	astrogliopathy	astrogliopathy	ADJ
fnp-5643	366	21	(	(	PUNCT
fnp-5643	366	22	artag	artag	ADJ
fnp-5643	366	23	)	)	PUNCT
fnp-5643	366	24	in	in	ADP
fnp-5643	366	25	the	the	DET
fnp-5643	366	26	human	human	ADJ
fnp-5643	366	27	brain	brain	NOUN
fnp-5643	366	28	.	.	PUNCT
fnp-5643	367	1	acta	acta	PROPN
fnp-5643	367	2	neuropathol	neuropathol	PROPN
fnp-5643	367	3	commun	commun	PROPN
fnp-5643	367	4	,	,	PUNCT
fnp-5643	367	5	2018	2018	NUM
fnp-5643	367	6	.	.	PUNCT
fnp-5643	368	1	6(1	6(1	NUM
fnp-5643	368	2	):	):	PUNCT
fnp-5643	369	1	p.	p.	NOUN
fnp-5643	369	2	50	50	NUM
fnp-5643	369	3	.	.	PUNCT
fnp-5643	370	1	doi	doi	NOUN
fnp-5643	370	2	:	:	PUNCT
fnp-5643	370	3	https://doi.org/10.1186/s40478-018-0552-y	https://doi.org/10.1186/s40478-018-0552-y	PROPN
fnp-5643	370	4	48	48	NUM
fnp-5643	370	5	.	.	PUNCT
fnp-5643	371	1	ferrer	ferrer	PROPN
fnp-5643	371	2	,	,	PUNCT
fnp-5643	371	3	i.	i.	PROPN
fnp-5643	371	4	,	,	PUNCT
fnp-5643	371	5	g.	g.	PROPN
fnp-5643	371	6	santpere	santpere	ADV
fnp-5643	371	7	,	,	PUNCT
fnp-5643	371	8	and	and	CCONJ
fnp-5643	371	9	f.w	f.w	PROPN
fnp-5643	371	10	.	.	PROPN
fnp-5643	371	11	van	van	PROPN
fnp-5643	371	12	leeuwen	leeuwen	PROPN
fnp-5643	371	13	,	,	PUNCT
fnp-5643	371	14	argyrophilic	argyrophilic	ADJ
fnp-5643	371	15	grain	grain	NOUN
fnp-5643	371	16	disease	disease	NOUN
fnp-5643	371	17	.	.	PUNCT
fnp-5643	372	1	brain	brain	NOUN
fnp-5643	372	2	,	,	PUNCT
fnp-5643	372	3	2008	2008	NUM
fnp-5643	372	4	.	.	PUNCT
fnp-5643	373	1	131(6	131(6	NUM
fnp-5643	373	2	):	):	PUNCT
fnp-5643	373	3	p.	p.	NOUN
fnp-5643	373	4	1416	1416	NUM
fnp-5643	373	5	-	-	SYM
fnp-5643	373	6	1432	1432	NUM
fnp-5643	373	7	.	.	PUNCT
fnp-5643	374	1	doi	doi	NOUN
fnp-5643	374	2	:	:	PUNCT
fnp-5643	374	3	https://doi.org/10.1093/brain/awm305	https://doi.org/10.1093/brain/awm305	NOUN
fnp-5643	374	4	49	49	NUM
fnp-5643	374	5	.	.	PUNCT
fnp-5643	375	1	crary	crary	PROPN
fnp-5643	375	2	,	,	PUNCT
fnp-5643	375	3	j.f	j.f	PROPN
fnp-5643	375	4	.	.	PROPN
fnp-5643	375	5	,	,	PUNCT
fnp-5643	375	6	et	et	PROPN
fnp-5643	375	7	al	al	PROPN
fnp-5643	375	8	.	.	PROPN
fnp-5643	375	9	,	,	PUNCT
fnp-5643	375	10	primary	primary	ADJ
fnp-5643	375	11	age	age	NOUN
fnp-5643	375	12	-	-	PUNCT
fnp-5643	375	13	related	relate	VERB
fnp-5643	375	14	tauopathy	tauopathy	NOUN
fnp-5643	375	15	(	(	PUNCT
fnp-5643	375	16	part	part	NOUN
fnp-5643	375	17	):	):	PUNCT
fnp-5643	375	18	a	a	DET
fnp-5643	375	19	common	common	ADJ
fnp-5643	375	20	pathology	pathology	NOUN
fnp-5643	375	21	associated	associate	VERB
fnp-5643	375	22	with	with	ADP
fnp-5643	375	23	human	human	ADJ
fnp-5643	375	24	aging	aging	NOUN
fnp-5643	375	25	.	.	PUNCT
fnp-5643	376	1	acta	acta	PROPN
fnp-5643	376	2	neuropathol	neuropathol	PROPN
fnp-5643	376	3	,	,	PUNCT
fnp-5643	376	4	2014	2014	NUM
fnp-5643	376	5	.	.	PUNCT
fnp-5643	377	1	128(6	128(6	NUM
fnp-5643	377	2	):	):	PUNCT
fnp-5643	378	1	p.	p.	NOUN
fnp-5643	378	2	755	755	NUM
fnp-5643	378	3	-	-	SYM
fnp-5643	378	4	66	66	NUM
fnp-5643	378	5	.	.	PUNCT
fnp-5643	379	1	doi	doi	NOUN
fnp-5643	379	2	:	:	PUNCT
fnp-5643	379	3	https://doi.org/10.1007/s00401-014-1349-0	https://doi.org/10.1007/s00401-014-1349-0	NUM
fnp-5643	379	4	50	50	NUM
fnp-5643	379	5	.	.	PUNCT
fnp-5643	380	1	nelson	nelson	PROPN
fnp-5643	380	2	,	,	PUNCT
fnp-5643	380	3	p.t	p.t	PROPN
fnp-5643	380	4	.	.	PROPN
fnp-5643	380	5	,	,	PUNCT
fnp-5643	380	6	et	et	PROPN
fnp-5643	380	7	al	al	PROPN
fnp-5643	380	8	.	.	PROPN
fnp-5643	380	9	,	,	PUNCT
fnp-5643	380	10	late	late	PROPN
fnp-5643	380	11	-	-	PUNCT
fnp-5643	380	12	nc	nc	NOUN
fnp-5643	380	13	staging	staging	NOUN
fnp-5643	380	14	in	in	ADP
fnp-5643	380	15	routine	routine	ADJ
fnp-5643	380	16	neuropathologic	neuropathologic	ADJ
fnp-5643	380	17	diagnosis	diagnosis	NOUN
fnp-5643	380	18	:	:	PUNCT
fnp-5643	380	19	an	an	DET
fnp-5643	380	20	update	update	NOUN
fnp-5643	380	21	.	.	PUNCT
fnp-5643	381	1	acta	acta	PROPN
fnp-5643	381	2	neuropathol	neuropathol	PROPN
fnp-5643	381	3	,	,	PUNCT
fnp-5643	381	4	2023	2023	NUM
fnp-5643	381	5	.	.	PUNCT
fnp-5643	382	1	145(2	145(2	NUM
fnp-5643	382	2	):	):	PUNCT
fnp-5643	382	3	p.	p.	NOUN
fnp-5643	382	4	159	159	NUM
fnp-5643	382	5	-	-	SYM
fnp-5643	382	6	173	173	NUM
fnp-5643	382	7	.	.	PUNCT
fnp-5643	383	1	doi	doi	NOUN
fnp-5643	383	2	:	:	PUNCT
fnp-5643	383	3	https://doi.org/10.1007/s00401-022-02524-2	https://doi.org/10.1007/s00401-022-02524-2	NUM
fnp-5643	383	4	51	51	NUM
fnp-5643	383	5	.	.	PUNCT
fnp-5643	384	1	josephs	josephs	PROPN
fnp-5643	384	2	,	,	PUNCT
fnp-5643	384	3	k.a	k.a	PROPN
fnp-5643	384	4	.	.	PROPN
fnp-5643	384	5	,	,	PUNCT
fnp-5643	384	6	et	et	PROPN
fnp-5643	384	7	al	al	PROPN
fnp-5643	384	8	.	.	PROPN
fnp-5643	384	9	,	,	PUNCT
fnp-5643	384	10	updated	update	VERB
fnp-5643	384	11	tdp-43	tdp-43	PROPN
fnp-5643	384	12	in	in	ADP
fnp-5643	384	13	alzheimer	alzheimer	PROPN
fnp-5643	384	14	's	's	PART
fnp-5643	384	15	disease	disease	NOUN
fnp-5643	384	16	staging	staging	NOUN
fnp-5643	384	17	scheme	scheme	NOUN
fnp-5643	384	18	.	.	PUNCT
fnp-5643	385	1	acta	acta	PROPN
fnp-5643	385	2	neuropathol	neuropathol	PROPN
fnp-5643	385	3	,	,	PUNCT
fnp-5643	385	4	2016	2016	NUM
fnp-5643	385	5	.	.	PUNCT
fnp-5643	386	1	131(4	131(4	NUM
fnp-5643	386	2	):	):	PUNCT
fnp-5643	386	3	p.	p.	NOUN
fnp-5643	386	4	571	571	NUM
fnp-5643	386	5	-	-	SYM
fnp-5643	386	6	85	85	NUM
fnp-5643	386	7	.	.	PUNCT
fnp-5643	387	1	doi	doi	NOUN
fnp-5643	387	2	:	:	PUNCT
fnp-5643	387	3	https://doi.org/10.1007/s00401-016-1537-1	https://doi.org/10.1007/s00401-016-1537-1	NUM
fnp-5643	387	4	52	52	NUM
fnp-5643	387	5	.	.	PUNCT
fnp-5643	388	1	watson	watson	PROPN
fnp-5643	388	2	,	,	PUNCT
fnp-5643	388	3	n.	n.	PROPN
fnp-5643	388	4	,	,	PUNCT
fnp-5643	388	5	et	et	PROPN
fnp-5643	388	6	al	al	PROPN
fnp-5643	388	7	.	.	PROPN
fnp-5643	388	8	,	,	PUNCT
fnp-5643	388	9	validation	validation	NOUN
fnp-5643	388	10	of	of	ADP
fnp-5643	388	11	revised	revise	VERB
fnp-5643	388	12	international	international	ADJ
fnp-5643	388	13	creutzfeldt	creutzfeldt	ADJ
fnp-5643	388	14	-	-	PUNCT
fnp-5643	388	15	jakob	jakob	ADJ
fnp-5643	388	16	disease	disease	PROPN
fnp-5643	388	17	surveillance	surveillance	NOUN
fnp-5643	388	18	network	network	NOUN
fnp-5643	388	19	diagnostic	diagnostic	ADJ
fnp-5643	388	20	criteria	criterion	NOUN
fnp-5643	388	21	for	for	ADP
fnp-5643	388	22	sporadic	sporadic	ADJ
fnp-5643	388	23	creutzfeldt	creutzfeldt	ADJ
fnp-5643	388	24	-	-	PUNCT
fnp-5643	388	25	jakob	jakob	ADJ
fnp-5643	388	26	disease	disease	NOUN
fnp-5643	388	27	.	.	PUNCT
fnp-5643	389	1	jama	jama	PROPN
fnp-5643	389	2	netw	netw	PROPN
fnp-5643	389	3	open	open	ADJ
fnp-5643	389	4	,	,	PUNCT
fnp-5643	389	5	2022	2022	NUM
fnp-5643	389	6	.	.	PUNCT
fnp-5643	390	1	5(1	5(1	NUM
fnp-5643	390	2	):	):	PUNCT
fnp-5643	390	3	p.	p.	PROPN
fnp-5643	390	4	e2146319	e2146319	PROPN
fnp-5643	390	5	.	.	PUNCT
fnp-5643	391	1	doi	doi	PROPN
fnp-5643	391	2	:	:	PUNCT
fnp-5643	391	3	https://doi.org/10.1001/jamanetworkopen.2021.46319	https://doi.org/10.1001/jamanetworkopen.2021.46319	PROPN
fnp-5643	391	4	53	53	NUM
fnp-5643	391	5	.	.	PUNCT
fnp-5643	392	1	mastrangelo	mastrangelo	PROPN
fnp-5643	392	2	,	,	PUNCT
fnp-5643	392	3	a.	a.	NOUN
fnp-5643	392	4	,	,	PUNCT
fnp-5643	392	5	et	et	PROPN
fnp-5643	392	6	al	al	PROPN
fnp-5643	392	7	.	.	PROPN
fnp-5643	392	8	,	,	PUNCT
fnp-5643	392	9	evaluation	evaluation	NOUN
fnp-5643	392	10	of	of	ADP
fnp-5643	392	11	the	the	DET
fnp-5643	392	12	impact	impact	NOUN
fnp-5643	392	13	of	of	ADP
fnp-5643	392	14	csf	csf	ADJ
fnp-5643	392	15	prion	prion	NOUN
fnp-5643	392	16	rt	rt	PROPN
fnp-5643	392	17	-	-	PUNCT
fnp-5643	392	18	quic	quic	PROPN
fnp-5643	392	19	and	and	CCONJ
fnp-5643	392	20	amended	amend	VERB
fnp-5643	392	21	criteria	criterion	NOUN
fnp-5643	392	22	on	on	ADP
fnp-5643	392	23	the	the	DET
fnp-5643	392	24	clinical	clinical	ADJ
fnp-5643	392	25	diagnosis	diagnosis	NOUN
fnp-5643	392	26	of	of	ADP
fnp-5643	392	27	creutzfeldt	creutzfeldt	ADJ
fnp-5643	392	28	-	-	PUNCT
fnp-5643	392	29	jakob	jakob	ADJ
fnp-5643	392	30	disease	disease	PROPN
fnp-5643	392	31	:	:	PUNCT
fnp-5643	392	32	a	a	DET
fnp-5643	392	33	10	10	NUM
fnp-5643	392	34	-	-	PUNCT
fnp-5643	392	35	year	year	NOUN
fnp-5643	392	36	study	study	NOUN
fnp-5643	392	37	in	in	ADP
fnp-5643	392	38	italy	italy	PROPN
fnp-5643	392	39	.	.	PUNCT
fnp-5643	393	1	j	j	PROPN
fnp-5643	393	2	neurol	neurol	PROPN
fnp-5643	393	3	neurosurg	neurosurg	PROPN
fnp-5643	393	4	psychiatry	psychiatry	PROPN
fnp-5643	393	5	,	,	PUNCT
fnp-5643	393	6	2023	2023	NUM
fnp-5643	393	7	.	.	PUNCT
fnp-5643	394	1	94(2	94(2	NUM
fnp-5643	394	2	):	):	PUNCT
fnp-5643	395	1	p.	p.	NOUN
fnp-5643	395	2	121	121	NUM
fnp-5643	395	3	-	-	SYM
fnp-5643	395	4	129	129	NUM
fnp-5643	395	5	.	.	PUNCT
fnp-5643	396	1	doi	doi	NOUN
fnp-5643	396	2	:	:	PUNCT
fnp-5643	396	3	https://doi.org/10.1136/jnnp-2022-330153	https://doi.org/10.1136/jnnp-2022-330153	PROPN
fnp-5643	396	4	54	54	NUM
fnp-5643	396	5	.	.	PUNCT
fnp-5643	397	1	bsoul	bsoul	PROPN
fnp-5643	397	2	,	,	PUNCT
fnp-5643	397	3	r.	r.	PROPN
fnp-5643	397	4	,	,	PUNCT
fnp-5643	397	5	et	et	PROPN
fnp-5643	397	6	al	al	PROPN
fnp-5643	397	7	.	.	PROPN
fnp-5643	397	8	,	,	PUNCT
fnp-5643	397	9	improved	improve	VERB
fnp-5643	397	10	real	real	ADJ
fnp-5643	397	11	-	-	PUNCT
fnp-5643	397	12	time	time	NOUN
fnp-5643	397	13	quaking	quake	VERB
fnp-5643	397	14	induced	induced	ADJ
fnp-5643	397	15	conversion	conversion	NOUN
fnp-5643	397	16	for	for	ADP
fnp-5643	397	17	early	early	ADJ
fnp-5643	397	18	diagnostics	diagnostic	NOUN
fnp-5643	397	19	of	of	ADP
fnp-5643	397	20	creutzfeldt	creutzfeldt	ADJ
fnp-5643	397	21	-	-	ADJ
fnp-5643	397	22	jakob	jakob	ADJ
fnp-5643	397	23	disease	disease	NOUN
fnp-5643	397	24	in	in	ADP
fnp-5643	397	25	denmark	denmark	NOUN
fnp-5643	397	26	.	.	PUNCT
fnp-5643	398	1	int	int	PROPN
fnp-5643	398	2	j	j	PROPN
fnp-5643	398	3	mol	mol	ADP
fnp-5643	398	4	sci	sci	PROPN
fnp-5643	398	5	,	,	PUNCT
fnp-5643	398	6	2023	2023	NUM
fnp-5643	398	7	.	.	PUNCT
fnp-5643	398	8	24(7	24(7	NUM
fnp-5643	398	9	)	)	PUNCT
fnp-5643	398	10	.	.	PUNCT
fnp-5643	399	1	doi	doi	NOUN
fnp-5643	399	2	:	:	PUNCT
fnp-5643	399	3	https://doi.org/10.3390/ijms24076098	https://doi.org/10.3390/ijms24076098	PROPN
fnp-5643	399	4	55	55	NUM
fnp-5643	399	5	.	.	PUNCT
fnp-5643	400	1	hermann	hermann	PROPN
fnp-5643	400	2	,	,	PUNCT
fnp-5643	400	3	p.	p.	PROPN
fnp-5643	400	4	,	,	PUNCT
fnp-5643	400	5	et	et	PROPN
fnp-5643	400	6	al	al	PROPN
fnp-5643	400	7	.	.	PROPN
fnp-5643	400	8	,	,	PUNCT
fnp-5643	400	9	application	application	NOUN
fnp-5643	400	10	of	of	ADP
fnp-5643	400	11	real	real	ADJ
fnp-5643	400	12	-	-	PUNCT
fnp-5643	400	13	time	time	NOUN
fnp-5643	400	14	quaking	quake	VERB
fnp-5643	400	15	-	-	PUNCT
fnp-5643	400	16	induced	induce	VERB
fnp-5643	400	17	conversion	conversion	NOUN
fnp-5643	400	18	in	in	ADP
fnp-5643	400	19	creutzfeldt	creutzfeldt	ADJ
fnp-5643	400	20	-	-	ADJ
fnp-5643	400	21	jakob	jakob	ADJ
fnp-5643	400	22	disease	disease	NOUN
fnp-5643	400	23	surveillance	surveillance	NOUN
fnp-5643	400	24	.	.	PUNCT
fnp-5643	401	1	j	j	PROPN
fnp-5643	401	2	neurol	neurol	NOUN
fnp-5643	401	3	,	,	PUNCT
fnp-5643	401	4	2023	2023	NUM
fnp-5643	401	5	.	.	PUNCT
fnp-5643	402	1	270(4	270(4	NUM
fnp-5643	402	2	):	):	PUNCT
fnp-5643	402	3	p.	p.	NOUN
fnp-5643	402	4	2149	2149	NUM
fnp-5643	402	5	-	-	SYM
fnp-5643	402	6	2161	2161	NUM
fnp-5643	402	7	.	.	PUNCT
fnp-5643	403	1	doi	doi	NOUN
fnp-5643	403	2	:	:	PUNCT
fnp-5643	403	3	https://doi.org/10.1007/s00415-022-11549-2	https://doi.org/10.1007/s00415-022-11549-2	NUM
fnp-5643	403	4	56	56	NUM
fnp-5643	403	5	.	.	PUNCT
fnp-5643	404	1	ng	ng	PROPN
fnp-5643	404	2	,	,	PUNCT
fnp-5643	404	3	d.	d.	PROPN
fnp-5643	404	4	,	,	PUNCT
fnp-5643	404	5	et	et	PROPN
fnp-5643	404	6	al	al	PROPN
fnp-5643	404	7	.	.	PROPN
fnp-5643	404	8	,	,	PUNCT
fnp-5643	404	9	characterisation	characterisation	NOUN
fnp-5643	404	10	of	of	ADP
fnp-5643	404	11	rt	rt	NOUN
fnp-5643	404	12	-	-	PUNCT
fnp-5643	404	13	quic	quic	NOUN
fnp-5643	404	14	negative	negative	ADJ
fnp-5643	404	15	cases	case	NOUN
fnp-5643	404	16	from	from	ADP
fnp-5643	404	17	the	the	DET
fnp-5643	404	18	uk	uk	PROPN
fnp-5643	404	19	national	national	PROPN
fnp-5643	404	20	cjd	cjd	PROPN
fnp-5643	404	21	research	research	PROPN
fnp-5643	404	22	and	and	CCONJ
fnp-5643	404	23	surveillance	surveillance	NOUN
fnp-5643	404	24	programme	programme	NOUN
fnp-5643	404	25	.	.	PUNCT
fnp-5643	405	1	j	j	PROPN
fnp-5643	405	2	neurol	neurol	NOUN
fnp-5643	405	3	,	,	PUNCT
fnp-5643	405	4	2024	2024	NUM
fnp-5643	405	5	.	.	PUNCT
fnp-5643	406	1	doi	doi	NOUN
fnp-5643	406	2	:	:	PUNCT
fnp-5643	406	3	https://doi.org/10.1007/s00415-024-12345-w	https://doi.org/10.1007/s00415-024-12345-w	ADP
fnp-5643	406	4	57	57	NUM
fnp-5643	406	5	.	.	PUNCT
fnp-5643	407	1	hermann	hermann	PROPN
fnp-5643	407	2	,	,	PUNCT
fnp-5643	407	3	p.	p.	PROPN
fnp-5643	407	4	,	,	PUNCT
fnp-5643	407	5	et	et	PROPN
fnp-5643	407	6	al	al	PROPN
fnp-5643	407	7	.	.	PROPN
fnp-5643	407	8	,	,	PUNCT
fnp-5643	407	9	validation	validation	NOUN
fnp-5643	407	10	and	and	CCONJ
fnp-5643	407	11	utilization	utilization	NOUN
fnp-5643	407	12	of	of	ADP
fnp-5643	407	13	amended	amend	VERB
fnp-5643	407	14	diagnostic	diagnostic	ADJ
fnp-5643	407	15	criteria	criterion	NOUN
fnp-5643	407	16	in	in	ADP
fnp-5643	407	17	creutzfeldt	creutzfeldt	ADJ
fnp-5643	407	18	-	-	ADJ
fnp-5643	407	19	jakob	jakob	ADJ
fnp-5643	407	20	disease	disease	NOUN
fnp-5643	407	21	surveillance	surveillance	NOUN
fnp-5643	407	22	.	.	PUNCT
fnp-5643	408	1	neurology	neurology	NOUN
fnp-5643	408	2	,	,	PUNCT
fnp-5643	408	3	2018	2018	NUM
fnp-5643	408	4	.	.	PUNCT
fnp-5643	409	1	91(4	91(4	NUM
fnp-5643	409	2	):	):	PUNCT
fnp-5643	410	1	p.	p.	NOUN
fnp-5643	410	2	e331	e331	PROPN
fnp-5643	410	3	-	-	PUNCT
fnp-5643	410	4	e338	e338	PROPN
fnp-5643	410	5	.	.	PUNCT
fnp-5643	411	1	doi	doi	PROPN
fnp-5643	411	2	:	:	PUNCT
fnp-5643	411	3	https://doi.org/10.1212/wnl.0000000000005860	https://doi.org/10.1212/wnl.0000000000005860	PROPN
fnp-5643	411	4	58	58	NUM
fnp-5643	411	5	.	.	PUNCT
fnp-5643	412	1	zerr	zerr	PROPN
fnp-5643	412	2	,	,	PUNCT
fnp-5643	412	3	i.	i.	PROPN
fnp-5643	412	4	,	,	PUNCT
fnp-5643	412	5	et	et	PROPN
fnp-5643	412	6	al	al	PROPN
fnp-5643	412	7	.	.	PROPN
fnp-5643	412	8	,	,	PUNCT
fnp-5643	412	9	phenotypic	phenotypic	ADJ
fnp-5643	412	10	variability	variability	NOUN
fnp-5643	412	11	in	in	ADP
fnp-5643	412	12	fatal	fatal	ADJ
fnp-5643	412	13	familial	familial	ADJ
fnp-5643	412	14	insomnia	insomnia	NOUN
fnp-5643	412	15	(	(	PUNCT
fnp-5643	412	16	d178n-129	d178n-129	PROPN
fnp-5643	412	17	m	m	PROPN
fnp-5643	412	18	)	)	PUNCT
fnp-5643	412	19	genotype	genotype	NOUN
fnp-5643	412	20	.	.	PUNCT
fnp-5643	412	21	neurology	neurology	NOUN
fnp-5643	412	22	,	,	PUNCT
fnp-5643	412	23	1998	1998	NUM
fnp-5643	412	24	.	.	PUNCT
fnp-5643	413	1	51(5	51(5	NUM
fnp-5643	413	2	):	):	PUNCT
fnp-5643	413	3	p.	p.	NOUN
fnp-5643	413	4	1398	1398	NUM
fnp-5643	413	5	-	-	SYM
fnp-5643	413	6	405	405	NUM
fnp-5643	413	7	.	.	PUNCT
fnp-5643	414	1	doi	doi	NOUN
fnp-5643	414	2	:	:	PUNCT
fnp-5643	414	3	https://doi.org/10.1212/wnl.51.5.1398	https://doi.org/10.1212/wnl.51.5.1398	PROPN
fnp-5643	414	4	59	59	NUM
fnp-5643	414	5	.	.	PUNCT
fnp-5643	415	1	peden	peden	PROPN
fnp-5643	415	2	,	,	PUNCT
fnp-5643	415	3	a.h	a.h	PROPN
fnp-5643	415	4	.	.	PROPN
fnp-5643	415	5	,	,	PUNCT
fnp-5643	415	6	et	et	PROPN
fnp-5643	415	7	al	al	PROPN
fnp-5643	415	8	.	.	PROPN
fnp-5643	415	9	,	,	PUNCT
fnp-5643	415	10	enhanced	enhance	VERB
fnp-5643	415	11	creutzfeldt	creutzfeldt	ADJ
fnp-5643	415	12	-	-	PUNCT
fnp-5643	415	13	jakob	jakob	ADJ
fnp-5643	415	14	disease	disease	NOUN
fnp-5643	415	15	surveillance	surveillance	NOUN
fnp-5643	415	16	in	in	ADP
fnp-5643	415	17	the	the	DET
fnp-5643	415	18	older	old	ADJ
fnp-5643	415	19	population	population	NOUN
fnp-5643	415	20	:	:	PUNCT
fnp-5643	415	21	assessment	assessment	NOUN
fnp-5643	415	22	of	of	ADP
fnp-5643	415	23	a	a	DET
fnp-5643	415	24	protocol	protocol	NOUN
fnp-5643	415	25	for	for	ADP
fnp-5643	415	26	screening	screen	VERB
fnp-5643	415	27	brain	brain	NOUN
fnp-5643	415	28	tissue	tissue	NOUN
fnp-5643	415	29	donations	donation	NOUN
fnp-5643	415	30	for	for	ADP
fnp-5643	415	31	prion	prion	NOUN
fnp-5643	415	32	disease	disease	NOUN
fnp-5643	415	33	.	.	PUNCT
fnp-5643	416	1	brain	brain	NOUN
fnp-5643	416	2	pathol	pathol	NOUN
fnp-5643	416	3	,	,	PUNCT
fnp-5643	416	4	2023	2023	NUM
fnp-5643	416	5	:	:	PUNCT
fnp-5643	417	1	p.	p.	NOUN
fnp-5643	417	2	e13214	e13214	NOUN
fnp-5643	417	3	.	.	PUNCT
fnp-5643	418	1	doi	doi	NOUN
fnp-5643	418	2	:	:	PUNCT
fnp-5643	418	3	https://doi.org/10.1111/bpa.13214	https://doi.org/10.1111/bpa.13214	PROPN
fnp-5643	418	4	60	60	NUM
fnp-5643	418	5	.	.	PUNCT
fnp-5643	419	1	kovacs	kovacs	PROPN
fnp-5643	419	2	,	,	PUNCT
fnp-5643	419	3	g.g	g.g	PROPN
fnp-5643	419	4	.	.	PROPN
fnp-5643	419	5	,	,	PUNCT
fnp-5643	419	6	et	et	PROPN
fnp-5643	419	7	al	al	PROPN
fnp-5643	419	8	.	.	PROPN
fnp-5643	419	9	,	,	PUNCT
fnp-5643	419	10	distribution	distribution	NOUN
fnp-5643	419	11	patterns	pattern	NOUN
fnp-5643	419	12	of	of	ADP
fnp-5643	419	13	tau	tau	PROPN
fnp-5643	419	14	pathology	pathology	NOUN
fnp-5643	419	15	in	in	ADP
fnp-5643	419	16	progressive	progressive	ADJ
fnp-5643	419	17	supranuclear	supranuclear	ADJ
fnp-5643	419	18	palsy	palsy	ADJ
fnp-5643	419	19	.	.	PUNCT
fnp-5643	420	1	acta	acta	PROPN
fnp-5643	420	2	neuropathol	neuropathol	PROPN
fnp-5643	420	3	,	,	PUNCT
fnp-5643	420	4	2020	2020	NUM
fnp-5643	420	5	.	.	PUNCT
fnp-5643	421	1	140(2	140(2	NUM
fnp-5643	421	2	):	):	PUNCT
fnp-5643	422	1	p.	p.	NOUN
fnp-5643	422	2	99	99	NUM
fnp-5643	422	3	-	-	SYM
fnp-5643	422	4	119	119	NUM
fnp-5643	422	5	.	.	PUNCT
fnp-5643	423	1	doi	doi	NOUN
fnp-5643	423	2	:	:	PUNCT
fnp-5643	423	3	https://doi.org/10.1007/s00401-020-02158-2	https://doi.org/10.1007/s00401-020-02158-2	NUM
fnp-5643	423	4	copyright	copyright	NOUN
fnp-5643	423	5	:	:	PUNCT
fnp-5643	423	6	©	©	PROPN
fnp-5643	423	7	2024	2024	NUM
fnp-5643	423	8	the	the	DET
fnp-5643	423	9	author(s	author(s	NOUN
fnp-5643	423	10	)	)	PUNCT
fnp-5643	423	11	.	.	PUNCT
fnp-5643	424	1	this	this	PRON
fnp-5643	424	2	is	be	AUX
fnp-5643	424	3	an	an	DET
fnp-5643	424	4	open	open	ADJ
fnp-5643	424	5	access	access	NOUN
fnp-5643	424	6	article	article	NOUN
fnp-5643	424	7	distributed	distribute	VERB
fnp-5643	424	8	under	under	ADP
fnp-5643	424	9	the	the	DET
fnp-5643	424	10	terms	term	NOUN
fnp-5643	424	11	of	of	ADP
fnp-5643	424	12	the	the	DET
fnp-5643	424	13	creative	creative	ADJ
fnp-5643	424	14	commons	common	NOUN
fnp-5643	424	15	attribution	attribution	NOUN
fnp-5643	424	16	4.0	4.0	NUM
fnp-5643	424	17	international	international	ADJ
fnp-5643	424	18	license	license	NOUN
fnp-5643	424	19	(	(	PUNCT
fnp-5643	424	20	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
fnp-5643	424	21	)	)	PUNCT
fnp-5643	424	22	,	,	PUNCT
fnp-5643	424	23	which	which	PRON
fnp-5643	424	24	permits	permit	VERB
fnp-5643	424	25	unrestricted	unrestricted	ADJ
fnp-5643	424	26	use	use	NOUN
fnp-5643	424	27	,	,	PUNCT
fnp-5643	424	28	distribution	distribution	NOUN
fnp-5643	424	29	,	,	PUNCT
fnp-5643	424	30	and	and	CCONJ
fnp-5643	424	31	reproduction	reproduction	NOUN
fnp-5643	424	32	in	in	ADP
fnp-5643	424	33	any	any	DET
fnp-5643	424	34	medium	medium	NOUN
fnp-5643	424	35	,	,	PUNCT
fnp-5643	424	36	provided	provide	VERB
fnp-5643	424	37	the	the	DET
fnp-5643	424	38	original	original	ADJ
fnp-5643	424	39	author	author	NOUN
fnp-5643	424	40	and	and	CCONJ
fnp-5643	424	41	source	source	NOUN
fnp-5643	424	42	are	be	AUX
fnp-5643	424	43	credited	credit	VERB
fnp-5643	424	44	,	,	PUNCT
fnp-5643	424	45	a	a	DET
fnp-5643	424	46	link	link	NOUN
fnp-5643	424	47	to	to	ADP
fnp-5643	424	48	the	the	DET
fnp-5643	424	49	creative	creative	ADJ
fnp-5643	424	50	commons	common	NOUN
fnp-5643	424	51	license	license	NOUN
fnp-5643	424	52	is	be	AUX
fnp-5643	424	53	provided	provide	VERB
fnp-5643	424	54	,	,	PUNCT
fnp-5643	424	55	and	and	CCONJ
fnp-5643	424	56	any	any	DET
fnp-5643	424	57	changes	change	NOUN
fnp-5643	424	58	are	be	AUX
fnp-5643	424	59	indicated	indicate	VERB
fnp-5643	424	60	.	.	PUNCT
fnp-5643	425	1	the	the	DET
fnp-5643	425	2	creative	creative	ADJ
fnp-5643	425	3	commons	common	NOUN
fnp-5643	425	4	public	public	ADJ
fnp-5643	425	5	domain	domain	NOUN
fnp-5643	425	6	dedication	dedication	NOUN
fnp-5643	425	7	waiver	waiver	NOUN
fnp-5643	425	8	(	(	PUNCT
fnp-5643	425	9	https://creativecommons.org/publicdomain/zero/1.0/	https://creativecommons.org/publicdomain/zero/1.0/	PROPN
fnp-5643	425	10	)	)	PUNCT
fnp-5643	425	11	applies	apply	VERB
fnp-5643	425	12	to	to	ADP
fnp-5643	425	13	the	the	DET
fnp-5643	425	14	data	datum	NOUN
fnp-5643	425	15	made	make	VERB
fnp-5643	425	16	available	available	ADJ
fnp-5643	425	17	in	in	ADP
fnp-5643	425	18	this	this	DET
fnp-5643	425	19	article	article	NOUN
fnp-5643	425	20	,	,	PUNCT
fnp-5643	425	21	unless	unless	SCONJ
fnp-5643	425	22	otherwise	otherwise	ADV
fnp-5643	425	23	stated	state	VERB
fnp-5643	425	24	.	.	PUNCT